1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_1	[p1l52t82r142b106],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_1	[p1l155t81r255b106],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_1	[p1l267t82r318b106],
4	Treat	NNP	ORGANIZATION	Treat	dep	9	SENT_1	[p1l331t82r406b106],
5	(	CD	NUMBER	(	num	6	SENT_1	[p1l419t81r510b112],
6	2013	CD	DATE	2013	dep	4	SENT_1	[p1l419t81r510b112],
7	)	CD	NUMBER	)	dep	9	SENT_1	[p1l419t81r510b112],
8	138:807	CD	NUMBER	138:807	num	9	SENT_1	[p1l528t81r673b106],
9	—	NN	O	—	dep	13	SENT_1	[p1l528t81r673b106],
10	8	CD	NUMBER	8	number	11	SENT_1	[p1l528t81r673b106],
11	16	CD	NUMBER	16	dep	9	SENT_1	[p1l679t81r709b106],
12	DOI	NNP	O	DOI	dep	11	SENT_1	[p1l52t124r114b150],
13	10.1007	CD	NUMBER	10.1007	_	0	SENT_1	[p1l130t124r527b150],
14	/	:	O	/	punct	13	SENT_1	[p1l130t124r527b150],
15	s10549-0l3	NN	O	s10549-0l3	dep	13	SENT_1	[p1l130t124r527b150],
16	—	CD	NUMBER	—	number	17	SENT_1	[p1l130t124r527b150],
17	2504	CD	DATE	2504	num	18	SENT_1	[p1l130t124r527b150],
18	—	NN	O	—	dep	15	SENT_1	[p1l130t124r527b150],
19	3	CD	NUMBER	3	dep	18	SENT_1	[p1l130t124r527b150],

1	Genetic	JJ	O	genetic	amod	2	SENT_2	[p1l54t342r269b390],
2	associations	NNS	O	association	_	0	SENT_2	[p1l294t342r626b389],
3	with	IN	O	with	_	0	SENT_2	[p1l651t342r774b389],
4	toxicity-related	JJ	O	toxicity-related	amod	5	SENT_2	[p1l798t342r1229b402],
5	discontinuation	NN	O	discontinuation	prep_with	2	SENT_2	[p1l1254t342r1690b389],
6	of	IN	O	of	_	0	SENT_2	[p1l53t416r111b463],
7	aromatase	NN	O	aromatase	nn	9	SENT_2	[p1l131t420r423b463],
8	inhibitor	NN	O	inhibitor	nn	9	SENT_2	[p1l448t416r697b463],
9	therapy	NN	O	therapy	prep_of	2	SENT_2	[p1l721t417r940b476],
10	for	IN	O	for	_	0	SENT_2	[p1l964t416r1047b463],
11	breast	NN	O	breast	nn	12	SENT_2	[p1l1071t417r1247b463],
12	cancer	NN	O	cancer	prep_for	9	SENT_2	[p1l1271t431r1457b463],

1	N.	NNP	PERSON	N.	_	0	SENT_3	[p1l52t551r91b581],
2	Lynn	NNP	PERSON	Lynn	nn	3	SENT_3	[p1l107t551r200b589],
3	Henry	NNP	PERSON	Henry	dep	1	SENT_3	[p1l215t551r327b589],
4	-	:	O	-	_	0	SENT_3	[p1l343t562r350b570],
5	Todd	NNP	PERSON	Todd	nn	7	SENT_3	[p1l366t551r458b581],
6	C.	NNP	PERSON	C.	nn	7	SENT_3	[p1l475t551r512b581],
7	Skaar	NNP	PERSON	Skaar	dep	1	SENT_3	[p1l528t551r633b581],
8	-	:	O	-	_	0	SENT_3	[p1l648t562r656b570],
9	Jessica	NNP	PERSON	Jessica	nn	10	SENT_3	[p1l670t551r792b584],
10	Dantzer	NNP	PERSON	Dantzer	dep	7	SENT_3	[p1l807t552r949b581],
11	-	:	O	-	_	0	SENT_3	[p1l964t562r972b570],
12	Lang	NNP	PERSON	Lang	nn	13	SENT_3	[p1l987t551r1078b589],
13	Li	NNP	PERSON	Li	dep	10	SENT_3	[p1l1093t551r1131b580],
14	-	:	O	-	_	0	SENT_3	[p1l1147t562r1154b570],
15	Kelley	NNP	PERSON	Kelley	nn	16	SENT_3	[p1l1170t551r1282b589],
16	Kidwell	NNP	PERSON	Kidwell	dep	1	SENT_3	[p1l1298t551r1435b581],
17	Christina	NNP	PERSON	Christina	nn	18	SENT_3	[p1l1450t562r1458b570, p1l54t603r220b633],
18	Gersch	NNP	PERSON	Gersch	dep	16	SENT_3	[p1l236t603r361b633],
19	-	:	O	-	_	0	SENT_3	[p1l376t614r384b622],
20	Anne	NNP	PERSON	Anne	nn	22	SENT_3	[p1l399t603r492b633],
21	T.	NNP	PERSON	T.	nn	22	SENT_3	[p1l508t603r543b633],
22	Nguyen	NNP	PERSON	Nguyen	dep	16	SENT_3	[p1l559t603r695b641],
23	-	:	O	-	_	0	SENT_3	[p1l709t614r717b622],
24	James	NNP	PERSON	James	nn	26	SENT_3	[p1l731t603r842b636],
25	M.	NNP	PERSON	M.	nn	26	SENT_3	[p1l857t604r905b633],
26	Rae	NNP	PERSON	Rae	dep	22	SENT_3	[p1l921t604r988b633],
27	-	:	O	-	_	0	SENT_3	[p1l1004t614r1012b622],
28	Zeruesenay	NNP	ORGANIZATION	Zeruesenay	nn	29	SENT_3	[p1l1027t603r1231b641],
29	Desta	NNP	ORGANIZATION	Desta	dep	16	SENT_3	[p1l1246t604r1345b633],
30	Stefﬁ	NNP	ORGANIZATION	Stefﬁ	nn	31	SENT_3	[p1l1360t614r1367b622, p1l53t655r144b685],
31	Oesterreich	NNP	ORGANIZATION	Oesterreich	dep	29	SENT_3	[p1l159t655r366b685],
32	-	:	O	-	_	0	SENT_3	[p1l382t666r389b674],
33	Santosh	NNP	ORGANIZATION	Santosh	nn	34	SENT_3	[p1l405t655r543b685],
34	Philips	NNP	ORGANIZATION	Philips	dep	29	SENT_3	[p1l558t655r680b693],
35	-	:	O	-	_	0	SENT_3	[p1l695t666r703b674],
36	Janet	NNP	PERSON	Janet	nn	38	SENT_3	[p1l717t655r814b688],
37	S.	NNP	PERSON	S.	nn	38	SENT_3	[p1l829t655r860b685],
38	Carpenter	NNP	PERSON	Carpenter	dep	34	SENT_3	[p1l877t655r1060b693],
39	-	:	O	-	_	0	SENT_3	[p1l1075t666r1083b674],
40	Anna	NNP	PERSON	Anna	nn	41	SENT_3	[p1l1097t655r1193b685],
41	M.	NNP	PERSON	M.	dep	29	SENT_3	[p1l1208t655r1256b685],
42	Storniolo	NNP	PERSON	Storniolo	nn	44	SENT_3	[p1l1273t655r1435b685],
43	Vered	NNP	PERSON	Vered	nn	44	SENT_3	[p1l1450t666r1458b674, p1l52t707r160b736],
44	Stearns	NNP	PERSON	Stearns	dep	41	SENT_3	[p1l176t706r308b736],
45	-	:	O	-	_	0	SENT_3	[p1l323t717r331b725],
46	Daniel	NNP	PERSON	Daniel	nn	48	SENT_3	[p1l346t706r460b736],
47	F.	NNP	PERSON	F.	nn	48	SENT_3	[p1l475t707r509b736],
48	Hayes	NNP	PERSON	Hayes	dep	41	SENT_3	[p1l525t707r633b744],
49	-	:	O	-	_	0	SENT_3	[p1l648t717r656b725],
50	David	NNP	PERSON	David	nn	52	SENT_3	[p1l670t706r775b736],
51	A.	NNP	PERSON	A.	nn	52	SENT_3	[p1l790t706r829b736],
52	Flockhart	NNP	PERSON	Flockhart	dep	48	SENT_3	[p1l845t707r1020b736],

1	Received	VBN	O	receive	_	0	SENT_4	[p1l52t819r191b844],
2	:	:	O	:	_	0	SENT_4	[p1l52t819r191b844],
3	21	CD	DATE	21	num	4	SENT_4	[p1l207t819r237b843],
4	March	NNP	DATE	March	dobj	1	SENT_4	[p1l253t819r345b844],
5	2013	CD	DATE	2013	num	4	SENT_4	[p1l358t819r444b844],
6	/	:	O	/	punct	7	SENT_4	[p1l358t819r444b844],
7	Accepted	JJ	O	accepted	dep	4	SENT_4	[p1l450t819r590b851],
8	:	:	O	:	_	0	SENT_4	[p1l450t819r590b851],
9	23	CD	DATE	23	dep	7	SENT_4	[p1l606t819r638b844],
10	March	NNP	DATE	March	tmod	9	SENT_4	[p1l652t819r743b844],
11	2013	CD	DATE	2013	num	10	SENT_4	[p1l757t819r842b844],
12	/	:	O	/	punct	7	SENT_4	[p1l757t819r842b844],
13	Published	VBN	O	publish	partmod	4	SENT_4	[p1l849t819r987b844],
14	online	NN	O	online	prep	13	SENT_4	[p1l1000t819r1095b844],
15	:	:	O	:	_	0	SENT_4	[p1l1000t819r1095b844],
16	2	CD	DATE	2	num	17	SENT_4	[p1l1111t819r1127b843],
17	April	NNP	DATE	April	dep	4	SENT_4	[p1l1139t819r1213b851],
18	2013	CD	DATE	2013	num	17	SENT_4	[p1l1226t819r1294b844],
19	©	NNP	O	©	nn	21	SENT_4	[p1l9t871r63b924],
20	Springer	NNP	O	Springer	nn	21	SENT_4	[p1l95t871r356b940],
21	Science	NNP	O	Science	dep	17	SENT_4	[p1l383t871r930b924],
22	+	CC	O	+	_	0	SENT_4	[p1l383t871r930b924],
23	Business	NNP	O	Business	nn	26	SENT_4	[p1l383t871r930b924],
24	Media	NNP	O	Media	nn	26	SENT_4	[p1l959t871r1154b924],
25	New	NNP	LOCATION	New	nn	26	SENT_4	[p1l1180t872r1322b924],
26	York	NNP	LOCATION	York	dep	17	SENT_4	[p1l1350t871r1506b924],
27	2013	CD	DATE	2013	num	26	SENT_4	[p1l1533t871r1679b924],

1	Abstract	JJ	O	abstract	amod	5	SENT_5	[p1l7t1102r340b1166],
2	Up	IN	O	up	quantmod	5	SENT_5	[p1l432t1105r537b1184],
3	to	TO	O	to	dep	5	SENT_5	[p1l585t1113r652b1166],
4	25	CD	PERCENT	25	number	5	SENT_5	[p1l701t1103r783b1166],
5	%	NN	PERCENT	%	nsubj	8	SENT_5	[p1l823t1103r888b1166],
6	of	IN	O	of	_	0	SENT_5	[p1l939t1103r1016b1166],
7	patients	NNS	O	patient	prep_of	5	SENT_5	[p1l1056t1103r1333b1184],
8	discontinue	VBP	O	discontinue	_	0	SENT_5	[p1l1383t1103r1795b1166],
9	adjuvant	JJ	O	adjuvant	amod	15	SENT_5	[p1l1844t1103r2152b1184],
10	aromatase	NN	O	aromatase	nn	15	SENT_5	[p1l9t1224r370b1277],
11	inhibitor	NN	O	inhibitor	nn	15	SENT_5	[p1l407t1214r717b1277],
12	(	NN	O	(	nn	15	SENT_5	[p1l753t1215r900b1292],
13	AI	NN	O	aus	nn	15	SENT_5	[p1l753t1215r900b1292],
14	)	NN	O	)	nn	15	SENT_5	[p1l753t1215r900b1292],
15	therapy	NN	O	therapy	dobj	8	SENT_5	[p1l938t1214r1205b1295],
16	due	JJ	O	due	_	0	SENT_5	[p1l1243t1214r1369b1277],
17	to	TO	O	to	_	0	SENT_5	[p1l1405t1224r1472b1277],
18	intolerable	JJ	O	intolerable	amod	19	SENT_5	[p1l1509t1214r1892b1277],
19	symptoms	NNS	O	symptom	prep_due_to	15	SENT_5	[p1l1932t1234r2148b1295, p1l7t1335r198b1388],
20	.	.	O	.	_	0	SENT_5	[p1l1932t1234r2148b1295, p1l7t1335r198b1388],

1	Predictors	NNS	O	predictor	nsubjpass	15	SENT_6	[p1l227t1325r588b1388],
2	of	IN	O	of	_	0	SENT_6	[p1l616t1325r693b1388],
3	which	WDT	O	which	rel	7	SENT_6	[p1l712t1325r929b1388],
4	patients	NNS	O	patient	nsubj	7	SENT_6	[p1l952t1325r1230b1406],
5	will	MD	O	will	aux	7	SENT_6	[p1l1257t1325r1394b1388],
6	be	VB	O	be	cop	7	SENT_6	[p1l1418t1325r1501b1388],
7	unable	JJ	O	unable	rcmod	1	SENT_6	[p1l1526t1325r1764b1388],
8	to	TO	O	to	aux	9	SENT_6	[p1l1789t1335r1856b1388],
9	tolerate	VB	O	tolerate	xcomp	7	SENT_6	[p1l1881t1325r2150b1388],
10	these	DT	O	these	det	11	SENT_6	[p1l7t1436r189b1499],
11	medications	NNS	O	medication	dobj	9	SENT_6	[p1l218t1436r651b1499],
12	have	VBP	O	have	aux	15	SENT_6	[p1l680t1436r847b1499],
13	not	RB	O	not	neg	15	SENT_6	[p1l877t1446r990b1499],
14	been	VBN	O	be	auxpass	15	SENT_6	[p1l1016t1436r1185b1499],
15	deﬁned	VBN	O	deﬁned	_	0	SENT_6	[p1l1214t1436r1493b1499],
16	.	.	O	.	_	0	SENT_6	[p1l1214t1436r1493b1499],

1	We	PRP	O	we	nsubj	2	SENT_7	[p1l1525t1438r1648b1499],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_7	[p1l1677t1436r2151b1517],
3	that	IN	O	that	complm	10	SENT_7	[p1l7t1547r141b1609],
4	inherited	VBN	O	inherit	amod	5	SENT_7	[p1l161t1547r480b1609],
5	variants	NNS	O	variant	nsubjpass	10	SENT_7	[p1l499t1547r780b1610],
6	in	IN	O	in	_	0	SENT_7	[p1l802t1547r870b1609],
7	candidate	NN	O	candidate	nn	8	SENT_7	[p1l891t1547r1233b1609],
8	genes	NNS	O	gene	prep_in	5	SENT_7	[p1l1255t1566r1454b1628],
9	are	VBP	O	be	auxpass	10	SENT_7	[p1l1479t1566r1584b1609],
10	associated	VBN	O	associate	ccomp	2	SENT_7	[p1l1607t1547r1974b1609],
11	with	IN	O	with	_	0	SENT_7	[p1l1994t1547r2151b1610],
12	treatment	NN	O	treatment	nn	13	SENT_7	[p1l7t1666r348b1719],
13	discontinuation	NN	O	discontinuation	prep_with	10	SENT_7	[p1l368t1657r922b1719],
14	because	IN	O	because	_	0	SENT_7	[p1l942t1657r1224b1719],
15	of	IN	O	of	_	0	SENT_7	[p1l1248t1657r1326b1719],
16	AI	NN	O	aus	nn	17	SENT_7	[p1l1340t1657r1834b1719],
17	—	NN	O	—	prep_because_of	10	SENT_7	[p1l1340t1657r1834b1719],
18	associated	VBN	O	associate	partmod	17	SENT_7	[p1l1340t1657r1834b1719],
19	toxicity	NN	O	toxicity	dobj	18	SENT_7	[p1l1854t1657r2146b1738],
20	.	.	O	.	_	0	SENT_7	[p1l1854t1657r2146b1738],

1	We	PRP	O	we	nsubj	3	SENT_8	[p1l6t1769r129b1830],
2	prospectively	RB	O	prospectively	advmod	3	SENT_8	[p1l166t1768r650b1849],
3	evaluated	VBD	O	evaluate	_	0	SENT_8	[p1l689t1768r1032b1831],
4	reasons	NNS	O	reason	dobj	3	SENT_8	[p1l1068t1787r1333b1830],
5	for	IN	O	for	_	0	SENT_8	[p1l1373t1767r1477b1830],
6	treatment	NN	O	treatment	nn	7	SENT_8	[p1l1512t1777r1852b1830],
7	discontinuation	NN	O	discontinuation	prep_for	4	SENT_8	[p1l1889t1768r2148b1830, p1l7t1880r325b1943],
8	in	IN	O	in	_	0	SENT_8	[p1l359t1880r427b1942],
9	women	NNS	O	woman	prep_in	3	SENT_8	[p1l460t1900r722b1943],
10	with	IN	O	with	_	0	SENT_8	[p1l755t1880r913b1943],
11	hormone	NN	O	hormone	nn	12	SENT_8	[p1l945t1880r1262b1943],
12	receptor	NN	O	receptor	prep_with	9	SENT_8	[p1l1295t1880r1904b1961],
13	—	CD	NUMBER	—	num	16	SENT_8	[p1l1295t1880r1904b1961],
14	positiVe	JJ	O	positive	amod	16	SENT_8	[p1l1295t1880r1904b1961],
15	breast	NN	O	breast	nn	16	SENT_8	[p1l1937t1880r2152b1943],
16	cancer	NN	O	cancer	tmod	3	SENT_8	[p1l8t2011r242b2054],
17	initiating	VBG	O	initiate	partmod	16	SENT_8	[p1l282t1991r606b2072],
18	adjuvant	JJ	O	adjuvant	amod	19	SENT_8	[p1l650t1991r958b2072],
19	AI	NN	O	aus	dobj	17	SENT_8	[p1l998t1992r1090b2053],
20	through	IN	O	through	_	0	SENT_8	[p1l1131t1991r1410b2072],
21	a	DT	O	a	det	28	SENT_8	[p1l1453t2011r1490b2054],
22	multicenter	NN	O	multicenter	nn	28	SENT_8	[p1l1530t1991r1959b2065],
23	,	,	O	,	_	0	SENT_8	[p1l1530t1991r1959b2065],
24	prospective	JJ	O	prospective	amod	28	SENT_8	[p1l2003t2011r2148b2072, p1l10t2102r320b2183],
25	,	,	O	,	_	0	SENT_8	[p1l2003t2011r2148b2072, p1l10t2102r320b2183],
26	randomized	JJ	O	randomized	amod	28	SENT_8	[p1l349t2102r774b2165],
27	clinical	JJ	O	clinical	amod	28	SENT_8	[p1l801t2102r1063b2165],
28	trial	NN	O	trial	prep_through	17	SENT_8	[p1l1090t2102r1233b2165],
29	of	IN	O	of	_	0	SENT_8	[p1l1262t2102r1339b2165],
30	exemestane	NN	O	exemestane	prep_of	28	SENT_8	[p1l1360t2112r1777b2165],
31	versus	CC	O	versus	prep	30	SENT_8	[p1l1805t2122r2030b2165],
32	letrozole	NN	O	letrozole	dep	31	SENT_8	[p1l2058t2102r2148b2165, p1l7t2213r274b2276],
33	.	.	O	.	_	0	SENT_8	[p1l2058t2102r2148b2165, p1l7t2213r274b2276],

1	Using	VBG	O	use	partmod	7	SENT_9	[p1l341t2213r551b2294],
2	multiple	JJ	O	multiple	amod	4	SENT_9	[p1l615t2213r914b2294],
3	genetic	JJ	O	genetic	amod	4	SENT_9	[p1l978t2213r1235b2294],
4	models	NNS	O	model	dobj	1	SENT_9	[p1l1299t2213r1576b2287],
5	,	,	O	,	_	0	SENT_9	[p1l1299t2213r1576b2287],
6	we	PRP	O	we	nsubj	7	SENT_9	[p1l1642t2233r1743b2276],
7	evaluated	VBD	O	evaluate	_	0	SENT_9	[p1l1807t2213r2151b2276],
8	potential	JJ	O	potential	amod	9	SENT_9	[p1l6t2324r321b2405],
9	associations	NNS	O	association	dobj	7	SENT_9	[p1l342t2324r771b2387],
10	between	IN	O	between	_	0	SENT_9	[p1l790t2324r1090b2387],
11	discontinuation	NN	O	discontinuation	prep_between	7	SENT_9	[p1l1109t2324r1662b2387],
12	of	IN	O	of	_	0	SENT_9	[p1l1682t2324r1759b2387],
13	AI	NN	O	aus	nn	14	SENT_9	[p1l1772t2325r1864b2386],
14	therapy	NN	O	therapy	prep_of	11	SENT_9	[p1l1882t2324r2150b2405],
15	because	IN	O	because	_	0	SENT_9	[p1l6t2435r290b2498],
16	of	IN	O	of	prepc_because_of	7	SENT_9	[p1l319t2435r396b2498],
17	toxicity	NN	O	toxicity	pobj	7	SENT_9	[p1l417t2435r691b2516],
18	and	CC	O	and	_	0	SENT_9	[p1l721t2435r847b2498],
19	138	CD	NUMBER	138	num	20	SENT_9	[p1l883t2436r1003b2498],
20	variants	NNS	O	variant	conj_and	17	SENT_9	[p1l1034t2435r1315b2498],
21	in	IN	O	in	_	0	SENT_9	[p1l1345t2435r1412b2497],
22	24	CD	NUMBER	24	num	24	SENT_9	[p1l1441t2436r1526b2497],
23	candidate	NN	O	candidate	nn	24	SENT_9	[p1l1555t2435r1898b2498],
24	genes	NNS	O	gene	prep_in	20	SENT_9	[p1l1927t2455r2148b2516],
25	,	,	O	,	_	0	SENT_9	[p1l1927t2455r2148b2516],

1	Daniel	NNP	PERSON	Daniel	nn	3	SENT_10	[p1l7t2734r209b2787],
2	F.	NNP	PERSON	F.	nn	3	SENT_10	[p1l234t2735r290b2787],
3	Hayes	NNP	PERSON	Hayes	nsubj	8	SENT_10	[p1l319t2735r506b2803],
4	and	CC	O	and	_	0	SENT_10	[p1l535t2734r642b2787],
5	David	NNP	PERSON	David	nn	7	SENT_10	[p1l667t2734r852b2787],
6	A.	NNP	PERSON	A.	nn	7	SENT_10	[p1l877t2734r945b2787],
7	Flockhart	NNP	PERSON	Flockhart	nsubj	8	SENT_10	[p1l974t2734r1266b2787],
8	served	VBD	O	serve	_	0	SENT_10	[p1l1294t2734r1489b2787],
9	as	IN	O	as	_	0	SENT_10	[p1l1516t2751r1575b2787],
10	co-senior	JJ	O	co-senior	amod	11	SENT_10	[p1l1602t2734r1885b2787],
11	authors	NNS	O	author	prep_as	8	SENT_10	[p1l1911t2734r2147b2787],
12	.	.	O	.	_	0	SENT_10	[p1l1911t2734r2147b2787],

1	The	DT	O	the	det	2	SENT_11	[p1l7t2916r124b2969],
2	results	NNS	O	result	nsubjpass	7	SENT_11	[p1l148t2916r345b2969],
3	of	IN	O	of	_	0	SENT_11	[p1l371t2915r437b2969],
4	this	DT	O	this	det	5	SENT_11	[p1l457t2915r564b2969],
5	study	NN	O	study	prep_of	2	SENT_11	[p1l592t2915r752b2984],
6	were	VBD	O	be	auxpass	7	SENT_11	[p1l777t2932r923b2969],
7	presented	VBN	O	present	_	0	SENT_11	[p1l947t2916r1240b2984],
8	in	IN	O	in	_	0	SENT_11	[p1l1264t2915r1322b2968],
9	part	NN	O	part	prep_in	7	SENT_11	[p1l1345t2923r1464b2984],
10	in	IN	O	in	_	0	SENT_11	[p1l1488t2915r1545b2968],
11	a	DT	O	a	det	14	SENT_11	[p1l1571t2932r1603b2969],
12	poster	NN	O	poster	nn	14	SENT_11	[p1l1625t2924r1812b2984],
13	discussion	NN	O	discussion	nn	14	SENT_11	[p1l1836t2915r2151b2969],
14	session	NN	O	session	prep_in	9	SENT_11	[p1l9t3003r225b3057],
15	at	IN	O	at	_	0	SENT_11	[p1l255t3011r307b3057],
16	the	DT	O	the	det	19	SENT_11	[p1l334t3004r425b3057],
17	2012	CD	DATE	2012	num	19	SENT_11	[p1l454t3004r603b3057],
18	American	NNP	ORGANIZATION	American	nn	19	SENT_11	[p1l631t3003r932b3057],
19	Society	NNP	ORGANIZATION	Society	prep_at	7	SENT_11	[p1l961t3003r1186b3072],
20	of	IN	ORGANIZATION	of	_	0	SENT_11	[p1l1215t3003r1280b3057],
21	Clinical	JJ	ORGANIZATION	clinical	amod	22	SENT_11	[p1l1304t3003r1544b3057],
22	Oncology	NNP	ORGANIZATION	Oncology	prep_of	19	SENT_11	[p1l1573t3004r1870b3072],
23	Annual	JJ	ORGANIZATION	annual	amod	19	SENT_11	[p1l1899t3003r2121b3057],
24	Meeting	VBG	ORGANIZATION	meet	partmod	19	SENT_11	[p1l7t3091r276b3160],
25	,	,	O	,	_	0	SENT_11	[p1l7t3091r276b3160],
26	Chicago	NNP	LOCATION	Chicago	appos	19	SENT_11	[p1l308t3091r576b3160],
27	,	,	O	,	_	0	SENT_11	[p1l308t3091r576b3160],
28	IL	NN	LOCATION	il	appos	19	SENT_11	[p1l606t3093r693b3154],
29	,	,	O	,	_	0	SENT_11	[p1l606t3093r693b3154],
30	USA	NNP	LOCATION	USA	nn	32	SENT_11	[p1l723t3092r890b3154],
31	,	,	O	,	_	0	SENT_11	[p1l723t3092r890b3154],
32	June	NNP	DATE	June	appos	28	SENT_11	[p1l919t3093r1057b3145],
33	1-5	CD	DATE	1-5	num	32	SENT_11	[p1l1093t3091r1214b3154],
34	,	,	DATE	,	_	0	SENT_11	[p1l1093t3091r1214b3154],
35	2012	CD	DATE	2012	num	32	SENT_11	[p1l1245t3092r1410b3145],
36	.	.	O	.	_	0	SENT_11	[p1l1245t3092r1410b3145],

1	Electronic	JJ	O	electronic	amod	3	SENT_12	[p1l7t3267r343b3321],
2	supplementary	JJ	O	supplementary	amod	3	SENT_12	[p1l372t3268r860b3336],
3	material	NN	O	material	dep	11	SENT_12	[p1l887t3267r1163b3321],
4	The	DT	O	the	det	6	SENT_12	[p1l1242t3268r1360b3321],
5	online	JJ	O	online	amod	6	SENT_12	[p1l1390t3268r1579b3321],
6	version	NN	O	version	dep	3	SENT_12	[p1l1608t3267r1832b3321],
7	of	IN	O	of	_	0	SENT_12	[p1l1860t3267r1927b3321],
8	this	DT	O	this	det	9	SENT_12	[p1l1949t3268r2057b3321],
9	article	NN	O	article	prep_of	6	SENT_12	[p1l9t3355r198b3409],
10	(	NN	O	(	dep	11	SENT_12	[p1l229t3355r1271b3422],
11	doi	FW	O	doi	dep	16	SENT_12	[p1l229t3355r1271b3422],
12	:10.1007	CD	NUMBER	:10.1007	dep	11	SENT_12	[p1l229t3355r1271b3422],
13	/	:	O	/	punct	16	SENT_12	[p1l229t3355r1271b3422],
14	sl0549	CD	NUMBER	sl0549	num	16	SENT_12	[p1l229t3355r1271b3422],
15	—	CD	NUMBER	—	num	16	SENT_12	[p1l229t3355r1271b3422],
16	0l3	NN	O	0l3	_	0	SENT_12	[p1l229t3355r1271b3422],
17	—	CD	NUMBER	—	num	19	SENT_12	[p1l229t3355r1271b3422],
18	2504	CD	DATE	2504	num	19	SENT_12	[p1l229t3355r1271b3422],
19	—	NN	O	—	nsubj	22	SENT_12	[p1l229t3355r1271b3422],
20	3	CD	NUMBER	3	num	21	SENT_12	[p1l229t3355r1271b3422],
21	)	NN	O	)	dep	19	SENT_12	[p1l229t3355r1271b3422],
22	contains	VBZ	O	contain	rcmod	16	SENT_12	[p1l1301t3355r1554b3409],
23	supplementary	JJ	O	supplementary	amod	24	SENT_12	[p1l1585t3355r2034b3425],
24	material	NN	O	material	dobj	22	SENT_12	[p1l7t3444r275b3508],
25	,	,	O	,	_	0	SENT_12	[p1l7t3444r275b3508],
26	which	WDT	O	which	nsubj	28	SENT_12	[p1l306t3444r492b3498],
27	is	VBZ	O	be	cop	28	SENT_12	[p1l519t3444r567b3498],
28	available	JJ	O	available	rcmod	24	SENT_12	[p1l598t3444r873b3498],
29	to	TO	O	to	_	0	SENT_12	[p1l901t3452r958b3498],
30	authorized	VBN	O	authorize	amod	31	SENT_12	[p1l988t3444r1311b3498],
31	users	NNS	O	user	prep_to	28	SENT_12	[p1l1338t3461r1509b3498],
32	.	.	O	.	_	0	SENT_12	[p1l1338t3461r1509b3498],

1	N.	NNP	PERSON	N.	nn	2	SENT_13	[p2l7t35r75b87],
2	L.	NNP	PERSON	L.	_	0	SENT_13	[p2l106t35r167b87],
3	Henry	NNP	PERSON	Henry	prep	2	SENT_13	[p2l198t35r386b102],
4	(	CD	NUMBER	(	num	5	SENT_13	[p2l417t30r547b99],
5	E	NN	O	e	dep	3	SENT_13	[p2l417t30r547b99],
6	)	SYM	O	)	dep	2	SENT_13	[p2l417t30r547b99],
7	-	:	O	-	_	0	SENT_13	[p2l583t62r591b71],
8	C.	FW	PERSON	c.	dep	2	SENT_13	[p2l624t34r687b87],
9	Gersch	NNP	PERSON	Gersch	dep	8	SENT_13	[p2l720t34r933b87],
10	-	:	O	-	_	0	SENT_13	[p2l966t62r974b71],
11	J.	NNP	PERSON	J.	nn	13	SENT_13	[p2l1006t35r1049b87],
12	M.	NNP	PERSON	M.	nn	13	SENT_13	[p2l1080t35r1161b87],
13	Rae	NNP	PERSON	Rae	dep	8	SENT_13	[p2l1193t35r1309b87],
14	-	:	O	-	_	0	SENT_13	[p2l1343t62r1351b71],
15	D.	NNP	PERSON	D.	nn	20	SENT_13	[p2l1384t35r1451b87],
16	F.	NNP	PERSON	F.	nn	20	SENT_13	[p2l1482t35r1538b87],
17	Hayes	NNP	PERSON	Hayes	nn	20	SENT_13	[p2l1570t35r1757b102],
18	Breast	NN	O	breast	nn	20	SENT_13	[p2l7t123r201b175],
19	Oncology	NNP	O	Oncology	nn	20	SENT_13	[p2l230t122r527b190],
20	Program	NNP	O	Program	dep	13	SENT_13	[p2l555t123r832b190],
21	,	,	O	,	_	0	SENT_13	[p2l555t123r832b190],
22	University	NNP	ORGANIZATION	University	appos	20	SENT_13	[p2l862t122r1183b190],
23	of	IN	ORGANIZATION	of	_	0	SENT_13	[p2l1212t122r1278b175],
24	Michigan	NNP	ORGANIZATION	Michigan	nn	27	SENT_13	[p2l1299t122r1591b191],
25	Comprehensive	NNP	ORGANIZATION	Comprehensive	nn	27	SENT_13	[p2l8t210r484b279],
26	Cancer	NNP	ORGANIZATION	Cancer	nn	27	SENT_13	[p2l508t210r723b263],
27	Center	NNP	ORGANIZATION	Center	prep_of	22	SENT_13	[p2l745t210r962b273],
28	,	,	O	,	_	0	SENT_13	[p2l745t210r962b273],
29	1500	CD	DATE	1500	appos	27	SENT_13	[p2l995t210r1137b263],
30	East	NNP	MISC	East	nn	33	SENT_13	[p2l1160t211r1291b263],
31	Medical	NNP	MISC	Medical	nn	33	SENT_13	[p2l1311t210r1560b263],
32	Center	NNP	MISC	Center	nn	33	SENT_13	[p2l1583t210r1786b263],
33	Drive	NNP	MISC	Drive	dep	29	SENT_13	[p2l1807t210r1995b273],
34	,	,	O	,	_	0	SENT_13	[p2l1807t210r1995b273],
35	Med	NNP	O	Med	nn	38	SENT_13	[p2l7t297r145b351],
36	Inn	NNP	O	Inn	nn	38	SENT_13	[p2l173t299r272b350],
37	Bldg	NNP	O	Bldg	nn	38	SENT_13	[p2l300t298r446b366],
38	C450	NN	O	c450	appos	33	SENT_13	[p2l474t297r653b360],
39	,	,	O	,	_	0	SENT_13	[p2l474t297r653b360],
40	Ann	NNP	PERSON	Ann	nn	41	SENT_13	[p2l684t298r813b350],
41	Arbor	NNP	PERSON	Arbor	appos	33	SENT_13	[p2l840t298r1037b360],
42	,	,	O	,	_	0	SENT_13	[p2l840t298r1037b360],
43	MI	NNP	LOCATION	MI	appos	33	SENT_13	[p2l1067t299r1158b350],
44	48109-5843	CD	NUMBER	48109-5843	num	43	SENT_13	[p2l1185t297r1569b360],
45	,	,	O	,	_	0	SENT_13	[p2l1185t297r1569b360],
46	USA	NNP	LOCATION	USA	appos	33	SENT_13	[p2l1599t298r1749b351],
47	e	SYM	O	e	dep	49	SENT_13	[p2l8t387r217b440],
48	—	CD	NUMBER	—	num	49	SENT_13	[p2l8t387r217b440],
49	mail	NN	O	mail	dep	22	SENT_13	[p2l8t387r217b440],
50	:	:	O	:	_	0	SENT_13	[p2l8t387r217b440],
51	norahh@med.umich.edu	NN	O	norahh@med.umich.edu	dep	2	SENT_13	[p2l250t387r1002b440],

1	T.	NNP	PERSON	T.	_	0	SENT_14	[p2l7t567r67b619],
2	C.	NNP	PERSON	C.	nn	3	SENT_14	[p2l99t566r162b619],
3	Skaar	NNP	PERSON	Skaar	dep	1	SENT_14	[p2l196t566r367b619],
4	-	:	O	-	_	0	SENT_14	[p2l399t594r407b603],
5	J.	NNP	PERSON	J.	nn	6	SENT_14	[p2l439t567r482b619],
6	Dantzer	NNP	PERSON	Dantzer	dep	1	SENT_14	[p2l513t567r755b619],
7	-	:	O	-	_	0	SENT_14	[p2l787t594r796b603],
8	L.	NNP	PERSON	L.	nn	9	SENT_14	[p2l827t567r888b619],
9	Li	NNP	PERSON	Li	dep	6	SENT_14	[p2l919t565r985b618],
10	-	:	O	-	_	0	SENT_14	[p2l1019t594r1027b603],
11	A.	NN	PERSON	a.	dep	1	SENT_14	[p2l1059t566r1127b619],
12	T.	NNP	PERSON	T.	nn	13	SENT_14	[p2l1159t567r1218b619],
13	Nguyen	NNP	PERSON	Nguyen	dep	11	SENT_14	[p2l1250t567r1490b634],
14	-	:	O	-	_	0	SENT_14	[p2l1522t594r1531b603],
15	Z.	NNP	PERSON	Z.	nn	18	SENT_14	[p2l1562t567r1623b619],
16	Desta	NNP	PERSON	Desta	nn	18	SENT_14	[p2l1654t567r1827b619],
17	S.	NNP	PERSON	S.	nn	18	SENT_14	[p2l1860t594r1868b603, p2l9t654r62b707],
18	Philips	NNP	PERSON	Philips	dep	11	SENT_14	[p2l94t653r303b722],
19	-	:	O	-	_	0	SENT_14	[p2l337t682r345b691],
20	D.	NNP	PERSON	D.	nn	23	SENT_14	[p2l377t655r445b706],
21	A.	NNP	PERSON	A.	nn	23	SENT_14	[p2l477t654r545b706],
22	Flockhart	NNP	PERSON	Flockhart	nn	23	SENT_14	[p2l576t653r868b706],
23	Division	NNP	O	Division	dep	18	SENT_14	[p2l7t741r268b795],
24	of	IN	O	of	_	0	SENT_14	[p2l297t741r363b794],
25	Clinical	JJ	O	clinical	amod	26	SENT_14	[p2l385t741r625b795],
26	Pharmacology	NN	O	pharmacology	prep_of	23	SENT_14	[p2l654t741r1109b810],
27	,	,	O	,	_	0	SENT_14	[p2l654t741r1109b810],
28	Department	NNP	ORGANIZATION	Department	appos	26	SENT_14	[p2l1140t743r1501b810],
29	of	IN	ORGANIZATION	of	_	0	SENT_14	[p2l1528t741r1594b794],
30	Medicine	NNP	ORGANIZATION	Medicine	prep_of	28	SENT_14	[p2l1616t741r1920b804],
31	,	,	O	,	_	0	SENT_14	[p2l1616t741r1920b804],
32	Indiana	NNP	ORGANIZATION	Indiana	nn	34	SENT_14	[p2l7t829r235b883],
33	University	NNP	ORGANIZATION	University	nn	34	SENT_14	[p2l262t829r583b898],
34	School	NNP	ORGANIZATION	School	appos	26	SENT_14	[p2l613t829r820b883],
35	of	IN	ORGANIZATION	of	_	0	SENT_14	[p2l849t829r915b883],
36	Medicine	NNP	ORGANIZATION	Medicine	nn	42	SENT_14	[p2l937t829r1241b892],
37	,	,	O	,	_	0	SENT_14	[p2l937t829r1241b892],
38	Indianapolis	NNP	LOCATION	Indianapolis	dep	42	SENT_14	[p2l1271t829r1646b898],
39	IN	IN	O	in	dep	38	SENT_14	[p2l7t920r86b972],
40	46202	CD	NUMBER	46202	pobj	39	SENT_14	[p2l112t919r318b982],
41	,	,	O	,	_	0	SENT_14	[p2l112t919r318b982],
42	USA	NNP	LOCATION	USA	prep_of	34	SENT_14	[p2l348t919r499b972],

1	K.	NNP	ORGANIZATION	K.	nn	3	SENT_15	[p2l8t1098r75b1150],
2	Kidwell	NNP	ORGANIZATION	Kidwell	nn	3	SENT_15	[p2l108t1097r350b1150],
3	Department	NNP	ORGANIZATION	Department	_	0	SENT_15	[p2l7t1186r367b1254],
4	of	IN	ORGANIZATION	of	_	0	SENT_15	[p2l395t1185r461b1238],
5	Biostatistics	NNP	ORGANIZATION	Biostatistics	prep_of	3	SENT_15	[p2l483t1185r871b1248],
6	,	,	ORGANIZATION	,	_	0	SENT_15	[p2l483t1185r871b1248],
7	University	NNP	ORGANIZATION	University	appos	3	SENT_15	[p2l902t1185r1222b1254],
8	of	IN	ORGANIZATION	of	_	0	SENT_15	[p2l1252t1185r1318b1238],
9	Michigan	NNP	ORGANIZATION	Michigan	nn	10	SENT_15	[p2l1339t1185r1631b1254],
10	School	NNP	ORGANIZATION	School	prep_of	7	SENT_15	[p2l1661t1185r1868b1238],
11	of	IN	ORGANIZATION	of	_	0	SENT_15	[p2l8t1274r74b1328],
12	Public	NNP	ORGANIZATION	Public	nn	13	SENT_15	[p2l96t1274r288b1328],
13	Health	NNP	ORGANIZATION	Health	prep_of	10	SENT_15	[p2l317t1274r536b1337],
14	,	,	O	,	_	0	SENT_15	[p2l317t1274r536b1337],
15	Ann	NNP	PERSON	Ann	nn	16	SENT_15	[p2l566t1275r695b1327],
16	Arbor	NNP	PERSON	Arbor	appos	3	SENT_15	[p2l723t1274r919b1337],
17	,	,	O	,	_	0	SENT_15	[p2l723t1274r919b1337],
18	MI	NNP	O	MI	appos	3	SENT_15	[p2l949t1276r1040b1327],
19	48109	CD	NUMBER	48109	num	18	SENT_15	[p2l1067t1275r1273b1337],
20	,	,	O	,	_	0	SENT_15	[p2l1067t1275r1273b1337],
21	USA	NNP	LOCATION	USA	nsubj	22	SENT_15	[p2l1303t1275r1454b1328],
22	selected	VBD	O	select	dep	3	SENT_15	[p2l11t1377r297b1440],
23	a	DT	O	a	det	24	SENT_15	[p2l317t1397r354b1440],
24	priori	FW	O	priori	dobj	22	SENT_15	[p2l369t1377r587b1458],
25	,	,	O	,	_	0	SENT_15	[p2l369t1377r587b1458],
26	primarily	RB	O	primarily	rcmod	24	SENT_15	[p2l608t1377r942b1458],
27	with	IN	O	with	dep	26	SENT_15	[p2l961t1377r1118b1440],
28	roles	NNS	O	role	pobj	27	SENT_15	[p2l1135t1377r1307b1440],
29	in	IN	O	in	_	0	SENT_15	[p2l1327t1377r1394b1439],
30	estrogen	NN	O	estrogen	nn	31	SENT_15	[p2l1413t1387r1715b1458],
31	metabolism	NN	O	metabolism	prep_in	22	SENT_15	[p2l1733t1377r2153b1440],
32	and	CC	O	and	_	0	SENT_15	[p2l10t1488r136b1551],
33	signaling	NN	O	signaling	prep_in	22	SENT_15	[p2l168t1488r510b1569],
34	.	.	O	.	_	0	SENT_15	[p2l168t1488r510b1569],

1	To	TO	O	to	aux	2	SENT_16	[p2l544t1490r640b1551],
2	account	VB	O	account	purpcl	10	SENT_16	[p2l671t1498r949b1551],
3	for	IN	O	for	_	0	SENT_16	[p2l977t1488r1080b1551],
4	multiple	JJ	O	multiple	amod	5	SENT_16	[p2l1107t1488r1406b1569],
5	comparisons	NNS	O	comparison	prep_for	2	SENT_16	[p2l1436t1488r1908b1569],
6	,	,	O	,	_	0	SENT_16	[p2l1436t1488r1908b1569],
7	statistical	JJ	O	statistical	amod	8	SENT_16	[p2l1942t1488r2149b1551, p2l8t1599r161b1662],
8	signiﬁcance	NN	O	signiﬁcance	nsubjpass	10	SENT_16	[p2l200t1599r625b1680],
9	was	VBD	O	be	auxpass	10	SENT_16	[p2l661t1619r796b1662],
10	deﬁned	VBN	O	deﬁned	_	0	SENT_16	[p2l834t1599r1096b1662],
11	as	IN	O	as	_	0	SENT_16	[p2l1132t1619r1201b1662],
12	p	NN	O	p	prep_as	10	SENT_16	[p2l1229t1621r1279b1679],
13	<	JJR	O	<	tmod	10	SENT_16	[p2l1314t1614r1371b1662],
14	0.00036	CD	NUMBER	0.00036	dep	13	SENT_16	[p2l1403t1599r1710b1662],
15	.	.	O	.	_	0	SENT_16	[p2l1403t1599r1710b1662],

1	Of	IN	O	of	ccomp	16	SENT_17	[p2l1751t1599r1847b1662],
2	the	DT	O	the	det	5	SENT_17	[p2l1876t1599r1983b1662],
3	467	CD	NUMBER	467	num	5	SENT_17	[p2l2019t1599r2149b1662],
4	enrolled	VBN	O	enrol	amod	5	SENT_17	[p2l9t1710r303b1773],
5	patients	NNS	O	patient	pobj	1	SENT_17	[p2l326t1710r603b1791],
6	with	IN	O	with	_	0	SENT_17	[p2l630t1710r787b1773],
7	available	JJ	O	available	amod	9	SENT_17	[p2l814t1710r1135b1773],
8	germline	NN	O	germline	nn	9	SENT_17	[p2l1162t1710r1478b1791],
9	DNA	NN	MISC	dna	prep_with	5	SENT_17	[p2l1505t1711r1715b1784],
10	,	,	O	,	_	0	SENT_17	[p2l1505t1711r1715b1784],
11	152	CD	PERCENT	152	number	12	SENT_17	[p2l1752t1710r1874b1773],
12	(	CD	PERCENT	(	nsubj	16	SENT_17	[p2l1903t1711r2013b1787],
13	33	CD	PERCENT	33	num	14	SENT_17	[p2l1903t1711r2013b1787],
14	%	NN	PERCENT	%	dep	12	SENT_17	[p2l2054t1711r2149b1787],
15	)	CD	NUMBER	)	dep	12	SENT_17	[p2l2054t1711r2149b1787],
16	discontinued	VBN	O	discontinue	_	0	SENT_17	[p2l9t1821r467b1883],
17	AI	NN	O	aus	nn	18	SENT_17	[p2l493t1821r585b1883],
18	therapy	NN	O	therapy	dobj	16	SENT_17	[p2l611t1821r878b1902],
19	because	IN	O	because	_	0	SENT_17	[p2l905t1821r1188b1883],
20	of	IN	O	of	prepc_because_of	16	SENT_17	[p2l1216t1821r1293b1883],
21	toxicity	NN	O	toxicity	pobj	16	SENT_17	[p2l1314t1821r1606b1902],
22	.	.	O	.	_	0	SENT_17	[p2l1314t1821r1606b1902],

1	Using	VBG	O	use	_	0	SENT_18	[p2l1637t1821r1847b1902],
2	a	DT	O	a	det	5	SENT_18	[p2l1877t1840r1914b1883],
3	recessive	JJ	O	recessive	amod	5	SENT_18	[p2l1938t1840r2149b1883, p2l11t1932r150b1995],
4	statistical	JJ	O	statistical	amod	5	SENT_18	[p2l231t1932r567b1994],
5	model	NN	O	model	dobj	1	SENT_18	[p2l645t1932r887b2006],
6	,	,	O	,	_	0	SENT_18	[p2l645t1932r887b2006],
7	an	DT	O	a	det	9	SENT_18	[p2l970t1952r1051b1994],
8	intronic	JJ	O	intronic	amod	9	SENT_18	[p2l1127t1932r1405b1994],
9	variant	NN	O	variant	appos	5	SENT_18	[p2l1484t1932r1732b1995],
10	in	IN	O	in	_	0	SENT_18	[p2l1809t1932r1877b1994],
11	ESRI	NNP	ORGANIZATION	ESRI	prep_in	9	SENT_18	[p2l1952t1932r2145b1995],
12	(	CD	NUMBER	(	num	11	SENT_18	[p2l11t2043r442b2121],
13	rs9322336	CD	NUMBER	rs9322336	num	14	SENT_18	[p2l11t2043r442b2121],
14	)	NN	O	)	dep	9	SENT_18	[p2l11t2043r442b2121],
15	was	VBD	O	be	auxpass	16	SENT_18	[p2l479t2063r614b2107],
16	associated	VBN	O	associate	aux	1	SENT_18	[p2l652t2044r1019b2106],
17	with	IN	O	with	_	0	SENT_18	[p2l1053t2044r1211b2107],
18	increased	VBN	O	increase	amod	19	SENT_18	[p2l1244t2044r1583b2106],
19	risk	NN	O	risk	prep_with	16	SENT_18	[p2l1615t2044r1751b2106],
20	of	IN	O	of	_	0	SENT_18	[p2l1784t2044r1861b2106],
21	musculoskeletal	JJ	O	musculoskeletal	amod	23	SENT_18	[p2l1889t2063r2149b2106, p2l8t2156r352b2219],
22	toxicity	NN	O	toxicity	nn	23	SENT_18	[p2l383t2156r934b2237],
23	—	NN	O	—	prep_of	19	SENT_18	[p2l383t2156r934b2237],
24	related	JJ	O	related	amod	26	SENT_18	[p2l383t2156r934b2237],
25	exemestane	NN	O	exemestane	nn	26	SENT_18	[p2l965t2166r1382b2219],
26	discontinuation	NN	O	discontinuation	dep	32	SENT_18	[p2l1415t2156r1969b2219],
27	[	CD	NUMBER	[	dep	26	SENT_18	[p2l2006t2158r2153b2232],
28	HR	NN	DURATION	hr	dep	32	SENT_18	[p2l2006t2158r2153b2232],
29	5.0	CD	PERCENT	5.0	num	28	SENT_18	[p2l10t2266r118b2329],
30	(	CD	PERCENT	(	num	32	SENT_18	[p2l153t2266r264b2343],
31	95	CD	PERCENT	95	num	32	SENT_18	[p2l153t2266r264b2343],
32	%	NN	PERCENT	%	dep	19	SENT_18	[p2l303t2266r368b2329],
33	CI	NN	O	ci	nn	35	SENT_18	[p2l405t2266r491b2329],
34	2.1	CD	NUMBER	2.1	num	35	SENT_18	[p2l525t2266r885b2343],
35	—	NN	O	—	dep	32	SENT_18	[p2l525t2266r885b2343],
36	11.8	CD	NUMBER	11.8	num	37	SENT_18	[p2l525t2266r885b2343],
37	)	NN	O	)	nsubj	1	SENT_18	[p2l525t2266r885b2343],
38	,	,	O	,	_	0	SENT_18	[p2l525t2266r885b2343],
39	p	NN	O	p	dep	40	SENT_18	[p2l912t2287r961b2346],
40	<	JJR	O	<	appos	37	SENT_18	[p2l996t2280r1053b2329],
41	0.0002	CD	NUMBER	0.0002	num	42	SENT_18	[p2l1085t2266r1377b2342],
42	]	NN	O	]	dep	40	SENT_18	[p2l1085t2266r1377b2342],
43	.	.	O	.	_	0	SENT_18	[p2l1085t2266r1377b2342],

1	An	DT	O	a	dep	3	SENT_19	[p2l1413t2267r1520b2328],
2	inherited	VBN	O	inherit	amod	1	SENT_19	[p2l1553t2266r1872b2329],
3	variant	JJ	O	variant	_	0	SENT_19	[p2l1903t2266r2153b2329],
4	potentially	RB	O	potentially	advmod	3	SENT_19	[p2l7t2378r392b2459],
5	affecting	VBG	O	affect	dep	3	SENT_19	[p2l429t2378r745b2459],
6	estrogen	NN	O	estrogen	nn	7	SENT_19	[p2l780t2387r1083b2459],
7	signaling	NN	O	signaling	nsubjpass	10	SENT_19	[p2l1120t2378r1444b2459],
8	may	MD	O	may	aux	10	SENT_19	[p2l1479t2398r1632b2459],
9	be	VB	O	be	auxpass	10	SENT_19	[p2l1665t2378r1748b2441],
10	associated	VBN	O	associate	ccomp	5	SENT_19	[p2l1785t2378r2153b2441],
11	with	IN	O	with	_	0	SENT_19	[p2l9t2489r166b2552],
12	exemestane	NN	O	exemestane	nn	13	SENT_19	[p2l197t2489r1017b2552],
13	—	NN	O	—	prep_with	3	SENT_19	[p2l197t2489r1017b2552],
14	associated	VBN	O	associate	partmod	13	SENT_19	[p2l197t2489r1017b2552],
15	toxicity	NN	O	toxicity	dobj	14	SENT_19	[p2l1048t2489r1341b2570],
16	,	,	O	,	_	0	SENT_19	[p2l1048t2489r1341b2570],
17	which	WDT	O	which	nsubj	20	SENT_19	[p2l1375t2489r1593b2552],
18	could	MD	O	could	aux	20	SENT_19	[p2l1625t2489r1822b2552],
19	partially	RB	O	partially	advmod	20	SENT_19	[p2l1851t2489r2151b2570],
20	account	VB	O	account	rcmod	15	SENT_19	[p2l10t2610r288b2663],
21	for	IN	O	for	_	0	SENT_19	[p2l314t2600r418b2663],
22	intra	FW	O	intra	nn	23	SENT_19	[p2l444t2600r884b2681],
23	—	FW	O	—	amod	25	SENT_19	[p2l444t2600r884b2681],
24	patient	NN	O	patient	nn	25	SENT_19	[p2l444t2600r884b2681],
25	differences	NNS	O	difference	prep_for	20	SENT_19	[p2l911t2600r1306b2663],
26	in	IN	O	in	_	0	SENT_19	[p2l1336t2600r1404b2662],
27	AI	NN	O	aus	nn	28	SENT_19	[p2l1431t2601r1523b2662],
28	tolerability	NN	O	tolerability	prep_in	25	SENT_19	[p2l1550t2600r1963b2681],
29	.	.	O	.	_	0	SENT_19	[p2l1550t2600r1963b2681],

1	Validation	NN	O	validation	nsubjpass	6	SENT_20	[p2l1994t2600r2149b2663, p2l8t2711r257b2774],
2	of	IN	O	of	_	0	SENT_20	[p2l283t2711r360b2774],
3	this	DT	O	this	det	4	SENT_20	[p2l379t2711r505b2774],
4	ﬁnding	NN	O	ﬁnding	prep_of	1	SENT_20	[p2l534t2711r783b2792],
5	is	VBZ	O	be	auxpass	6	SENT_20	[p2l809t2711r865b2774],
6	required	VBN	O	require	_	0	SENT_20	[p2l891t2711r1208b2792],
7	.	.	O	.	_	0	SENT_20	[p2l891t2711r1208b2792],

1	Keywords	NNPS	O	Keywords	_	0	SENT_21	[p2l9t2935r395b3014],
2	Breast	NN	O	breast	nn	3	SENT_21	[p2l488t2936r717b2997],
3	cancer	NN	O	cancer	dep	1	SENT_21	[p2l749t2954r983b2997],
4	-	:	O	-	_	0	SENT_21	[p2l1021t2968r1031b2978],
5	Aromatase	NN	O	aromatase	nn	6	SENT_21	[p2l1069t2935r1457b2997],
6	inhibitor	NN	O	inhibitor	dep	1	SENT_21	[p2l1490t2935r1800b2997],
7	-	:	O	-	_	0	SENT_21	[p2l1837t2968r1847b2978],
8	Singlenucleotide	NN	O	singlenucleotide	dep	6	SENT_21	[p2l1888t2935r2140b3016, p2l8t3046r381b3108],
9	polymorphism	NN	O	polymorphism	dep	8	SENT_21	[p2l414t3046r939b3127],
10	-	:	O	-	_	0	SENT_21	[p2l977t3079r987b3089],
11	Treatment	NN	O	treatment	nn	13	SENT_21	[p2l1025t3047r1395b3108],
12	discontinuation	NN	O	discontinuation	nn	13	SENT_21	[p2l1428t3046r1981b3108],
13	Toxicity	NN	O	toxicity	dep	6	SENT_21	[p2l2020t3079r2030b3089, p2l8t3157r311b3238],

1	Introduction	NN	O	introduction	_	0	SENT_22	[p2l8t3371r495b3434],

1	The	DT	O	the	det	6	SENT_23	[p2l8t3596r145b3658],
2	third	JJ	ORDINAL	third	amod	6	SENT_23	[p2l190t3596r769b3677],
3	—	NN	O	—	nn	6	SENT_23	[p2l190t3596r769b3677],
4	generation	NN	O	generation	nn	6	SENT_23	[p2l190t3596r769b3677],
5	aromatase	NN	O	aromatase	nn	6	SENT_23	[p2l814t3605r1175b3658],
6	inhibitors	NNS	O	inhibitor	nsubj	7	SENT_23	[p2l1219t3596r1561b3658],
7	(	VBP	O	(	_	0	SENT_23	[p2l1609t3596r1777b3673],
8	AI	NN	O	aus	nn	9	SENT_23	[p2l1609t3596r1777b3673],
9	)	NN	O	)	dobj	7	SENT_23	[p2l1609t3596r1777b3673],
10	,	,	O	,	_	0	SENT_23	[p2l1609t3596r1777b3673],
11	anastroz	NN	O	anastroz	nn	13	SENT_23	[p2l1826t3605r2149b3658],
12	—	NN	O	—	nn	13	SENT_23	[p2l1826t3605r2149b3658],
13	ole	NN	O	ole	dobj	7	SENT_23	[p2l9t3707r135b3781],
14	,	,	O	,	_	0	SENT_23	[p2l9t3707r135b3781],
15	exemestane	NN	O	exemestane	dobj	7	SENT_23	[p2l194t3717r631b3781],
16	,	,	O	,	_	0	SENT_23	[p2l194t3717r631b3781],
17	and	CC	O	and	_	0	SENT_23	[p2l691t3707r817b3770],
18	letrozole	NN	O	letrozole	conj_and	9	SENT_23	[p2l872t3707r1205b3781],
19	,	,	O	,	_	0	SENT_23	[p2l872t3707r1205b3781],
20	decrease	NN	O	decrease	nn	21	SENT_23	[p2l1263t3707r1570b3770],
21	risk	NN	O	risk	appos	18	SENT_23	[p2l1625t3707r1760b3770],
22	of	IN	O	of	_	0	SENT_23	[p2l1813t3707r1890b3770],
23	breast	NN	O	breast	prep_of	21	SENT_23	[p2l1938t3707r2153b3770],

1	S.	NNP	MISC	S.	nn	2	SENT_24	[p3l10t130r63b183],
2	Oesterreich	NNP	MISC	Oesterreich	_	0	SENT_24	[p3l96t129r445b183],
3	Women	NNP	MISC	Women	poss	7	SENT_24	[p3l7t218r302b271],
4	’s	POS	O	’s	_	0	SENT_24	[p3l7t218r302b271],
5	Cancer	NNP	O	Cancer	nn	7	SENT_24	[p3l332t218r547b271],
6	Research	NNP	O	Research	nn	7	SENT_24	[p3l573t218r852b271],
7	Center	NNP	O	Center	dep	2	SENT_24	[p3l881t218r1098b280],
8	,	,	O	,	_	0	SENT_24	[p3l881t218r1098b280],
9	University	NNP	ORGANIZATION	University	dep	13	SENT_24	[p3l1129t217r1449b286],
10	of	IN	ORGANIZATION	of	_	0	SENT_24	[p3l1478t217r1543b271],
11	Pittsburgh	NNP	ORGANIZATION	Pittsburgh	prep_of	9	SENT_24	[p3l1566t217r1878b286],
12	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_24	[p3l9t306r224b359],
13	Institute	NNP	ORGANIZATION	Institute	appos	7	SENT_24	[p3l251t306r516b369],
14	,	,	O	,	_	0	SENT_24	[p3l251t306r516b369],
15	Pittsburgh	NNP	LOCATION	Pittsburgh	appos	7	SENT_24	[p3l547t306r875b374],
16	,	,	O	,	_	0	SENT_24	[p3l547t306r875b374],
17	PA	NN	O	pa	appos	15	SENT_24	[p3l905t306r1000b358],
18	15213	CD	NUMBER	15213	num	17	SENT_24	[p3l1035t306r1233b369],
19	,	,	O	,	_	0	SENT_24	[p3l1035t306r1233b369],
20	USA	NNP	LOCATION	USA	dep	2	SENT_24	[p3l1263t306r1413b359],

1	J.	NNP	ORGANIZATION	J.	nn	6	SENT_25	[p3l8t485r50b537],
2	S.	NNP	ORGANIZATION	S.	nn	6	SENT_25	[p3l84t484r137b537],
3	Carpenter	NNP	ORGANIZATION	Carpenter	nn	6	SENT_25	[p3l169t484r470b553],
4	Indiana	NNP	ORGANIZATION	Indiana	nn	6	SENT_25	[p3l8t573r237b626],
5	University	NNP	ORGANIZATION	University	nn	6	SENT_25	[p3l263t573r584b642],
6	School	NNP	ORGANIZATION	School	_	0	SENT_25	[p3l614t573r821b626],
7	of	IN	ORGANIZATION	of	_	0	SENT_25	[p3l850t573r916b626],
8	Nursing	NNP	ORGANIZATION	Nursing	nn	10	SENT_25	[p3l938t573r1198b642],
9	,	,	O	,	_	0	SENT_25	[p3l938t573r1198b642],
10	Indianapolis	NNP	LOCATION	Indianapolis	prep_of	6	SENT_25	[p3l1229t573r1621b642],
11	,	,	O	,	_	0	SENT_25	[p3l1229t573r1621b642],
12	IN	IN	O	in	_	0	SENT_25	[p3l1652t574r1731b626],
13	46202	CD	NUMBER	46202	prep_in	6	SENT_25	[p3l1757t573r1963b636],
14	,	,	O	,	_	0	SENT_25	[p3l1757t573r1963b636],
15	USA	NNP	LOCATION	USA	appos	13	SENT_25	[p3l8t663r158b716],

1	A.	NN	O	a.	_	0	SENT_26	[p3l8t841r76b894],
2	M.	NNP	O	M.	nn	6	SENT_26	[p3l107t842r188b894],
3	Storniolo	NNP	O	Storniolo	nn	6	SENT_26	[p3l221t841r501b894],
4	Indiana	NNP	ORGANIZATION	Indiana	nn	6	SENT_26	[p3l8t929r236b982],
5	University	NNP	ORGANIZATION	University	nn	6	SENT_26	[p3l263t929r584b997],
6	Melvin	NNP	ORGANIZATION	Melvin	dep	1	SENT_26	[p3l611t929r831b982],
7	and	CC	O	and	_	0	SENT_26	[p3l860t929r967b982],
8	Bren	NNP	ORGANIZATION	Bren	nn	11	SENT_26	[p3l994t930r1141b982],
9	Simon	NNP	ORGANIZATION	Simon	nn	11	SENT_26	[p3l1170t929r1366b982],
10	Cancer	NNP	ORGANIZATION	Cancer	nn	11	SENT_26	[p3l1394t929r1610b982],
11	Center	NNP	ORGANIZATION	Center	dep	1	SENT_26	[p3l1637t929r1854b992],
12	,	,	O	,	_	0	SENT_26	[p3l1637t929r1854b992],
13	Indianapolis	NNP	LOCATION	Indianapolis	nn	18	SENT_26	[p3l8t1017r401b1086],
14	,	,	O	,	_	0	SENT_26	[p3l8t1017r401b1086],
15	IN	IN	O	in	dep	18	SENT_26	[p3l431t1018r510b1070],
16	46202	CD	NUMBER	46202	pobj	15	SENT_26	[p3l537t1017r742b1080],
17	,	,	O	,	_	0	SENT_26	[p3l537t1017r742b1080],
18	USA	NNP	LOCATION	USA	appos	6	SENT_26	[p3l772t1017r922b1070],

1	V.	NNP	O	V.	nn	4	SENT_27	[p3l8t1197r76b1249],
2	Stearns	NNP	O	Stearns	nn	4	SENT_27	[p3l110t1196r329b1249],
3	Breast	NN	O	breast	nn	4	SENT_27	[p3l8t1285r202b1337],
4	Cancer	NN	O	cancer	_	0	SENT_27	[p3l227t1284r443b1337],
5	Program	NN	O	program	dep	4	SENT_27	[p3l466t1285r744b1352],
6	,	,	O	,	_	0	SENT_27	[p3l466t1285r744b1352],
7	Sidney	NNP	PERSON	Sidney	nn	11	SENT_27	[p3l774t1283r981b1352],
8	Kimmel	NNP	PERSON	Kimmel	nn	11	SENT_27	[p3l1008t1283r1255b1337],
9	Comprehensive	NNP	O	Comprehensive	nn	11	SENT_27	[p3l1282t1283r1758b1352],
10	Cancer	NNP	O	Cancer	nn	11	SENT_27	[p3l1785t1284r2000b1337],
11	Center	NNP	O	Center	appos	5	SENT_27	[p3l9t1373r227b1436],
12	,	,	O	,	_	0	SENT_27	[p3l9t1373r227b1436],
13	Johns	NNP	ORGANIZATION	Johns	nn	15	SENT_27	[p3l257t1373r427b1426],
14	Hopkins	NNP	ORGANIZATION	Hopkins	nn	15	SENT_27	[p3l456t1373r710b1441],
15	University	NNP	ORGANIZATION	University	appos	5	SENT_27	[p3l740t1373r1077b1441],
16	,	,	O	,	_	0	SENT_27	[p3l740t1373r1077b1441],
17	Baltimore	NNP	LOCATION	Baltimore	appos	5	SENT_27	[p3l1107t1373r1428b1436],
18	,	,	O	,	_	0	SENT_27	[p3l1107t1373r1428b1436],
19	MD	NNP	O	MD	appos	5	SENT_27	[p3l1458t1374r1578b1425],
20	21231	CD	NUMBER	21231	num	19	SENT_27	[p3l1608t1373r1811b1436],
21	,	,	O	,	_	0	SENT_27	[p3l1608t1373r1811b1436],
22	USA	NNP	LOCATION	USA	appos	5	SENT_27	[p3l1842t1373r1992b1426],

1	@	IN	O	@	_	0	SENT_28	[p3l1783t1603r1860b1698],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_28	[p3l1890t1626r2153b1701],

1	808	CD	NUMBER	808	num	3	SENT_29	[p3l54t1776r103b1801],
2	Breast	NN	O	breast	nn	3	SENT_29	[p3l1450t1776r1540b1801],
3	Cancer	NN	O	cancer	_	0	SENT_29	[p3l1552t1776r1652b1801],
4	Res	NNP	O	Res	nn	5	SENT_29	[p3l1664t1776r1716b1801],
5	Treat	NNP	O	Treat	dep	3	SENT_29	[p3l1729t1776r1804b1801],
6	(	CD	NUMBER	(	num	7	SENT_29	[p3l1817t1776r1908b1806],
7	2013	CD	DATE	2013	dep	5	SENT_29	[p3l1817t1776r1908b1806],
8	)	CD	NUMBER	)	number	9	SENT_29	[p3l1817t1776r1908b1806],
9	138:807	CD	NUMBER	138:807	num	10	SENT_29	[p3l1925t1776r2107b1801],
10	—	NN	O	—	dep	7	SENT_29	[p3l1925t1776r2107b1801],
11	816	CD	NUMBER	816	dep	3	SENT_29	[p3l1925t1776r2107b1801],

1	cancer	NN	O	cancer	nn	2	SENT_30	[p3l8t1964r242b2007],
2	recurrence	NN	O	recurrence	_	0	SENT_30	[p3l289t1964r668b2007],
3	compared	VBN	O	compare	_	0	SENT_30	[p3l719t1944r1072b2025],
4	to	TO	O	to	prepc_compared_to	2	SENT_30	[p3l1121t1954r1188b2007],
5	tamoxifen	NN	O	tamoxifen	pobj	2	SENT_30	[p3l1239t1944r1603b2007],
6	in	IN	O	in	_	0	SENT_30	[p3l1653t1944r1720b2006],
7	postmenopausal	JJ	O	postmenopausal	amod	8	SENT_30	[p3l1769t1954r2145b2025, p3l6t2055r234b2136],
8	women	NNS	O	woman	prep_in	5	SENT_30	[p3l264t2075r526b2118],
9	with	IN	O	with	_	0	SENT_30	[p3l555t2055r712b2118],
10	hormone	NN	O	hormone	nn	11	SENT_30	[p3l740t2055r1057b2118],
11	receptor	NN	O	receptor	prep_with	8	SENT_30	[p3l1086t2065r1382b2136],
12	(	CD	NUMBER	(	num	14	SENT_30	[p3l1412t2055r1906b2136],
13	HR	NN	DURATION	hr	nn	14	SENT_30	[p3l1412t2055r1906b2136],
14	)	NN	O	)	dep	11	SENT_30	[p3l1412t2055r1906b2136],
15	.	.	O	.	_	0	SENT_30	[p3l1412t2055r1906b2136],

1	—	NN	O	—	_	0	SENT_31	[p3l1412t2055r1906b2136],
2	.	.	O	.	_	0	SENT_31	[p3l1412t2055r1906b2136],

1	positive	JJ	O	positive	amod	4	SENT_32	[p3l1412t2055r1906b2136],
2	breast	NN	O	breast	nn	4	SENT_32	[p3l1934t2055r2149b2118],
3	cancer	NN	O	cancer	nn	4	SENT_32	[p3l8t2185r242b2228],
4	[	NN	O	[	_	0	SENT_32	[p3l282t2167r395b2242],
5	7	CD	NUMBER	7	num	6	SENT_32	[p3l282t2167r395b2242],
6	]	NN	O	]	dep	4	SENT_32	[p3l282t2167r395b2242],
7	.	.	O	.	_	0	SENT_32	[p3l282t2167r395b2242],

1	Extended	VBN	O	extend	_	0	SENT_33	[p3l435t2166r774b2228],
2	adjuvant	JJ	O	adjuvant	amod	4	SENT_33	[p3l810t2166r1117b2247],
3	AI	NN	O	aus	nn	4	SENT_33	[p3l1151t2166r1243b2228],
4	therapy	NN	O	therapy	dobj	1	SENT_33	[p3l1277t2166r1544b2247],
5	after	IN	O	after	_	0	SENT_33	[p3l1583t2166r1745b2228],
6	5	CD	DURATION	5	num	7	SENT_33	[p3l1780t2166r1817b2229],
7	years	NNS	NUMBER	year	prep_after	1	SENT_33	[p3l1853t2185r2039b2247],
8	of	IN	O	of	_	0	SENT_33	[p3l2076t2166r2153b2228],
9	tamoxifen	NN	O	tamoxifen	prep_of	7	SENT_33	[p3l7t2277r371b2339],
10	further	RB	O	further	advmod	11	SENT_33	[p3l409t2277r652b2339],
11	decreases	VBZ	O	decrease	dep	1	SENT_33	[p3l689t2277r1028b2339],
12	recurrence	NN	O	recurrence	nn	13	SENT_33	[p3l1067t2296r1446b2339],
13	rates	NNS	O	rate	dobj	11	SENT_33	[p3l1483t2286r1650b2339],
14	compared	VBN	O	compare	_	0	SENT_33	[p3l1690t2277r2043b2358],
15	to	TO	O	to	prepc_compared_to	11	SENT_33	[p3l2080t2286r2146b2339],
16	placebo	NN	O	placebo	pobj	11	SENT_33	[p3l6t2387r284b2468],
17	[	NN	O	[	nsubj	1	SENT_33	[p3l328t2387r441b2462],
18	8	CD	NUMBER	8	num	19	SENT_33	[p3l328t2387r441b2462],
19	]	NN	O	]	dep	17	SENT_33	[p3l328t2387r441b2462],
20	.	.	O	.	_	0	SENT_33	[p3l328t2387r441b2462],

1	In	IN	O	in	_	0	SENT_34	[p3l482t2388r554b2448],
2	addition	NN	O	addition	_	0	SENT_34	[p3l592t2387r883b2449],
3	to	TO	O	to	_	0	SENT_34	[p3l919t2396r986b2449],
4	the	DT	O	the	det	6	SENT_34	[p3l1022t2387r1129b2449],
5	selective	JJ	O	selective	amod	6	SENT_34	[p3l1169t2387r1478b2449],
6	estrogen	NN	O	estrogen	prep_in_addition_to	9	SENT_34	[p3l1517t2396r1819b2468],
7	receptor	NN	O	receptor	nn	8	SENT_34	[p3l1854t2396r2149b2468],
8	modulators	NNS	O	modulator	nsubj	9	SENT_34	[p3l7t2499r408b2562],
9	(	VBP	O	(	dep	16	SENT_34	[p3l463t2500r781b2576],
10	SERM	NNP	ORGANIZATION	SERM	dobj	9	SENT_34	[p3l463t2500r781b2576],
11	)	CD	NUMBER	)	num	10	SENT_34	[p3l463t2500r781b2576],
12	,	,	O	,	_	0	SENT_34	[p3l463t2500r781b2576],
13	exemestane	NN	O	exemestane	appos	10	SENT_34	[p3l835t2509r1251b2562],
14	has	VBZ	O	have	aux	16	SENT_34	[p3l1303t2499r1419b2562],
15	been	VBN	O	be	auxpass	16	SENT_34	[p3l1470t2499r1639b2562],
16	found	VBN	O	find	_	0	SENT_34	[p3l1690t2499r1897b2562],
17	to	TO	O	to	aux	19	SENT_34	[p3l1947t2509r2014b2562],
18	be	VB	O	be	cop	19	SENT_34	[p3l2064t2499r2147b2562],
19	superior	JJ	O	superior	xcomp	16	SENT_34	[p3l10t2611r300b2692],
20	to	TO	O	to	_	0	SENT_34	[p3l353t2621r420b2674],
21	placebo	NN	O	placebo	prep_to	19	SENT_34	[p3l474t2611r751b2692],
22	for	IN	O	for	_	0	SENT_34	[p3l807t2611r911b2674],
23	prevention	NN	O	prevention	prep_for	21	SENT_34	[p3l962t2611r1346b2692],
24	of	IN	O	of	_	0	SENT_34	[p3l1401t2611r1478b2674],
25	breast	NN	O	breast	nn	26	SENT_34	[p3l1525t2611r1740b2674],
26	cancer	NN	O	cancer	prep_of	23	SENT_34	[p3l1794t2631r2027b2674],
27	in	IN	O	in	_	0	SENT_34	[p3l2080t2611r2148b2673],
28	postmenopausal	JJ	O	postmenopausal	amod	29	SENT_34	[p3l6t2722r584b2803],
29	women	NNS	O	woman	prep_in	26	SENT_34	[p3l630t2742r892b2785],
30	at	IN	O	at	_	0	SENT_34	[p3l938t2731r1001b2785],
31	increased	VBN	O	increase	amod	32	SENT_34	[p3l1044t2722r1383b2785],
32	risk	NN	O	risk	prep_at	19	SENT_34	[p3l1426t2722r1560b2785],
33	of	IN	O	of	_	0	SENT_34	[p3l1605t2722r1682b2785],
34	disease	NN	O	disease	prep_of	32	SENT_34	[p3l1722t2722r1977b2785],
35	[	CD	NUMBER	[	num	34	SENT_34	[p3l2030t2723r2143b2798],
36	9	CD	NUMBER	9	num	37	SENT_34	[p3l2030t2723r2143b2798],
37	]	NN	O	]	nsubjpass	16	SENT_34	[p3l2030t2723r2143b2798],
38	.	.	O	.	_	0	SENT_34	[p3l2030t2723r2143b2798],

1	Since	IN	O	since	mark	3	SENT_35	[p3l10t2833r204b2896],
2	there	EX	O	there	expl	3	SENT_35	[p3l233t2833r410b2896],
3	are	VBP	O	be	advcl	24	SENT_35	[p3l440t2853r545b2896],
4	now	RB	DATE	now	advmod	3	SENT_35	[p3l574t2853r725b2896],
5	multiple	JJ	O	multiple	amod	8	SENT_35	[p3l753t2833r1051b2914],
6	endocrine	NN	O	endocrine	nn	8	SENT_35	[p3l1080t2833r1432b2896],
7	therapy	NN	O	therapy	nn	8	SENT_35	[p3l1460t2834r1727b2914],
8	options	NNS	O	option	nsubj	3	SENT_35	[p3l1756t2833r2016b2914],
9	for	IN	O	for	_	0	SENT_35	[p3l2046t2833r2150b2896],
10	treatment	NN	O	treatment	prep_for	8	SENT_35	[p3l7t2954r347b3007],
11	and	CC	O	and	_	0	SENT_35	[p3l395t2944r521b3007],
12	prevention	NN	O	prevention	prep_for	8	SENT_35	[p3l566t2944r950b3025],
13	of	IN	O	of	_	0	SENT_35	[p3l998t2944r1075b3007],
14	breast	NN	O	breast	nn	15	SENT_35	[p3l1115t2944r1330b3007],
15	cancer	NN	O	cancer	prep_of	8	SENT_35	[p3l1376t2964r1611b3007],
16	in	IN	O	in	_	0	SENT_35	[p3l1656t2944r1723b3006],
17	postmenopausal	JJ	O	postmenopausal	amod	18	SENT_35	[p3l1769t2954r2145b3025, p3l6t3055r234b3136],
18	women	NNS	O	woman	prep_in	15	SENT_35	[p3l285t3074r566b3129],
19	,	,	O	,	_	0	SENT_35	[p3l285t3074r566b3129],
20	physicians	NNS	O	physician	nsubj	24	SENT_35	[p3l618t3055r994b3136],
21	and	CC	O	and	_	0	SENT_35	[p3l1048t3055r1174b3117],
22	patients	NNS	O	patient	nsubj	24	SENT_35	[p3l1222t3055r1499b3136],
23	must	MD	O	must	aux	24	SENT_35	[p3l1551t3064r1725b3117],
24	weigh	VB	O	weigh	_	0	SENT_35	[p3l1773t3055r1990b3136],
25	the	DT	O	the	det	26	SENT_35	[p3l2040t3055r2147b3117],
26	risks	NNS	O	risk	dobj	24	SENT_35	[p3l6t3166r172b3228],
27	and	CC	O	and	_	0	SENT_35	[p3l207t3166r333b3228],
28	beneﬁts	NNS	O	beneﬁts	dobj	24	SENT_35	[p3l362t3166r638b3228],
29	of	IN	O	of	_	0	SENT_35	[p3l673t3166r750b3228],
30	each	DT	O	each	det	32	SENT_35	[p3l775t3166r938b3228],
31	therapeutic	JJ	O	therapeutic	amod	32	SENT_35	[p3l968t3166r1365b3247],
32	option	NN	O	option	prep_of	26	SENT_35	[p3l1399t3166r1626b3247],
33	when	WRB	O	when	advmod	34	SENT_35	[p3l1657t3166r1849b3228],
34	making	VBG	O	make	advcl	24	SENT_35	[p3l1880t3166r2146b3247],
35	decisions	NNS	O	decision	dobj	34	SENT_35	[p3l8t3277r338b3339],
36	about	IN	O	about	_	0	SENT_35	[p3l374t3277r571b3339],
37	choice	NN	O	choice	prep_about	34	SENT_35	[p3l603t3277r835b3339],
38	of	IN	O	of	_	0	SENT_35	[p3l869t3277r946b3339],
39	therapy	NN	O	therapy	prep_of	37	SENT_35	[p3l973t3277r1258b3358],
40	.	.	O	.	_	0	SENT_35	[p3l973t3277r1258b3358],

1	Aromatase	NN	O	aromatase	nn	2	SENT_36	[p3l109t3389r496b3451],
2	inhibitors	NNS	O	inhibitor	nsubj	3	SENT_36	[p3l536t3388r878b3451],
3	have	VBP	O	have	_	0	SENT_36	[p3l918t3388r1085b3451],
4	a	DT	O	a	det	7	SENT_36	[p3l1128t3408r1165b3451],
5	different	JJ	O	different	amod	7	SENT_36	[p3l1204t3388r1513b3451],
6	risk	NN	O	risk	nn	7	SENT_36	[p3l1550t3388r1685b3451],
7	proﬁle	NN	O	proﬁle	dobj	3	SENT_36	[p3l1722t3388r1954b3469],
8	than	IN	O	than	_	0	SENT_36	[p3l1995t3388r2148b3451],
9	SERMS	NNS	O	serm	prep_than	3	SENT_36	[p3l10t3500r302b3562],
10	.	.	O	.	_	0	SENT_36	[p3l10t3500r302b3562],

1	In	IN	O	in	_	0	SENT_37	[p3l336t3501r409b3561],
2	addition	NN	O	addition	_	0	SENT_37	[p3l441t3499r732b3562],
3	to	TO	O	to	_	0	SENT_37	[p3l762t3509r829b3562],
4	the	DT	O	the	det	6	SENT_37	[p3l860t3499r967b3562],
5	increased	VBN	O	increase	amod	6	SENT_37	[p3l998t3499r1338b3562],
6	risk	NN	O	risk	prep_in_addition_to	17	SENT_37	[p3l1366t3499r1501b3562],
7	of	IN	O	of	_	0	SENT_37	[p3l1531t3499r1608b3562],
8	bone	NN	O	bone	nn	9	SENT_37	[p3l1631t3499r1804b3562],
9	fractures	NNS	O	fracture	prep_of	6	SENT_37	[p3l1835t3499r2146b3562],
10	and	CC	O	and	_	0	SENT_37	[p3l9t3611r136b3673],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_37	[p3l180t3611r703b3673],
12	disease	NN	O	disease	conj_and	9	SENT_37	[p3l747t3611r1022b3684],
13	,	,	O	,	_	0	SENT_37	[p3l747t3611r1022b3684],
14	AIs	NNS	O	ai	nsubjpass	17	SENT_37	[p3l1070t3612r1195b3673],
15	are	VBP	O	be	auxpass	17	SENT_37	[p3l1242t3631r1347b3673],
16	also	RB	O	also	advmod	17	SENT_37	[p3l1394t3611r1533b3673],
17	associated	VBN	O	associate	_	0	SENT_37	[p3l1580t3611r1947b3673],
18	with	IN	O	with	_	0	SENT_37	[p3l1991t3611r2148b3673],
19	bothersome	JJ	O	bothersome	amod	21	SENT_37	[p3l6t3722r424b3784],
20	side	JJ	O	side	amod	21	SENT_37	[p3l471t3722r610b3784],
21	effects	NNS	O	effect	prep_with	17	SENT_37	[p3l654t3721r890b3784],
22	that	WDT	O	that	nsubj	24	SENT_37	[p3l934t3722r1068b3784],
23	can	MD	O	can	aux	24	SENT_37	[p3l1111t3742r1233b3784],
24	lead	VB	O	lead	rcmod	21	SENT_37	[p3l1276t3722r1425b3784],
25	to	TO	O	to	_	0	SENT_37	[p3l1467t3731r1534b3784],
26	intolerance	NN	O	intolerance	nn	29	SENT_37	[p3l1578t3722r1976b3784],
27	and	CC	O	and	_	0	SENT_37	[p3l2022t3722r2148b3784],
28	subsequent	JJ	O	subsequent	nn	29	SENT_37	[p4l10t32r405b113],
29	discontinuation	NN	O	discontinuation	prep_to	24	SENT_37	[p4l433t32r985b95],
30	of	IN	O	of	_	0	SENT_37	[p4l1015t32r1092b95],
31	treatment	NN	O	treatment	nn	32	SENT_37	[p4l1113t42r1453b95],
32	[	NN	O	[	prep_of	29	SENT_37	[p4l1487t33r1572b108],
33	1	CD	NUMBER	1	num	32	SENT_37	[p4l1487t33r1572b108],
34	,	,	O	,	_	0	SENT_37	[p4l1487t33r1572b108],
35	11	CD	NUMBER	11	num	36	SENT_37	[p4l1612t33r1738b108],
36	]	NN	O	]	appos	29	SENT_37	[p4l1612t33r1738b108],
37	.	.	O	.	_	0	SENT_37	[p4l1612t33r1738b108],

1	Cross	NNP	O	Cross	nn	3	SENT_38	[p4l1771t32r2147b95],
2	—	CD	NUMBER	—	num	3	SENT_38	[p4l1771t32r2147b95],
3	trial	NN	O	trial	nsubj	8	SENT_38	[p4l1771t32r2147b95],
4	and	CC	O	and	_	0	SENT_38	[p4l9t143r136b206],
5	direct	JJ	O	direct	amod	6	SENT_38	[p4l160t143r363b206],
6	comparisons	NNS	O	comparison	conj_and	3	SENT_38	[p4l387t143r836b224],
7	have	VBP	O	have	aux	8	SENT_38	[p4l861t143r1029b206],
8	demonstrated	VBN	O	demonstrate	ccomp	22	SENT_38	[p4l1054t143r1537b206],
9	that	IN	O	that	complm	12	SENT_38	[p4l1560t143r1694b206],
10	all	DT	O	all	det	11	SENT_38	[p4l1720t143r1805b206],
11	Als	NNS	MISC	al	nsubj	12	SENT_38	[p4l1829t144r1954b206],
12	have	VBP	O	have	ccomp	8	SENT_38	[p4l1979t143r2146b206],
13	similar	JJ	O	similar	amod	14	SENT_38	[p4l10t254r257b316],
14	toxicities	NNS	O	toxicity	dobj	12	SENT_38	[p4l305t254r652b328],
15	,	,	O	,	_	0	SENT_38	[p4l305t254r652b328],
16	especially	RB	O	especially	advmod	17	SENT_38	[p4l707t254r1064b335],
17	musculoskeletal	JJ	O	musculoskeletal	amod	21	SENT_38	[p4l1114t254r1692b316],
18	and	CC	O	and	_	0	SENT_38	[p4l1745t254r1870b316],
19	menopausal	JJ	O	menopausal	conj_and	17	SENT_38	[p4l1920t273r2145b316, p4l6t365r234b446],
20	side	JJ	O	side	amod	21	SENT_38	[p4l270t365r408b427],
21	effects	NNS	O	effect	nsubj	22	SENT_38	[p4l443t365r678b427],
22	[	VBP	O	[	_	0	SENT_38	[p4l719t365r803b441],
23	3	CD	NUMBER	3	dobj	22	SENT_38	[p4l719t365r803b441],
24	,	,	O	,	_	0	SENT_38	[p4l719t365r803b441],
25	10	CD	NUMBER	10	num	26	SENT_38	[p4l847t365r974b441],
26	]	NN	O	]	appos	23	SENT_38	[p4l847t365r974b441],
27	.	.	O	.	_	0	SENT_38	[p4l847t365r974b441],

1	These	DT	O	these	det	2	SENT_39	[p4l1011t365r1223b427],
2	observations	NNS	O	observation	nsubj	3	SENT_39	[p4l1257t365r1706b428],
3	suggest	VBP	O	suggest	_	0	SENT_39	[p4l1744t374r2009b446],
4	the	DT	O	the	det	6	SENT_39	[p4l2040t365r2147b427],
5	side	JJ	O	side	amod	6	SENT_39	[p4l10t476r149b538],
6	effects	NNS	O	effect	dobj	3	SENT_39	[p4l186t476r422b538],
7	that	WDT	O	that	nsubj	10	SENT_39	[p4l459t476r593b538],
8	are	VBP	O	be	cop	10	SENT_39	[p4l630t495r734b538],
9	likely	JJ	O	likely	amod	10	SENT_39	[p4l771t476r974b557],
10	due	JJ	O	due	rcmod	6	SENT_39	[p4l1011t476r1137b538],
11	to	TO	O	to	_	0	SENT_39	[p4l1173t485r1240b538],
12	a	DT	O	a	det	14	SENT_39	[p4l1279t495r1316b538],
13	class	NN	O	class	nn	14	SENT_39	[p4l1351t476r1520b538],
14	effect	NN	O	effect	prep_to	10	SENT_39	[p4l1559t476r1762b538],
15	from	IN	O	from	_	0	SENT_39	[p4l1798t476r1970b538],
16	aromatase	NN	O	aromatase	nn	17	SENT_39	[p4l2007t495r2145b538, p4l7t597r255b650],
17	inhibition	NN	O	inhibition	prep_from	14	SENT_39	[p4l309t587r675b650],
18	.	.	O	.	_	0	SENT_39	[p4l309t587r675b650],

1	However	RB	O	however	advmod	25	SENT_40	[p4l734t589r1079b661],
2	,	,	O	,	_	0	SENT_40	[p4l734t589r1079b661],
3	since	IN	O	since	mark	7	SENT_40	[p4l1140t587r1318b650],
4	several	JJ	O	several	amod	5	SENT_40	[p4l1376t587r1624b650],
5	reports	NNS	O	report	nsubj	7	SENT_40	[p4l1678t597r1924b668],
6	have	VBP	O	have	aux	7	SENT_40	[p4l1979t587r2146b650],
7	suggested	VBN	O	suggest	advcl	25	SENT_40	[p4l10t698r360b779],
8	that	IN	O	that	complm	17	SENT_40	[p4l399t698r534b761],
9	patients	NNS	O	patient	nsubj	17	SENT_40	[p4l572t698r850b779],
10	who	WP	O	who	nsubj	12	SENT_40	[p4l893t698r1042b761],
11	are	VBP	O	be	cop	12	SENT_40	[p4l1086t718r1191b761],
12	intolerant	JJ	O	intolerant	rcmod	9	SENT_40	[p4l1233t698r1577b761],
13	to	TO	O	to	_	0	SENT_40	[p4l1616t707r1683b761],
14	one	CD	NUMBER	one	num	15	SENT_40	[p4l1726t718r1851b761],
15	AI	NN	O	aus	prep_to	12	SENT_40	[p4l1893t699r1985b760],
16	can	MD	O	can	aux	17	SENT_40	[p4l2025t718r2148b761],
17	tolerate	VB	O	tolerate	ccomp	7	SENT_40	[p4l7t809r282b872],
18	a	DT	O	a	det	20	SENT_40	[p4l331t829r368b872],
19	different	JJ	O	different	amod	20	SENT_40	[p4l415t809r730b872],
20	one	CD	NUMBER	one	dobj	17	SENT_40	[p4l777t829r925b883],
21	,	,	O	,	_	0	SENT_40	[p4l777t829r925b883],
22	host	NN	O	host	nn	23	SENT_40	[p4l974t809r1126b872],
23	factors	NNS	O	factor	nsubj	25	SENT_40	[p4l1171t809r1418b872],
24	may	MD	O	may	aux	25	SENT_40	[p4l1466t829r1620b890],
25	make	VB	O	make	_	0	SENT_40	[p4l1667t809r1861b872],
26	a	DT	O	a	det	28	SENT_40	[p4l1911t829r1948b872],
27	substantial	JJ	O	substantial	amod	28	SENT_40	[p4l1996t809r2145b872, p4l10t920r271b983],
28	contribution	NN	O	contribution	dobj	25	SENT_40	[p4l311t920r759b983],
29	to	TO	O	to	_	0	SENT_40	[p4l796t930r864b983],
30	drug	NN	O	drug	nn	32	SENT_40	[p4l903t920r1066b1001],
31	tolerance	NN	O	tolerance	nn	32	SENT_40	[p4l1105t920r1440b983],
32	[	NN	O	[	prep_to	25	SENT_40	[p4l1486t921r1573b996],
33	2	CD	NUMBER	2	dep	32	SENT_40	[p4l1486t921r1573b996],
34	,	,	O	,	_	0	SENT_40	[p4l1486t921r1573b996],
35	14	CD	NUMBER	14	num	36	SENT_40	[p4l1623t921r1752b996],
36	]	NN	O	]	appos	32	SENT_40	[p4l1623t921r1752b996],
37	.	.	O	.	_	0	SENT_40	[p4l1623t921r1752b996],

1	The	DT	O	the	det	4	SENT_41	[p4l1794t920r1934b983],
2	most	RBS	O	most	advmod	3	SENT_41	[p4l1973t930r2149b983],
3	common	JJ	O	common	amod	4	SENT_41	[p4l8t1051r325b1094],
4	toxicity	NN	O	toxicity	nsubj	15	SENT_41	[p4l357t1031r636b1112],
5	leading	VBG	O	lead	partmod	4	SENT_41	[p4l670t1031r937b1112],
6	to	TO	O	to	_	0	SENT_41	[p4l970t1041r1039b1094],
7	premature	JJ	O	premature	amod	8	SENT_41	[p4l1071t1041r1442b1112],
8	discontinuation	NN	O	discontinuation	prep_to	5	SENT_41	[p4l1477t1031r2042b1094],
9	of	IN	O	of	_	0	SENT_41	[p4l2075t1031r2153b1094],
10	AI	NN	O	aus	nn	11	SENT_41	[p4l7t1143r100b1204],
11	therapy	NN	O	therapy	prep_of	8	SENT_41	[p4l126t1142r399b1223],
12	is	VBZ	O	be	cop	15	SENT_41	[p4l425t1142r481b1205],
13	the	DT	O	the	det	15	SENT_41	[p4l508t1142r617b1205],
14	AI	NNP	O	AI	nn	15	SENT_41	[p4l644t1142r1148b1205],
15	—	NN	O	—	_	0	SENT_41	[p4l644t1142r1148b1205],
16	associated	VBN	O	associate	partmod	15	SENT_41	[p4l644t1142r1148b1205],
17	musculoskeletal	JJ	O	musculoskeletal	amod	21	SENT_41	[p4l1172t1142r1763b1205],
18	syndrome	NN	O	syndrome	nn	21	SENT_41	[p4l1793t1142r2147b1223],
19	(	CD	NUMBER	(	num	21	SENT_41	[p4l10t1252r363b1329],
20	AIMSS	NN	O	aimss	nn	21	SENT_41	[p4l10t1252r363b1329],
21	)	NN	O	)	dep	16	SENT_41	[p4l10t1252r363b1329],
22	,	,	O	,	_	0	SENT_41	[p4l10t1252r363b1329],
23	which	WDT	O	which	nsubjpass	26	SENT_41	[p4l420t1252r641b1315],
24	has	VBZ	O	have	aux	26	SENT_41	[p4l693t1252r810b1314],
25	been	VBN	O	be	auxpass	26	SENT_41	[p4l864t1252r1036b1314],
26	reported	VBN	O	report	rcmod	15	SENT_41	[p4l1087t1252r1393b1333],
27	in	IN	O	in	_	0	SENT_41	[p4l1445t1252r1514b1314],
28	up	RB	O	up	quantmod	30	SENT_41	[p4l1565t1271r1653b1333],
29	to	TO	O	to	dep	30	SENT_41	[p4l1707t1261r1774b1314],
30	25	CD	PERCENT	25	num	31	SENT_41	[p4l1830t1251r1912b1315],
31	%	NN	PERCENT	%	prep_in	26	SENT_41	[p4l1953t1252r2017b1315],
32	of	IN	O	of	_	0	SENT_41	[p4l2075t1252r2153b1314],
33	patients	NNS	O	patient	prep_of	31	SENT_41	[p4l6t1364r290b1445],
34	[	CD	NUMBER	[	number	35	SENT_41	[p4l362t1364r525b1440],
35	14	CD	NUMBER	14	num	36	SENT_41	[p4l362t1364r525b1440],
36	]	NN	O	]	dep	33	SENT_41	[p4l362t1364r525b1440],
37	.	.	O	.	_	0	SENT_41	[p4l362t1364r525b1440],

1	Prior	JJ	O	prior	amod	2	SENT_42	[p4l594t1364r776b1426],
2	studies	NNS	O	study	nsubj	4	SENT_42	[p4l842t1364r1090b1426],
3	have	VBP	O	have	aux	4	SENT_42	[p4l1156t1364r1326b1427],
4	implicated	VBN	O	implicate	_	0	SENT_42	[p4l1391t1364r1779b1445],
5	multiple	JJ	O	multiple	amod	7	SENT_42	[p4l1842t1364r2146b1445],
6	clinical	JJ	O	clinical	amod	7	SENT_42	[p4l8t1474r276b1536],
7	factors	NNS	O	factor	dobj	4	SENT_42	[p4l308t1474r555b1536],
8	in	IN	O	in	_	0	SENT_42	[p4l588t1474r656b1535],
9	development	NN	O	development	prep_in	4	SENT_42	[p4l688t1474r1161b1555],
10	of	IN	O	of	_	0	SENT_42	[p4l1192t1473r1270b1536],
11	AIMSS	NNP	LOCATION	AIMSS	prep_of	9	SENT_42	[p4l1294t1474r1589b1547],
12	,	,	O	,	_	0	SENT_42	[p4l1294t1474r1589b1547],
13	including	VBG	O	include	_	0	SENT_42	[p4l1623t1474r1967b1555],
14	age	NN	O	age	prep_including	4	SENT_42	[p4l2002t1493r2144b1555],
15	,	,	O	,	_	0	SENT_42	[p4l2002t1493r2144b1555],
16	body	NN	O	body	nn	18	SENT_42	[p4l6t1586r186b1667],
17	mass	NN	O	mass	nn	18	SENT_42	[p4l229t1606r408b1649],
18	index	NN	O	index	conj_and	14	SENT_42	[p4l451t1586r672b1660],
19	,	,	O	,	_	0	SENT_42	[p4l451t1586r672b1660],
20	prior	JJ	O	prior	amod	22	SENT_42	[p4l716t1586r896b1667],
21	taxane	NN	O	taxane	nn	22	SENT_42	[p4l936t1596r1173b1649],
22	chemotherapy	NN	O	chemotherapy	conj_and	14	SENT_42	[p4l1217t1586r1755b1667],
23	,	,	O	,	_	0	SENT_42	[p4l1217t1586r1755b1667],
24	and	CC	O	and	_	0	SENT_42	[p4l1802t1586r1930b1649],
25	prior	RB	O	prior	advmod	26	SENT_42	[p4l1971t1586r2150b1667],
26	tamoxifen	NN	O	tamoxifen	conj_and	14	SENT_42	[p4l7t1697r378b1760],
27	[	CD	NUMBER	[	number	28	SENT_42	[p4l417t1697r505b1773],
28	5	CD	NUMBER	5	dep	26	SENT_42	[p4l417t1697r505b1773],
29	,	,	O	,	_	0	SENT_42	[p4l417t1697r505b1773],
30	14	CD	NUMBER	14	conj_and	14	SENT_42	[p4l549t1697r650b1771],
31	,	,	O	,	_	0	SENT_42	[p4l549t1697r650b1771],
32	18	CD	NUMBER	18	conj_and	14	SENT_42	[p4l694t1698r794b1771],
33	,	,	O	,	_	0	SENT_42	[p4l694t1698r794b1771],
34	25	CD	NUMBER	25	num	35	SENT_42	[p4l832t1697r968b1773],
35	]	NN	O	]	conj_and	14	SENT_42	[p4l832t1697r968b1773],
36	.	.	O	.	_	0	SENT_42	[p4l832t1697r968b1773],

1	In	IN	O	in	_	0	SENT_43	[p4l109t1811r182b1870],
2	addition	NN	O	addition	_	0	SENT_43	[p4l242t1809r533b1871],
3	to	TO	O	to	_	0	SENT_43	[p4l591t1818r657b1871],
4	clinical	JJ	O	clinical	amod	5	SENT_43	[p4l718t1809r980b1871],
5	factors	NNS	O	factor	prep_in_addition_to	13	SENT_43	[p4l1039t1809r1301b1882],
6	,	,	O	,	_	0	SENT_43	[p4l1039t1809r1301b1882],
7	inherited	VBN	O	inherit	nsubj	13	SENT_43	[p4l1362t1809r1681b1871],
8	or	CC	O	or	_	0	SENT_43	[p4l1740t1829r1813b1871],
9	somatic	JJ	O	somatic	amod	11	SENT_43	[p4l1873t1809r2145b1871],
10	genetic	JJ	O	genetic	amod	11	SENT_43	[p4l8t1920r263b2001],
11	variants	NNS	O	variant	nsubj	13	SENT_43	[p4l317t1920r597b1983],
12	may	MD	O	may	aux	13	SENT_43	[p4l650t1940r801b2001],
13	impact	VB	O	impact	_	0	SENT_43	[p4l853t1920r1097b2001],
14	beneﬁt	NN	O	beneﬁt	dobj	13	SENT_43	[p4l1146t1920r1391b1983],
15	or	CC	O	or	_	0	SENT_43	[p4l1441t1940r1514b1983],
16	toxicity	NN	O	toxicity	conj_or	14	SENT_43	[p4l1563t1920r1836b2001],
17	from	IN	O	from	_	0	SENT_43	[p4l1887t1920r2060b1983],
18	a	DT	O	a	det	19	SENT_43	[p4l2112t1940r2149b1983],
19	medication	NN	O	medication	prep_from	13	SENT_43	[p4l7t2031r406b2094],
20	[	CD	NUMBER	[	number	21	SENT_43	[p4l478t2032r637b2107],
21	28	CD	NUMBER	28	num	22	SENT_43	[p4l478t2032r637b2107],
22	]	NN	O	]	dep	13	SENT_43	[p4l478t2032r637b2107],
23	.	.	O	.	_	0	SENT_43	[p4l478t2032r637b2107],

1	For	IN	O	for	_	0	SENT_44	[p4l708t2033r831b2094],
2	example	NN	O	example	prep_for	35	SENT_44	[p4l896t2031r1218b2112],
3	,	,	O	,	_	0	SENT_44	[p4l896t2031r1218b2112],
4	a	DT	O	a	det	6	SENT_44	[p4l1290t2051r1327b2094],
5	possible	JJ	O	possible	amod	6	SENT_44	[p4l1390t2031r1683b2112],
6	association	NN	O	association	nsubjpass	35	SENT_44	[p4l1751t2031r2148b2094],
7	between	IN	O	between	_	0	SENT_44	[p4l6t2142r305b2205],
8	a	DT	O	a	det	15	SENT_44	[p4l351t2162r388b2205],
9	single	JJ	O	single	amod	15	SENT_44	[p4l435t2142r1050b2223],
10	—	NN	O	—	nn	15	SENT_44	[p4l435t2142r1050b2223],
11	nucleotide	NN	O	nucleotide	nn	15	SENT_44	[p4l435t2142r1050b2223],
12	polymorphism	NN	O	polymorphism	nn	15	SENT_44	[p4l1094t2142r1618b2223],
13	(	CD	NUMBER	(	num	15	SENT_44	[p4l1665t2143r1881b2220],
14	SNP	NN	O	snp	nn	15	SENT_44	[p4l1665t2143r1881b2220],
15	)	NN	O	)	prep_between	6	SENT_44	[p4l1665t2143r1881b2220],
16	in	IN	O	in	_	0	SENT_44	[p4l1928t2142r1995b2204],
17	the	DT	O	the	det	22	SENT_44	[p4l2040t2142r2147b2205],
18	aromatase	NN	O	aromatase	nn	22	SENT_44	[p4l9t2262r370b2315],
19	gene	NN	O	gene	nn	22	SENT_44	[p4l399t2272r565b2334],
20	(	CD	NUMBER	(	num	22	SENT_44	[p4l597t2253r1003b2330],
21	CYP19AI	NN	O	cyp19aus	nn	22	SENT_44	[p4l597t2253r1003b2330],
22	)	NN	O	)	prep_in	15	SENT_44	[p4l597t2253r1003b2330],
23	and	CC	O	and	_	0	SENT_44	[p4l1035t2253r1162b2315],
24	response	NN	O	response	prep_in	15	SENT_44	[p4l1187t2272r1500b2334],
25	to	TO	O	to	_	0	SENT_44	[p4l1528t2262r1595b2315],
26	treatment	NN	O	treatment	prep_to	24	SENT_44	[p4l1624t2262r1964b2315],
27	with	IN	O	with	_	0	SENT_44	[p4l1991t2253r2148b2316],
28	letrozole	NN	O	letrozole	prep_with	26	SENT_44	[p4l7t2364r320b2427],
29	in	IN	O	in	_	0	SENT_44	[p4l346t2364r414b2426],
30	metastatic	JJ	O	metastatic	amod	32	SENT_44	[p4l439t2364r801b2427],
31	breast	NN	O	breast	nn	32	SENT_44	[p4l827t2364r1042b2427],
32	cancer	NN	O	cancer	prep_in	28	SENT_44	[p4l1067t2384r1301b2427],
33	has	VBZ	O	have	aux	35	SENT_44	[p4l1324t2364r1440b2427],
34	been	VBN	O	be	auxpass	35	SENT_44	[p4l1466t2364r1635b2427],
35	identiﬁed	VBN	O	identiﬁed	_	0	SENT_44	[p4l1660t2364r1998b2427],
36	[	CD	NUMBER	[	number	37	SENT_44	[p4l2030t2364r2143b2440],
37	4	CD	NUMBER	4	num	38	SENT_44	[p4l2030t2364r2143b2440],
38	]	NN	O	]	dobj	35	SENT_44	[p4l2030t2364r2143b2440],
39	.	.	O	.	_	0	SENT_44	[p4l2030t2364r2143b2440],

1	Likewise	RB	O	likewise	advmod	5	SENT_45	[p4l7t2475r354b2549],
2	,	,	O	,	_	0	SENT_45	[p4l7t2475r354b2549],
3	investigators	NNS	O	investigator	nsubj	5	SENT_45	[p4l402t2474r857b2556],
4	have	VBP	O	have	aux	5	SENT_45	[p4l903t2475r1070b2537],
5	reported	VBN	O	report	_	0	SENT_45	[p4l1114t2475r1414b2556],
6	potential	JJ	O	potential	amod	7	SENT_45	[p4l1456t2475r1771b2556],
7	polymorphisms	NNS	O	polymorphism	dobj	5	SENT_45	[p4l1814t2475r2145b2556, p4l6t2587r257b2668],
8	associated	VBN	O	associate	partmod	7	SENT_45	[p4l286t2587r653b2650],
9	with	IN	O	with	_	0	SENT_45	[p4l678t2587r835b2650],
10	the	DT	O	the	det	11	SENT_45	[p4l860t2587r967b2650],
11	presence	NN	O	presence	prep_with	8	SENT_45	[p4l992t2607r1305b2668],
12	of	IN	O	of	_	0	SENT_45	[p4l1332t2587r1410b2650],
13	AIMSS	NNP	LOCATION	AIMSS	prep_of	11	SENT_45	[p4l1428t2588r1718b2661],
14	,	,	O	,	_	0	SENT_45	[p4l1428t2588r1718b2661],
15	including	VBG	O	include	_	0	SENT_45	[p4l1747t2587r2084b2668],
16	a	DT	O	a	det	17	SENT_45	[p4l2112t2607r2149b2650],
17	SNP	NN	O	snp	prep_including	8	SENT_45	[p4l9t2698r169b2761],
18	in	IN	O	in	_	0	SENT_45	[p4l225t2698r292b2760],
19	the	DT	O	the	det	21	SENT_45	[p4l348t2698r455b2761],
20	gene	NN	O	gene	nn	21	SENT_45	[p4l513t2718r678b2779],
21	TCLIA	NN	O	tclium	prep_in	17	SENT_45	[p4l740t2699r989b2761],
22	identiﬁed	VBN	O	identiﬁed	partmod	21	SENT_45	[p4l1049t2698r1387b2761],
23	in	IN	O	in	_	0	SENT_45	[p4l1442t2698r1510b2760],
24	a	DT	O	a	det	29	SENT_45	[p4l1568t2718r1605b2761],
25	genome	NN	O	genome	nn	29	SENT_45	[p4l1661t2698r2147b2779],
26	—	CD	NUMBER	—	num	29	SENT_45	[p4l1661t2698r2147b2779],
27	wide	JJ	O	wide	amod	29	SENT_45	[p4l1661t2698r2147b2779],
28	association	NN	O	association	nn	29	SENT_45	[p4l9t2809r405b2872],
29	study	NN	O	study	prep_in	22	SENT_45	[p4l433t2809r622b2890],
30	(	CD	NUMBER	(	num	31	SENT_45	[p4l651t2809r966b2886],
31	GWAS	NNS	O	gwa	dep	32	SENT_45	[p4l651t2809r966b2886],
32	)	RB	O	)	amod	29	SENT_45	[p4l651t2809r966b2886],
33	as	RB	O	as	_	0	SENT_45	[p4l996t2829r1064b2872],
34	well	RB	O	well	_	0	SENT_45	[p4l1092t2809r1243b2872],
35	as	IN	O	as	_	0	SENT_45	[p4l1271t2829r1340b2872],
36	a	DT	O	a	det	37	SENT_45	[p4l1368t2829r1405b2872],
37	variant	NN	O	variant	dobj	5	SENT_45	[p4l1429t2809r1679b2872],
38	in	IN	O	in	_	0	SENT_45	[p4l1703t2809r1771b2871],
39	CYPI	NNP	O	CYPI	nn	40	SENT_45	[p4l1800t2810r1996b2872],
40	9A1	NN	O	9a1	prep_in	37	SENT_45	[p4l2005t2809r2141b2872],
41	[	CD	NUMBER	[	number	42	SENT_45	[p4l13t2920r144b2996],
42	16	CD	NUMBER	16	dep	40	SENT_45	[p4l13t2920r144b2996],
43	,	,	O	,	_	0	SENT_45	[p4l13t2920r144b2996],
44	19	CD	NUMBER	19	appos	40	SENT_45	[p4l184t2921r282b2995],
45	,	,	O	,	_	0	SENT_45	[p4l184t2921r282b2995],
46	21	CD	NUMBER	21	num	47	SENT_45	[p4l315t2921r449b2996],
47	]	NN	O	]	appos	44	SENT_45	[p4l315t2921r449b2996],
48	.	.	O	.	_	0	SENT_45	[p4l315t2921r449b2996],

1	None	NN	O	none	nsubjpass	7	SENT_46	[p4l482t2922r674b2983],
2	of	IN	O	of	_	0	SENT_46	[p4l704t2920r782b2983],
3	these	DT	O	these	det	4	SENT_46	[p4l804t2920r986b2983],
4	associations	NNS	O	association	prep_of	1	SENT_46	[p4l1017t2920r1446b2983],
5	has	VBZ	O	have	aux	7	SENT_46	[p4l1476t2920r1592b2983],
6	been	VBN	O	be	auxpass	7	SENT_46	[p4l1622t2920r1790b2983],
7	validated	VBN	O	validate	_	0	SENT_46	[p4l1819t2920r2148b2983],
8	in	IN	O	in	_	0	SENT_46	[p4l7t3032r75b3094],
9	an	DT	O	a	det	11	SENT_46	[p4l109t3052r190b3095],
10	independent	JJ	O	independent	amod	11	SENT_46	[p4l223t3032r662b3113],
11	cohort	NN	O	cohort	prep_in	7	SENT_46	[p4l694t3032r938b3095],
12	.	.	O	.	_	0	SENT_46	[p4l694t3032r938b3095],

1	The	DT	O	the	det	2	SENT_47	[p4l109t3143r246b3206],
2	Consortium	NNP	O	Consortium	nsubj	7	SENT_47	[p4l290t3143r711b3206],
3	on	IN	O	on	_	0	SENT_47	[p4l753t3163r840b3206],
4	Breast	NN	O	breast	nn	6	SENT_47	[p4l881t3145r1109b3206],
5	Cancer	NN	O	cancer	nn	6	SENT_47	[p4l1151t3144r1404b3206],
6	Pharmacogenomics	NNS	O	pharmacogenomic	prep_on	2	SENT_47	[p4l1444t3143r2146b3224],
7	conducted	VBD	O	conduct	_	0	SENT_47	[p4l8t3254r376b3316],
8	a	DT	O	a	det	9	SENT_47	[p4l415t3273r452b3316],
9	prospective	JJ	O	prospective	dobj	7	SENT_47	[p4l488t3254r901b3335],
10	randomized	VBN	O	randomize	partmod	9	SENT_47	[p4l939t3254r1364b3316],
11	clinical	JJ	O	clinical	amod	12	SENT_47	[p4l1402t3254r1664b3316],
12	trial	NN	O	trial	dobj	10	SENT_47	[p4l1703t3254r1845b3316],
13	of	IN	O	of	_	0	SENT_47	[p4l1885t3254r1962b3316],
14	exemestane	NN	O	exemestane	prep_of	12	SENT_47	[p4l1996t3273r2145b3316, p4l7t3374r300b3427],
15	versus	CC	O	versus	_	0	SENT_47	[p4l341t3384r565b3428],
16	letrozole	NN	O	letrozole	dobj	10	SENT_47	[p4l608t3365r920b3427],
17	in	IN	O	in	_	0	SENT_47	[p4l962t3365r1030b3427],
18	postmenopausal	JJ	O	postmenopausal	amod	19	SENT_47	[p4l1068t3365r1647b3446],
19	women	NNS	O	woman	prep_in	16	SENT_47	[p4l1688t3384r1949b3428],
20	with	IN	O	with	_	0	SENT_47	[p4l1991t3365r2148b3428],
21	HR	NN	DURATION	hr	nn	22	SENT_47	[p4l7t3475r444b3556],
22	—	NN	O	—	nn	25	SENT_47	[p4l7t3475r444b3556],
23	positive	JJ	O	positive	amod	25	SENT_47	[p4l7t3475r444b3556],
24	breast	NN	O	breast	nn	25	SENT_47	[p4l473t3475r688b3537],
25	cancer	NN	O	cancer	prep_with	10	SENT_47	[p4l718t3494r951b3537],
26	who	WP	O	who	nsubj	28	SENT_47	[p4l980t3475r1130b3537],
27	were	VBD	O	be	aux	28	SENT_47	[p4l1162t3494r1334b3537],
28	initiating	VBG	O	initiate	rcmod	9	SENT_47	[p4l1364t3475r1687b3556],
29	adjuvant	JJ	O	adjuvant	amod	31	SENT_47	[p4l1719t3475r2027b3556],
30	AI	NN	O	aus	nn	31	SENT_47	[p4l2056t3475r2148b3536],
31	therapy	NN	O	therapy	dobj	28	SENT_47	[p4l7t3587r292b3668],
32	.	.	O	.	_	0	SENT_47	[p4l7t3587r292b3668],

1	We	PRP	O	we	nsubj	3	SENT_48	[p4l334t3589r457b3650],
2	prospectively	RB	O	prospectively	advmod	3	SENT_48	[p4l495t3587r979b3668],
3	collected	VBD	O	collect	dep	25	SENT_48	[p4l1018t3587r1342b3650],
4	whole	JJ	O	whole	amod	5	SENT_48	[p4l1380t3587r1596b3650],
5	blood	NN	O	blood	dobj	3	SENT_48	[p4l1634t3587r1838b3650],
6	for	IN	O	for	_	0	SENT_48	[p4l1875t3587r1979b3650],
7	isolation	NN	O	isolation	prep_for	3	SENT_48	[p4l2016t3587r2145b3650, p4l7t3698r210b3761],
8	of	IN	O	of	_	0	SENT_48	[p4l253t3698r330b3761],
9	germ	NN	O	germ	nn	11	SENT_48	[p4l368t3718r550b3779],
10	line	NN	O	line	nn	11	SENT_48	[p4l591t3698r723b3761],
11	DNA	NN	MISC	dna	prep_of	7	SENT_48	[p4l766t3699r976b3772],
12	,	,	O	,	_	0	SENT_48	[p4l766t3699r976b3772],
13	as	RB	O	as	_	0	SENT_48	[p4l1023t3718r1092b3761],
14	well	RB	O	well	_	0	SENT_48	[p4l1136t3698r1287b3761],
15	as	IN	O	as	_	0	SENT_48	[p4l1332t3718r1400b3761],
16	non	JJ	O	non	amod	18	SENT_48	[p4l1443t3718r1843b3761],
17	—	NN	O	—	nn	18	SENT_48	[p4l1443t3718r1843b3761],
18	cancer	NN	O	cancer	conj_and	7	SENT_48	[p4l1443t3718r1843b3761],
19	clinical	JJ	O	clinical	amod	20	SENT_48	[p4l1884t3698r2147b3761],
20	endpoints	NNS	O	endpoint	dep	18	SENT_48	[p5l8t22r374b103],
21	,	,	O	,	_	0	SENT_48	[p5l8t22r374b103],
22	including	VBG	O	include	_	0	SENT_48	[p5l407t22r744b103],
23	patient	NN	O	patient	prep_including	3	SENT_48	[p5l774t22r1350b103],
24	—	RB	O	—	advmod	25	SENT_48	[p5l774t22r1350b103],
25	reported	VBD	O	report	_	0	SENT_48	[p5l774t22r1350b103],
26	reasons	NNS	O	reason	dobj	25	SENT_48	[p5l1378t42r1643b85],
27	for	IN	O	for	_	0	SENT_48	[p5l1677t22r1780b85],
28	treatment	NN	O	treatment	nn	29	SENT_48	[p5l1808t31r2148b85],
29	discontinuation	NN	O	discontinuation	prep_for	25	SENT_48	[p5l8t133r560b196],
30	[	CD	NUMBER	[	num	29	SENT_48	[p5l620t134r778b209],
31	11	CD	NUMBER	11	num	32	SENT_48	[p5l620t134r778b209],
32	]	NN	O	]	nsubj	25	SENT_48	[p5l620t134r778b209],
33	.	.	O	.	_	0	SENT_48	[p5l620t134r778b209],

1	For	IN	O	for	_	0	SENT_49	[p5l835t135r960b196],
2	this	DT	O	this	det	4	SENT_49	[p5l1011t133r1137b196],
3	exploratory	JJ	O	exploratory	amod	4	SENT_49	[p5l1192t133r1603b214],
4	endpoint	NN	O	endpoint	pobj	1	SENT_49	[p5l1658t133r1989b214],
5	,	,	O	,	_	0	SENT_49	[p5l1658t133r1989b214],
6	we	PRP	O	we	appos	4	SENT_49	[p5l2046t153r2147b196],

1	@	IN	O	@	_	0	SENT_50	[p5l6t376r83b471],
2	Springer	NNP	PERSON	Springer	prep_@	3	SENT_50	[p5l113t399r375b474],
3	hypothesized	VBD	O	hypothesize	_	0	SENT_50	[p5l8t501r481b582],
4	that	IN	O	that	complm	7	SENT_50	[p5l541t501r675b564],
5	we	PRP	O	we	nsubj	10	SENT_50	[p5l735t521r836b564],
6	could	MD	O	could	aux	7	SENT_50	[p5l898t501r1095b564],
7	identify	VB	O	identify	ccomp	3	SENT_50	[p5l1155t501r1432b582],
8	or	CC	O	or	_	0	SENT_50	[p5l1495t521r1568b564],
9	further	RB	O	further	advmod	10	SENT_50	[p5l1627t501r1870b564],
10	assess	VB	O	assess	conj_or	7	SENT_50	[p5l1931t521r2143b564],
11	associations	NNS	O	association	dobj	10	SENT_50	[p5l10t612r438b675],
12	between	IN	O	between	_	0	SENT_50	[p5l477t612r776b675],
13	A1	NN	O	a1	nn	15	SENT_50	[p5l814t613r906b674],
14	treatment	NN	O	treatment	nn	15	SENT_50	[p5l944t622r1284b675],
15	discontinuation	NN	O	discontinuation	prep_between	11	SENT_50	[p5l1322t612r1874b675],
16	due	JJ	O	due	amod	18	SENT_50	[p5l1913t612r2039b675],
17	to	TO	O	to	dep	18	SENT_50	[p5l2077t622r2144b675],
18	intolerable	JJ	O	intolerable	amod	15	SENT_50	[p5l8t723r391b785],
19	symptoms	NNS	O	symptom	nsubj	3	SENT_50	[p5l450t732r812b804],
20	and	CC	O	and	_	0	SENT_50	[p5l871t723r997b785],
21	inherited	VBN	O	inherit	amod	23	SENT_50	[p5l1053t723r1370b785],
22	genetic	JJ	O	genetic	amod	23	SENT_50	[p5l1427t723r1682b804],
23	variants	NNS	O	variant	nsubj	3	SENT_50	[p5l1740t723r2020b785],
24	in	IN	O	in	_	0	SENT_50	[p5l2078t723r2145b784],
25	candidate	NN	O	candidate	nn	26	SENT_50	[p5l9t834r351b896],
26	genes	NNS	O	gene	prep_in	23	SENT_50	[p5l398t853r597b915],
27	identiﬁed	JJ	O	identiﬁed	amod	26	SENT_50	[p5l645t834r983b896],
28	because	IN	O	because	prep	27	SENT_50	[p5l1028t834r1310b896],
29	of	IN	O	of	_	0	SENT_50	[p5l1358t834r1435b896],
30	their	PRP$	O	they	poss	31	SENT_50	[p5l1476t834r1640b896],
31	potential	NN	O	potential	prep_of	23	SENT_50	[p5l1684t834r1996b915],
32	for	IN	O	for	_	0	SENT_50	[p5l2044t834r2147b896],
33	involvement	NN	O	involvement	prep_for	23	SENT_50	[p5l8t945r457b1008],
34	in	IN	O	in	_	0	SENT_50	[p5l493t945r560b1006],
35	biologically	RB	O	biologically	advmod	36	SENT_50	[p5l596t945r1024b1026],
36	relevant	JJ	O	relevant	amod	37	SENT_50	[p5l1061t945r1351b1008],
37	pathways	NNS	O	pathway	prep_in	33	SENT_50	[p5l1385t945r1721b1026],
38	or	CC	O	or	_	0	SENT_50	[p5l1761t964r1834b1007],
39	through	IN	O	through	_	0	SENT_50	[p5l1869t945r2146b1026],
40	review	NN	O	review	prep_through	23	SENT_50	[p5l7t1057r249b1120],
41	of	IN	O	of	_	0	SENT_50	[p5l284t1057r361b1120],
42	the	DT	O	the	det	43	SENT_50	[p5l387t1057r494b1120],
43	literature	NN	O	literature	prep_of	40	SENT_50	[p5l528t1057r869b1120],
44	.	.	O	.	_	0	SENT_50	[p5l528t1057r869b1120],

1	Materials	NNPS	O	Materials	_	0	SENT_51	[p5l8t1282r375b1345],
2	and	CC	O	and	_	0	SENT_51	[p5l409t1283r549b1345],
3	methods	NNS	O	method	conj_and	1	SENT_51	[p5l582t1283r902b1345],

1	Patients	NNS	O	patient	_	0	SENT_52	[p5l8t1506r289b1569],

1	Postmenopausal	JJ	O	postmenopausal	amod	2	SENT_53	[p5l8t1730r589b1811],
2	women	NNS	O	woman	nsubjpass	21	SENT_53	[p5l627t1749r888b1792],
3	who	WP	O	who	nsubj	4	SENT_53	[p5l925t1730r1075b1793],
4	had	VBD	O	have	rcmod	2	SENT_53	[p5l1112t1730r1241b1792],
5	HR	NN	DURATION	hr	nn	6	SENT_53	[p5l1276t1730r1712b1811],
6	—	NN	O	—	dobj	4	SENT_53	[p5l1276t1730r1712b1811],
7	positive	JJ	O	positive	amod	8	SENT_53	[p5l1276t1730r1712b1811],
8	stage	NN	O	stage	dep	6	SENT_53	[p5l1753t1739r1931b1811],
9	0-111	CD	NUMBER	0-111	num	11	SENT_53	[p5l1970t1730r2145b1793],
10	breast	NN	O	breast	nn	11	SENT_53	[p5l7t1841r221b1904],
11	cancer	NN	O	cancer	dep	8	SENT_53	[p5l267t1861r501b1904],
12	and	CC	O	and	_	0	SENT_53	[p5l547t1841r673b1904],
13	were	VBD	O	be	aux	14	SENT_53	[p5l718t1861r888b1904],
14	planning	VBG	O	plan	conj_and	4	SENT_53	[p5l934t1841r1246b1922],
15	to	TO	O	to	aux	16	SENT_53	[p5l1293t1851r1359b1904],
16	initiate	VB	O	initiate	xcomp	14	SENT_53	[p5l1406t1841r1654b1904],
17	adjuvant	JJ	O	adjuvant	amod	19	SENT_53	[p5l1702t1841r2009b1922],
18	A1	NN	O	a1	nn	19	SENT_53	[p5l2054t1842r2146b1903],
19	therapy	NN	O	therapy	dobj	16	SENT_53	[p5l8t1952r274b2033],
20	were	VBD	O	be	auxpass	21	SENT_53	[p5l323t1972r494b2015],
21	enrolled	VBN	O	enrol	_	0	SENT_53	[p5l542t1952r834b2015],
22	in	IN	O	in	_	0	SENT_53	[p5l880t1952r948b2014],
23	the	DT	O	the	det	24	SENT_53	[p5l995t1952r1101b2015],
24	Exemestane	NN	O	exemestane	prep_in	21	SENT_53	[p5l1149t1954r1581b2015],
25	and	CC	O	and	_	0	SENT_53	[p5l1630t1952r1756b2015],
26	Letrozole	NNP	ORGANIZATION	Letrozole	nn	27	SENT_53	[p5l1802t1952r2144b2015],
27	Pharmacogenetics	NNPS	ORGANIZATION	Pharmacogenetics	prep_in	21	SENT_53	[p5l8t2063r659b2144],
28	(	CD	NUMBER	(	num	29	SENT_53	[p5l710t2063r966b2140],
29	ELPh	NN	O	elph	tmod	21	SENT_53	[p5l710t2063r966b2140],
30	)	CD	NUMBER	)	num	34	SENT_53	[p5l710t2063r966b2140],
31	clinical	JJ	O	clinical	amod	34	SENT_53	[p5l1016t2063r1278b2126],
32	trial	NN	O	trial	nn	34	SENT_53	[p5l1325t2063r1467b2126],
33	(	NN	O	(	nn	34	SENT_53	[p5l1517t2063r2145b2144],
34	clinicaltrials	NNS	O	clinicaltrial	dep	29	SENT_53	[p5l1517t2063r2145b2144],
35	.	.	O	.	_	0	SENT_53	[p5l1517t2063r2145b2144],

1	gov	NN	O	gov	nn	3	SENT_54	[p5l1517t2063r2145b2144],
2	NCTOO228956	NN	O	nctoo228956	nn	3	SENT_54	[p5l8t2172r571b2250],
3	)	NN	O	)	_	0	SENT_54	[p5l8t2172r571b2250],
4	between	IN	O	between	_	0	SENT_54	[p5l634t2173r932b2235],
5	August	NNP	DATE	August	prep_between	3	SENT_54	[p5l994t2173r1251b2254],
6	2005	CD	DATE	2005	num	5	SENT_54	[p5l1313t2172r1484b2236],
7	and	CC	O	and	_	0	SENT_54	[p5l1551t2173r1678b2235],
8	July	NNP	DATE	July	prep_between	3	SENT_54	[p5l1738t2173r1884b2254],
9	2009	CD	DATE	2009	num	8	SENT_54	[p5l1948t2173r2140b2236],
10	.	.	O	.	_	0	SENT_54	[p5l1948t2173r2140b2236],

1	Detailed	JJ	O	detailed	amod	3	SENT_55	[p5l8t2285r312b2348],
2	eligibility	NN	O	eligibility	nn	3	SENT_55	[p5l341t2285r688b2366],
3	criteria	NNS	O	criterion	nsubjpass	7	SENT_55	[p5l719t2285r972b2348],
4	have	VBP	O	have	aux	7	SENT_55	[p5l1000t2285r1167b2348],
5	previously	RB	DATE	previously	advmod	7	SENT_55	[p5l1195t2285r1573b2366],
6	been	VBN	O	be	auxpass	7	SENT_55	[p5l1602t2285r1770b2348],
7	published	VBN	O	publish	_	0	SENT_55	[p5l1797t2285r2147b2366],
8	[	CD	NUMBER	[	number	9	SENT_55	[p5l14t2397r173b2472],
9	11	CD	NUMBER	11	num	10	SENT_55	[p5l14t2397r173b2472],
10	]	NN	O	]	dobj	7	SENT_55	[p5l14t2397r173b2472],
11	.	.	O	.	_	0	SENT_55	[p5l14t2397r173b2472],

1	In	IN	O	in	_	0	SENT_56	[p5l222t2398r295b2458],
2	brief	NN	O	brief	prep_in	5	SENT_56	[p5l338t2396r525b2471],
3	,	,	O	,	_	0	SENT_56	[p5l338t2396r525b2471],
4	all	DT	O	all	nsubj	5	SENT_56	[p5l575t2396r661b2459],
5	recommended	VBD	O	recommend	_	0	SENT_56	[p5l705t2396r1214b2459],
6	surgery	NN	O	surgery	nn	8	SENT_56	[p5l1261t2416r1543b2477],
7	,	,	O	,	_	0	SENT_56	[p5l1261t2416r1543b2477],
8	neoadjuvant	NN	O	neoadjuvant	nn	11	SENT_56	[p5l1591t2396r2030b2477],
9	or	CC	O	or	_	0	SENT_56	[p5l2074t2416r2147b2459],
10	adjuvant	JJ	O	adjuvant	nn	11	SENT_56	[p5l10t2507r316b2588],
11	chemotherapy	NN	O	chemotherapy	dobj	5	SENT_56	[p5l372t2507r898b2588],
12	,	,	O	,	_	0	SENT_56	[p5l372t2507r898b2588],
13	and	CC	O	and	_	0	SENT_56	[p5l959t2507r1085b2569],
14	adjuvant	JJ	O	adjuvant	amod	16	SENT_56	[p5l1142t2507r1449b2588],
15	radiation	NN	O	radiation	nn	16	SENT_56	[p5l1503t2507r1822b2569],
16	therapy	NN	O	therapy	nsubjpass	18	SENT_56	[p5l1878t2507r2144b2588],
17	were	VBD	O	be	auxpass	18	SENT_56	[p5l9t2637r179b2681],
18	completed	VBN	O	complete	conj_and	5	SENT_56	[p5l228t2618r600b2699],
19	before	IN	O	before	_	0	SENT_56	[p5l645t2618r872b2680],
20	enrollment	NN	O	enrollment	prep_before	18	SENT_56	[p5l920t2618r1325b2680],
21	.	.	O	.	_	0	SENT_56	[p5l920t2618r1325b2680],

1	Prior	RB	O	prior	advmod	4	SENT_57	[p5l1377t2618r1555b2680],
2	tamoxifen	NN	O	tamoxifen	nsubjpass	4	SENT_57	[p5l1600t2618r1963b2680],
3	was	VBD	O	be	auxpass	4	SENT_57	[p5l2010t2637r2144b2681],
4	permitted	VBN	O	permit	_	0	SENT_57	[p5l7t2729r370b2810],
5	,	,	O	,	_	0	SENT_57	[p5l7t2729r370b2810],
6	but	CC	O	but	_	0	SENT_57	[p5l427t2729r542b2791],
7	prior	RB	O	prior	advmod	12	SENT_57	[p5l594t2729r770b2810],
8	A1	NN	O	a1	nn	9	SENT_57	[p5l822t2729r914b2791],
9	therapy	NN	O	therapy	nsubjpass	12	SENT_57	[p5l968t2729r1235b2810],
10	was	VBD	O	be	auxpass	12	SENT_57	[p5l1291t2748r1425b2792],
11	not	RB	O	not	neg	12	SENT_57	[p5l1482t2738r1595b2791],
12	allowed	VBN	O	allow	conj_but	4	SENT_57	[p5l1650t2729r1948b2792],
13	.	.	O	.	_	0	SENT_57	[p5l1650t2729r1948b2792],

1	The	DT	O	the	det	3	SENT_58	[p5l2008t2729r2145b2791],
2	clinical	JJ	O	clinical	amod	3	SENT_58	[p5l9t2840r271b2903],
3	trial	NN	O	trial	nsubjpass	5	SENT_58	[p5l324t2840r466b2903],
4	was	VBD	O	be	auxpass	5	SENT_58	[p5l519t2860r653b2903],
5	approved	VBN	O	approve	_	0	SENT_58	[p5l709t2840r1039b2921],
6	by	IN	O	by	_	0	SENT_58	[p5l1089t2840r1177b2921],
7	the	DT	O	the	det	10	SENT_58	[p5l1230t2840r1336b2903],
8	Institutional	JJ	O	institutional	amod	10	SENT_58	[p5l1389t2840r1821b2903],
9	Review	NN	O	review	nn	10	SENT_58	[p5l1874t2840r2144b2903],
10	Boards	NNS	O	board	agent	5	SENT_58	[p5l8t2951r257b3014],
11	at	IN	O	at	_	0	SENT_58	[p5l297t2961r359b3014],
12	all	DT	O	all	det	15	SENT_58	[p5l395t2951r481b3014],
13	three	CD	NUMBER	three	num	15	SENT_58	[p5l517t2951r693b3014],
14	participating	VBG	O	participate	amod	15	SENT_58	[p5l728t2951r1182b3032],
15	institutions	NNS	O	institution	prep_at	5	SENT_58	[p5l1218t2951r1614b3014],
16	(	CD	NUMBER	(	num	18	SENT_58	[p5l1654t2951r1949b3028],
17	Indiana	NNP	ORGANIZATION	Indiana	nn	18	SENT_58	[p5l1654t2951r1949b3028],
18	University	NNP	ORGANIZATION	University	dep	15	SENT_58	[p5l1983t2951r2142b3014, p5l8t3062r270b3143],
19	,	,	O	,	_	0	SENT_58	[p5l1983t2951r2142b3014, p5l8t3062r270b3143],
20	Johns	NNP	ORGANIZATION	Johns	nn	22	SENT_58	[p5l319t3062r518b3125],
21	Hopkins	NNP	ORGANIZATION	Hopkins	nn	22	SENT_58	[p5l568t3062r867b3143],
22	University	NNP	ORGANIZATION	University	nsubj	27	SENT_58	[p5l915t3062r1311b3143],
23	,	,	O	,	_	0	SENT_58	[p5l915t3062r1311b3143],
24	University	NNP	ORGANIZATION	University	appos	22	SENT_58	[p5l1361t3062r1737b3143],
25	of	IN	ORGANIZATION	of	_	0	SENT_58	[p5l1785t3062r1862b3125],
26	Michigan	NNP	ORGANIZATION	Michigan	prep_of	24	SENT_58	[p5l1903t3062r2143b3125, p5l9t3172r184b3253],
27	)	VBP	O	)	ccomp	5	SENT_58	[p5l1903t3062r2143b3125, p5l9t3172r184b3253],
28	,	,	O	,	_	0	SENT_58	[p5l1903t3062r2143b3125, p5l9t3172r184b3253],
29	and	CC	O	and	_	0	SENT_58	[p5l228t3172r354b3234],
30	all	DT	O	all	det	32	SENT_58	[p5l393t3172r478b3234],
31	enrolled	VBN	O	enrol	amod	32	SENT_58	[p5l518t3172r810b3234],
32	subjects	NNS	O	subject	nsubj	33	SENT_58	[p5l851t3172r1132b3253],
33	provided	VBD	O	provide	conj_and	5	SENT_58	[p5l1172t3172r1490b3253],
34	written	VBN	O	write	amod	36	SENT_58	[p5l1528t3172r1780b3234],
35	informed	VBN	O	inform	amod	36	SENT_58	[p5l1819t3172r2146b3234],
36	consent	NN	O	consent	dobj	33	SENT_58	[p5l9t3272r298b3325],
37	.	.	O	.	_	0	SENT_58	[p5l9t3272r298b3325],

1	Following	VBG	O	follow	_	0	SENT_59	[p5l110t3374r476b3455],
2	enrollment	NN	O	enrollment	prep_following	7	SENT_59	[p5l507t3374r914b3449],
3	,	,	O	,	_	0	SENT_59	[p5l507t3374r914b3449],
4	subjects	NNS	O	subject	nsubjpass	7	SENT_59	[p5l950t3374r1233b3455],
5	were	VBD	O	be	auxpass	7	SENT_59	[p5l1264t3394r1435b3437],
6	randomly	RB	O	randomly	advmod	7	SENT_59	[p5l1465t3374r1808b3455],
7	assigned	VBN	O	assign	_	0	SENT_59	[p5l1841t3374r2146b3455],
8	to	TO	O	to	_	0	SENT_59	[p5l8t3494r75b3547],
9	exemestane	NN	O	exemestane	nn	11	SENT_59	[p5l133t3494r549b3547],
10	25	CD	NUMBER	25	num	11	SENT_59	[p5l608t3485r690b3548],
11	mg	NN	O	mg	prep_to	7	SENT_59	[p5l726t3504r837b3566],
12	orally	RB	O	orally	advmod	13	SENT_59	[p5l896t3485r1101b3566],
13	daily	JJ	SET	daily	amod	11	SENT_59	[p5l1160t3485r1336b3566],
14	or	CC	O	or	_	0	SENT_59	[p5l1394t3504r1467b3547],
15	letrozole	JJ	O	letrozole	amod	17	SENT_59	[p5l1522t3485r1834b3547],
16	2.5	CD	NUMBER	2.5	tmod	15	SENT_59	[p5l1893t3485r1997b3548],
17	mg	NN	O	mg	prep_to	7	SENT_59	[p5l2033t3504r2144b3566],
18	orally	RB	O	orally	advmod	11	SENT_59	[p5l9t3596r215b3677],
19	daily	RB	SET	daily	advmod	7	SENT_59	[p5l260t3596r454b3677],
20	.	.	O	.	_	0	SENT_59	[p5l260t3596r454b3677],

1	Three	CD	NUMBER	three	num	2	SENT_60	[p5l502t3596r709b3658],
2	subjects	NNS	O	subject	nsubjpass	7	SENT_60	[p5l755t3596r1038b3677],
3	withdrew	VBD	O	withdraw	_	0	SENT_60	[p5l1083t3596r1419b3659],
4	and	CC	O	and	_	0	SENT_60	[p5l1464t3596r1590b3658],
5	were	VBD	O	be	auxpass	7	SENT_60	[p5l1633t3615r1804b3658],
6	not	RB	O	not	neg	7	SENT_60	[p5l1848t3605r1961b3658],
7	randomized	VBN	O	randomize	conj_and	3	SENT_60	[p5l2003t3615r2143b3658, p5l9t3707r317b3769],
8	(	CD	NUMBER	(	num	9	SENT_60	[p5l360t3707r522b3788],
9	Fig	NN	O	fig	dobj	7	SENT_60	[p5l360t3707r522b3788],
10	.	.	O	.	_	0	SENT_60	[p5l360t3707r522b3788],

1	1	CD	NUMBER	1	_	0	SENT_61	[p5l567t3707r649b3784],
2	)	NN	O	)	dep	1	SENT_61	[p5l567t3707r649b3784],
3	.	.	O	.	_	0	SENT_61	[p5l567t3707r649b3784],

1	Randomization	NN	O	randomization	nsubj	3	SENT_62	[p5l695t3707r1242b3769],
2	was	VBD	O	be	cop	3	SENT_62	[p5l1284t3726r1418b3770],
3	Stratiﬁed	JJ	O	stratiﬁed	_	0	SENT_62	[p5l1464t3707r1775b3769],
4	based	VBN	O	base	_	0	SENT_62	[p5l1814t3707r2017b3769],
5	on	IN	O	on	prepc_based_on	3	SENT_62	[p5l2059t3726r2146b3769],
6	prior	JJ	O	prior	amod	9	SENT_62	[p6l7t22r182b103],
7	tamoxifen	NN	O	tamoxifen	nn	9	SENT_62	[p6l220t22r602b96],
8	,	,	O	,	_	0	SENT_62	[p6l220t22r602b96],
9	chemotherapy	NN	O	chemotherapy	pobj	3	SENT_62	[p6l646t22r1171b103],
10	,	,	O	,	_	0	SENT_62	[p6l646t22r1171b103],
11	and	CC	O	and	_	0	SENT_62	[p6l1217t22r1343b85],
12	bisphosphonate	NN	O	bisphosphonate	nn	13	SENT_62	[p6l1381t22r1937b103],
13	therapy	NN	O	therapy	conj_and	9	SENT_62	[p6l1978t22r2142b85, p6l10t153r153b214],
14	.	.	O	.	_	0	SENT_62	[p6l1978t22r2142b85, p6l10t153r153b214],

1	At	IN	O	at	_	0	SENT_63	[p6l197t134r285b196],
2	baseline	NN	O	baseline	prep_at	20	SENT_63	[p6l323t133r615b196],
3	and	CC	O	and	_	0	SENT_63	[p6l658t133r784b196],
4	after	IN	O	after	prep_at	20	SENT_63	[p6l825t133r987b196],
5	1	CD	NUMBER	1	pobj	4	SENT_63	[p6l1033t134r1086b207],
6	,	,	O	,	_	0	SENT_63	[p6l1033t134r1086b207],
7	3	CD	NUMBER	3	pobj	4	SENT_63	[p6l1132t134r1190b207],
8	,	,	O	,	_	0	SENT_63	[p6l1132t134r1190b207],
9	6	CD	NUMBER	6	pobj	4	SENT_63	[p6l1235t133r1295b207],
10	,	,	O	,	_	0	SENT_63	[p6l1235t133r1295b207],
11	l2	NN	O	l2	conj_and	5	SENT_63	[p6l1345t134r1443b207],
12	,	,	O	,	_	0	SENT_63	[p6l1345t134r1443b207],
13	and	CC	O	and	_	0	SENT_63	[p6l1488t133r1614b196],
14	24	CD	DURATION	24	num	15	SENT_63	[p6l1654t134r1739b195],
15	months	NNS	NUMBER	month	conj_and	5	SENT_63	[p6l1772t133r2032b196],
16	of	IN	O	of	_	0	SENT_63	[p6l2074t133r2151b196],
17	therapy	NN	O	therapy	prep_of	15	SENT_63	[p6l8t244r294b325],
18	,	,	O	,	_	0	SENT_63	[p6l8t244r294b325],
19	subjects	NNS	O	subject	nsubj	20	SENT_63	[p6l337t244r619b325],
20	underwent	VBD	O	undergo	_	0	SENT_63	[p6l657t244r1035b307],
21	serial	JJ	O	serial	amod	23	SENT_63	[p6l1073t244r1261b307],
22	clinical	JJ	O	clinical	amod	23	SENT_63	[p6l1300t244r1562b307],
23	assessments	NNS	O	assessment	dobj	20	SENT_63	[p6l1601t253r2048b307],
24	.	.	O	.	_	0	SENT_63	[p6l1601t253r2048b307],

1	If	IN	O	if	mark	3	SENT_64	[p6l2088t244r2152b306],
2	subjects	NNS	O	subject	nsubj	3	SENT_64	[p6l11t354r294b435],
3	discontinued	VBN	O	discontinue	advcl	23	SENT_64	[p6l378t354r835b416],
4	initial	JJ	O	initial	amod	6	SENT_64	[p6l916t354r1124b416],
5	AI	NN	O	aus	nn	6	SENT_64	[p6l1206t354r1298b415],
6	therapy	NN	O	therapy	dobj	3	SENT_64	[p6l1380t354r1646b435],
7	before	IN	O	before	_	0	SENT_64	[p6l1728t353r1955b416],
8	the	DT	DURATION	the	det	12	SENT_64	[p6l2038t354r2145b416],
9	24	CD	DURATION	24	num	12	SENT_64	[p6l9t467r95b528],
10	month	NN	NUMBER	month	nn	12	SENT_64	[p6l128t466r355b529],
11	study	NN	O	study	nn	12	SENT_64	[p6l408t466r596b547],
12	visit	NN	O	visit	prep_before	3	SENT_64	[p6l647t466r801b529],
13	for	IN	O	for	_	0	SENT_64	[p6l850t466r954b529],
14	any	DT	O	any	det	15	SENT_64	[p6l1004t486r1129b547],
15	reason	NN	O	reason	prep_for	3	SENT_64	[p6l1179t486r1431b540],
16	,	,	O	,	_	0	SENT_64	[p6l1179t486r1431b540],
17	reasons	NNS	O	reason	nsubjpass	23	SENT_64	[p6l1484t486r1749b529],
18	for	IN	O	for	_	0	SENT_64	[p6l1801t466r1905b529],
19	study	NN	O	study	nn	20	SENT_64	[p6l1957t466r2145b547],
20	discontinuation	NN	O	discontinuation	prep_for	17	SENT_64	[p6l9t577r560b640],
21	were	VBD	O	be	auxpass	23	SENT_64	[p6l618t597r788b640],
22	prospectively	RB	O	prospectively	advmod	23	SENT_64	[p6l845t577r1327b658],
23	recorded	VBN	O	record	_	0	SENT_64	[p6l1384t577r1698b640],
24	on	IN	O	on	_	0	SENT_64	[p6l1756t597r1842b640],
25	a	DT	O	a	det	28	SENT_64	[p6l1900t597r1937b640],
26	case	NN	O	case	nn	28	SENT_64	[p6l1994t597r2145b640],
27	report	NN	O	report	nn	28	SENT_64	[p6l7t697r221b769],
28	form	NN	O	form	prep_on	23	SENT_64	[p6l253t688r426b750],
29	by	IN	O	by	_	0	SENT_64	[p6l457t688r544b769],
30	the	DT	O	the	det	31	SENT_64	[p6l577t688r684b750],
31	study	NN	O	study	agent	23	SENT_64	[p6l721t688r908b769],
32	coordinators	NNS	O	coordinator	nsubj	33	SENT_64	[p6l942t688r1386b750],
33	[	VBP	O	[	rcmod	31	SENT_64	[p6l1427t688r1586b764],
34	14	CD	NUMBER	14	num	35	SENT_64	[p6l1427t688r1586b764],
35	]	CD	NUMBER	]	dobj	33	SENT_64	[p6l1427t688r1586b764],
36	.	.	O	.	_	0	SENT_64	[p6l1427t688r1586b764],

1	Sample	NN	O	sample	nn	2	SENT_65	[p6l10t912r275b993],
2	processing	NN	O	processing	_	0	SENT_65	[p6l307t912r688b993],
3	and	CC	O	and	_	0	SENT_65	[p6l724t912r850b974],
4	genotyping	NN	O	genotyping	conj_and	2	SENT_65	[p6l883t912r1283b993],

1	Whole	JJ	O	whole	amod	2	SENT_66	[p6l7t1135r244b1198],
2	blood	NN	O	blood	nsubjpass	4	SENT_66	[p6l273t1135r477b1198],
3	was	VBD	O	be	auxpass	4	SENT_66	[p6l505t1155r639b1198],
4	collected	VBN	O	collect	_	0	SENT_66	[p6l671t1135r995b1198],
5	at	IN	O	at	_	0	SENT_66	[p6l1025t1145r1087b1198],
6	the	DT	O	the	det	9	SENT_66	[p6l1114t1135r1221b1198],
7	baseline	NN	O	baseline	nn	9	SENT_66	[p6l1249t1135r1542b1198],
8	study	NN	O	study	nn	9	SENT_66	[p6l1575t1135r1763b1216],
9	visit	NN	O	visit	prep_at	4	SENT_66	[p6l1792t1135r1945b1198],
10	from	IN	O	from	_	0	SENT_66	[p6l1974t1135r2146b1198],
11	each	DT	O	each	det	13	SENT_66	[p6l9t1246r171b1309],
12	study	NN	O	study	nn	13	SENT_66	[p6l222t1246r409b1327],
13	participant	NN	O	participant	prep_from	4	SENT_66	[p6l457t1246r859b1327],
14	.	.	O	.	_	0	SENT_66	[p6l457t1246r859b1327],

1	DNA	NN	O	dna	nsubjpass	3	SENT_67	[p6l911t1247r1102b1309],
2	was	VBD	O	be	auxpass	3	SENT_67	[p6l1149t1266r1284b1309],
3	extracted	VBN	O	extract	_	0	SENT_67	[p6l1334t1246r1662b1309],
4	from	IN	O	from	_	0	SENT_67	[p6l1709t1246r1882b1309],
5	whole	JJ	O	whole	amod	6	SENT_67	[p6l1929t1246r2144b1309],
6	blood	NN	O	blood	prep_from	3	SENT_67	[p6l7t1356r211b1418],
7	using	VBG	O	use	partmod	6	SENT_67	[p6l246t1356r438b1437],
8	Qiaﬁlter	NNP	O	Qiaﬁlter	nn	12	SENT_67	[p6l476t1356r774b1433],
9	Blood	NNP	O	Blood	nn	12	SENT_67	[p6l808t1356r1026b1418],
10	DNA	NNP	O	DNA	nn	12	SENT_67	[p6l1063t1356r1253b1418],
11	Maxi	NNP	O	Maxi	nn	12	SENT_67	[p6l1289t1356r1475b1418],
12	kit	NN	O	kit	dobj	7	SENT_67	[p6l1512t1356r1607b1418],
13	(	CD	NUMBER	(	num	12	SENT_67	[p6l1645t1356r1948b1437],
14	Qiagen	NNP	ORGANIZATION	Qiagen	nn	22	SENT_67	[p6l1645t1356r1948b1437],
15	,	,	ORGANIZATION	,	_	0	SENT_67	[p6l1645t1356r1948b1437],
16	Inc.	NNP	ORGANIZATION	Inc.	appos	22	SENT_67	[p6l1988t1357r2142b1429],
17	,	,	O	,	_	0	SENT_67	[p6l1988t1357r2142b1429],
18	Valencia	NNP	LOCATION	Valencia	appos	22	SENT_67	[p6l8t1468r345b1543],
19	,	,	O	,	_	0	SENT_67	[p6l8t1468r345b1543],
20	CA	NNP	LOCATION	CA	appos	22	SENT_67	[p6l383t1469r522b1543],
21	,	,	O	,	_	0	SENT_67	[p6l383t1469r522b1543],
22	USA	NNP	LOCATION	USA	dep	12	SENT_67	[p6l559t1469r783b1546],
23	)	CD	NUMBER	)	num	22	SENT_67	[p6l559t1469r783b1546],
24	.	.	O	.	_	0	SENT_67	[p6l559t1469r783b1546],

1	Germ	NN	O	germ	nn	3	SENT_68	[p6l822t1469r1024b1531],
2	line	NN	O	line	nn	3	SENT_68	[p6l1056t1468r1188b1531],
3	DNA	NN	MISC	dna	nsubj	15	SENT_68	[p6l1222t1469r1413b1531],
4	was	VBD	O	be	cop	15	SENT_68	[p6l1447t1488r1581b1531],
5	available	JJ	O	available	amod	15	SENT_68	[p6l1619t1468r1939b1531],
6	from	IN	O	from	_	0	SENT_68	[p6l1974t1468r2146b1531],
7	467	CD	PERCENT	467	number	8	SENT_68	[p6l8t1580r137b1643],
8	(	CD	PERCENT	(	prep_from	5	SENT_68	[p6l200t1581r380b1658],
9	93.4	CD	PERCENT	93.4	num	10	SENT_68	[p6l200t1581r380b1658],
10	%	NN	PERCENT	%	dep	8	SENT_68	[p6l417t1581r513b1658],
11	)	CD	NUMBER	)	num	13	SENT_68	[p6l417t1581r513b1658],
12	eligible	JJ	O	eligible	amod	13	SENT_68	[p6l573t1580r839b1661],
13	subjects	NNS	O	subject	dep	10	SENT_68	[p6l900t1580r1181b1661],
14	(	JJ	O	(	amod	15	SENT_68	[p6l1243t1580r1405b1661],
15	Fig	NN	O	fig	_	0	SENT_68	[p6l1243t1580r1405b1661],
16	.	.	O	.	_	0	SENT_68	[p6l1243t1580r1405b1661],

1	1	CD	NUMBER	1	_	0	SENT_69	[p6l1450t1581r1531b1658],
2	)	NN	O	)	dep	1	SENT_69	[p6l1450t1581r1531b1658],
3	.	.	O	.	_	0	SENT_69	[p6l1450t1581r1531b1658],

1	DNA	NN	O	dna	nsubj	4	SENT_70	[p6l1593t1581r1784b1643],
2	was	VBD	O	be	cop	4	SENT_70	[p6l1840t1600r1974b1643],
3	not	RB	O	not	neg	4	SENT_70	[p6l2033t1590r2147b1643],
4	available	JJ	O	available	_	0	SENT_70	[p6l10t1691r331b1754],
5	for	IN	O	for	_	0	SENT_70	[p6l390t1691r493b1753],
6	analysis	NN	O	analysis	prep_for	4	SENT_70	[p6l552t1691r836b1772],
7	from	IN	O	from	_	0	SENT_70	[p6l896t1691r1068b1753],
8	the	DT	O	the	det	11	SENT_70	[p6l1126t1691r1233b1753],
9	remaining	VBG	O	remain	amod	11	SENT_70	[p6l1291t1691r1654b1772],
10	33	CD	NUMBER	33	num	11	SENT_70	[p6l1715t1691r1795b1754],
11	subjects	NNS	O	subject	prep_from	6	SENT_70	[p6l1861t1691r2144b1772],
12	because	IN	O	because	_	0	SENT_70	[p6l7t1802r290b1864],
13	of	IN	O	of	_	0	SENT_70	[p6l344t1802r421b1864],
14	technical	JJ	O	technical	amod	15	SENT_70	[p6l467t1802r790b1864],
15	errors	NNS	O	error	prep_because_of	16	SENT_70	[p6l844t1821r1048b1864],
16	(	VBP	O	(	advcl	4	SENT_70	[p6l1105t1803r1173b1879],
17	n	NN	O	n	nsubj	18	SENT_70	[p6l1105t1803r1173b1879],
18	=	JJ	O	=	xcomp	16	SENT_70	[p6l1209t1830r1270b1854],
19	2	CD	NUMBER	2	num	20	SENT_70	[p6l1307t1802r1397b1879],
20	)	CD	NUMBER	)	nsubj	16	SENT_70	[p6l1307t1802r1397b1879],
21	,	,	O	,	_	0	SENT_70	[p6l1307t1802r1397b1879],
22	inability	NN	O	inability	appos	20	SENT_70	[p6l1453t1802r1751b1883],
23	to	TO	O	to	aux	24	SENT_70	[p6l1803t1811r1870b1864],
24	obtain	VB	O	obtain	infmod	22	SENT_70	[p6l1924t1802r2145b1864],
25	blood	NN	O	blood	nn	43	SENT_70	[p6l7t1913r211b1975],
26	at	IN	O	at	_	0	SENT_70	[p6l243t1922r306b1975],
27	baseline	NN	O	baseline	nn	29	SENT_70	[p6l335t1913r628b1975],
28	(	CD	NUMBER	(	num	29	SENT_70	[p6l663t1914r731b1990],
29	n	NN	O	n	prep_at	25	SENT_70	[p6l663t1914r731b1990],
30	=	JJ	O	=	amod	32	SENT_70	[p6l768t1941r828b1965],
31	8	CD	NUMBER	8	tmod	30	SENT_70	[p6l868t1913r955b1990],
32	)	NN	O	)	dep	29	SENT_70	[p6l868t1913r955b1990],
33	,	,	O	,	_	0	SENT_70	[p6l868t1913r955b1990],
34	or	CC	O	or	_	0	SENT_70	[p6l991t1932r1064b1975],
35	insufﬁcient	JJ	O	insufﬁcient	amod	36	SENT_70	[p6l1094t1913r1496b1975],
36	quantity	NN	O	quantity	prep_at	25	SENT_70	[p6l1528t1913r1818b1994],
37	of	IN	O	of	_	0	SENT_70	[p6l1852t1913r1929b1975],
38	DNA	NN	O	dna	nn	40	SENT_70	[p6l1954t1913r2146b1976],
39	(	NN	O	(	nn	40	SENT_70	[p6l11t2025r80b2102],
40	n	NN	O	n	prep_of	36	SENT_70	[p6l11t2025r80b2102],
41	=	JJ	O	=	amod	43	SENT_70	[p6l116t2053r177b2077],
42	23	CD	NUMBER	23	tmod	41	SENT_70	[p6l213t2025r347b2101],
43	)	NN	O	)	dobj	24	SENT_70	[p6l213t2025r347b2101],
44	.	.	O	.	_	0	SENT_70	[p6l213t2025r347b2101],

1	At	IN	O	at	_	0	SENT_71	[p6l110t2137r198b2199],
2	the	DT	O	the	det	3	SENT_71	[p6l242t2136r349b2199],
3	time	NN	O	time	prep_at	12	SENT_71	[p6l395t2136r553b2199],
4	of	IN	O	of	_	0	SENT_71	[p6l600t2136r677b2199],
5	protocol	NN	O	protocol	nn	6	SENT_71	[p6l715t2136r1012b2217],
6	development	NN	O	development	prep_of	3	SENT_71	[p6l1060t2136r1541b2217],
7	,	,	O	,	_	0	SENT_71	[p6l1060t2136r1541b2217],
8	candidate	NN	O	candidate	nn	10	SENT_71	[p6l1590t2136r1931b2199],
9	gene	NN	O	gene	nn	10	SENT_71	[p6l1979t2156r2144b2217],
10	Variants	NNS	O	variant	appos	6	SENT_71	[p6l9t2247r289b2310],
11	were	VBD	O	be	auxpass	12	SENT_71	[p6l350t2267r520b2310],
12	identiﬁed	VBN	O	identiﬁed	_	0	SENT_71	[p6l581t2247r919b2310],
13	that	WDT	O	that	nsubjpass	15	SENT_71	[p6l976t2247r1111b2310],
14	are	VBP	O	be	auxpass	15	SENT_71	[p6l1171t2267r1275b2310],
15	involved	VBN	O	involve	ccomp	12	SENT_71	[p6l1336t2247r1648b2310],
16	in	IN	O	in	_	0	SENT_71	[p6l1706t2247r1774b2309],
17	A1	NN	O	a1	nn	19	SENT_71	[p6l1833t2248r1924b2309],
18	drug	NN	O	drug	nn	19	SENT_71	[p6l1985t2247r2144b2328],
19	metabolism	NN	O	metabolism	prep_in	15	SENT_71	[p6l8t2357r427b2419],
20	(	CD	NUMBER	(	num	21	SENT_71	[p6l499t2356r852b2434],
21	CYP2A6	NN	O	cyp2a6	nsubjpass	12	SENT_71	[p6l499t2356r852b2434],
22	,	,	O	,	_	0	SENT_71	[p6l499t2356r852b2434],
23	CYP3A5	NN	O	cyp3a5	nn	24	SENT_71	[p6l930t2357r1282b2434],
24	)	NN	O	)	appos	21	SENT_71	[p6l930t2357r1282b2434],
25	,	,	O	,	_	0	SENT_71	[p6l930t2357r1282b2434],
26	estrogen	NN	O	estrogen	nn	27	SENT_71	[p6l1356t2366r1658b2438],
27	metabolism	NN	O	metabolism	appos	24	SENT_71	[p6l1728t2357r2147b2419],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_72	[p6l53t2513r142b2538],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_72	[p6l155t2513r255b2538],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_72	[p6l267t2513r318b2538],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_72	[p6l331t2513r406b2538],
5	(	CD	NUMBER	(	num	6	SENT_72	[p6l419t2513r510b2544],
6	2013	CD	DATE	2013	dep	4	SENT_72	[p6l419t2513r510b2544],
7	)	CD	NUMBER	)	number	8	SENT_72	[p6l419t2513r510b2544],
8	138:807	CD	NUMBER	138:807	num	9	SENT_72	[p6l528t2513r709b2538],
9	—	NN	O	—	dep	6	SENT_72	[p6l528t2513r709b2538],
10	816	CD	NUMBER	816	number	11	SENT_72	[p6l528t2513r709b2538],
11	809	CD	NUMBER	809	num	9	SENT_72	[p6l2056t2513r2106b2538],

1	503	CD	NUMBER	503	nsubj	2	SENT_73	[p6l897t2635r953b2660],
2	enrolled	VBN	O	enrol	_	0	SENT_73	[p6l966t2633r1098b2660],
3	subjects	NNS	O	subject	dobj	2	SENT_73	[p6l1110t2633r1241b2667],

1	252	CD	NUMBER	252	_	0	SENT_74	[p6l610t2742r666b2768],
2	randomized	VBN	O	randomize	partmod	1	SENT_74	[p6l679t2741r868b2768],
3	3	CD	NUMBER	3	dobj	2	SENT_74	[p6l1027t2740r1041b2763],
4	not	RB	O	not	neg	6	SENT_74	[p6l1053t2742r1098b2763],
5	248	CD	NUMBER	248	pobj	4	SENT_74	[p6l1235t2742r1291b2768],
6	randomized	VBN	O	randomize	partmod	3	SENT_74	[p6l1304t2741r1493b2768],
7	to	TO	O	to	prep	6	SENT_74	[p6l1504t2745r1536b2768],
8	'	''	O	'	_	0	SENT_74	[p6l980t2780r1144b2805],
9	a	DT	O	a	det	11	SENT_74	[p6l980t2780r1144b2805],
10	“	NN	O	“	nn	11	SENT_74	[p6l980t2780r1144b2805],
11	d	NN	O	d	dep	17	SENT_74	[p6l980t2780r1144b2805],
12	°	CD	NUMBER	°	num	14	SENT_74	[p6l980t2780r1144b2805],
13	miZed	JJ	O	mized	amod	14	SENT_74	[p6l980t2780r1144b2805],
14	exemestane	NN	O	exemestane	dep	11	SENT_74	[p6l1222t2792r1416b2815],
15	(	NN	O	(	dep	17	SENT_74	[p6l1429t2787r1548b2821],
16	49.3	CD	PERCENT	49.3	num	17	SENT_74	[p6l1429t2787r1548b2821],
17	%	NN	PERCENT	%	dep	1	SENT_74	[p6l1429t2787r1548b2821],
18	)	CD	NUMBER	)	dep	17	SENT_74	[p6l1429t2787r1548b2821],

1	20	CD	NUMBER	20	num	2	SENT_75	[p6l378t2821r411b2844],
2	t	NN	O	t	_	0	SENT_75	[p6l457t2822r467b2844],
3	to	TO	O	to	aux	4	SENT_75	[p6l581t2792r614b2815],
4	letrozole	VB	O	letrozole	dep	2	SENT_75	[p6l626t2788r765b2815],
5	(	CD	PERCENT	(	number	6	SENT_75	[p6l777t2787r896b2821],
6	50.1	CD	PERCENT	50.1	num	7	SENT_75	[p6l777t2787r896b2821],
7	%	NN	PERCENT	%	dobj	4	SENT_75	[p6l777t2787r896b2821],
8	)	CD	NUMBER	)	tmod	4	SENT_75	[p6l777t2787r896b2821],
9	no	DT	O	no	det	10	SENT_75	[p6l422t2826r455b2844],
10	genotyped	NN	O	genotyped	dep	8	SENT_75	[p6l347t2861r496b2891],

1	232	CD	NUMBER	232	_	0	SENT_76	[p6l593t2901r649b2926],
2	genotyped	JJ	O	genotyped	amod	1	SENT_76	[p6l660t2899r832b2932],
3	235	CD	NUMBER	235	tmod	2	SENT_76	[p6l1302t2901r1357b2926],
4	genotyped	VBN	O	genotype	partmod	1	SENT_76	[p6l1369t2899r1541b2932],

1	13	CD	NUMBER	13	npadvmod	2	SENT_77	[p6l1662t2821r1693b2844],
2	not	RB	O	not	neg	3	SENT_77	[p6l1705t2822r1750b2844],
3	genotyped	VBN	O	genotype	_	0	SENT_77	[p6l1630t2861r1779b2891],

1	Letrozolez	NNP	O	Letrozolez	_	0	SENT_78	[p6l1476t3051r1811b3109],
2	219	CD	NUMBER	219	dep	1	SENT_78	[p6l1838t3055r1960b3109],

1	13	CD	NUMBER	13	_	0	SENT_79	[p6l715t3104r790b3159],
2	d/c	JJ	O	d/c	amod	3	SENT_79	[p6l817t3097r923b3170],
3	letrozole	NN	O	letrozole	dep	1	SENT_79	[p6l951t3101r1242b3159],
4	for	IN	O	for	_	0	SENT_79	[p6l681t3202r777b3262],
5	other	JJ	O	other	amod	6	SENT_79	[p6l800t3202r986b3262],
6	reasons	NNS	O	reason	prep_for	3	SENT_79	[p6l1012t3220r1271b3262],

1	68	CD	NUMBER	68	num	3	SENT_80	[p6l1427t3357r1507b3413],
2	d/c	JJ	O	d/c	amod	3	SENT_80	[p6l1532t3350r1641b3424],
3	letrozole	NN	O	letrozole	_	0	SENT_80	[p6l1669t3354r1968b3413],
4	for	IN	O	for	_	0	SENT_80	[p6l1991t3354r2090b3412],
5	toxicity	NN	O	toxicity	prep_for	3	SENT_80	[p6l1487t3457r1744b3528],
6	(	CD	PERCENT	(	number	7	SENT_80	[p6l1767t3455r2024b3528],
7	29.3	CD	PERCENT	29.3	num	8	SENT_80	[p6l1767t3455r2024b3528],
8	%	NN	PERCENT	%	dep	3	SENT_80	[p6l1767t3455r2024b3528],
9	)	CD	NUMBER	)	dep	8	SENT_80	[p6l1767t3455r2024b3528],

1	AIMSS	NNP	O	AIMSS	_	0	SENT_81	[p7l1193t90r1439b144],
2	:	:	O	:	_	0	SENT_81	[p7l1193t90r1439b144],
3	53	CD	PERCENT	53	number	4	SENT_81	[p7l1706t90r1784b144],
4	(	CD	PERCENT	(	dep	9	SENT_81	[p7l1812t85r2069b158],
5	77.9	CD	PERCENT	77.9	num	6	SENT_81	[p7l1812t85r2069b158],
6	%	NN	PERCENT	%	dep	4	SENT_81	[p7l1812t85r2069b158],
7	)	CD	NUMBER	)	dep	4	SENT_81	[p7l1812t85r2069b158],
8	No	DT	O	no	det	9	SENT_81	[p7l1198t192r1290b246],
9	AIMSS	NN	O	aimss	dep	1	SENT_81	[p7l1314t191r1560b246],
10	:	:	O	:	_	0	SENT_81	[p7l1314t191r1560b246],
11	15	CD	PERCENT	15	dep	15	SENT_81	[p7l1708t192r1784b246],
12	(	CD	PERCENT	(	number	13	SENT_81	[p7l1812t187r2069b260],
13	22.1	CD	PERCENT	22.1	dep	14	SENT_81	[p7l1812t187r2069b260],
14	%	NN	PERCENT	%	dep	11	SENT_81	[p7l1812t187r2069b260],
15	)	CD	NUMBER	)	parataxis	9	SENT_81	[p7l1812t187r2069b260],

1	Fig	NN	O	fig	_	0	SENT_82	[p7l7t419r129b487],
2	.	.	O	.	_	0	SENT_82	[p7l7t419r129b487],

1	1	LS	NUMBER	1	dep	3	SENT_83	[p7l161t419r191b472],
2	Consort	NN	O	consort	nn	3	SENT_83	[p7l268t420r507b473],
3	diagram	NN	O	diagram	_	0	SENT_83	[p7l535t420r784b488],
4	of	IN	O	of	_	0	SENT_83	[p7l811t419r877b473],
5	patient	NN	O	patient	nn	6	SENT_83	[p7l898t419r1106b488],
6	ﬂow	NN	O	ﬂow	prep_of	3	SENT_83	[p7l1134t419r1265b473],
7	in	IN	O	in	_	0	SENT_83	[p7l1294t419r1352b472],
8	the	DT	O	the	det	9	SENT_83	[p7l1379t419r1470b473],
9	study	NN	O	study	prep_in	3	SENT_83	[p7l1501t420r1661b488],

1	(	NN	O	(	nn	2	SENT_84	[p7l10t650r335b727],
2	ARVCF	NN	O	arvcf	_	0	SENT_84	[p7l10t650r335b727],
3	,	,	O	,	_	0	SENT_84	[p7l10t650r335b727],
4	COMT	NNP	O	COMT	appos	2	SENT_84	[p7l382t651r643b724],
5	,	,	O	,	_	0	SENT_84	[p7l382t651r643b724],
6	CYP	NNP	O	CYP	nn	8	SENT_84	[p7l690t650r1086b727],
7	]	CD	NUMBER	]	num	8	SENT_84	[p7l690t650r1086b727],
8	9A	NN	O	9a	appos	2	SENT_84	[p7l690t650r1086b727],
9	]	CD	NUMBER	]	num	10	SENT_84	[p7l690t650r1086b727],
10	)	NN	O	)	dep	8	SENT_84	[p7l690t650r1086b727],
11	,	,	O	,	_	0	SENT_84	[p7l690t650r1086b727],
12	estrogen	NN	O	estrogen	nn	13	SENT_84	[p7l1130t659r1432b731],
13	receptor	NN	O	receptor	appos	2	SENT_84	[p7l1470t659r1766b731],
14	(	CD	NUMBER	(	num	16	SENT_84	[p7l1807t651r1973b727],
15	ER	NN	O	er	nn	16	SENT_84	[p7l1807t651r1973b727],
16	)	NN	O	)	dep	13	SENT_84	[p7l1807t651r1973b727],
17	signaling	NN	O	signaling	nn	19	SENT_84	[p7l2019t650r2145b731, p7l7t761r229b842],
18	(	CD	NUMBER	(	num	19	SENT_84	[p7l271t762r515b838],
19	ESRI	NNP	ORGANIZATION	ESRI	dep	2	SENT_84	[p7l271t762r515b838],
20	,	,	O	,	_	0	SENT_84	[p7l271t762r515b838],
21	ESR2	NN	O	esr2	conj_and	19	SENT_84	[p7l554t762r773b835],
22	,	,	O	,	_	0	SENT_84	[p7l554t762r773b835],
23	PGR	NN	O	pgr	nn	24	SENT_84	[p7l812t762r1035b838],
24	)	NN	O	)	conj_and	19	SENT_84	[p7l812t762r1035b838],
25	,	,	O	,	_	0	SENT_84	[p7l812t762r1035b838],
26	co	NN	O	co	nn	28	SENT_84	[p7l1077t761r1555b842],
27	—	NN	O	—	nn	28	SENT_84	[p7l1077t761r1555b842],
28	regulation	NN	O	regulation	conj_and	19	SENT_84	[p7l1077t761r1555b842],
29	of	IN	O	of	_	0	SENT_84	[p7l1594t761r1671b824],
30	ER	NN	O	er	nn	32	SENT_84	[p7l1702t763r1815b823],
31	(	NN	O	(	nn	32	SENT_84	[p7l1856t762r2144b838],
32	EP300	NN	O	ep300	prep_of	28	SENT_84	[p7l1856t762r2144b838],
33	,	,	O	,	_	0	SENT_84	[p7l1856t762r2144b838],
34	EZH2	NN	O	ezh2	conj_and	32	SENT_84	[p7l6t873r238b946],
35	,	,	O	,	_	0	SENT_84	[p7l6t873r238b946],
36	NCOAI-3	NN	O	ncoai-3	conj_and	32	SENT_84	[p7l281t873r660b946],
37	,	,	O	,	_	0	SENT_84	[p7l281t873r660b946],
38	NCOR1-2	NN	O	ncor1-2	conj_and	32	SENT_84	[p7l704t873r1083b947],
39	,	,	O	,	_	0	SENT_84	[p7l704t873r1083b947],
40	NRIP	NN	O	nrip	conj_and	32	SENT_84	[p7l1126t875r1346b946],
41	,	,	O	,	_	0	SENT_84	[p7l1126t875r1346b946],
42	PELPI	NN	O	pelpus	nn	43	SENT_84	[p7l1390t873r1699b950],
43	)	NN	O	)	conj_and	32	SENT_84	[p7l1390t873r1699b950],
44	,	,	O	,	_	0	SENT_84	[p7l1390t873r1699b950],
45	and	CC	O	and	_	0	SENT_84	[p7l1747t872r1873b935],
46	neurotransmitter	NN	O	neurotransmitter	conj_and	32	SENT_84	[p7l1915t892r2145b935, p7l7t984r397b1047],
47	and	CC	O	and	_	0	SENT_84	[p7l442t984r568b1047],
48	neuropeptide	NN	O	neuropeptide	nn	49	SENT_84	[p7l611t984r1078b1065],
49	signaling	NN	O	signaling	dep	2	SENT_84	[p7l1126t984r1450b1065],
50	(	CD	NUMBER	(	num	51	SENT_84	[p7l1498t985r1811b1062],
51	HTRIA	NN	LOCATION	htrium	dep	2	SENT_84	[p7l1498t985r1811b1062],
52	,	,	O	,	_	0	SENT_84	[p7l1498t985r1811b1062],
53	HTR2A	NN	O	htr2a	appos	51	SENT_84	[p7l1856t985r2144b1058],
54	,	,	O	,	_	0	SENT_84	[p7l1856t985r2144b1058],
55	SCL6A4	NN	O	scl6a4	appos	51	SENT_84	[p7l7t1094r323b1169],
56	,	,	O	,	_	0	SENT_84	[p7l7t1094r323b1169],
57	HCRT	NN	O	hcrt	appos	51	SENT_84	[p7l352t1096r600b1169],
58	,	,	O	,	_	0	SENT_84	[p7l352t1096r600b1169],
59	HCRTR1	NN	O	hcrtr1	appos	51	SENT_84	[p7l629t1095r951b1158],
60	,	,	O	,	_	0	SENT_84	[p7l965t1147r977b1169],
61	HCRTR2	NN	O	hcrtr2	nn	62	SENT_84	[p7l1006t1095r1383b1172],
62	)	NN	O	)	appos	51	SENT_84	[p7l1006t1095r1383b1172],
63	.	.	O	.	_	0	SENT_84	[p7l1006t1095r1383b1172],

1	SNPs	NNS	O	snp	nsubjpass	3	SENT_85	[p7l1418t1095r1609b1158],
2	were	VBD	O	be	auxpass	3	SENT_85	[p7l1640t1114r1811b1158],
3	included	VBN	O	include	_	0	SENT_85	[p7l1840t1095r2149b1157],
4	based	VBN	O	base	_	0	SENT_85	[p7l6t1206r210b1268],
5	on	IN	O	on	prepc_based_on	3	SENT_85	[p7l263t1225r350b1268],
6	their	PRP$	O	they	poss	9	SENT_85	[p7l402t1206r567b1268],
7	potential	JJ	O	potential	amod	9	SENT_85	[p7l616t1206r930b1287],
8	functional	JJ	O	functional	amod	9	SENT_85	[p7l984t1206r1346b1268],
9	signiﬁcance	NN	O	signiﬁcance	pobj	3	SENT_85	[p7l1403t1206r1826b1287],
10	and	CC	O	and	_	0	SENT_85	[p7l1882t1206r2008b1268],
11	on	IN	O	on	conj_and	3	SENT_85	[p7l2061t1225r2148b1268],
12	mapping	NN	O	mapping	pobj	11	SENT_85	[p7l7t1318r318b1399],
13	of	IN	O	of	_	0	SENT_85	[p7l359t1318r436b1381],
14	tag	NN	O	tag	nn	15	SENT_85	[p7l468t1328r575b1399],
15	SNPs	NNS	O	snp	prep_of	12	SENT_85	[p7l617t1319r828b1381],
16	.	.	O	.	_	0	SENT_85	[p7l617t1319r828b1381],

1	Before	IN	O	before	_	0	SENT_86	[p7l871t1318r1112b1381],
2	analyzing	VBG	O	analyze	prepc_before	18	SENT_86	[p7l1153t1318r1498b1399],
3	DNA	NN	MISC	dna	nn	7	SENT_86	[p7l1537t1319r1748b1393],
4	,	,	O	,	_	0	SENT_86	[p7l1537t1319r1748b1393],
5	additional	JJ	O	additional	amod	7	SENT_86	[p7l1791t1318r2147b1381],
6	candidate	NN	O	candidate	nn	7	SENT_86	[p7l8t1429r350b1492],
7	SNPS	NN	O	snp	dobj	2	SENT_86	[p7l399t1429r591b1492],
8	near	IN	O	near	_	0	SENT_86	[p7l639t1449r793b1492],
9	the	DT	O	the	det	11	SENT_86	[p7l838t1429r945b1492],
10	TCLIA	NN	O	tclium	nn	11	SENT_86	[p7l995t1430r1245b1492],
11	gene	NN	O	gene	prep_near	2	SENT_86	[p7l1295t1449r1461b1510],
12	and	CC	O	and	_	0	SENT_86	[p7l1510t1429r1637b1492],
13	in	IN	O	in	_	0	SENT_86	[p7l1682t1429r1749b1491],
14	CYPI	NNP	O	CYPI	nn	16	SENT_86	[p7l1800t1430r1996b1492],
15	9A	NN	O	9a	nn	16	SENT_86	[p7l2005t1429r2141b1492],
16	]	NN	O	]	prep_in	2	SENT_86	[p7l2005t1429r2141b1492],
17	were	VBD	O	be	auxpass	18	SENT_86	[p7l8t1559r178b1603],
18	identiﬁed	VBN	O	identiﬁed	_	0	SENT_86	[p7l225t1540r563b1602],
19	through	IN	O	through	_	0	SENT_86	[p7l607t1540r885b1621],
20	ongoing	JJ	O	ongoing	amod	21	SENT_86	[p7l930t1540r1220b1621],
21	review	NN	O	review	prep_through	18	SENT_86	[p7l1265t1540r1508b1603],
22	of	IN	O	of	_	0	SENT_86	[p7l1555t1540r1632b1602],
23	the	DT	O	the	det	25	SENT_86	[p7l1671t1540r1778b1602],
24	literature	NN	O	literature	nn	25	SENT_86	[p7l1824t1540r2146b1602],
25	[	NN	O	[	prep_of	21	SENT_86	[p7l13t1651r143b1727],
26	16	CD	NUMBER	16	nsubjpass	18	SENT_86	[p7l13t1651r143b1727],
27	,	,	O	,	_	0	SENT_86	[p7l13t1651r143b1727],
28	19	CD	NUMBER	19	num	29	SENT_86	[p7l193t1651r319b1727],
29	]	NN	O	]	appos	26	SENT_86	[p7l193t1651r319b1727],
30	.	.	O	.	_	0	SENT_86	[p7l193t1651r319b1727],

1	In	IN	O	in	_	0	SENT_87	[p7l360t1652r433b1713],
2	total	NN	O	total	prep_in	12	SENT_87	[p7l469t1651r647b1725],
3	,	,	O	,	_	0	SENT_87	[p7l469t1651r647b1725],
4	178	CD	NUMBER	178	num	6	SENT_87	[p7l695t1651r816b1714],
5	candidate	NN	O	candidate	nn	6	SENT_87	[p7l857t1651r1199b1714],
6	variants	NNS	O	variant	nsubjpass	12	SENT_87	[p7l1237t1651r1517b1714],
7	in	IN	O	in	_	0	SENT_87	[p7l1556t1651r1624b1713],
8	24	CD	NUMBER	24	num	10	SENT_87	[p7l1662t1651r1747b1713],
9	individual	JJ	O	individual	amod	10	SENT_87	[p7l1785t1651r2147b1714],
10	genes	NNS	O	gene	prep_in	6	SENT_87	[p7l8t1783r207b1844],
11	were	VBD	O	be	auxpass	12	SENT_87	[p7l250t1783r420b1826],
12	identiﬁed	VBN	O	identiﬁed	_	0	SENT_87	[p7l462t1763r816b1826],
13	.	.	O	.	_	0	SENT_87	[p7l462t1763r816b1826],

1	Genotype	NN	MISC	genotype	nn	3	SENT_88	[p7l863t1764r1208b1844],
2	quality	NN	O	quality	nn	3	SENT_88	[p7l1249t1763r1495b1844],
3	control	NN	O	control	nsubjpass	5	SENT_88	[p7l1537t1763r1788b1826],
4	was	VBD	O	be	auxpass	5	SENT_88	[p7l1829t1783r1963b1826],
5	performed	VBN	O	perform	_	0	SENT_88	[p7l2004t1783r2145b1844, p7l8t1874r265b1937],
6	before	IN	O	before	_	0	SENT_88	[p7l295t1874r522b1937],
7	analysis	NN	O	analysis	prep_before	5	SENT_88	[p7l557t1874r841b1955],
8	of	IN	O	of	_	0	SENT_88	[p7l874t1874r951b1937],
9	the	DT	O	the	det	11	SENT_88	[p7l977t1874r1084b1937],
10	genetic	JJ	O	genetic	amod	11	SENT_88	[p7l1116t1874r1372b1955],
11	associations	NNS	O	association	prep_of	7	SENT_88	[p7l1407t1874r1855b1937],
12	.	.	O	.	_	0	SENT_88	[p7l1407t1874r1855b1937],

1	The	DT	O	the	det	3	SENT_89	[p7l1891t1874r2028b1937],
2	37	CD	NUMBER	37	num	3	SENT_89	[p7l2063t1875r2145b1937],
3	variants	NNS	O	variant	_	0	SENT_89	[p7l7t1985r288b2048],
4	with	IN	O	with	_	0	SENT_89	[p7l327t1985r484b2048],
5	minor	JJ	O	minor	amod	7	SENT_89	[p7l521t1985r735b2048],
6	allele	NN	O	allele	nn	7	SENT_89	[p7l773t1985r963b2048],
7	frequencies	NNS	O	frequency	prep_with	3	SENT_89	[p7l1002t1985r1412b2066],
8	less	JJR	O	less	mwe	9	SENT_89	[p7l1451t1985r1582b2048],
9	than	IN	O	than	quantmod	10	SENT_89	[p7l1620t1985r1773b2048],
10	5	CD	PERCENT	5	num	11	SENT_89	[p7l1811t1985r1848b2048],
11	%	NN	PERCENT	%	dep	7	SENT_89	[p7l1888t1986r1975b2059],
12	,	,	O	,	_	0	SENT_89	[p7l1888t1986r1975b2059],
13	two	CD	NUMBER	two	appos	7	SENT_89	[p7l2015t1995r2147b2048],
14	that	WDT	O	that	nsubj	17	SENT_89	[p7l7t2095r141b2157],
15	did	VBD	O	do	aux	17	SENT_89	[p7l165t2095r277b2157],
16	not	RB	O	not	neg	17	SENT_89	[p7l300t2104r413b2157],
17	meet	VB	O	meet	rcmod	13	SENT_89	[p7l436t2104r611b2157],
18	Hardy	NNP	PERSON	Hardy	dobj	17	SENT_89	[p7l633t2095r1254b2176],
19	.	.	O	.	_	0	SENT_89	[p7l633t2095r1254b2176],

1	—	NN	O	—	_	0	SENT_90	[p7l633t2095r1254b2176],
2	.	.	O	.	_	0	SENT_90	[p7l633t2095r1254b2176],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_91	[p7l633t2095r1254b2176],
2	equilibrium	NN	O	equilibrium	nsubjpass	20	SENT_91	[p7l1279t2095r1717b2176],
3	,	,	O	,	_	0	SENT_91	[p7l1279t2095r1717b2176],
4	and	CC	O	and	_	0	SENT_91	[p7l1746t2095r1871b2157],
5	one	CD	NUMBER	one	conj_and	2	SENT_91	[p7l1896t2114r2021b2157],
6	for	IN	O	for	_	0	SENT_91	[p7l2046t2094r2149b2157],
7	which	WDT	O	which	rel	11	SENT_91	[p7l8t2206r224b2268],
8	genotype	NN	O	genotype	nsubjpass	11	SENT_91	[p7l251t2215r576b2287],
9	could	MD	O	could	aux	11	SENT_91	[p7l603t2206r801b2268],
10	be	VB	O	be	auxpass	11	SENT_91	[p7l824t2206r907b2268],
11	determined	VBN	O	determine	rcmod	2	SENT_91	[p7l933t2206r1337b2268],
12	in	IN	O	in	_	0	SENT_91	[p7l1361t2206r1428b2267],
13	fewer	JJR	O	fewer	mwe	14	SENT_91	[p7l1454t2205r1657b2268],
14	than	IN	O	than	quantmod	15	SENT_91	[p7l1681t2206r1833b2268],
15	80	CD	PERCENT	80	num	16	SENT_91	[p7l1862t2206r1946b2269],
16	%	NN	PERCENT	%	prep_in	11	SENT_91	[p7l1982t2206r2046b2268],
17	of	IN	O	of	_	0	SENT_91	[p7l2076t2206r2153b2268],
18	subjects	NNS	O	subject	prep_of	16	SENT_91	[p7l10t2318r293b2399],
19	were	VBD	O	be	auxpass	20	SENT_91	[p7l351t2338r522b2381],
20	excluded	VBN	O	exclude	_	0	SENT_91	[p7l580t2318r903b2381],
21	from	IN	O	from	_	0	SENT_91	[p7l959t2318r1132b2381],
22	analysis	NN	O	analysis	prep_from	20	SENT_91	[p7l1190t2318r1492b2399],
23	.	.	O	.	_	0	SENT_91	[p7l1190t2318r1492b2399],

1	A	DT	O	a	det	2	SENT_92	[p7l1554t2319r1616b2380],
2	total	NN	O	total	nsubjpass	10	SENT_92	[p7l1672t2318r1829b2381],
3	of	IN	O	of	_	0	SENT_92	[p7l1888t2318r1965b2381],
4	138	CD	NUMBER	138	num	5	SENT_92	[p7l2024t2319r2144b2381],
5	variants	NNS	O	variant	prep_of	2	SENT_92	[p7l7t2429r288b2492],
6	in	IN	O	in	_	0	SENT_92	[p7l314t2429r382b2491],
7	24	CD	NUMBER	24	num	8	SENT_92	[p7l407t2429r492b2491],
8	genes	NNS	O	gene	prep_in	5	SENT_92	[p7l518t2449r717b2510],
9	were	VBD	O	be	auxpass	10	SENT_92	[p7l744t2449r914b2492],
10	included	VBN	O	include	_	0	SENT_92	[p7l939t2429r1248b2492],
11	in	IN	O	in	_	0	SENT_92	[p7l1271t2429r1339b2491],
12	the	DT	O	the	det	14	SENT_92	[p7l1363t2429r1470b2492],
13	ﬁnal	JJ	O	ﬁnal	amod	14	SENT_92	[p7l1496t2429r1651b2492],
14	analysis	NN	O	analysis	prep_in	10	SENT_92	[p7l1678t2429r1981b2510],
15	.	.	O	.	_	0	SENT_92	[p7l1678t2429r1981b2510],

1	The	DT	O	the	det	4	SENT_93	[p7l2010t2429r2147b2492],
2	reference	NN	O	reference	nn	4	SENT_93	[p7l6t2540r340b2602],
3	SNP	NN	O	snp	nn	4	SENT_93	[p7l401t2540r560b2603],
4	numbers	NNS	O	number	nsubjpass	18	SENT_93	[p7l617t2540r944b2614],
5	,	,	O	,	_	0	SENT_93	[p7l617t2540r944b2614],
6	minor	JJ	O	minor	amod	8	SENT_93	[p7l1005t2540r1219b2602],
7	allele	NN	O	allele	nn	8	SENT_93	[p7l1277t2540r1467b2602],
8	frequencies	NNS	O	frequency	conj_and	4	SENT_93	[p7l1528t2540r1959b2621],
9	,	,	O	,	_	0	SENT_93	[p7l1528t2540r1959b2621],
10	and	CC	O	and	_	0	SENT_93	[p7l2022t2540r2148b2602],
11	genotype	NN	O	genotype	nn	12	SENT_93	[p7l8t2660r334b2732],
12	frequencies	NNS	O	frequency	conj_and	4	SENT_93	[p7l372t2651r782b2732],
13	for	IN	O	for	_	0	SENT_93	[p7l820t2651r923b2713],
14	each	DT	O	each	det	16	SENT_93	[p7l958t2651r1120b2713],
15	analyzed	VBN	O	analyze	amod	16	SENT_93	[p7l1158t2651r1476b2732],
16	SNP	NN	ORGANIZATION	snp	prep_for	12	SENT_93	[p7l1513t2651r1672b2714],
17	are	VBP	O	be	auxpass	18	SENT_93	[p7l1709t2670r1814b2713],
18	listed	VBN	O	list	_	0	SENT_93	[p7l1851t2651r2044b2713],
19	in	IN	O	in	_	0	SENT_93	[p7l2080t2651r2148b2713],
20	Supplemental	NNP	O	Supplemental	nn	21	SENT_93	[p7l9t2762r500b2843],
21	Table	NNP	O	Table	prep_in	18	SENT_93	[p7l533t2762r735b2825],
22	1	CD	NUMBER	1	num	21	SENT_93	[p7l777t2763r829b2825],
23	.	.	O	.	_	0	SENT_93	[p7l777t2763r829b2825],

1	Genotyping	VBG	O	genotype	_	0	SENT_94	[p7l111t2873r515b2954],
2	for	IN	O	for	_	0	SENT_94	[p7l544t2873r644b2936],
3	all	DT	O	all	det	4	SENT_94	[p7l672t2873r754b2936],
4	SNPS	NNS	O	snp	prep_for	1	SENT_94	[p7l785t2874r990b2947],
5	,	,	O	,	_	0	SENT_94	[p7l785t2874r990b2947],
6	except	IN	O	except	_	0	SENT_94	[p7l1022t2882r1246b2954],
7	for	IN	O	for	prepc_except_for	1	SENT_94	[p7l1273t2873r1373b2936],
8	the	DT	O	the	det	9	SENT_94	[p7l1399t2873r1503b2936],
9	TCLIA	NNP	LOCATION	TCLIA	pobj	1	SENT_94	[p7l1535t2874r1798b2947],
10	,	,	O	,	_	0	SENT_94	[p7l1535t2874r1798b2947],
11	CYP3A5	NN	O	cyp3a5	pobj	1	SENT_94	[p7l1833t2874r2144b2947],
12	,	,	O	,	_	0	SENT_94	[p7l1833t2874r2144b2947],
13	CYP2A6	NN	O	cyp2a6	conj_and	9	SENT_94	[p7l11t2984r317b3057],
14	,	,	O	,	_	0	SENT_94	[p7l11t2984r317b3057],
15	and	CC	O	and	_	0	SENT_94	[p7l346t2984r469b3047],
16	two	CD	NUMBER	two	pobj	1	SENT_94	[p7l486t2994r614b3047],
17	of	IN	O	of	_	0	SENT_94	[p7l635t2984r710b3047],
18	the	DT	O	the	det	21	SENT_94	[p7l722t2984r826b3047],
19	CYPI	NNP	MISC	CYPI	nn	21	SENT_94	[p7l849t2985r1040b3047],
20	9A1	NN	MISC	9a1	nn	21	SENT_94	[p7l1048t2985r1180b3047],
21	SNPs	NNS	MISC	snp	prep_of	16	SENT_94	[p7l1207t2985r1412b3058],
22	,	,	O	,	_	0	SENT_94	[p7l1207t2985r1412b3058],
23	was	VBD	O	be	auxpass	24	SENT_94	[p7l1435t3004r1566b3047],
24	performed	VBN	O	perform	aux	1	SENT_94	[p7l1585t2984r1946b3065],
25	using	VBG	O	use	xcomp	24	SENT_94	[p7l1963t2984r2147b3065],
26	the	DT	O	the	det	29	SENT_94	[p7l7t3096r111b3158],
27	BioTrove	NNP	O	BioTrove	nn	29	SENT_94	[p7l152t3096r482b3159],
28	OpenArrayTM	NN	O	openarraytm	nn	29	SENT_94	[p7l525t3078r1009b3177],
29	platform	NN	O	platform	dobj	25	SENT_94	[p7l1048t3096r1345b3177],
30	(	CD	NUMBER	(	num	32	SENT_94	[p7l1388t3096r1691b3177],
31	Applied	NNP	ORGANIZATION	Applied	nn	32	SENT_94	[p7l1388t3096r1691b3177],
32	Biosystems	NNP	ORGANIZATION	Biosystems	nsubj	1	SENT_94	[p7l1731t3096r2144b3177],
33	,	,	ORGANIZATION	,	_	0	SENT_94	[p7l1731t3096r2144b3177],
34	Inc	NNP	ORGANIZATION	Inc	appos	32	SENT_94	[p7l7t3209r134b3281],
35	,	,	O	,	_	0	SENT_94	[p7l7t3209r134b3281],
36	Foster	NNP	LOCATION	Foster	nn	41	SENT_94	[p7l155t3209r371b3270],
37	City	NNP	LOCATION	City	nn	41	SENT_94	[p7l389t3208r553b3289],
38	,	,	O	,	_	0	SENT_94	[p7l389t3208r553b3289],
39	CA	NNP	LOCATION	CA	appos	41	SENT_94	[p7l576t3208r712b3282],
40	,	,	O	,	_	0	SENT_94	[p7l576t3208r712b3282],
41	USA	NNP	LOCATION	USA	appos	34	SENT_94	[p7l734t3208r951b3285],
42	)	CD	NUMBER	)	num	41	SENT_94	[p7l734t3208r951b3285],
43	.	.	O	.	_	0	SENT_94	[p7l734t3208r951b3285],

1	The	DT	O	the	det	3	SENT_95	[p7l974t3208r1108b3270],
2	TCLIA	NN	MISC	tclium	nn	3	SENT_95	[p7l1130t3208r1373b3271],
3	SNPs	NNS	MISC	snp	nsubjpass	5	SENT_95	[p7l1397t3208r1583b3270],
4	were	VBD	O	be	auxpass	5	SENT_95	[p7l1604t3227r1769b3270],
5	genotyped	VBN	O	genotype	_	0	SENT_95	[p7l1790t3208r2148b3289],
6	using	VBG	O	use	xcomp	5	SENT_95	[p7l7t3319r191b3400],
7	individual	JJ	O	individual	amod	11	SENT_95	[p7l226t3319r572b3381],
8	TaqMan	NNP	O	TaqMan	nn	11	SENT_95	[p7l607t3300r950b3400],
9	®	NN	O	®	nn	11	SENT_95	[p7l607t3300r950b3400],
10	genotyping	NN	O	genotyping	nn	11	SENT_95	[p7l986t3319r1371b3400],
11	assays	NNS	O	assay	nsubj	12	SENT_95	[p7l1408t3339r1622b3400],
12	(	VBP	O	(	ccomp	6	SENT_95	[p7l1660t3319r1963b3400],
13	Applied	NNP	O	Applied	nn	14	SENT_95	[p7l1660t3319r1963b3400],
14	Biosystems	NNP	O	Biosystems	dobj	12	SENT_95	[p7l1995t3319r2145b3381, p7l10t3440r296b3512],
15	,	,	O	,	_	0	SENT_95	[p7l1995t3319r2145b3381, p7l10t3440r296b3512],
16	Inc	NNP	ORGANIZATION	Inc	appos	14	SENT_95	[p7l321t3433r447b3505],
17	,	,	O	,	_	0	SENT_95	[p7l321t3433r447b3505],
18	Foster	NNP	LOCATION	Foster	nn	19	SENT_95	[p7l471t3433r686b3494],
19	City	NNP	LOCATION	City	appos	14	SENT_95	[p7l707t3431r871b3512],
20	,	,	O	,	_	0	SENT_95	[p7l707t3431r871b3512],
21	CA	NNP	LOCATION	CA	appos	14	SENT_95	[p7l897t3431r1033b3505],
22	,	,	O	,	_	0	SENT_95	[p7l897t3431r1033b3505],
23	USA	NNP	LOCATION	USA	appos	14	SENT_95	[p7l1057t3431r1274b3508],
24	)	CD	NUMBER	)	num	23	SENT_95	[p7l1057t3431r1274b3508],
25	.	.	O	.	_	0	SENT_95	[p7l1057t3431r1274b3508],

1	The	DT	O	the	det	3	SENT_96	[p7l1300t3431r1433b3494],
2	assay	NN	O	assay	nn	3	SENT_96	[p7l1457t3451r1640b3512],
3	numbers	NNS	O	number	nsubj	8	SENT_96	[p7l1663t3431r1957b3494],
4	were	VBD	O	be	cop	8	SENT_96	[p7l1981t3451r2146b3494],
5	C_1927667_1O	NN	O	c_1927667_1o	nn	8	SENT_96	[p7l8t3542r581b3615],
6	(	CD	NUMBER	(	num	8	SENT_96	[p7l607t3542r1084b3619],
7	rs11849538	NN	O	rs11849538	nn	8	SENT_96	[p7l607t3542r1084b3619],
8	)	NN	O	)	_	0	SENT_96	[p7l607t3542r1084b3619],
9	,	,	O	,	_	0	SENT_96	[p7l607t3542r1084b3619],
10	C_1927662_10	NN	O	c_1927662_10	nn	13	SENT_96	[p7l1112t3542r1685b3615],
11	(	CD	NUMBER	(	num	13	SENT_96	[p7l1711t3542r2145b3619],
12	rs7159713	NN	O	rs7159713	nn	13	SENT_96	[p7l1711t3542r2145b3619],
13	)	NN	O	)	conj_and	8	SENT_96	[p7l1711t3542r2145b3619],
14	,	,	O	,	_	0	SENT_96	[p7l1711t3542r2145b3619],
15	C_1927663_2O	NN	O	c_1927663_2o	nn	18	SENT_96	[p7l8t3654r582b3727],
16	(	CD	NUMBER	(	num	18	SENT_96	[p7l713t3654r1146b3731],
17	rs2369049	NN	O	rs2369049	nn	18	SENT_96	[p7l713t3654r1146b3731],
18	)	NN	O	)	conj_and	8	SENT_96	[p7l713t3654r1146b3731],
19	,	,	O	,	_	0	SENT_96	[p7l713t3654r1146b3731],
20	and	CC	O	and	_	0	SENT_96	[p7l1280t3654r1403b3717],
21	C_29078024_lO	NN	O	c_29078024_lo	conj_and	8	SENT_96	[p7l1531t3654r2148b3727],

1	(	NN	O	(	nn	2	SENT_97	[p8l10t24r423b102],
2	rs7158782	NN	O	rs7158782	_	0	SENT_97	[p8l10t24r423b102],
3	)	CD	NUMBER	)	number	4	SENT_97	[p8l10t24r423b102],
4	[	CD	NUMBER	[	dep	2	SENT_97	[p8l446t24r575b100],
5	16	CD	NUMBER	16	num	6	SENT_97	[p8l446t24r575b100],
6	]	NN	O	]	dep	4	SENT_97	[p8l446t24r575b100],
7	.	.	O	.	_	0	SENT_97	[p8l588t77r598b87],

1	CYP3A5	NN	O	cyp3a5	nsubjpass	5	SENT_98	[p8l621t25r916b88],
2	*	CD	NUMBER	*	num	3	SENT_98	[p8l921t25r997b87],
3	3	CD	NUMBER	3	dep	1	SENT_98	[p8l921t25r997b87],
4	was	VBD	O	be	auxpass	5	SENT_98	[p8l1017t44r1148b87],
5	genotyped	VBN	O	genotype	_	0	SENT_98	[p8l1165t24r1522b105],
6	using	VBG	O	use	xcomp	5	SENT_98	[p8l1535t24r1720b105],
7	the	DT	O	the	det	12	SENT_98	[p8l1735t24r1839b87],
8	TaqMan	NN	O	taqman	nn	12	SENT_98	[p8l1854t26r2148b105],
9	assay	NN	O	assay	nn	12	SENT_98	[p8l9t155r192b216],
10	(	CD	NUMBER	(	num	12	SENT_98	[p8l253t135r940b213],
11	C_26201809_30	NN	O	c_26201809_30	nn	12	SENT_98	[p8l253t135r940b213],
12	)	NN	O	)	dobj	6	SENT_98	[p8l253t135r940b213],
13	.	.	O	.	_	0	SENT_98	[p8l253t135r940b213],

1	CYP2A6	NN	O	cyp2a6	nn	2	SENT_99	[p8l1003t135r1317b198],
2	genotyping	NN	O	genotyping	nsubjpass	4	SENT_99	[p8l1377t135r1761b216],
3	was	VBD	O	be	auxpass	4	SENT_99	[p8l1820t155r1951b198],
4	performed	VBN	O	perform	_	0	SENT_99	[p8l2009t155r2145b216, p8l8t246r256b309],
5	as	IN	O	as	mark	7	SENT_99	[p8l302t266r369b309],
6	previously	RB	DATE	previously	advmod	7	SENT_99	[p8l415t246r777b327],
7	described	VBN	O	describe	advcl	4	SENT_99	[p8l823t246r1151b309],
8	[	NN	O	[	nn	10	SENT_99	[p8l1202t246r1311b322],
9	6	CD	NUMBER	6	num	10	SENT_99	[p8l1202t246r1311b322],
10	]	NN	O	]	dobj	7	SENT_99	[p8l1202t246r1311b322],
11	.	.	O	.	_	0	SENT_99	[p8l1202t246r1311b322],

1	The	DT	O	the	det	8	SENT_100	[p8l1360t246r1493b309],
2	CYP19A1	NN	O	cyp19a1	nn	8	SENT_100	[p8l1544t247r1874b309],
3	TTT	NN	O	ttt	nn	8	SENT_100	[p8l1925t248r2085b308],
4	A	NN	O	a	nn	8	SENT_100	[p8l2085t247r2148b308],
5	repeat	NN	O	repeat	nn	8	SENT_100	[p8l6t365r218b437],
6	(	CD	NUMBER	(	num	8	SENT_100	[p8l265t355r722b433],
7	rs60271534	NN	O	rs60271534	nn	8	SENT_100	[p8l265t355r722b433],
8	)	NN	O	)	nsubjpass	17	SENT_100	[p8l265t355r722b433],
9	and	CC	O	and	_	0	SENT_100	[p8l773t356r895b418],
10	T	NN	O	t	nn	15	SENT_100	[p8l940t357r993b417],
11	CT	NN	O	ct	nn	15	SENT_100	[p8l995t356r1104b419],
12	deletion	NN	O	deletion	nn	15	SENT_100	[p8l1152t355r1427b418],
13	(	CD	NUMBER	(	num	15	SENT_100	[p8l1477t355r1932b433],
14	rs11575899	NN	O	rs11575899	nn	15	SENT_100	[p8l1477t355r1932b433],
15	)	NN	O	)	nsubjpass	17	SENT_100	[p8l1477t355r1932b433],
16	were	VBD	O	be	auxpass	17	SENT_100	[p8l1982t375r2148b418],
17	determined	VBN	O	determine	_	0	SENT_100	[p8l8t467r395b529],
18	using	VBG	O	use	xcomp	17	SENT_100	[p8l429t467r614b548],
19	PCR	NN	MISC	pcr	nn	22	SENT_100	[p8l650t467r814b530],
20	and	CC	O	and	_	0	SENT_100	[p8l851t467r974b529],
21	direct	JJ	O	direct	conj_and	19	SENT_100	[p8l1009t467r1203b529],
22	sequencing	NN	O	sequencing	dobj	18	SENT_100	[p8l1241t467r1641b548],
23	,	,	O	,	_	0	SENT_100	[p8l1241t467r1641b548],
24	as	IN	O	as	mark	26	SENT_100	[p8l1682t486r1749b529],
25	previously	RB	DATE	previously	advmod	26	SENT_100	[p8l1785t467r2147b548],
26	described	VBN	O	describe	dep	22	SENT_100	[p8l8t578r337b640],
27	[	NN	O	[	nn	29	SENT_100	[p8l376t578r528b653],
28	29	CD	NUMBER	29	num	29	SENT_100	[p8l376t578r528b653],
29	]	NN	O	]	dobj	26	SENT_100	[p8l376t578r528b653],
30	.	.	O	.	_	0	SENT_100	[p8l376t578r528b653],

1	For	IN	O	for	dep	8	SENT_101	[p8l566t579r687b640],
2	quality	NN	O	quality	nn	4	SENT_101	[p8l721t578r957b659],
3	control	NN	O	control	nn	4	SENT_101	[p8l992t578r1233b640],
4	purposes	NNS	O	purpose	pobj	1	SENT_101	[p8l1267t597r1590b659],
5	,	,	O	,	_	0	SENT_101	[p8l1267t597r1590b659],
6	~	NN	O	~	appos	4	SENT_101	[p8l1642t578r1801b641],
7	10	CD	PERCENT	10	num	8	SENT_101	[p8l1642t578r1801b641],
8	%	NN	PERCENT	%	_	0	SENT_101	[p8l1835t578r1899b641],
9	of	IN	O	of	_	0	SENT_101	[p8l1939t577r2015b640],
10	the	DT	O	the	prep_of	8	SENT_101	[p8l2044t578r2147b640],

1	Exemestane	NNP	O	Exemestane	_	0	SENT_102	[p8l161t853r592b906],
2	:	:	O	:	_	0	SENT_102	[p8l161t853r592b906],
3	22	CD	NUMBER	22	num	5	SENT_102	[p8l887t891r963b946],
4	d/c	NN	O	d/c	nn	5	SENT_102	[p8l989t885r1094b957],
5	exemestane	NN	O	exemestane	nsubj	7	SENT_102	[p8l1119t896r1523b947],
6	213	CD	NUMBER	213	num	7	SENT_102	[p8l175t953r295b1007],
7	(	NN	O	(	dep	1	SENT_102	[p8l322t948r576b1021],
8	905	CD	PERCENT	905	num	9	SENT_102	[p8l322t948r576b1021],
9	%	NN	PERCENT	%	dobj	7	SENT_102	[p8l322t948r576b1021],
10	)	CD	NUMBER	)	dep	9	SENT_102	[p8l322t948r576b1021],
11	for	IN	O	for	_	0	SENT_102	[p8l912t989r1007b1047],
12	other	JJ	O	other	amod	13	SENT_102	[p8l1030t989r1213b1047],
13	reasons	NNS	O	reason	prep_for	7	SENT_102	[p8l1240t1006r1495b1047],

1	84	CD	NUMBER	84	num	3	SENT_103	[p8l72t1151r153b1206],
2	d/c	NN	O	d/c	nn	3	SENT_103	[p8l177t1144r285b1217],
3	exemestane	NN	O	exemestane	_	0	SENT_103	[p8l310t1156r724b1206],
4	for	IN	O	for	_	0	SENT_103	[p8l71t1249r169b1306],
5	toxicity	NN	O	toxicity	prep_for	3	SENT_103	[p8l190t1250r444b1320],
6	(	CD	PERCENT	(	number	7	SENT_103	[p8l468t1248r722b1320],
7	35.7	CD	PERCENT	35.7	num	8	SENT_103	[p8l468t1248r722b1320],
8	%	NN	PERCENT	%	dep	3	SENT_103	[p8l468t1248r722b1320],
9	)	CD	NUMBER	)	dep	8	SENT_103	[p8l468t1248r722b1320],

1	AIMSS	NNP	O	AIMSS	_	0	SENT_104	[p8l47t1495r289b1550],
2	:	:	O	:	_	0	SENT_104	[p8l47t1495r289b1550],
3	64	CD	PERCENT	64	dep	1	SENT_104	[p8l553t1495r632b1550],
4	(	CD	PERCENT	(	number	5	SENT_104	[p8l658t1491r911b1563],
5	75.2	CD	PERCENT	75.2	num	6	SENT_104	[p8l658t1491r911b1563],
6	%	NN	PERCENT	%	dep	3	SENT_104	[p8l658t1491r911b1563],
7	)	CD	NUMBER	)	dep	14	SENT_104	[p8l658t1491r911b1563],
8	No	DT	O	no	det	9	SENT_104	[p8l52t1597r143b1650],
9	AIMSS	NN	O	aimss	dep	7	SENT_104	[p8l166t1596r408b1650],
10	:	:	O	:	_	0	SENT_104	[p8l166t1596r408b1650],
11	20	CD	PERCENT	20	dep	9	SENT_104	[p8l553t1596r632b1650],
12	(	CD	PERCENT	(	dep	14	SENT_104	[p8l658t1591r911b1664],
13	23.8	CD	PERCENT	23.8	num	14	SENT_104	[p8l658t1591r911b1664],
14	%	NN	PERCENT	%	dep	1	SENT_104	[p8l658t1591r911b1664],
15	)	CD	NUMBER	)	dep	14	SENT_104	[p8l658t1591r911b1664],

1	samples	NNS	O	sample	nsubjpass	4	SENT_105	[p8l37t1876r306b1956],
2	were	VBD	O	be	auxpass	4	SENT_105	[p8l340t1895r503b1938],
3	randomly	RB	O	randomly	advmod	4	SENT_105	[p8l535t1876r862b1956],
4	selected	VBN	O	select	_	0	SENT_105	[p8l898t1876r1168b1937],
5	and	CC	O	and	_	0	SENT_105	[p8l1201t1876r1322b1937],
6	genotyped	VBN	O	genotype	conj_and	4	SENT_105	[p8l1355t1876r1708b1956],
7	in	IN	O	in	_	0	SENT_105	[p8l1740t1876r1805b1937],
8	duplicate	VB	O	duplicate	prepc_in	4	SENT_105	[p8l1838t1876r2147b1956],
9	using	VBG	O	use	xcomp	8	SENT_105	[p8l33t1985r215b2065],
10	the	DT	O	the	det	12	SENT_105	[p8l250t1985r352b2047],
11	same	JJ	O	same	amod	12	SENT_105	[p8l390t2005r561b2047],
12	assay	NN	O	assay	dobj	9	SENT_105	[p8l597t2005r795b2065],
13	,	,	O	,	_	0	SENT_105	[p8l597t2005r795b2065],
14	and	CC	O	and	_	0	SENT_105	[p8l834t1985r955b2047],
15	the	DT	O	the	det	18	SENT_105	[p8l988t1985r1090b2047],
16	overall	JJ	O	overall	amod	18	SENT_105	[p8l1126t1985r1359b2047],
17	concordance	NN	O	concordance	nn	18	SENT_105	[p8l1394t1985r1822b2047],
18	rate	NN	O	rate	nsubj	21	SENT_105	[p8l1855t1994r1981b2047],
19	was	VBD	O	be	cop	21	SENT_105	[p8l2016t2005r2146b2047],
20	97	CD	PERCENT	97	num	21	SENT_105	[p8l35t2096r116b2158],
21	%	NN	PERCENT	%	conj_and	4	SENT_105	[p8l152t2096r235b2157],
22	.	.	O	.	_	0	SENT_105	[p8l152t2096r235b2157],

1	Statistical	JJ	O	statistical	amod	2	SENT_106	[p8l36t2316r383b2378],
2	analysis	NN	O	analysis	_	0	SENT_106	[p8l417t2316r698b2396],

1	The	DT	O	the	det	3	SENT_107	[p8l34t2536r169b2598],
2	primary	JJ	O	primary	amod	3	SENT_107	[p8l196t2536r476b2616],
3	endpoint	NN	O	endpoint	nsubj	10	SENT_107	[p8l504t2536r814b2616],
4	of	IN	O	of	_	0	SENT_107	[p8l841t2536r917b2598],
5	the	DT	O	the	det	7	SENT_107	[p8l938t2536r1044b2598],
6	ELPh	NN	MISC	elph	nn	7	SENT_107	[p8l1071t2536r1272b2597],
7	trial	NN	O	trial	prep_of	3	SENT_107	[p8l1299t2536r1440b2598],
8	was	VBD	O	be	cop	10	SENT_107	[p8l1468t2556r1601b2598],
9	the	DT	O	the	det	10	SENT_107	[p8l1630t2536r1736b2598],
10	correlation	NN	O	correlation	_	0	SENT_107	[p8l1765t2536r2148b2598],
11	between	IN	O	between	_	0	SENT_107	[p8l32t2646r328b2708],
12	change	NN	O	change	prep_between	10	SENT_107	[p8l362t2646r609b2726],
13	in	IN	O	in	_	0	SENT_107	[p8l644t2646r710b2707],
14	breast	NN	O	breast	nn	15	SENT_107	[p8l742t2646r955b2708],
15	density	NN	O	density	prep_in	12	SENT_107	[p8l987t2646r1240b2726],
16	with	IN	O	with	_	0	SENT_107	[p8l1274t2646r1430b2708],
17	2	CD	DURATION	2	num	18	SENT_107	[p8l1464t2646r1504b2707],
18	years	NNS	NUMBER	year	prep_with	15	SENT_107	[p8l1536t2665r1719b2726],
19	of	IN	O	of	_	0	SENT_107	[p8l1755t2646r1831b2708],
20	AI	NN	O	aus	nn	21	SENT_107	[p8l1858t2647r1949b2707],
21	therapy	NN	O	therapy	prep_of	18	SENT_107	[p8l1982t2646r2145b2708, p8l36t2775r159b2836],
22	and	CC	O	and	_	0	SENT_107	[p8l192t2756r316b2817],
23	inherited	VBN	O	inherit	amod	25	SENT_107	[p8l346t2756r661b2817],
24	genetic	JJ	O	genetic	amod	25	SENT_107	[p8l692t2756r944b2836],
25	variants	NNS	O	variant	conj_and	12	SENT_107	[p8l977t2756r1253b2818],
26	in	IN	O	in	_	0	SENT_107	[p8l1286t2756r1352b2817],
27	CYP19	NN	O	cyp19	prep_in	25	SENT_107	[p8l1387t2756r1650b2829],
28	,	,	O	,	_	0	SENT_107	[p8l1387t2756r1650b2829],
29	the	DT	O	the	det	30	SENT_107	[p8l1683t2756r1789b2817],
30	gene	NN	O	gene	appos	27	SENT_107	[p8l1821t2775r1986b2836],
31	that	WDT	O	that	nsubj	32	SENT_107	[p8l2016t2756r2148b2817],
32	encodes	VBZ	O	encode	rcmod	30	SENT_107	[p8l35t2866r316b2927],
33	aromatase	NN	O	aromatase	dobj	32	SENT_107	[p8l348t2875r723b2928],
34	.	.	O	.	_	0	SENT_107	[p8l348t2875r723b2928],

1	These	DT	O	these	det	2	SENT_108	[p8l756t2866r965b2927],
2	data	NNS	O	datum	nsubjpass	5	SENT_108	[p8l995t2866r1141b2927],
3	will	MD	O	will	aux	5	SENT_108	[p8l1170t2866r1304b2928],
4	be	VB	O	be	auxpass	5	SENT_108	[p8l1333t2866r1415b2927],
5	reported	VBN	O	report	_	0	SENT_108	[p8l1443t2866r1738b2946],
6	separately	RB	O	separately	advmod	5	SENT_108	[p8l1770t2866r2143b2946],
7	.	.	O	.	_	0	SENT_108	[p8l1770t2866r2143b2946],

1	In	IN	O	in	_	0	SENT_109	[p8l34t2978r105b3037],
2	the	DT	O	the	det	4	SENT_109	[p8l129t2976r235b3038],
3	current	JJ	DATE	current	amod	4	SENT_109	[p8l261t2986r510b3038],
4	study	NN	O	study	prep_in	12	SENT_109	[p8l537t2976r742b3056],
5	,	,	O	,	_	0	SENT_109	[p8l537t2976r742b3056],
6	the	DT	O	the	det	9	SENT_109	[p8l770t2976r876b3038],
7	main	JJ	O	main	amod	9	SENT_109	[p8l901t2976r1077b3038],
8	exploratory	JJ	O	exploratory	amod	9	SENT_109	[p8l1102t2976r1508b3056],
9	objective	NN	O	objective	nsubj	12	SENT_109	[p8l1534t2976r1857b3056],
10	was	VBD	O	be	cop	12	SENT_109	[p8l1882t2996r2015b3038],
11	the	DT	O	the	det	12	SENT_109	[p8l2041t2976r2147b3038],
12	correlation	NN	O	correlation	_	0	SENT_109	[p8l35t3086r418b3148],
13	between	IN	O	between	_	0	SENT_109	[p8l453t3086r748b3148],
14	early	JJ	O	early	amod	16	SENT_109	[p8l785t3086r959b3166],
15	treatment	NN	O	treatment	nn	16	SENT_109	[p8l996t3095r1332b3148],
16	discontinuation	NN	O	discontinuation	prep_between	12	SENT_109	[p8l1368t3086r1914b3148],
17	of	IN	O	of	_	0	SENT_109	[p8l1950t3086r2026b3148],
18	AI	NN	O	aus	nn	19	SENT_109	[p8l2057t3087r2148b3147],
19	therapy	NN	O	therapy	prep_of	16	SENT_109	[p8l34t3196r297b3276],
20	due	JJ	O	due	_	0	SENT_109	[p8l326t3196r450b3258],
21	to	TO	O	to	_	0	SENT_109	[p8l477t3205r542b3258],
22	any	DT	O	any	det	23	SENT_109	[p8l572t3216r695b3276],
23	patient	NN	O	patient	prep_due_to	19	SENT_109	[p8l721t3196r1289b3276],
24	—	RB	O	—	advmod	25	SENT_109	[p8l721t3196r1289b3276],
25	reported	VBD	O	report	partmod	23	SENT_109	[p8l721t3196r1289b3276],
26	side	JJ	O	side	amod	27	SENT_109	[p8l1318t3196r1455b3258],
27	effect	NN	O	effect	dobj	25	SENT_109	[p8l1483t3196r1683b3258],
28	and	CC	O	and	_	0	SENT_109	[p8l1711t3196r1836b3258],
29	SNPs	NNS	O	snp	conj_and	27	SENT_109	[p8l1864t3197r2053b3258],
30	in	IN	O	in	_	0	SENT_109	[p8l2080t3196r2148b3257],
31	candidate	NN	O	candidate	nn	32	SENT_109	[p8l35t3306r373b3367],
32	genes	NNS	O	gene	prep_in	25	SENT_109	[p8l432t3325r649b3386],
33	.	.	O	.	_	0	SENT_109	[p8l432t3325r649b3386],

1	Treatment	NN	O	treatment	nn	2	SENT_110	[p8l712t3307r1077b3367],
2	discontinuation	NN	O	discontinuation	nsubj	8	SENT_110	[p8l1135t3306r1681b3367],
3	because	IN	O	because	_	0	SENT_110	[p8l1737t3306r2017b3367],
4	of	IN	O	of	prepc_because_of	8	SENT_110	[p8l2077t3306r2153b3367],
5	toxicity	NN	O	toxicity	pobj	8	SENT_110	[p8l34t3416r303b3496],
6	could	MD	O	could	aux	8	SENT_110	[p8l353t3416r548b3477],
7	have	VB	O	have	aux	8	SENT_110	[p8l595t3416r760b3477],
8	resulted	VBN	O	result	_	0	SENT_110	[p8l808t3416r1089b3477],
9	from	IN	O	from	prep	8	SENT_110	[p8l1137t3415r1308b3477],
10	either	CC	O	either	dep	9	SENT_110	[p8l1356t3416r1557b3477],
11	request	NN	O	request	conj	9	SENT_110	[p8l1603t3425r1859b3496],
12	by	IN	O	by	_	0	SENT_110	[p8l1906t3416r1992b3496],
13	the	DT	O	the	det	14	SENT_110	[p8l2041t3416r2147b3477],
14	patient	NN	O	patient	prep_by	9	SENT_110	[p8l32t3526r275b3606],
15	or	CC	O	or	_	0	SENT_110	[p8l310t3546r382b3588],
16	recommendation	NN	O	recommendation	conj_or	14	SENT_110	[p8l413t3526r1011b3588],
17	of	IN	O	of	_	0	SENT_110	[p8l1047t3526r1123b3588],
18	the	DT	O	the	det	20	SENT_110	[p8l1151t3526r1257b3588],
19	treating	VBG	O	treat	amod	20	SENT_110	[p8l1292t3526r1561b3606],
20	physician	NN	O	physician	prep_of	14	SENT_110	[p8l1596t3526r1953b3606],
21	.	.	O	.	_	0	SENT_110	[p8l1596t3526r1953b3606],

1	Secondary	JJ	O	secondary	amod	2	SENT_111	[p8l1994t3527r2145b3588, p8l35t3636r278b3716],
2	objectives	NNS	O	objective	nsubj	6	SENT_111	[p8l328t3636r683b3716],
3	of	IN	O	of	_	0	SENT_111	[p8l735t3636r811b3698],
4	this	DT	O	this	det	5	SENT_111	[p8l854t3636r978b3698],
5	study	NN	O	study	prep_of	2	SENT_111	[p8l1031t3636r1217b3716],
6	included	VBD	O	include	_	0	SENT_111	[p8l1266t3636r1572b3698],
7	(	CD	NUMBER	(	dobj	6	SENT_111	[p8l1622t3637r1713b3712],
8	a	DT	O	a	det	10	SENT_111	[p8l1622t3637r1713b3712],
9	)	NN	O	)	nn	10	SENT_111	[p8l1622t3637r1713b3712],
10	correlation	NN	O	correlation	npadvmod	6	SENT_111	[p8l1765t3636r2148b3698],
11	between	IN	O	between	_	0	SENT_111	[p9l33t22r328b84],
12	early	JJ	O	early	amod	14	SENT_111	[p9l359t22r532b102],
13	treatment	NN	O	treatment	nn	14	SENT_111	[p9l564t31r900b83],
14	discontinuation	NN	O	discontinuation	prep_between	10	SENT_111	[p9l930t22r1475b83],
15	of	IN	O	of	_	0	SENT_111	[p9l1506t22r1582b83],
16	AI	NN	O	aus	nn	17	SENT_111	[p9l1607t22r1697b83],
17	therapy	NN	O	therapy	prep_of	14	SENT_111	[p9l1727t22r1991b102],
18	due	JJ	O	due	amod	17	SENT_111	[p9l2023t22r2147b83],
19	to	TO	O	to	_	0	SENT_111	[p9l34t141r100b193],
20	AIMSS	NN	O	aimss	prep_to	18	SENT_111	[p9l144t132r407b194],
21	and	CC	O	and	_	0	SENT_111	[p9l457t132r581b193],
22	SNPs	NNS	O	snp	conj_and	20	SENT_111	[p9l627t132r816b194],
23	in	IN	O	in	_	0	SENT_111	[p9l861t132r928b193],
24	candidate	NN	O	candidate	nn	25	SENT_111	[p9l972t132r1310b193],
25	genes	NNS	O	gene	prep_in	17	SENT_111	[p9l1355t151r1573b212],
26	,	,	O	,	_	0	SENT_111	[p9l1355t151r1573b212],
27	(	NN	O	(	nn	30	SENT_111	[p9l1623t132r1718b208],
28	b	NN	O	b	nn	30	SENT_111	[p9l1623t132r1718b208],
29	)	NN	O	)	nn	30	SENT_111	[p9l1623t132r1718b208],
30	correlation	NN	O	correlation	conj_and	14	SENT_111	[p9l1765t132r2147b193],
31	between	IN	O	between	_	0	SENT_111	[p9l32t242r328b304],
32	early	JJ	O	early	amod	34	SENT_111	[p9l384t242r558b322],
33	treatment	NN	O	treatment	nn	34	SENT_111	[p9l614t251r950b304],
34	discontinuation	NN	O	discontinuation	prep_between	30	SENT_111	[p9l1005t242r1551b304],
35	of	IN	O	of	_	0	SENT_111	[p9l1607t242r1683b304],
36	speciﬁc	NN	O	speciﬁc	nn	38	SENT_111	[p9l1736t242r1999b322],
37	AI	NN	O	aus	nn	38	SENT_111	[p9l2057t243r2148b303],
38	medications	NNS	O	medication	prep_of	34	SENT_111	[p9l34t352r460b414],
39	due	JJ	O	due	amod	38	SENT_111	[p9l496t352r620b414],
40	to	TO	O	to	_	0	SENT_111	[p9l655t361r720b414],
41	any	DT	O	any	det	43	SENT_111	[p9l757t372r880b432],
42	side	JJ	O	side	amod	43	SENT_111	[p9l917t352r1054b414],
43	effect	NN	O	effect	prep_to	39	SENT_111	[p9l1089t352r1289b414],
44	and	CC	O	and	_	0	SENT_111	[p9l1324t352r1449b414],
45	SNPs	NNS	O	snp	conj_and	14	SENT_111	[p9l1484t353r1673b414],
46	in	IN	O	in	_	0	SENT_111	[p9l1708t352r1776b413],
47	candidate	NN	O	candidate	nn	48	SENT_111	[p9l1809t352r2147b414],
48	genes	NNS	O	gene	prep_in	45	SENT_111	[p9l35t482r253b542],
49	,	,	O	,	_	0	SENT_111	[p9l35t482r253b542],
50	and	CC	O	and	_	0	SENT_111	[p9l308t462r432b524],
51	(	NN	O	(	nn	54	SENT_111	[p9l485t463r575b538],
52	c	NN	O	c	nn	54	SENT_111	[p9l485t463r575b538],
53	)	NN	O	)	nn	54	SENT_111	[p9l485t463r575b538],
54	correlation	NN	O	correlation	conj_and	10	SENT_111	[p9l629t462r1012b524],
55	between	IN	O	between	_	0	SENT_111	[p9l1061t462r1356b524],
56	early	JJ	O	early	amod	58	SENT_111	[p9l1407t462r1581b542],
57	treatment	NN	O	treatment	nn	58	SENT_111	[p9l1632t471r1968b524],
58	discontinuation	NN	O	discontinuation	prep_between	54	SENT_111	[p9l2018t462r2145b524, p9l35t572r477b633],
59	of	IN	O	of	_	0	SENT_111	[p9l506t572r582b633],
60	speciﬁc	NN	O	speciﬁc	nn	62	SENT_111	[p9l608t572r871b652],
61	AI	NN	O	aus	nn	62	SENT_111	[p9l902t572r993b633],
62	medications	NNS	O	medication	prep_of	58	SENT_111	[p9l1021t572r1447b633],
63	due	JJ	O	due	_	0	SENT_111	[p9l1478t572r1602b633],
64	to	TO	O	to	_	0	SENT_111	[p9l1631t581r1697b633],
65	AIMSS	NN	O	aimss	prep_due_to	6	SENT_111	[p9l1726t572r1989b634],
66	and	CC	O	and	_	0	SENT_111	[p9l2024t572r2148b633],
67	SNPs	NNS	O	snp	prep_due_to	6	SENT_111	[p9l36t682r225b744],
68	in	IN	O	in	_	0	SENT_111	[p9l265t682r332b743],
69	candidate	NN	O	candidate	nn	70	SENT_111	[p9l371t682r709b743],
70	genes	NNS	O	gene	prep_in	6	SENT_111	[p9l748t701r965b762],
71	.	.	O	.	_	0	SENT_111	[p9l748t701r965b762],

1	Discontinuation	NN	O	discontinuation	nsubjpass	6	SENT_112	[p9l1007t682r1574b743],
2	due	JJ	O	due	_	0	SENT_112	[p9l1612t682r1736b743],
3	to	TO	O	to	_	0	SENT_112	[p9l1775t691r1841b743],
4	AIMSS	NNP	O	AIMSS	prep_due_to	1	SENT_112	[p9l1880t682r2144b744],
5	was	VBD	O	be	auxpass	6	SENT_112	[p9l34t812r167b854],
6	deﬁned	VBN	O	deﬁned	_	0	SENT_112	[p9l215t792r473b854],
7	as	IN	O	as	_	0	SENT_112	[p9l521t812r588b854],
8	premature	JJ	O	premature	amod	9	SENT_112	[p9l634t802r993b872],
9	discontinuation	NN	O	discontinuation	prep_as	6	SENT_112	[p9l1040t792r1586b854],
10	of	IN	O	of	_	0	SENT_112	[p9l1632t792r1708b854],
11	AI	NN	O	aus	nn	12	SENT_112	[p9l1747t793r1838b853],
12	therapy	NN	O	therapy	prep_of	9	SENT_112	[p9l1883t792r2147b872],
13	because	IN	O	because	_	0	SENT_112	[p9l32t902r312b964],
14	of	IN	O	of	_	0	SENT_112	[p9l358t902r434b964],
15	patient-reported	JJ	O	patient-reported	amod	17	SENT_112	[p9l470t902r1038b982],
16	intolerable	JJ	O	intolerable	amod	17	SENT_112	[p9l1081t902r1459b964],
17	arthralgias	NNS	O	arthralgia	prep_because_of	6	SENT_112	[p9l1505t902r1895b982],
18	,	,	O	,	_	0	SENT_112	[p9l1505t902r1895b982],
19	myalgias	NNS	O	myalgia	conj_or	17	SENT_112	[p9l1942t902r2145b982, p9l35t1012r193b1092],
20	,	,	O	,	_	0	SENT_112	[p9l1942t902r2145b982, p9l35t1012r193b1092],
21	joint	JJ	O	joint	amod	22	SENT_112	[p9l234t1012r403b1092],
22	pain	NN	O	pain	prep_because_of	6	SENT_112	[p9l445t1012r597b1092],
23	or	CC	O	or	_	0	SENT_112	[p9l643t1031r715b1073],
24	stiffness	NN	O	stiffness	conj_or	17	SENT_112	[p9l761t1012r1070b1085],
25	,	,	O	,	_	0	SENT_112	[p9l761t1012r1070b1085],
26	tendinitis	NN	O	tendinitis	prep_because_of	6	SENT_112	[p9l1117t1012r1466b1085],
27	,	,	O	,	_	0	SENT_112	[p9l1117t1012r1466b1085],
28	numbness	NN	O	numbness	prep_because_of	6	SENT_112	[p9l1514t1012r1864b1073],
29	or	CC	O	or	_	0	SENT_112	[p9l1912t1031r1984b1073],
30	tingling	JJ	O	tingling	amod	35	SENT_112	[p9l2026t1012r2145b1073, p9l35t1122r233b1202],
31	,	,	O	,	_	0	SENT_112	[p9l2026t1012r2145b1073, p9l35t1122r233b1202],
32	and/or	JJ	O	and/or	amod	35	SENT_112	[p9l270t1122r495b1184],
33	carpal	JJ	O	carpal	amod	35	SENT_112	[p9l526t1122r740b1202],
34	tunnel	NN	O	tunnel	nn	35	SENT_112	[p9l773t1122r992b1183],
35	syndrome	NN	O	syndrome	prep_because_of	6	SENT_112	[p9l1028t1122r1391b1202],
36	.	.	O	.	_	0	SENT_112	[p9l1028t1122r1391b1202],

1	Discontinuation	NN	O	discontinuation	nsubjpass	10	SENT_113	[p9l135t1232r700b1294],
2	because	IN	O	because	_	0	SENT_113	[p9l723t1232r1001b1294],
3	of	IN	O	of	_	0	SENT_113	[p9l1027t1232r1103b1294],
4	either	CC	O	either	preconj	6	SENT_113	[p9l1121t1232r1322b1294],
5	any	DT	O	any	det	6	SENT_113	[p9l1346t1252r1469b1312],
6	toxicity	NN	O	toxicity	prep_because_of	1	SENT_113	[p9l1493t1232r1762b1312],
7	or	CC	O	or	_	0	SENT_113	[p9l1787t1252r1859b1294],
8	AIMSS	NN	O	aimss	prep_because_of	1	SENT_113	[p9l1880t1233r2144b1294],
9	was	VBD	O	be	auxpass	10	SENT_113	[p9l34t1362r167b1404],
10	analyzed	VBN	O	analyze	_	0	SENT_113	[p9l196t1342r509b1422],
11	as	IN	O	as	_	0	SENT_113	[p9l535t1362r603b1404],
12	a	DT	O	a	det	13	SENT_113	[p9l631t1362r668b1404],
13	time	NN	O	time	prep_as	10	SENT_113	[p9l691t1342r847b1404],
14	to	TO	O	to	_	0	SENT_113	[p9l873t1351r938b1404],
15	event	NN	O	event	nn	16	SENT_113	[p9l965t1351r1155b1404],
16	outcome	NN	O	outcome	prep_to	10	SENT_113	[p9l1181t1352r1502b1404],
17	.	.	O	.	_	0	SENT_113	[p9l1181t1352r1502b1404],

1	Step	NN	O	step	npadvmod	3	SENT_114	[p9l1533t1342r1878b1422],
2	—	CD	NUMBER	—	num	1	SENT_114	[p9l1533t1342r1878b1422],
3	wise	JJ	O	wise	amod	4	SENT_114	[p9l1533t1342r1878b1422],
4	regression	NN	O	regression	nsubjpass	6	SENT_114	[p9l1902t1362r2145b1422, p9l37t1452r179b1514],
5	was	VBD	O	be	auxpass	6	SENT_114	[p9l207t1472r340b1514],
6	used	VBN	O	use	_	0	SENT_114	[p9l368t1452r530b1514],
7	to	TO	O	to	aux	8	SENT_114	[p9l556t1461r622b1514],
8	estimate	VB	O	estimate	xcomp	6	SENT_114	[p9l651t1452r945b1514],
9	the	DT	O	the	det	10	SENT_114	[p9l973t1452r1079b1514],
10	associations	NNS	O	association	dobj	8	SENT_114	[p9l1109t1452r1532b1514],
11	between	IN	O	between	_	0	SENT_114	[p9l1560t1452r1856b1514],
12	the	DT	O	the	det	13	SENT_114	[p9l1883t1452r1989b1514],
13	discontinuation	NN	O	discontinuation	prep_between	10	SENT_114	[p9l2018t1452r2145b1514, p9l35t1562r477b1623],
14	because	IN	O	because	_	0	SENT_114	[p9l508t1562r788b1623],
15	of	IN	O	of	_	0	SENT_114	[p9l822t1562r898b1623],
16	either	CC	O	either	preconj	18	SENT_114	[p9l925t1562r1127b1623],
17	any	DT	O	any	det	18	SENT_114	[p9l1160t1581r1283b1642],
18	toxicity	NN	O	toxicity	prep_because_of	8	SENT_114	[p9l1316t1562r1586b1642],
19	or	CC	O	or	_	0	SENT_114	[p9l1619t1581r1691b1623],
20	AIMSS	NN	O	aimss	nn	23	SENT_114	[p9l1722t1562r1986b1624],
21	and	CC	O	and	_	0	SENT_114	[p9l2024t1562r2148b1623],
22	SN	NN	O	sn	nn	23	SENT_114	[p9l36t1672r145b1734],
23	Ps	NNS	O	p	conj_or	18	SENT_114	[p9l146t1673r225b1733],
24	and	CC	O	and	_	0	SENT_114	[p9l251t1672r376b1733],
25	other	JJ	O	other	amod	27	SENT_114	[p9l398t1672r580b1733],
26	clinical	JJ	O	clinical	amod	27	SENT_114	[p9l601t1672r860b1733],
27	variables	NNS	O	variable	conj_and	18	SENT_114	[p9l883t1672r1219b1734],
28	.	.	O	.	_	0	SENT_114	[p9l883t1672r1219b1734],

1	The	DT	O	the	det	2	SENT_115	[p9l1246t1672r1381b1733],
2	associations	NNS	O	association	_	0	SENT_115	[p9l1406t1672r1830b1733],
3	between	IN	O	between	dep	2	SENT_115	[p9l1852t1672r2148b1734],
4	the	DT	O	the	det	5	SENT_115	[p9l34t1782r140b1844],
5	SNPs	NNS	O	snp	pobj	3	SENT_115	[p9l167t1783r356b1844],
6	and	CC	O	and	_	0	SENT_115	[p9l384t1782r508b1844],
7	discontinuation	NN	O	discontinuation	conj_and	5	SENT_115	[p9l533t1782r1079b1844],
8	because	IN	O	because	_	0	SENT_115	[p9l1102t1782r1382b1844],
9	of	IN	O	of	prepc_because_of	2	SENT_115	[p9l1408t1782r1484b1844],
10	either	CC	O	either	dep	2	SENT_115	[p9l1503t1782r1704b1844],
11	any	DT	O	any	det	12	SENT_115	[p9l1729t1802r1852b1862],
12	toxicity	NN	O	toxicity	conj	2	SENT_115	[p9l1878t1782r2147b1862],

1	@	IN	O	@	_	0	SENT_116	[p9l1784t2022r1860b2116],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_116	[p9l1889t2045r2148b2119],

1	810	CD	NUMBER	810	num	3	SENT_117	[p9l54t2194r104b2219],
2	Breast	NN	ORGANIZATION	breast	nn	3	SENT_117	[p9l1450t2194r1540b2219],
3	Cancer	NN	ORGANIZATION	cancer	dep	8	SENT_117	[p9l1552t2194r1652b2219],
4	Res	NNP	ORGANIZATION	Res	nn	5	SENT_117	[p9l1664t2194r1716b2219],
5	Treat	NNP	ORGANIZATION	Treat	dep	3	SENT_117	[p9l1729t2194r1804b2219],
6	(	CD	NUMBER	(	dep	8	SENT_117	[p9l1817t2194r1908b2224],
7	2013	CD	DATE	2013	num	8	SENT_117	[p9l1817t2194r1908b2224],
8	)	CD	NUMBER	)	dep	12	SENT_117	[p9l1817t2194r1908b2224],
9	l38	NN	O	l38	dep	8	SENT_117	[p9l1925t2194r2107b2219],
10	:807	CD	NUMBER	:807	num	9	SENT_117	[p9l1925t2194r2107b2219],
11	—	CD	NUMBER	—	num	12	SENT_117	[p9l1925t2194r2107b2219],
12	8l6	NN	O	8l6	_	0	SENT_117	[p9l1925t2194r2107b2219],

1	or	CC	O	or	cc	4	SENT_118	[p9l8t2382r81b2425],
2	AIMSS	NNP	O	AIMSS	nsubjpass	4	SENT_118	[p9l97t2363r363b2425],
3	were	VBD	O	be	auxpass	4	SENT_118	[p9l385t2382r556b2425],
4	analyzed	VBN	O	analyze	conj_or	4	SENT_118	[p9l576t2362r893b2443],
5	either	CC	O	either	advmod	4	SENT_118	[p9l911t2362r1115b2425],
6	without	IN	O	without	_	0	SENT_118	[p9l1131t2362r1405b2425],
7	or	CC	O	or	_	0	SENT_118	[p9l1422t2382r1495b2425],
8	with	IN	O	with	_	0	SENT_118	[p9l1511t2362r1668b2425],
9	justifying	VBG	O	justify	prepc_without	4	SENT_118	[p9l1678t2362r2027b2443],
10	for	IN	O	for	_	0	SENT_118	[p9l2046t2362r2149b2425],
11	the	DT	O	the	det	13	SENT_118	[p9l7t2473r114b2536],
12	other	JJ	O	other	amod	13	SENT_118	[p9l175t2473r358b2536],
13	variables	NNS	O	variable	prep_for	9	SENT_118	[p9l414t2473r755b2536],
14	.	.	O	.	_	0	SENT_118	[p9l414t2473r755b2536],

1	Three	CD	NUMBER	three	num	3	SENT_119	[p9l818t2473r1025b2536],
2	genetic	JJ	O	genetic	amod	3	SENT_119	[p9l1086t2473r1340b2554],
3	models	NNS	O	model	nsubjpass	14	SENT_119	[p9l1401t2473r1678b2547],
4	,	,	O	,	_	0	SENT_119	[p9l1401t2473r1678b2547],
5	speciﬁcally	RB	O	speciﬁcally	advmod	6	SENT_119	[p9l1743t2473r2147b2554],
6	dominant	JJ	O	dominant	amod	3	SENT_119	[p9l8t2584r365b2657],
7	,	,	O	,	_	0	SENT_119	[p9l8t2584r365b2657],
8	recessive	JJ	O	recessive	amod	3	SENT_119	[p9l395t2584r743b2657],
9	,	,	O	,	_	0	SENT_119	[p9l395t2584r743b2657],
10	and	CC	O	and	_	0	SENT_119	[p9l777t2584r904b2646],
11	additive	JJ	O	additive	amod	3	SENT_119	[p9l933t2584r1238b2657],
12	,	,	O	,	_	0	SENT_119	[p9l933t2584r1238b2657],
13	were	VBD	O	be	auxpass	14	SENT_119	[p9l1271t2603r1441b2646],
14	used	VBN	O	use	_	0	SENT_119	[p9l1471t2584r1634b2646],
15	to	TO	O	to	aux	16	SENT_119	[p9l1662t2593r1729b2646],
16	test	VB	O	test	xcomp	14	SENT_119	[p9l1758t2593r1881b2646],
17	for	IN	O	for	_	0	SENT_119	[p9l1909t2584r2013b2646],
18	the	DT	O	the	det	19	SENT_119	[p9l2040t2584r2147b2646],
19	associations	NNS	O	association	prep_for	16	SENT_119	[p9l9t2695r438b2758],
20	between	IN	O	between	_	0	SENT_119	[p9l473t2695r772b2758],
21	SNPs	NNS	O	snp	prep_between	19	SENT_119	[p9l809t2695r1000b2758],
22	and	CC	O	and	_	0	SENT_119	[p9l1038t2695r1164b2758],
23	treatment	NN	O	treatment	nn	24	SENT_119	[p9l1198t2704r1539b2758],
24	discontinuation	NN	O	discontinuation	prep_between	19	SENT_119	[p9l1573t2695r2143b2758],
25	.	.	O	.	_	0	SENT_119	[p9l1573t2695r2143b2758],

1	Statistical	JJ	O	statistical	amod	2	SENT_120	[p9l9t2806r360b2869],
2	signiﬁcance	NN	O	signiﬁcance	nsubjpass	4	SENT_120	[p9l398t2806r821b2887],
3	was	VBD	O	be	auxpass	4	SENT_120	[p9l856t2825r990b2869],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_120	[p9l1026t2806r1288b2868],
5	as	IN	O	as	_	0	SENT_120	[p9l1322t2825r1391b2868],
6	a	DT	O	a	det	8	SENT_120	[p9l1428t2825r1465b2868],
7	p	NN	O	p	nn	8	SENT_120	[p9l1489t2827r1538b2886],
8	value	NN	O	value	prep_as	4	SENT_120	[p9l1572t2806r1765b2868],
9	<	JJR	O	<	amod	8	SENT_120	[p9l1800t2805r2146b2869],
10	0.00036	CD	NUMBER	0.00036	dobj	4	SENT_120	[p9l1800t2805r2146b2869],
11	based	VBN	O	base	_	0	SENT_120	[p9l6t2918r210b2981],
12	on	IN	O	on	prepc_based_on	10	SENT_120	[p9l240t2938r326b2981],
13	Bonferroni	NNP	LOCATION	Bonferroni	nn	14	SENT_120	[p9l355t2918r746b2981],
14	correction	NN	O	correction	pobj	10	SENT_120	[p9l777t2918r1157b2981],
15	.	.	O	.	_	0	SENT_120	[p9l777t2918r1157b2981],

1	Manhattan	NNP	LOCATION	Manhattan	nn	2	SENT_121	[p9l1190t2918r1573b2981],
2	plots	NNS	O	plot	nsubjpass	4	SENT_121	[p9l1602t2918r1773b2999],
3	were	VBD	O	be	auxpass	4	SENT_121	[p9l1804t2938r1975b2981],
4	presented	VBN	O	present	_	0	SENT_121	[p9l2004t2938r2145b2999, p9l10t3029r235b3092],
5	to	TO	O	to	aux	6	SENT_121	[p9l262t3038r329b3092],
6	illustrate	VB	O	illustrate	xcomp	4	SENT_121	[p9l357t3029r669b3092],
7	the	DT	O	the	det	9	SENT_121	[p9l698t3029r805b3092],
8	statistical	JJ	O	statistical	amod	9	SENT_121	[p9l836t3029r1170b3092],
9	signiﬁcance	NN	O	signiﬁcance	dobj	6	SENT_121	[p9l1202t3029r1626b3110],
10	and	CC	O	and	_	0	SENT_121	[p9l1656t3029r1783b3092],
11	the	DT	O	the	det	13	SENT_121	[p9l1809t3029r1916b3092],
12	effect	NN	O	effect	nn	13	SENT_121	[p9l1945t3029r2149b3092],
13	size	NN	O	size	dobj	6	SENT_121	[p9l10t3140r144b3203],
14	of	IN	O	of	_	0	SENT_121	[p9l168t3140r245b3203],
15	the	DT	O	the	det	16	SENT_121	[p9l261t3140r368b3203],
16	SNPs	NNS	O	snp	prep_of	13	SENT_121	[p9l394t3140r604b3203],
17	.	.	O	.	_	0	SENT_121	[p9l394t3140r604b3203],

1	All	PDT	O	all	predet	4	SENT_122	[p9l631t3140r743b3202],
2	the	DT	O	the	det	4	SENT_122	[p9l765t3140r872b3203],
3	data	NN	O	datum	nn	4	SENT_122	[p9l896t3140r1044b3203],
4	analyses	NNS	O	analysis	nsubjpass	16	SENT_122	[p9l1067t3140r1366b3221],
5	were	VBD	O	be	auxpass	6	SENT_122	[p9l1390t3160r1560b3203],
6	performed	VBN	O	perform	rcmod	4	SENT_122	[p9l1583t3140r1957b3221],
7	in	IN	O	in	_	0	SENT_122	[p9l1978t3140r2046b3202],
8	R.	NNP	O	R.	nn	10	SENT_122	[p9l2068t3142r2143b3203],
9	The	NNP	O	The	nn	10	SENT_122	[p9l7t3251r144b3314],
10	data	NNS	O	datum	prep_in	6	SENT_122	[p9l166t3251r313b3314],
11	from	IN	O	from	_	0	SENT_122	[p9l332t3251r504b3314],
12	this	DT	O	this	det	14	SENT_122	[p9l523t3251r649b3314],
13	prospective	JJ	O	prospective	amod	14	SENT_122	[p9l669t3251r1081b3332],
14	trial	NN	O	trial	prep_from	6	SENT_122	[p9l1101t3251r1244b3314],
15	are	VBP	O	be	auxpass	16	SENT_122	[p9l1266t3271r1371b3314],
16	reported	VBN	O	report	_	0	SENT_122	[p9l1390t3251r1690b3332],
17	according	VBG	O	accord	_	0	SENT_122	[p9l1710t3251r2060b3332],
18	to	TO	O	to	prepc_according_to	16	SENT_122	[p9l2080t3261r2146b3314],
19	the	DT	O	the	det	20	SENT_122	[p9l7t3362r114b3425],
20	REMARK	NN	MISC	remark	pobj	16	SENT_122	[p9l140t3363r523b3424],
21	guidelines	NNS	O	guideline	nsubj	22	SENT_122	[p9l547t3362r912b3443],
22	[	VBP	O	[	rcmod	20	SENT_122	[p9l945t3363r1104b3438],
23	20	CD	NUMBER	20	number	24	SENT_122	[p9l945t3363r1104b3438],
24	]	CD	NUMBER	]	dobj	22	SENT_122	[p9l945t3363r1104b3438],
25	.	.	O	.	_	0	SENT_122	[p9l945t3363r1104b3438],

1	Results	NNS	O	result	_	0	SENT_123	[p9l8t3605r283b3668],

1	Patient	NN	O	patient	_	0	SENT_124	[p10l7t87r256b150],
2	and	CC	O	and	_	0	SENT_124	[p10l290t87r416b150],
3	sample	NN	O	sample	nn	4	SENT_124	[p10l451t87r700b168],
4	ﬂow	NN	O	ﬂow	conj_and	1	SENT_124	[p10l735t87r889b150],

1	Five	CD	NUMBER	five	num	2	SENT_125	[p10l7t311r164b373],
2	hundred	CD	NUMBER	hundred	nsubjpass	7	SENT_125	[p10l190t311r484b373],
3	and	CC	NUMBER	and	_	0	SENT_125	[p10l511t311r637b373],
4	three	CD	NUMBER	three	num	5	SENT_125	[p10l662t311r840b373],
5	subjects	NNS	O	subject	conj_and	2	SENT_125	[p10l870t311r1152b392],
6	were	VBD	O	be	auxpass	7	SENT_125	[p10l1181t330r1352b374],
7	enrolled	VBN	O	enrol	_	0	SENT_125	[p10l1380t311r1673b373],
8	on	IN	O	on	_	0	SENT_125	[p10l1699t330r1786b373],
9	the	DT	O	the	det	13	SENT_125	[p10l1811t311r1918b373],
10	ELPh	NN	O	elph	nn	13	SENT_125	[p10l1944t311r2148b372],
11	trial	NN	O	trial	nn	13	SENT_125	[p10l7t422r150b485],
12	(	CD	NUMBER	(	num	13	SENT_125	[p10l177t422r340b503],
13	Fig	NN	O	fig	prep_on	7	SENT_125	[p10l177t422r340b503],
14	.	.	O	.	_	0	SENT_125	[p10l177t422r340b503],

1	1	CD	NUMBER	1	_	0	SENT_126	[p10l385t423r467b500],
2	)	NN	O	)	dep	1	SENT_126	[p10l385t423r467b500],
3	.	.	O	.	_	0	SENT_126	[p10l385t423r467b500],

1	Five	CD	NUMBER	five	num	2	SENT_127	[p10l495t422r652b485],
2	hundred	CD	NUMBER	hundred	nsubjpass	4	SENT_127	[p10l677t422r970b485],
3	were	VBD	O	be	auxpass	4	SENT_127	[p10l994t442r1165b485],
4	randomized	VBN	O	randomize	_	0	SENT_127	[p10l1189t422r1614b485],
5	to	TO	O	to	_	0	SENT_127	[p10l1638t432r1704b485],
6	exemestane	NN	O	exemestane	nn	8	SENT_127	[p10l1730t432r2146b485],
7	(	NN	O	(	nn	8	SENT_127	[p10l10t534r79b611],
8	n	NN	O	n	prep_to	4	SENT_127	[p10l10t534r79b611],
9	=	JJ	O	=	quantmod	10	SENT_127	[p10l115t562r176b586],
10	248	CD	NUMBER	248	num	11	SENT_127	[p10l213t534r370b610],
11	)	NN	O	)	dep	8	SENT_127	[p10l213t534r370b610],
12	or	CC	O	or	_	0	SENT_127	[p10l406t553r479b596],
13	letrozole	NN	O	letrozole	nn	15	SENT_127	[p10l510t533r822b596],
14	(	NN	O	(	nn	15	SENT_127	[p10l858t534r926b611],
15	n	NN	O	n	conj_or	8	SENT_127	[p10l858t534r926b611],
16	=	JJ	O	=	amod	18	SENT_127	[p10l963t562r1023b586],
17	252	CD	NUMBER	252	tmod	16	SENT_127	[p10l1061t533r1240b611],
18	)	NN	O	)	dep	15	SENT_127	[p10l1061t533r1240b611],
19	,	,	O	,	_	0	SENT_127	[p10l1061t533r1240b611],
20	and	CC	O	and	_	0	SENT_127	[p10l1278t533r1404b596],
21	the	DT	O	the	det	24	SENT_127	[p10l1435t533r1542b596],
22	remaining	VBG	O	remain	amod	24	SENT_127	[p10l1574t533r1937b614],
23	three	CD	NUMBER	three	num	24	SENT_127	[p10l1969t533r2146b596],
24	subjects	NNS	O	subject	nsubj	25	SENT_127	[p10l10t644r293b725],
25	withdrew	VBD	O	withdraw	conj_and	4	SENT_127	[p10l348t644r684b707],
26	before	IN	O	before	_	0	SENT_127	[p10l737t644r964b706],
27	treatment	NN	O	treatment	nn	28	SENT_127	[p10l1018t653r1358b706],
28	initiation	NN	O	initiation	prep_before	25	SENT_127	[p10l1410t644r1752b706],
29	.	.	O	.	_	0	SENT_127	[p10l1410t644r1752b706],

1	Germline	NN	O	germline	nn	2	SENT_128	[p10l1811t644r2147b707],
2	DNA	NN	O	dna	nsubj	4	SENT_128	[p10l7t755r198b817],
3	was	VBD	O	be	cop	4	SENT_128	[p10l240t774r374b818],
4	available	JJ	O	available	_	0	SENT_128	[p10l419t755r740b818],
5	from	IN	O	from	_	0	SENT_128	[p10l782t755r955b817],
6	467	CD	PERCENT	467	number	7	SENT_128	[p10l995t755r1124b818],
7	(	CD	PERCENT	(	prep_from	4	SENT_128	[p10l1171t755r1352b832],
8	93.4	CD	PERCENT	93.4	num	9	SENT_128	[p10l1171t755r1352b832],
9	%	NN	PERCENT	%	dep	7	SENT_128	[p10l1389t755r1484b832],
10	)	CD	NUMBER	)	num	12	SENT_128	[p10l1389t755r1484b832],
11	eligible	JJ	O	eligible	amod	12	SENT_128	[p10l1529t755r1796b836],
12	subjects	NNS	O	subject	dep	9	SENT_128	[p10l1841t755r2143b836],
13	.	.	O	.	_	0	SENT_128	[p10l1841t755r2143b836],

1	Thirty	CD	NUMBER	thirty	num	5	SENT_129	[p10l7t866r394b947],
2	—	CD	NUMBER	—	num	5	SENT_129	[p10l7t866r394b947],
3	ﬁve	NN	O	ﬁve	nn	5	SENT_129	[p10l7t866r394b947],
4	eligible	JJ	O	eligible	amod	5	SENT_129	[p10l423t866r691b947],
5	subjects	NNS	O	subject	nsubj	46	SENT_129	[p10l722t866r1005b947],
6	with	IN	O	with	_	0	SENT_129	[p10l1035t866r1192b929],
7	available	JJ	O	available	amod	8	SENT_129	[p10l1221t866r1542b928],
8	DNA	NN	O	dna	prep_with	5	SENT_129	[p10l1571t866r1762b928],
9	discontinued	VBN	O	discontinue	amod	11	SENT_129	[p10l1791t866r2145b928, p10l7t977r136b1040],
10	AI	NN	O	aus	nn	11	SENT_129	[p10l152t978r244b1039],
11	therapy	NN	O	therapy	dep	8	SENT_129	[p10l261t977r528b1058],
12	for	IN	O	for	_	0	SENT_129	[p10l547t977r650b1040],
13	reasons	NNS	O	reason	prep_for	11	SENT_129	[p10l665t997r931b1040],
14	unrelated	JJ	O	unrelated	amod	11	SENT_129	[p10l950t977r1284b1040],
15	to	TO	O	to	_	0	SENT_129	[p10l1301t987r1368b1040],
16	toxicity	NN	O	toxicity	nn	18	SENT_129	[p10l1386t977r1659b1058],
17	[	CD	NUMBER	[	num	18	SENT_129	[p10l1683t977r2040b1053],
18	letrozole	NN	O	letrozole	prep_to	14	SENT_129	[p10l1683t977r2040b1053],
19	,	,	O	,	_	0	SENT_129	[p10l1683t977r2040b1053],
20	13	CD	PERCENT	13	number	21	SENT_129	[p10l2069t978r2143b1040],
21	(	CD	PERCENT	(	appos	11	SENT_129	[p10l10t1088r145b1165],
22	5.6	CD	PERCENT	5.6	num	23	SENT_129	[p10l10t1088r145b1165],
23	%	NN	PERCENT	%	dep	21	SENT_129	[p10l183t1089r278b1165],
24	)	CD	NUMBER	)	dep	21	SENT_129	[p10l183t1089r278b1165],
25	of	IN	O	of	_	0	SENT_129	[p10l326t1088r404b1151],
26	252	CD	NUMBER	252	num	27	SENT_129	[p10l443t1088r573b1151],
27	patients	NNS	O	patient	prep_of	24	SENT_129	[p10l616t1088r917b1169],
28	;	:	O	;	_	0	SENT_129	[p10l616t1088r917b1169],
29	exemestane	NN	O	exemestane	dep	11	SENT_129	[p10l966t1098r1403b1162],
30	,	,	O	,	_	0	SENT_129	[p10l966t1098r1403b1162],
31	22	CD	PERCENT	22	number	32	SENT_129	[p10l1452t1089r1536b1150],
32	(	CD	PERCENT	(	appos	29	SENT_129	[p10l1584t1089r1720b1165],
33	9.4	CD	PERCENT	9.4	num	34	SENT_129	[p10l1584t1089r1720b1165],
34	%	NN	PERCENT	%	dep	32	SENT_129	[p10l1757t1089r1853b1166],
35	)	CD	NUMBER	)	dep	11	SENT_129	[p10l1757t1089r1853b1166],
36	of	IN	O	of	_	0	SENT_129	[p10l1900t1088r1977b1151],
37	248	CD	NUMBER	248	num	38	SENT_129	[p10l2017t1089r2144b1151],
38	patients	NNS	O	patient	prep_of	35	SENT_129	[p10l6t1199r308b1280],
39	]	CD	NUMBER	]	dep	35	SENT_129	[p10l6t1199r308b1280],
40	and	CC	O	and	_	0	SENT_129	[p10l372t1199r498b1262],
41	were	VBD	O	be	auxpass	42	SENT_129	[p10l553t1219r723b1262],
42	excluded	VBN	O	exclude	dep	35	SENT_129	[p10l780t1199r1102b1262],
43	from	IN	O	from	_	0	SENT_129	[p10l1157t1199r1330b1262],
44	these	DT	O	these	det	45	SENT_129	[p10l1384t1199r1565b1262],
45	analyses	NNS	O	analysis	prep_from	42	SENT_129	[p10l1623t1199r1921b1280],
46	[	VBP	O	[	_	0	SENT_129	[p10l1985t1199r2143b1275],
47	14	CD	NUMBER	14	num	48	SENT_129	[p10l1985t1199r2143b1275],
48	]	CD	NUMBER	]	dobj	46	SENT_129	[p10l1985t1199r2143b1275],
49	.	.	O	.	_	0	SENT_129	[p10l1985t1199r2143b1275],

1	Baseline	NN	O	baseline	nn	2	SENT_130	[p10l7t1309r314b1371],
2	characteristics	NNS	O	characteristic	nsubj	7	SENT_130	[p10l333t1309r844b1371],
3	for	IN	O	for	_	0	SENT_130	[p10l862t1308r966b1371],
4	the	DT	O	the	det	6	SENT_130	[p10l980t1309r1087b1371],
5	432	CD	NUMBER	432	num	6	SENT_130	[p10l1104t1309r1236b1372],
6	subjects	NNS	O	subject	prep_for	2	SENT_130	[p10l1256t1309r1539b1390],
7	included	VBD	O	include	_	0	SENT_130	[p10l1557t1309r1866b1371],
8	in	IN	O	in	mark	12	SENT_130	[p10l1882t1309r1949b1370],
9	these	DT	O	these	det	10	SENT_130	[p10l1965t1309r2147b1371],
10	analyses	NNS	O	analysis	nsubjpass	12	SENT_130	[p10l9t1421r307b1502],
11	are	VBP	O	be	auxpass	12	SENT_130	[p10l338t1441r443b1484],
12	listed	VBN	O	list	advcl	7	SENT_130	[p10l470t1421r663b1484],
13	in	IN	O	in	_	0	SENT_130	[p10l688t1421r756b1483],
14	Table	NNP	O	Table	prep_in	12	SENT_130	[p10l782t1421r984b1484],
15	1	CD	NUMBER	1	num	14	SENT_130	[p10l1026t1422r1078b1484],
16	.	.	O	.	_	0	SENT_130	[p10l1026t1422r1078b1484],

1	The	DT	O	the	det	4	SENT_131	[p10l1108t1421r1245b1484],
2	reference	NN	O	reference	nn	4	SENT_131	[p10l1271t1421r1604b1484],
3	SNP	NN	O	snp	nn	4	SENT_131	[p10l1633t1422r1792b1484],
4	numbers	NNS	O	number	nsubjpass	18	SENT_131	[p10l1818t1421r2144b1495],
5	,	,	O	,	_	0	SENT_131	[p10l1818t1421r2144b1495],
6	minor	JJ	O	minor	amod	8	SENT_131	[p10l7t1532r221b1595],
7	allele	NN	O	allele	nn	8	SENT_131	[p10l245t1532r436b1595],
8	frequencies	NNS	O	frequency	conj_and	4	SENT_131	[p10l461t1532r893b1613],
9	,	,	O	,	_	0	SENT_131	[p10l461t1532r893b1613],
10	and	CC	O	and	_	0	SENT_131	[p10l922t1532r1048b1595],
11	genotype	NN	O	genotype	nn	12	SENT_131	[p10l1072t1542r1397b1613],
12	frequencies	NNS	O	frequency	conj_and	4	SENT_131	[p10l1423t1532r1833b1613],
13	for	IN	O	for	_	0	SENT_131	[p10l1859t1532r1963b1595],
14	each	DT	O	each	det	16	SENT_131	[p10l1985t1532r2148b1595],
15	analyzed	VBN	O	analyze	amod	16	SENT_131	[p10l9t1643r326b1724],
16	SNP	NN	ORGANIZATION	snp	prep_for	12	SENT_131	[p10l353t1643r512b1706],
17	are	VBP	O	be	auxpass	18	SENT_131	[p10l538t1662r643b1705],
18	listed	VBN	O	list	_	0	SENT_131	[p10l670t1643r864b1705],
19	in	IN	O	in	_	0	SENT_131	[p10l888t1643r955b1705],
20	Supplemental	NNP	O	Supplemental	nn	21	SENT_131	[p10l983t1643r1473b1724],
21	Table	NNP	O	Table	prep_in	18	SENT_131	[p10l1499t1643r1701b1705],
22	1	CD	NUMBER	1	num	21	SENT_131	[p10l1742t1643r1794b1705],
23	.	.	O	.	_	0	SENT_131	[p10l1742t1643r1794b1705],

1	We	PRP	O	we	nsubj	3	SENT_132	[p10l108t1755r231b1817],
2	previously	RB	DATE	previously	advmod	3	SENT_132	[p10l267t1754r645b1835],
3	reported	VBD	O	report	_	0	SENT_132	[p10l681t1754r980b1835],
4	treatment	NN	O	treatment	nn	6	SENT_132	[p10l1015t1763r1355b1816],
5	discontinuation	NN	O	discontinuation	nn	6	SENT_132	[p10l1391t1754r1944b1816],
6	rates	NNS	O	rate	dobj	3	SENT_132	[p10l1979t1763r2146b1816],
7	for	IN	O	for	_	0	SENT_132	[p10l8t1865r111b1927],
8	this	DT	O	this	det	14	SENT_132	[p10l143t1865r269b1927],
9	entire	JJ	O	entire	amod	14	SENT_132	[p10l306t1865r506b1927],
10	patient	NN	O	patient	nn	14	SENT_132	[p10l541t1865r787b1946],
11	cohort	NN	O	cohort	nn	14	SENT_132	[p10l820t1865r1048b1927],
12	[	NN	O	[	nn	14	SENT_132	[p10l1088t1865r1246b1941],
13	14	CD	NUMBER	14	num	14	SENT_132	[p10l1088t1865r1246b1941],
14	]	NN	O	]	prep_for	3	SENT_132	[p10l1088t1865r1246b1941],
15	.	.	O	.	_	0	SENT_132	[p10l1088t1865r1246b1941],

1	Of	IN	O	of	_	0	SENT_133	[p10l1287t1865r1382b1928],
2	those	DT	O	those	prep_of	14	SENT_133	[p10l1411t1865r1597b1927],
3	with	IN	O	with	_	0	SENT_133	[p10l1633t1865r1790b1928],
4	available	JJ	O	available	amod	6	SENT_133	[p10l1826t1865r2147b1928],
5	germline	NN	O	germline	nn	6	SENT_133	[p10l8t1976r325b2057],
6	DNA	NN	MISC	dna	prep_with	2	SENT_133	[p10l356t1977r566b2050],
7	,	,	O	,	_	0	SENT_133	[p10l356t1977r566b2050],
8	152	CD	PERCENT	152	number	9	SENT_133	[p10l608t1976r731b2039],
9	(	CD	PERCENT	(	nsubj	14	SENT_133	[p10l765t1976r943b2054],
10	32.5	CD	PERCENT	32.5	num	11	SENT_133	[p10l765t1976r943b2054],
11	%	NN	PERCENT	%	dep	9	SENT_133	[p10l983t1977r1079b2053],
12	)	CD	NUMBER	)	num	13	SENT_133	[p10l983t1977r1079b2053],
13	subjects	NNS	O	subject	dep	9	SENT_133	[p10l1114t1976r1397b2057],
14	discontinued	VBN	O	discontinue	_	0	SENT_133	[p10l1430t1976r1887b2039],
15	the	DT	O	the	det	16	SENT_133	[p10l1917t1976r2025b2039],
16	AI	NN	O	aus	dobj	14	SENT_133	[p10l2056t1977r2148b2038],
17	because	IN	O	because	_	0	SENT_133	[p10l6t2087r289b2150],
18	of	IN	O	of	prepc_because_of	14	SENT_133	[p10l339t2087r417b2150],
19	toxicity	NN	O	toxicity	pobj	14	SENT_133	[p10l459t2087r751b2168],
20	.	.	O	.	_	0	SENT_133	[p10l459t2087r751b2168],

1	Of	IN	O	of	ccomp	20	SENT_134	[p10l805t2087r901b2150],
2	the	DT	O	the	det	4	SENT_134	[p10l944t2087r1051b2150],
3	235	CD	NUMBER	235	num	4	SENT_134	[p10l1102t2087r1229b2150],
4	patients	NNS	O	patient	pobj	1	SENT_134	[p10l1280t2087r1557b2168],
5	randomized	VBN	O	randomize	partmod	4	SENT_134	[p10l1607t2087r2032b2150],
6	to	TO	O	to	_	0	SENT_134	[p10l2079t2097r2146b2150],
7	exemestane	NN	O	exemestane	prep_to	5	SENT_134	[p10l8t2208r425b2261],
8	who	WP	O	who	nsubj	9	SENT_134	[p10l471t2198r621b2261],
9	had	VBD	O	have	rcmod	7	SENT_134	[p10l667t2198r795b2261],
10	DNA	NN	MISC	dna	dobj	9	SENT_134	[p10l839t2199r1031b2261],
11	available	JJ	O	available	amod	10	SENT_134	[p10l1077t2198r1397b2261],
12	for	IN	O	for	_	0	SENT_134	[p10l1444t2198r1547b2261],
13	genotyping	VBG	O	genotype	prepc_for	11	SENT_134	[p10l1591t2198r2012b2279],
14	,	,	O	,	_	0	SENT_134	[p10l1591t2198r2012b2279],
15	84	CD	PERCENT	84	nsubj	20	SENT_134	[p10l2064t2198r2147b2261],
16	(	CD	PERCENT	(	number	17	SENT_134	[p10l10t2309r189b2387],
17	35.7	CD	PERCENT	35.7	num	18	SENT_134	[p10l10t2309r189b2387],
18	%	NN	PERCENT	%	dep	15	SENT_134	[p10l228t2310r324b2387],
19	)	CD	NUMBER	)	dep	15	SENT_134	[p10l228t2310r324b2387],
20	discontinued	VBN	O	discontinue	_	0	SENT_134	[p10l362t2309r820b2372],
21	therapy	NN	O	therapy	dobj	20	SENT_134	[p10l854t2309r1121b2390],
22	because	IN	O	because	_	0	SENT_134	[p10l1156t2309r1439b2372],
23	of	IN	O	of	prepc_because_of	20	SENT_134	[p10l1476t2309r1553b2372],
24	toxicity	NN	O	toxicity	pobj	20	SENT_134	[p10l1582t2309r1873b2390],
25	.	.	O	.	_	0	SENT_134	[p10l1582t2309r1873b2390],

1	Of	IN	O	of	_	0	SENT_135	[p10l1914t2309r2011b2372],
2	the	DT	O	the	det	4	SENT_135	[p10l2040t2309r2147b2372],
3	232	CD	NUMBER	232	num	4	SENT_135	[p10l8t2421r138b2483],
4	patients	NNS	O	patient	prep_of	9	SENT_135	[p10l203t2420r481b2501],
5	randomized	VBN	O	randomize	partmod	4	SENT_135	[p10l547t2420r971b2483],
6	to	TO	O	to	_	0	SENT_135	[p10l1036t2430r1102b2483],
7	letrozole	NN	O	letrozole	prep_to	5	SENT_135	[p10l1169t2420r1480b2483],
8	who	WP	O	who	rcmod	7	SENT_135	[p10l1547t2420r1697b2483],
9	had	VBD	O	have	_	0	SENT_135	[p10l1763t2420r1892b2483],
10	DNA	NN	MISC	dna	dobj	9	SENT_135	[p10l1956t2421r2148b2483],
11	available	JJ	O	available	amod	10	SENT_135	[p10l9t2531r350b2606],
12	,	,	O	,	_	0	SENT_135	[p10l9t2531r350b2606],
13	68	CD	PERCENT	68	number	14	SENT_135	[p10l406t2531r489b2594],
14	(	CD	PERCENT	(	appos	10	SENT_135	[p10l546t2532r723b2609],
15	29.3	CD	PERCENT	29.3	num	16	SENT_135	[p10l546t2532r723b2609],
16	%	NN	PERCENT	%	dep	14	SENT_135	[p10l764t2532r859b2609],
17	)	CD	NUMBER	)	num	19	SENT_135	[p10l764t2532r859b2609],
18	discontinued	VBN	O	discontinue	amod	19	SENT_135	[p10l914t2531r1372b2594],
19	therapy	NN	O	therapy	nsubj	9	SENT_135	[p10l1422t2531r1690b2612],
20	because	IN	O	because	prep	19	SENT_135	[p10l1740t2531r2023b2594],
21	of	IN	O	of	_	0	SENT_135	[p10l2076t2531r2153b2594],
22	toxicity	NN	O	toxicity	prep_of	19	SENT_135	[p10l7t2642r298b2723],
23	.	.	O	.	_	0	SENT_135	[p10l7t2642r298b2723],

1	There	EX	O	there	expl	2	SENT_136	[p10l354t2642r561b2704],
2	was	VBD	O	be	_	0	SENT_136	[p10l613t2661r747b2705],
3	a	DT	O	a	det	4	SENT_136	[p10l802t2661r839b2704],
4	trend	NN	O	trend	nsubj	2	SENT_136	[p10l888t2642r1072b2704],
5	toward	IN	O	toward	_	0	SENT_136	[p10l1122t2642r1370b2705],
6	increased	VBN	O	increase	amod	8	SENT_136	[p10l1420t2642r1758b2704],
7	treatment	NN	O	treatment	nn	8	SENT_136	[p10l1809t2651r2148b2704],
8	discontinuation	NN	O	discontinuation	prep_toward	4	SENT_136	[p10l8t2753r560b2815],
9	in	IN	O	in	_	0	SENT_136	[p10l594t2753r662b2815],
10	exemestane	NN	O	exemestane	nn	11	SENT_136	[p10l697t2753r1391b2815],
11	—	NN	O	—	prep_in	8	SENT_136	[p10l697t2753r1391b2815],
12	treated	VBN	O	treat	partmod	11	SENT_136	[p10l697t2753r1391b2815],
13	patients	NNS	O	patient	nn	18	SENT_136	[p10l1423t2753r1701b2834],
14	(	CD	NUMBER	(	num	15	SENT_136	[p10l1739t2753r1808b2833],
15	p	NN	O	p	dep	13	SENT_136	[p10l1739t2753r1808b2833],
16	=	JJ	O	=	amod	18	SENT_136	[p10l1844t2781r1905b2805],
17	0.08	CD	NUMBER	0.08	tmod	16	SENT_136	[p10l1941t2753r2142b2830],
18	)	NN	O	)	dobj	12	SENT_136	[p10l1941t2753r2142b2830],
19	.	.	O	.	_	0	SENT_136	[p10l1941t2753r2142b2830],

1	Of	IN	O	of	_	0	SENT_137	[p10l9t2863r105b2926],
2	the	DT	O	the	det	3	SENT_137	[p10l135t2863r242b2925],
3	patients	NNS	O	patient	prep_of	46	SENT_137	[p10l278t2863r556b2944],
4	who	WP	O	who	nsubj	5	SENT_137	[p10l593t2863r744b2925],
5	discontinued	VBD	O	discontinue	rcmod	3	SENT_137	[p10l781t2863r1239b2925],
6	therapy	NN	O	therapy	dobj	5	SENT_137	[p10l1275t2863r1541b2944],
7	because	IN	O	because	_	0	SENT_137	[p10l1577t2863r1860b2925],
8	of	IN	O	of	_	0	SENT_137	[p10l1898t2862r1975b2925],
9	toxicity	NN	O	toxicity	prep_of	15	SENT_137	[p10l2005t2872r2145b2925, p10l7t2975r184b3056],
10	,	,	O	,	_	0	SENT_137	[p10l2005t2872r2145b2925, p10l7t2975r184b3056],
11	64	CD	PERCENT	64	number	12	SENT_137	[p10l232t2975r316b3038],
12	(	CD	PERCENT	(	appos	9	SENT_137	[p10l362t2975r543b3052],
13	76.2	CD	PERCENT	76.2	num	14	SENT_137	[p10l362t2975r543b3052],
14	%	NN	PERCENT	%	dep	12	SENT_137	[p10l580t2976r676b3053],
15	)	CD	NUMBER	)	prep_because	5	SENT_137	[p10l580t2976r676b3053],
16	of	IN	O	of	_	0	SENT_137	[p10l721t2975r798b3038],
17	exemestane	NN	O	exemestane	nn	18	SENT_137	[p10l835t2975r1529b3038],
18	—	NN	O	—	prep_of	15	SENT_137	[p10l835t2975r1529b3038],
19	treated	VBN	O	treat	partmod	18	SENT_137	[p10l835t2975r1529b3038],
20	patients	NNS	O	patient	dobj	19	SENT_137	[p10l1570t2975r1847b3056],
21	and	CC	O	and	_	0	SENT_137	[p10l1893t2975r2019b3038],
22	53	CD	PERCENT	53	number	23	SENT_137	[p10l2062t2975r2143b3038],
23	(	CD	PERCENT	(	prep_because	5	SENT_137	[p10l10t3086r190b3163],
24	77.9	CD	PERCENT	77.9	num	25	SENT_137	[p10l10t3086r190b3163],
25	%	NN	PERCENT	%	dep	23	SENT_137	[p10l228t3086r324b3163],
26	)	CD	NUMBER	)	num	28	SENT_137	[p10l228t3086r324b3163],
27	letrozole	NN	O	letrozole	nn	28	SENT_137	[p10l384t3086r973b3149],
28	—	NN	O	—	nsubj	46	SENT_137	[p10l384t3086r973b3149],
29	treated	VBN	O	treat	partmod	28	SENT_137	[p10l384t3086r973b3149],
30	patients	NNS	O	patient	dobj	29	SENT_137	[p10l1029t3086r1306b3167],
31	discontinued	VBN	O	discontinue	amod	32	SENT_137	[p10l1366t3086r1823b3149],
32	therapy	NN	O	therapy	dep	30	SENT_137	[p10l1880t3086r2146b3167],
33	speciﬁcally	RB	O	speciﬁcally	advmod	30	SENT_137	[p10l10t3197r415b3278],
34	because	IN	O	because	_	0	SENT_137	[p10l452t3197r734b3260],
35	of	IN	O	of	_	0	SENT_137	[p10l775t3197r852b3260],
36	AIMSS	NNP	LOCATION	AIMSS	prep_because_of	30	SENT_137	[p10l883t3197r1172b3271],
37	,	,	O	,	_	0	SENT_137	[p10l883t3197r1172b3271],
38	a	DT	O	a	det	39	SENT_137	[p10l1216t3217r1253b3260],
39	difference	NN	O	difference	appos	36	SENT_137	[p10l1290t3197r1651b3260],
40	that	WDT	O	that	rcmod	39	SENT_137	[p10l1690t3197r1824b3260],
41	was	VBD	O	be	cop	46	SENT_137	[p10l1861t3217r1996b3260],
42	not	RB	O	not	neg	46	SENT_137	[p10l2035t3207r2149b3260],
43	statistically	RB	O	statistically	advmod	44	SENT_137	[p10l10t3308r415b3389],
44	signiﬁcant	JJ	O	signiﬁcant	amod	46	SENT_137	[p10l452t3308r823b3389],
45	(	NN	O	(	nn	46	SENT_137	[p10l857t3309r925b3388],
46	p	NN	O	p	_	0	SENT_137	[p10l857t3309r925b3388],
47	=	JJ	O	=	amod	46	SENT_137	[p10l962t3337r1022b3361],
48	0.21	CD	NUMBER	0.21	num	49	SENT_137	[p10l1059t3309r1260b3386],
49	)	NN	O	)	dep	47	SENT_137	[p10l1059t3309r1260b3386],
50	.	.	O	.	_	0	SENT_137	[p10l1059t3309r1260b3386],

1	Associations	NNS	O	association	_	0	SENT_138	[p10l7t3532r462b3595],
2	between	IN	O	between	_	0	SENT_138	[p10l495t3532r795b3595],
3	variants	NNS	O	variant	prep_between	1	SENT_138	[p10l827t3532r1108b3595],
4	in	IN	O	in	_	0	SENT_138	[p10l1142t3532r1209b3594],
5	candidate	NN	O	candidate	nn	6	SENT_138	[p10l1243t3532r1585b3595],
6	genes	NNS	O	gene	prep_in	3	SENT_138	[p10l1619t3552r1818b3613],
7	and	CC	O	and	_	0	SENT_138	[p10l9t3642r136b3704],
8	discontinuation	NN	O	discontinuation	prep_between	1	SENT_138	[p10l168t3642r721b3704],
9	of	IN	O	of	_	0	SENT_138	[p10l754t3642r831b3704],
10	AI	NN	O	aus	nn	11	SENT_138	[p10l858t3642r950b3704],
11	therapy	NN	O	therapy	prep_of	8	SENT_138	[p10l982t3642r1249b3723],

1	Univariate	JJ	O	univariate	amod	2	SENT_139	[p11l15t96r393b157],
2	analyses	NNS	O	analysis	_	0	SENT_139	[p11l427t94r734b174],

1	We	PRP	O	we	nsubj	2	SENT_140	[p11l6t319r129b380],
2	evaluated	VBD	O	evaluate	_	0	SENT_140	[p11l177t317r520b380],
3	associations	NNS	O	association	dobj	2	SENT_140	[p11l568t317r997b380],
4	between	IN	O	between	_	0	SENT_140	[p11l1044t317r1343b380],
5	candidate	NN	O	candidate	nn	6	SENT_140	[p11l1389t317r1731b380],
6	SNPs	NNS	O	snp	prep_between	3	SENT_140	[p11l1780t317r1972b380],
7	and	CC	O	and	_	0	SENT_140	[p11l2022t317r2148b380],
8	discontinuation	NN	O	discontinuation	conj_and	3	SENT_140	[p11l8t429r560b492],
9	of	IN	O	of	_	0	SENT_140	[p11l586t429r663b492],
10	AI	NN	O	aus	nn	11	SENT_140	[p11l682t430r774b491],
11	therapy	NN	O	therapy	prep_of	8	SENT_140	[p11l798t429r1065b510],
12	because	IN	O	because	_	0	SENT_140	[p11l1089t429r1372b492],
13	of	IN	O	of	_	0	SENT_140	[p11l1399t429r1476b492],
14	either	CC	O	either	preconj	16	SENT_140	[p11l1495t429r1699b492],
15	any	DT	O	any	det	16	SENT_140	[p11l1724t449r1849b510],
16	toxicity	NN	O	toxicity	prep_because_of	2	SENT_140	[p11l1874t429r2146b510],
17	or	CC	O	or	_	0	SENT_140	[p11l8t559r81b602],
18	AIMSS	NN	O	aimss	nn	21	SENT_140	[p11l121t540r388b602],
19	(	CD	NUMBER	(	num	21	SENT_140	[p11l438t539r957b620],
20	Supplemental	NNP	O	Supplemental	nn	21	SENT_140	[p11l438t539r957b620],
21	Fig	NNP	O	Fig	conj_or	16	SENT_140	[p11l1000t539r1135b620],
22	.	.	O	.	_	0	SENT_140	[p11l1000t539r1135b620],

1	1	CD	NUMBER	1	_	0	SENT_141	[p11l1181t540r1236b613],
2	;	:	O	;	_	0	SENT_141	[p11l1181t540r1236b613],
3	Supplemental	NNP	O	Supplemental	nn	4	SENT_141	[p11l1284t539r1774b620],
4	Table	NNP	O	Table	dep	1	SENT_141	[p11l1817t539r2019b602],
5	2	CD	NUMBER	2	number	6	SENT_141	[p11l2054t540r2143b617],
6	)	CD	NUMBER	)	dep	4	SENT_141	[p11l2054t540r2143b617],
7	.	.	O	.	_	0	SENT_141	[p11l2054t540r2143b617],

1	@	IN	O	@	_	0	SENT_142	[p11l6t782r83b877],
2	Springer	NNP	O	Springer	prep_@	22	SENT_142	[p11l113t805r375b880],
3	When	WRB	O	when	advmod	4	SENT_142	[p11l12t907r225b970],
4	assessed	VBN	O	assess	dep	2	SENT_142	[p11l254t907r554b970],
5	using	VBG	O	use	xcomp	4	SENT_142	[p11l579t907r770b988],
6	a	DT	O	a	det	8	SENT_142	[p11l800t927r837b970],
7	recessive	JJ	O	recessive	amod	8	SENT_142	[p11l861t907r1188b970],
8	model	NN	O	model	dobj	5	SENT_142	[p11l1216t907r1457b981],
9	,	,	O	,	_	0	SENT_142	[p11l1216t907r1457b981],
10	an	DT	O	a	det	12	SENT_142	[p11l1489t927r1569b970],
11	intronic	JJ	O	intronic	amod	12	SENT_142	[p11l1596t907r1871b970],
12	variant	NN	O	variant	appos	8	SENT_142	[p11l1900t907r2149b970],
13	in	IN	O	in	_	0	SENT_142	[p11l14t1018r81b1080],
14	the	DT	O	the	det	17	SENT_142	[p11l114t1018r220b1081],
15	estrogen	NN	O	estrogen	nn	17	SENT_142	[p11l255t1028r556b1099],
16	receptor	NN	O	receptor	nn	17	SENT_142	[p11l588t1028r883b1099],
17	ESRI	NN	ORGANIZATION	esrus	prep_in	12	SENT_142	[p11l912t1019r1104b1081],
18	(	CD	NUMBER	(	num	20	SENT_142	[p11l1146t1018r1576b1096],
19	rs9322336	NN	O	rs9322336	nn	20	SENT_142	[p11l1146t1018r1576b1096],
20	)	NN	O	)	nsubjpass	22	SENT_142	[p11l1146t1018r1576b1096],
21	was	VBD	O	be	auxpass	22	SENT_142	[p11l1612t1038r1746b1081],
22	associated	VBN	O	associate	_	0	SENT_142	[p11l1783t1018r2148b1081],
23	with	IN	O	with	_	0	SENT_142	[p11l14t1129r171b1192],
24	increased	VBN	O	increase	amod	25	SENT_142	[p11l203t1129r540b1191],
25	risk	NN	O	risk	prep_with	22	SENT_142	[p11l571t1129r706b1191],
26	of	IN	O	of	_	0	SENT_142	[p11l738t1128r815b1191],
27	discontinuation	NN	O	discontinuation	prep_of	25	SENT_142	[p11l843t1129r1393b1191],
28	of	IN	O	of	_	0	SENT_142	[p11l1427t1128r1504b1191],
29	exemestane	NN	O	exemestane	nn	30	SENT_142	[p11l1531t1138r1946b1191],
30	therapy	NN	O	therapy	prep_of	27	SENT_142	[p11l1980t1129r2145b1191, p11l15t1259r140b1321],
31	because	IN	O	because	mark	36	SENT_142	[p11l191t1240r473b1302],
32	of	IN	O	of	dep	36	SENT_142	[p11l526t1240r603b1302],
33	AIMSS	NNP	O	AIMSS	pobj	32	SENT_142	[p11l648t1240r914b1303],
34	{	CD	NUMBER	{	num	33	SENT_142	[p11l976t1240r1164b1317],
35	[	CD	NUMBER	[	num	36	SENT_142	[p11l976t1240r1164b1317],
36	HR	NN	DURATION	hr	dep	30	SENT_142	[p11l976t1240r1164b1317],
37	5.0	CD	PERCENT	5.0	num	41	SENT_142	[p11l1216t1239r1323b1303],
38	(	CD	PERCENT	(	number	39	SENT_142	[p11l1377t1239r1487b1317],
39	95	CD	PERCENT	95	dep	40	SENT_142	[p11l1377t1239r1487b1317],
40	%	NN	PERCENT	%	dep	41	SENT_142	[p11l1527t1240r1591b1303],
41	CI	NN	O	ci	dep	36	SENT_142	[p11l1648t1240r1733b1303],
42	2.2	CD	NUMBER	2.2	number	43	SENT_142	[p11l1786t1240r2144b1317],
43	—	CD	NUMBER	—	num	44	SENT_142	[p11l1786t1240r2144b1317],
44	l1	NN	O	l1	dep	27	SENT_142	[p11l1786t1240r2144b1317],
45	.8	CD	NUMBER	.8	num	46	SENT_142	[p11l1786t1240r2144b1317],
46	)	NN	O	)	dep	44	SENT_142	[p11l1786t1240r2144b1317],
47	,	,	O	,	_	0	SENT_142	[p11l1786t1240r2144b1317],
48	p	NN	O	p	appos	27	SENT_142	[p11l6t1372r55b1431],
49	=	JJ	O	=	amod	51	SENT_142	[p11l91t1379r152b1403],
50	0.0002	CD	NUMBER	0.0002	tmod	49	SENT_142	[p11l188t1351r482b1426],
51	]	NN	O	]	dep	48	SENT_142	[p11l188t1351r482b1426],
52	;	:	O	;	_	0	SENT_142	[p11l188t1351r482b1426],
53	Table	NNP	O	Table	dep	48	SENT_142	[p11l528t1351r730b1413],
54	2	CD	NUMBER	2	num	53	SENT_142	[p11l764t1351r827b1425],
55	;	:	O	;	_	0	SENT_142	[p11l764t1351r827b1425],
56	Figs	NNS	O	fig	dep	53	SENT_142	[p11l871t1350r1041b1432],
57	.	.	O	.	_	0	SENT_142	[p11l871t1350r1041b1432],

1	2a	NN	O	2a	_	0	SENT_143	[p11l1079t1351r1179b1425],
2	,	,	O	,	_	0	SENT_143	[p11l1079t1351r1179b1425],
3	3a	NN	O	3a	nn	4	SENT_143	[p11l1227t1351r1367b1428],
4	}	NN	O	}	appos	1	SENT_143	[p11l1227t1351r1367b1428],
5	.	.	O	.	_	0	SENT_143	[p11l1227t1351r1367b1428],

1	Analyses	NNS	O	analysis	nsubj	16	SENT_144	[p11l1414t1351r1737b1432],
2	also	RB	O	also	advmod	3	SENT_144	[p11l1783t1351r1923b1413],
3	demonstrated	VBD	O	demonstrate	_	0	SENT_144	[p11l1967t1351r2145b1413, p11l15t1462r341b1524],
4	a	DT	O	a	det	5	SENT_144	[p11l376t1482r413b1524],
5	trend	NN	O	trend	dobj	3	SENT_144	[p11l446t1462r630b1524],
6	toward	IN	O	toward	_	0	SENT_144	[p11l663t1462r911b1524],
7	an	DT	O	a	det	8	SENT_144	[p11l946t1482r1027b1524],
8	association	NN	O	association	prep_toward	3	SENT_144	[p11l1063t1462r1458b1524],
9	between	IN	O	between	_	0	SENT_144	[p11l1491t1462r1789b1524],
10	the	DT	O	the	det	12	SENT_144	[p11l1823t1462r1930b1524],
11	same	JJ	O	same	amod	12	SENT_144	[p11l1969t1482r2147b1524],
12	SNP	NN	ORGANIZATION	snp	prep_between	8	SENT_144	[p11l16t1572r175b1634],
13	in	IN	O	in	_	0	SENT_144	[p11l208t1572r276b1633],
14	ESRI	NNP	ORGANIZATION	ESRI	prep_in	12	SENT_144	[p11l308t1573r500b1634],
15	and	CC	O	and	_	0	SENT_144	[p11l543t1572r668b1634],
16	increased	VBD	O	increase	conj_and	3	SENT_144	[p11l701t1572r1039b1634],
17	risk	NN	O	risk	dobj	16	SENT_144	[p11l1071t1572r1206b1634],
18	of	IN	O	of	_	0	SENT_144	[p11l1239t1572r1316b1634],
19	discontinuation	NN	O	discontinuation	prep_of	17	SENT_144	[p11l1345t1572r1896b1634],
20	of	IN	O	of	_	0	SENT_144	[p11l1930t1572r2008b1634],
21	exemestane	NN	O	exemestane	nn	22	SENT_144	[p11l2036t1591r2145b1634, p11l14t1692r345b1745],
22	therapy	NN	O	therapy	prep_of	19	SENT_144	[p11l378t1683r644b1764],
23	because	IN	O	because	_	0	SENT_144	[p11l676t1683r958b1745],
24	of	IN	O	of	_	0	SENT_144	[p11l992t1683r1069b1745],
25	any	DT	O	any	det	26	SENT_144	[p11l1097t1702r1221b1764],
26	toxicity	NN	O	toxicity	prep_of	31	SENT_144	[p11l1254t1683r1526b1764],
27	{	CD	NUMBER	{	number	28	SENT_144	[p11l1567t1683r1754b1761],
28	[	CD	NUMBER	[	num	29	SENT_144	[p11l1567t1683r1754b1761],
29	HR	NN	DURATION	hr	dep	26	SENT_144	[p11l1567t1683r1754b1761],
30	4.2	CD	PERCENT	4.2	number	31	SENT_144	[p11l1785t1683r1894b1745],
31	(	CD	PERCENT	(	prep_because	16	SENT_144	[p11l1930t1683r2039b1760],
32	95	CD	PERCENT	95	number	33	SENT_144	[p11l1930t1683r2039b1760],
33	%	NN	PERCENT	%	amod	31	SENT_144	[p11l2079t1683r2143b1746],
34	CI	NN	O	ci	nn	37	SENT_144	[p11l15t1795r101b1857],
35	1.9-9	CD	NUMBER	1.9-9	num	37	SENT_144	[p11l163t1795r470b1872],
36	.2	NN	NUMBER	.2	nn	37	SENT_144	[p11l163t1795r470b1872],
37	)	NN	O	)	dobj	3	SENT_144	[p11l163t1795r470b1872],
38	,	,	O	,	_	0	SENT_144	[p11l163t1795r470b1872],
39	19	CD	NUMBER	19	num	42	SENT_144	[p11l519t1816r568b1874],
40	=	JJ	O	=	amod	42	SENT_144	[p11l605t1823r665b1847],
41	0.0003	CD	NUMBER	0.0003	tmod	40	SENT_144	[p11l702t1795r996b1870],
42	]	NN	O	]	appos	37	SENT_144	[p11l702t1795r996b1870],
43	;	:	O	;	_	0	SENT_144	[p11l702t1795r996b1870],
44	Table	NNP	O	Table	dep	37	SENT_144	[p11l1053t1794r1255b1857],
45	2	CD	NUMBER	2	num	44	SENT_144	[p11l1290t1795r1350b1869],
46	,	,	O	,	_	0	SENT_144	[p11l1290t1795r1350b1869],
47	Fig	NN	O	fig	appos	44	SENT_144	[p11l1407t1794r1542b1875],
48	.	.	O	.	_	0	SENT_144	[p11l1407t1794r1542b1875],

1	3b	NN	O	3b	_	0	SENT_145	[p11l1580t1794r1726b1872],
2	}	NN	O	}	dep	1	SENT_145	[p11l1580t1794r1726b1872],
3	.	.	O	.	_	0	SENT_145	[p11l1580t1794r1726b1872],

1	A	DT	O	a	det	3	SENT_146	[p11l1784t1795r1846b1856],
2	similar	JJ	O	similar	amod	3	SENT_146	[p11l1903t1794r2149b1857],
3	trend	NN	O	trend	nsubjpass	6	SENT_146	[p11l13t1905r196b1968],
4	was	VBD	O	be	auxpass	6	SENT_146	[p11l241t1925r375b1968],
5	not	RB	O	not	neg	6	SENT_146	[p11l421t1915r535b1968],
6	detected	VBN	O	detect	_	0	SENT_146	[p11l580t1905r877b1968],
7	for	IN	O	for	_	0	SENT_146	[p11l922t1905r1025b1968],
8	letrozole	NN	O	letrozole	prep_for	6	SENT_146	[p11l1069t1905r1400b1979],
9	,	,	O	,	_	0	SENT_146	[p11l1069t1905r1400b1979],
10	suggesting	VBG	O	suggest	xcomp	6	SENT_146	[p11l1451t1905r1828b1986],
11	a	DT	O	a	det	13	SENT_146	[p11l1876t1925r1913b1968],
12	drugspeciﬁc	NN	O	drugspeciﬁc	nn	13	SENT_146	[p11l1957t1905r2145b1986, p11l17t2016r283b2097],
13	association	NN	O	association	dobj	10	SENT_146	[p11l336t2016r731b2078],
14	(	CD	NUMBER	(	num	15	SENT_146	[p11l783t2016r1012b2093],
15	Table	NNP	O	Table	dep	13	SENT_146	[p11l783t2016r1012b2093],
16	2	CD	NUMBER	2	num	15	SENT_146	[p11l1046t2016r1108b2090],
17	;	:	O	;	_	0	SENT_146	[p11l1046t2016r1108b2090],
18	Fig	NN	O	fig	dep	13	SENT_146	[p11l1161t2016r1296b2097],
19	.	.	O	.	_	0	SENT_146	[p11l1161t2016r1296b2097],

1	2b	JJ	O	2b	amod	2	SENT_147	[p11l1334t2016r1467b2093],
2	)	NN	O	)	_	0	SENT_147	[p11l1334t2016r1467b2093],
3	.	.	O	.	_	0	SENT_147	[p11l1334t2016r1467b2093],

1	In	IN	O	in	_	0	SENT_148	[p11l1521t2017r1593b2078],
2	addition	NN	O	addition	prep_in	17	SENT_148	[p11l1644t2016r1953b2090],
3	,	,	O	,	_	0	SENT_148	[p11l1644t2016r1953b2090],
4	also	RB	O	also	advmod	5	SENT_148	[p11l2008t2016r2147b2078],
5	after	IN	O	after	dep	2	SENT_148	[p11l16t2125r177b2188],
6	Bonferroni	NNP	PERSON	Bonferroni	nn	7	SENT_148	[p11l218t2126r608b2188],
7	correction	NN	O	correction	pobj	5	SENT_148	[p11l652t2126r1014b2188],
8	and	CC	O	and	_	0	SENT_148	[p11l1057t2126r1183b2188],
9	using	VBG	O	use	dep	2	SENT_148	[p11l1224t2126r1415b2207],
10	any	DT	O	any	dobj	9	SENT_148	[p11l1459t2145r1584b2207],
11	of	IN	O	of	_	0	SENT_148	[p11l1628t2126r1705b2188],
12	the	DT	O	the	det	14	SENT_148	[p11l1741t2126r1847b2188],
13	genetic	JJ	O	genetic	amod	14	SENT_148	[p11l1891t2126r2146b2207],
14	models	NNS	O	model	prep_of	10	SENT_148	[p11l14t2237r289b2310],
15	,	,	O	,	_	0	SENT_148	[p11l14t2237r289b2310],
16	we	PRP	O	we	nsubj	17	SENT_148	[p11l336t2256r437b2299],
17	failed	VBD	O	fail	_	0	SENT_148	[p11l481t2237r683b2299],
18	to	TO	O	to	aux	19	SENT_148	[p11l726t2246r792b2299],
19	observe	VB	O	observe	xcomp	17	SENT_148	[p11l837t2237r1111b2299],
20	any	DT	O	any	det	24	SENT_148	[p11l1157t2256r1281b2318],
21	statistically	RB	O	statistically	advmod	22	SENT_148	[p11l1328t2237r1732b2318],
22	signiﬁcant	JJ	O	signiﬁcant	amod	24	SENT_148	[p11l1779t2237r2148b2318],
23	potential	JJ	O	potential	amod	24	SENT_148	[p11l12t2349r326b2430],
24	associations	NNS	O	association	dobj	19	SENT_148	[p11l362t2349r789b2412],
25	between	IN	O	between	_	0	SENT_148	[p11l824t2349r1122b2412],
26	the	DT	O	the	det	28	SENT_148	[p11l1156t2349r1263b2412],
27	other	JJ	O	other	amod	28	SENT_148	[p11l1299t2349r1481b2412],
28	candidate	NN	O	candidate	prep_between	24	SENT_148	[p11l1514t2349r1855b2412],
29	genetic	JJ	O	genetic	amod	30	SENT_148	[p11l1891t2349r2146b2430],
30	variants	NNS	O	variant	xcomp	19	SENT_148	[p11l14t2460r294b2523],
31	and	CC	O	and	_	0	SENT_148	[p11l353t2460r479b2523],
32	discontinuation	NN	O	discontinuation	conj_and	30	SENT_148	[p11l534t2460r1086b2523],
33	of	IN	O	of	_	0	SENT_148	[p11l1142t2460r1219b2523],
34	AI	NN	O	aus	nn	35	SENT_148	[p11l1269t2461r1360b2522],
35	therapy	NN	O	therapy	prep_of	32	SENT_148	[p11l1415t2460r1681b2541],
36	because	IN	O	because	_	0	SENT_148	[p11l1737t2460r2019b2523],
37	of	IN	O	of	_	0	SENT_148	[p11l2076t2460r2153b2523],
38	either	CC	O	either	preconj	40	SENT_148	[p11l14t2571r217b2634],
39	any	DT	O	any	det	40	SENT_148	[p11l250t2591r375b2652],
40	toxicity	NN	O	toxicity	prep_because_of	19	SENT_148	[p11l408t2571r680b2652],
41	or	CC	O	or	_	0	SENT_148	[p11l714t2591r787b2634],
42	AIMSS	NN	O	aimss	conj_or	40	SENT_148	[p11l818t2571r1083b2634],
43	(	CD	NUMBER	(	num	47	SENT_148	[p11l1123t2571r1641b2652],
44	Supplemental	NNP	O	Supplemental	nn	47	SENT_148	[p11l1123t2571r1641b2652],
45	Table	NNP	O	Table	nn	47	SENT_148	[p11l1674t2571r1875b2634],
46	3	CD	NUMBER	3	num	47	SENT_148	[p11l1911t2571r1998b2648],
47	)	NN	O	)	dobj	19	SENT_148	[p11l1911t2571r1998b2648],
48	.	.	O	.	_	0	SENT_148	[p11l1911t2571r1998b2648],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_149	[p11l11t2794r459b2858],
2	analyses	NNS	O	analysis	_	0	SENT_149	[p11l494t2794r799b2874],

1	Step	NN	O	step	npadvmod	3	SENT_150	[p11l16t3018r364b3099],
2	—	CD	NUMBER	—	num	1	SENT_150	[p11l16t3018r364b3099],
3	wise	JJ	O	wise	amod	4	SENT_150	[p11l16t3018r364b3099],
4	regression	NN	O	regression	nsubjpass	6	SENT_150	[p11l414t3018r781b3099],
5	was	VBD	O	be	auxpass	6	SENT_150	[p11l832t3037r966b3081],
6	performed	VBN	O	perform	_	0	SENT_150	[p11l1016t3018r1390b3099],
7	to	TO	O	to	aux	8	SENT_150	[p11l1439t3027r1505b3080],
8	identify	VB	O	identify	xcomp	6	SENT_150	[p11l1557t3018r1833b3099],
9	clinical	JJ	O	clinical	amod	10	SENT_150	[p11l1885t3018r2147b3080],
10	covariates	NNS	O	covariate	dobj	8	SENT_150	[p11l14t3128r374b3190],
11	that	WDT	O	that	nsubjpass	13	SENT_150	[p11l410t3128r543b3190],
12	were	VBD	O	be	auxpass	13	SENT_150	[p11l577t3147r748b3190],
13	associated	VBN	O	associate	rcmod	10	SENT_150	[p11l784t3128r1150b3190],
14	with	IN	O	with	_	0	SENT_150	[p11l1184t3128r1340b3190],
15	treatment	NN	O	treatment	nn	16	SENT_150	[p11l1374t3137r1713b3190],
16	discontinuation	NN	O	discontinuation	prep_with	13	SENT_150	[p11l1747t3128r2145b3190, p11l16t3238r209b3300],
17	.	.	O	.	_	0	SENT_150	[p11l1747t3128r2145b3190, p11l16t3238r209b3300],

1	As	IN	O	as	mark	3	SENT_151	[p11l246t3238r340b3300],
2	previously	RB	DATE	previously	advmod	3	SENT_151	[p11l373t3238r749b3319],
3	reported	VBN	O	report	advcl	12	SENT_151	[p11l781t3238r1098b3319],
4	,	,	O	,	_	0	SENT_151	[p11l781t3238r1098b3319],
5	age	NN	O	age	nsubjpass	12	SENT_151	[p11l1136t3257r1255b3319],
6	<	JJR	O	<	dep	5	SENT_151	[p11l1289t3238r1431b3301],
7	55	CD	NUMBER	55	dep	5	SENT_151	[p11l1289t3238r1431b3301],
8	and	CC	O	and	_	0	SENT_151	[p11l1469t3238r1595b3300],
9	AI	NN	O	aus	nn	10	SENT_151	[p11l1626t3238r1718b3300],
10	medication	NN	O	medication	dep	5	SENT_151	[p11l1750t3238r2148b3300],
11	were	VBD	O	be	auxpass	12	SENT_151	[p11l14t3370r184b3413],
12	found	VBN	O	find	_	0	SENT_151	[p11l219t3350r426b3413],
13	to	TO	O	to	aux	16	SENT_151	[p11l458t3360r525b3413],
14	be	VB	O	be	cop	16	SENT_151	[p11l558t3350r640b3413],
15	statistically	RB	O	statistically	advmod	16	SENT_151	[p11l678t3350r1081b3431],
16	signiﬁcantly	RB	O	signiﬁcantly	xcomp	12	SENT_151	[p11l1119t3350r1557b3431],
17	associated	VBN	O	associate	dep	16	SENT_151	[p11l1592t3350r1958b3413],
18	with	IN	O	with	_	0	SENT_151	[p11l1991t3350r2148b3413],
19	discontinuation	NN	O	discontinuation	prep_with	17	SENT_151	[p11l14t3461r565b3524],
20	due	JJ	O	due	_	0	SENT_151	[p11l611t3461r736b3524],
21	to	TO	O	to	_	0	SENT_151	[p11l782t3471r848b3524],
22	any	DT	O	any	det	23	SENT_151	[p11l897t3481r1021b3542],
23	toxicity	NN	O	toxicity	prep_due_to	26	SENT_151	[p11l1066t3461r1338b3542],
24	[	CD	NUMBER	[	number	25	SENT_151	[p11l1390t3462r1549b3537],
25	14	CD	NUMBER	14	num	23	SENT_151	[p11l1390t3462r1549b3537],
26	]	NN	O	]	dobj	17	SENT_151	[p11l1390t3462r1549b3537],
27	.	.	O	.	_	0	SENT_151	[p11l1390t3462r1549b3537],

1	Similarly	RB	O	similarly	advmod	17	SENT_152	[p11l1601t3461r1950b3542],
2	,	,	O	,	_	0	SENT_152	[p11l1601t3461r1950b3542],
3	age	NN	O	age	nsubjpass	17	SENT_152	[p11l1999t3481r2119b3542],
4	<	JJR	O	<	dep	3	SENT_152	[p11l30t3572r195b3646],
5	55	CD	NUMBER	55	dep	3	SENT_152	[p11l30t3572r195b3646],
6	,	,	O	,	_	0	SENT_152	[p11l30t3572r195b3646],
7	prior	RB	O	prior	advmod	9	SENT_152	[p11l230t3572r404b3653],
8	taxane	JJ	O	taxane	amod	9	SENT_152	[p11l434t3582r666b3635],
9	chemotherapy	NN	O	chemotherapy	dep	3	SENT_152	[p11l701t3572r1225b3653],
10	,	,	O	,	_	0	SENT_152	[p11l701t3572r1225b3653],
11	and	CC	O	and	_	0	SENT_152	[p11l1263t3572r1389b3635],
12	AI	NN	O	aus	nn	13	SENT_152	[p11l1421t3573r1513b3634],
13	medication	NN	O	medication	conj_and	5	SENT_152	[p11l1546t3572r1943b3635],
14	were	VBD	O	be	auxpass	17	SENT_152	[p11l1976t3592r2146b3635],
15	statistically	RB	O	statistically	advmod	17	SENT_152	[p11l17t3682r421b3763],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_152	[p11l477t3682r915b3763],
17	associated	VBN	O	associate	_	0	SENT_152	[p11l969t3682r1335b3744],
18	with	IN	O	with	_	0	SENT_152	[p11l1387t3682r1544b3744],
19	discontinuation	NN	O	discontinuation	prep_with	17	SENT_152	[p11l1597t3682r2148b3744],
20	due	JJ	O	due	_	0	SENT_152	[p12l14t22r140b85],
21	to	TO	O	to	_	0	SENT_152	[p12l194t32r260b85],
22	AIMSS	NNP	O	AIMSS	prep_due_to	17	SENT_152	[p12l315t23r581b85],
23	in	IN	O	in	_	0	SENT_152	[p12l639t22r706b84],
24	our	PRP$	O	we	poss	25	SENT_152	[p12l761t42r879b85],
25	study	NN	O	study	prep_in	22	SENT_152	[p12l934t22r1140b103],
26	.	.	O	.	_	0	SENT_152	[p12l934t22r1140b103],

1	After	IN	O	after	_	0	SENT_153	[p12l1199t22r1387b85],
2	adjustment	NN	O	adjustment	prep_after	8	SENT_153	[p12l1440t22r1831b103],
3	for	IN	O	for	_	0	SENT_153	[p12l1885t22r1988b85],
4	the	DT	O	the	det	5	SENT_153	[p12l2040t22r2147b85],
5	covariates	NNS	O	covariate	prep_for	2	SENT_153	[p12l14t133r395b207],
6	,	,	O	,	_	0	SENT_153	[p12l14t133r395b207],
7	there	EX	O	there	expl	8	SENT_153	[p12l441t133r617b195],
8	remained	VBD	O	remain	_	0	SENT_153	[p12l658t133r993b195],
9	a	DT	O	a	det	10	SENT_153	[p12l1036t153r1073b195],
10	trend	NN	O	trend	nsubj	8	SENT_153	[p12l1114t133r1297b195],
11	toward	IN	O	toward	_	0	SENT_153	[p12l1338t133r1586b195],
12	an	DT	O	a	det	13	SENT_153	[p12l1629t153r1709b195],
13	association	NN	O	association	prep_toward	8	SENT_153	[p12l1753t133r2148b195],
14	between	IN	O	between	_	0	SENT_153	[p12l12t244r311b307],
15	the	DT	O	the	det	18	SENT_153	[p12l349t244r455b306],
16	rs9322336	CD	NUMBER	rs9322336	num	18	SENT_153	[p12l495t244r869b307],
17	ESRI	NNP	ORGANIZATION	ESRI	nn	18	SENT_153	[p12l907t244r1100b307],
18	SNP	NN	O	snp	prep_between	13	SENT_153	[p12l1147t244r1306b307],
19	and	CC	O	and	_	0	SENT_153	[p12l1346t244r1472b307],
20	treatment	NN	O	treatment	nn	21	SENT_153	[p12l1510t253r1849b307],
21	discontinuation	NN	O	discontinuation	conj_and	18	SENT_153	[p12l1887t244r2144b307, p12l13t356r331b418],
22	because	IN	O	because	_	0	SENT_153	[p12l374t356r656b418],
23	of	IN	O	of	prepc_because_of	8	SENT_153	[p12l702t356r779b418],
24	AIMSS	NNP	LOCATION	AIMSS	pobj	8	SENT_153	[p12l817t356r1105b429],
25	,	,	O	,	_	0	SENT_153	[p12l817t356r1105b429],
26	with	IN	O	with	_	0	SENT_153	[p12l1153t356r1310b418],
27	a	DT	O	a	det	29	SENT_153	[p12l1355t375r1392b418],
28	hazard	NN	O	hazard	nn	29	SENT_153	[p12l1434t356r1673b418],
29	ratio	NN	O	ratio	prep_with	8	SENT_153	[p12l1715t356r1877b418],
30	of	IN	O	of	_	0	SENT_153	[p12l1923t356r2000b418],
31	3.2	CD	PERCENT	3.2	number	32	SENT_153	[p12l2041t356r2147b418],
32	(	CD	PERCENT	(	prep_of	29	SENT_153	[p12l17t467r127b544],
33	95	CD	PERCENT	95	num	34	SENT_153	[p12l17t467r127b544],
34	%	NN	PERCENT	%	dep	32	SENT_153	[p12l167t467r231b530],
35	CI	NN	O	ci	nn	38	SENT_153	[p12l261t467r347b530],
36	1.6-6	CD	NUMBER	1.6-6	num	38	SENT_153	[p12l382t467r689b544],
37	.2	NN	NUMBER	.2	nn	38	SENT_153	[p12l382t467r689b544],
38	)	NN	O	)	dep	32	SENT_153	[p12l382t467r689b544],
39	,	,	O	,	_	0	SENT_153	[p12l382t467r689b544],
40	p	NN	O	p	appos	32	SENT_153	[p12l710t488r759b547],
41	=	JJ	O	=	amod	40	SENT_153	[p12l796t495r856b519],
42	0.0006	CD	NUMBER	0.0006	tmod	41	SENT_153	[p12l892t467r1153b530],
43	.	.	O	.	_	0	SENT_153	[p12l892t467r1153b530],

1	As	IN	O	as	mark	2	SENT_154	[p12l1184t467r1278b529],
2	shown	VBN	O	show	advcl	17	SENT_154	[p12l1309t467r1537b530],
3	in	IN	O	in	_	0	SENT_154	[p12l1563t467r1630b529],
4	Supplemental	NNP	O	Supplemental	nn	5	SENT_154	[p12l1658t467r2147b548],
5	Tables	NNP	O	Tables	prep_in	2	SENT_154	[p12l13t578r248b641],
6	4	CD	NUMBER	4	dep	5	SENT_154	[p12l282t579r324b640],
7	and	CC	O	and	_	0	SENT_154	[p12l357t578r483b641],
8	5	CD	NUMBER	5	dep	5	SENT_154	[p12l514t578r574b652],
9	,	,	O	,	_	0	SENT_154	[p12l514t578r574b652],
10	no	DT	O	no	det	13	SENT_154	[p12l608t598r694b641],
11	other	JJ	O	other	amod	13	SENT_154	[p12l726t578r909b641],
12	genetic	JJ	O	genetic	amod	13	SENT_154	[p12l938t578r1193b659],
13	variants	NNS	O	variant	nsubjpass	17	SENT_154	[p12l1226t578r1505b641],
14	were	VBD	O	be	auxpass	17	SENT_154	[p12l1538t598r1708b641],
15	statistically	RB	O	statistically	advmod	17	SENT_154	[p12l1743t578r2147b659],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_154	[p12l17t689r454b770],
17	associated	VBN	O	associate	_	0	SENT_154	[p12l499t689r865b752],
18	with	IN	O	with	_	0	SENT_154	[p12l907t689r1064b752],
19	treatment	NN	O	treatment	nn	20	SENT_154	[p12l1106t699r1445b752],
20	discontinuation	NN	O	discontinuation	prep_with	17	SENT_154	[p12l1487t689r2038b752],
21	in	IN	O	in	_	0	SENT_154	[p12l2080t689r2148b751],
22	the	DT	O	the	det	24	SENT_154	[p12l13t800r120b863],
23	multivariate	JJ	O	multivariate	amod	24	SENT_154	[p12l154t800r586b863],
24	analysis	NN	O	analysis	prep_in	20	SENT_154	[p12l621t800r924b881],
25	.	.	O	.	_	0	SENT_154	[p12l621t800r924b881],

1	Other	JJ	O	other	amod	4	SENT_155	[p12l18t1023r224b1087],
2	candidate	NN	O	candidate	nn	4	SENT_155	[p12l253t1023r603b1086],
3	gene	NN	O	gene	nn	4	SENT_155	[p12l636t1045r802b1103],
4	variants	NNS	O	variant	_	0	SENT_155	[p12l837t1026r1127b1087],

1	Other	JJ	O	other	amod	2	SENT_156	[p12l15t1247r217b1310],
2	authors	NNS	O	author	nsubj	25	SENT_156	[p12l275t1247r532b1309],
3	have	VBP	O	have	aux	4	SENT_156	[p12l592t1247r758b1309],
4	reported	VBN	O	report	_	0	SENT_156	[p12l816t1247r1115b1328],
5	a	DT	O	a	det	8	SENT_156	[p12l1173t1266r1210b1309],
6	non-signiﬁcant	JJ	O	non-signiﬁcant	amod	8	SENT_156	[p12l1267t1247r1804b1328],
7	putative	JJ	O	putative	amod	8	SENT_156	[p12l1859t1247r2146b1328],
8	association	NN	O	association	dobj	4	SENT_156	[p12l16t1358r410b1420],
9	between	IN	O	between	_	0	SENT_156	[p12l451t1358r748b1421],
10	four	CD	NUMBER	four	num	11	SENT_156	[p12l790t1358r938b1420],
11	SNPs	NNS	O	snp	prep_between	8	SENT_156	[p12l980t1358r1171b1421],
12	in	IN	O	in	_	0	SENT_156	[p12l1214t1358r1281b1420],
13	linkage	NN	O	linkage	nn	14	SENT_156	[p12l1323t1358r1584b1439],
14	disequilibrium	NN	O	disequilibrium	prep_in	11	SENT_156	[p12l1626t1358r2148b1439],
15	near	IN	O	near	_	0	SENT_156	[p12l13t1488r167b1531],
16	the	DT	O	the	det	18	SENT_156	[p12l198t1469r305b1531],
17	TCLIA	NN	O	tclium	nn	18	SENT_156	[p12l342t1469r590b1532],
18	gene	NN	O	gene	prep_near	14	SENT_156	[p12l627t1488r812b1550],
19	,	,	O	,	_	0	SENT_156	[p12l627t1488r812b1550],
20	identiﬁed	VBN	O	identiﬁed	partmod	11	SENT_156	[p12l848t1469r1185b1531],
21	by	IN	O	by	_	0	SENT_156	[p12l1216t1469r1304b1550],
22	GWAS	NNP	ORGANIZATION	GWAS	agent	20	SENT_156	[p12l1338t1469r1615b1543],
23	,	,	O	,	_	0	SENT_156	[p12l1338t1469r1615b1543],
24	and	CC	O	and	_	0	SENT_156	[p12l1653t1469r1779b1531],
25	increased	VBD	O	increase	conj_and	4	SENT_156	[p12l1811t1469r2148b1531],
26	musculoskeletal	JJ	O	musculoskeletal	amod	30	SENT_156	[p12l14t1580r590b1643],
27	toxicity	NN	O	toxicity	nn	30	SENT_156	[p12l617t1580r889b1661],
28	(	CD	NUMBER	(	num	30	SENT_156	[p12l919t1580r1111b1657],
29	odds	NNS	O	odds	nn	30	SENT_156	[p12l919t1580r1111b1657],
30	ratios	NNS	O	ratio	nsubj	33	SENT_156	[p12l1139t1580r1335b1643],
31	2.09-2	CD	NUMBER	2.09-2	num	33	SENT_156	[p12l1365t1581r1746b1657],
32	.21	CD	NUMBER	.21	num	33	SENT_156	[p12l1365t1581r1746b1657],
33	)	NN	O	)	xcomp	25	SENT_156	[p12l1365t1581r1746b1657],
34	in	IN	O	in	_	0	SENT_156	[p12l1776t1580r1844b1642],
35	patients	NNS	O	patient	prep_in	33	SENT_156	[p12l1869t1580r2145b1661],
36	who	WP	O	who	nsubjpass	38	SENT_156	[p12l14t1690r164b1752],
37	were	VBD	O	be	auxpass	38	SENT_156	[p12l214t1710r385b1752],
38	treated	VBN	O	treat	rcmod	35	SENT_156	[p12l434t1690r678b1752],
39	with	IN	O	with	_	0	SENT_156	[p12l726t1690r883b1752],
40	anastrozole	NN	O	anastrozole	prep_with	38	SENT_156	[p12l934t1690r1338b1752],
41	or	CC	O	or	_	0	SENT_156	[p12l1389t1710r1461b1752],
42	exemestane	NN	O	exemestane	conj_or	40	SENT_156	[p12l1509t1700r1925b1752],
43	on	IN	O	on	_	0	SENT_156	[p12l1975t1710r2062b1752],
44	a	DT	O	a	det	45	SENT_156	[p12l2112t1710r2149b1752],
45	prospective	JJ	O	prospective	prep_on	38	SENT_156	[p12l12t1801r424b1882],
46	randomized	VBN	O	randomize	partmod	45	SENT_156	[p12l467t1801r890b1864],
47	controlled	JJ	O	controlled	ccomp	46	SENT_156	[p12l933t1801r1295b1864],
48	trial	NN	O	trial	iobj	47	SENT_156	[p12l1336t1801r1478b1864],
49	(	CD	NUMBER	(	num	51	SENT_156	[p12l1524t1801r1831b1878],
50	MA27	NN	O	ma27	nn	51	SENT_156	[p12l1524t1801r1831b1878],
51	)	NN	O	)	dobj	47	SENT_156	[p12l1524t1801r1831b1878],
52	,	,	O	,	_	0	SENT_156	[p12l1524t1801r1831b1878],
53	using	VBG	O	use	xcomp	46	SENT_156	[p12l1876t1801r2067b1882],
54	a	DT	O	a	det	58	SENT_156	[p12l2112t1821r2149b1864],
55	gene	NN	O	gene	nn	58	SENT_156	[p12l15t1911r374b1992],
56	—	NN	O	—	nn	58	SENT_156	[p12l15t1911r374b1992],
57	dose	NN	O	dose	nn	58	SENT_156	[p12l15t1911r374b1992],
58	model	NN	O	model	dobj	53	SENT_156	[p12l413t1911r634b1973],
59	[	CD	NUMBER	[	num	61	SENT_156	[p12l679t1910r837b1986],
60	16	CD	NUMBER	16	num	61	SENT_156	[p12l679t1910r837b1986],
61	]	NN	O	]	dobj	4	SENT_156	[p12l679t1910r837b1986],
62	.	.	O	.	_	0	SENT_156	[p12l679t1910r837b1986],

1	We	PRP	O	we	nsubj	3	SENT_157	[p12l879t1912r1001b1973],
2	therefore	RB	O	therefore	advmod	3	SENT_157	[p12l1040t1910r1362b1973],
3	analyzed	VBD	O	analyze	_	0	SENT_157	[p12l1402t1911r1718b1992],
4	the	DT	O	the	det	5	SENT_157	[p12l1755t1911r1862b1973],
5	association	NN	O	association	dobj	3	SENT_157	[p12l1903t1911r2145b1973, p12l15t2023r191b2086],
6	between	IN	O	between	_	0	SENT_157	[p12l215t2023r512b2086],
7	the	DT	O	the	det	8	SENT_157	[p12l538t2023r645b2086],
8	SNPs	NNS	O	snp	prep_between	5	SENT_157	[p12l672t2024r863b2086],
9	near	IN	O	near	_	0	SENT_157	[p12l890t2043r1043b2086],
10	TCLIA	NN	LOCATION	tclium	prep_near	8	SENT_157	[p12l1071t2024r1319b2087],
11	and	CC	O	and	_	0	SENT_157	[p12l1349t2023r1475b2086],
12	discontinuation	NN	O	discontinuation	conj_and	10	SENT_157	[p12l1500t2023r2051b2086],
13	of	IN	O	of	_	0	SENT_157	[p12l2076t2023r2153b2086],
14	AI	NN	O	aus	nn	15	SENT_157	[p12l13t2136r105b2197],
15	therapy	NN	O	therapy	prep_of	5	SENT_157	[p12l145t2135r411b2216],
16	in	IN	O	in	_	0	SENT_157	[p12l453t2135r520b2197],
17	the	DT	O	the	det	19	SENT_157	[p12l560t2135r667b2198],
18	ELPh	NN	O	elph	nn	19	SENT_157	[p12l707t2135r909b2197],
19	trial	NN	O	trial	prep_in	15	SENT_157	[p12l950t2135r1092b2198],
20	(	CD	NUMBER	(	num	22	SENT_157	[p12l1135t2135r1654b2216],
21	Supplemental	NNP	O	Supplemental	nn	22	SENT_157	[p12l1135t2135r1654b2216],
22	Tables	NNP	O	Tables	tmod	3	SENT_157	[p12l1694t2135r1929b2198],
23	3-5	CD	NUMBER	3-5	num	24	SENT_157	[p12l1966t2135r2142b2213],
24	)	CD	NUMBER	)	dep	22	SENT_157	[p12l1966t2135r2142b2213],
25	.	.	O	.	_	0	SENT_157	[p12l1966t2135r2142b2213],

1	Using	VBG	O	use	_	0	SENT_158	[p12l13t2246r223b2327],
2	a	DT	O	a	det	6	SENT_158	[p12l272t2265r309b2308],
3	gene	NN	O	gene	nn	6	SENT_158	[p12l353t2246r712b2327],
4	—	NN	O	—	nn	6	SENT_158	[p12l353t2246r712b2327],
5	dose	NN	O	dose	nn	6	SENT_158	[p12l353t2246r712b2327],
6	model	NN	O	model	dobj	1	SENT_158	[p12l757t2246r999b2320],
7	,	,	O	,	_	0	SENT_158	[p12l757t2246r999b2320],
8	in	IN	O	in	_	0	SENT_158	[p12l1047t2246r1114b2308],
9	contrast	NN	O	contrast	prep_in	6	SENT_158	[p12l1160t2255r1442b2308],
10	to	TO	O	to	_	0	SENT_158	[p12l1486t2255r1552b2308],
11	the	DT	O	the	det	12	SENT_158	[p12l1597t2246r1704b2308],
12	ﬁndings	NNS	O	ﬁndings	prep_to	9	SENT_158	[p12l1751t2246r2034b2327],
13	in	IN	O	in	_	0	SENT_158	[p12l2080t2246r2148b2308],
14	MA27	NN	O	ma27	prep_in	12	SENT_158	[p12l13t2357r241b2419],
15	we	PRP	O	we	nsubj	16	SENT_158	[p12l289t2376r390b2419],
16	observed	VBD	O	observe	rcmod	14	SENT_158	[p12l437t2357r758b2420],
17	just	RB	O	just	advmod	19	SENT_158	[p12l794t2357r929b2438],
18	the	DT	O	the	det	19	SENT_158	[p12l973t2357r1079b2419],
19	opposite	JJ	O	opposite	nn	26	SENT_158	[p12l1126t2357r1446b2438],
20	,	,	O	,	_	0	SENT_158	[p12l1126t2357r1446b2438],
21	a	DT	O	a	det	23	SENT_158	[p12l1495t2376r1532b2419],
22	non	JJ	O	non	amod	23	SENT_158	[p12l1575t2357r2147b2438],
23	—	NN	O	—	appos	19	SENT_158	[p12l1575t2357r2147b2438],
24	statistically	RB	O	statistically	advmod	25	SENT_158	[p12l1575t2357r2147b2438],
25	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_158	[p12l17t2468r386b2549],
26	trend	NN	O	trend	dobj	16	SENT_158	[p12l419t2468r602b2530],
27	toward	IN	O	toward	_	0	SENT_158	[p12l636t2468r884b2531],
28	an	DT	O	a	det	29	SENT_158	[p12l919t2487r999b2530],
29	association	NN	O	association	prep_toward	16	SENT_158	[p12l1035t2468r1431b2530],
30	between	IN	O	between	_	0	SENT_158	[p12l1463t2468r1762b2531],
31	decreased	VBN	O	decrease	amod	32	SENT_158	[p12l1796t2468r2148b2530],
32	likelihood	NN	O	likelihood	prep_between	29	SENT_158	[p12l14t2578r377b2640],
33	of	IN	O	of	_	0	SENT_158	[p12l413t2578r490b2640],
34	discontinuation	NN	O	discontinuation	prep_of	32	SENT_158	[p12l520t2578r1071b2640],
35	of	IN	O	of	prep	16	SENT_158	[p12l1108t2578r1185b2640],
36	either	CC	O	either	dep	35	SENT_158	[p12l1215t2578r1418b2640],
37	AI	NN	O	aus	conj	35	SENT_158	[p12l1453t2579r1544b2639],
38	because	IN	O	because	_	0	SENT_158	[p12l1579t2578r1861b2640],
39	of	IN	O	of	_	0	SENT_158	[p12l1899t2578r1976b2640],
40	toxicity	NN	O	toxicity	prep_because_of	16	SENT_158	[p12l2006t2588r2145b2640, p12l14t2689r171b2770],
41	and	CC	O	and	_	0	SENT_158	[p12l205t2689r330b2752],
42	two	CD	NUMBER	two	prep_because_of	16	SENT_158	[p12l360t2699r492b2752],
43	of	IN	O	of	_	0	SENT_158	[p12l525t2689r602b2752],
44	the	DT	O	the	det	45	SENT_158	[p12l626t2689r733b2752],
45	SNPs	NNS	O	snp	prep_of	6	SENT_158	[p12l768t2690r979b2763],
46	,	,	O	,	_	0	SENT_158	[p12l768t2690r979b2763],
47	the	DT	O	the	det	52	SENT_158	[p12l1014t2689r1121b2752],
48	imputed	JJ	O	imputed	amod	52	SENT_158	[p12l1153t2689r1446b2770],
49	SNP	NN	O	snp	nn	52	SENT_158	[p12l1479t2690r1637b2752],
50	(	CD	NUMBER	(	num	52	SENT_158	[p12l1671t2689r2145b2767],
51	rsl1849538	NN	O	rsl1849538	nn	52	SENT_158	[p12l1671t2689r2145b2767],
52	)	NN	O	)	prep_of	6	SENT_158	[p12l1671t2689r2145b2767],
53	and	CC	O	and	_	0	SENT_158	[p12l16t2799r141b2861],
54	a	DT	DURATION	a	det	59	SENT_158	[p12l179t2819r216b2861],
55	second	JJ	DURATION	second	amod	59	SENT_158	[p12l255t2799r499b2861],
56	SNP	NN	O	snp	nn	59	SENT_158	[p12l538t2799r697b2861],
57	(	CD	NUMBER	(	num	59	SENT_158	[p12l736t2799r1187b2875],
58	rs2369049	NN	O	rs2369049	nn	59	SENT_158	[p12l736t2799r1187b2875],
59	)	NN	O	)	prep_of	6	SENT_158	[p12l736t2799r1187b2875],
60	,	,	O	,	_	0	SENT_158	[p12l736t2799r1187b2875],
61	with	IN	O	with	_	0	SENT_158	[p12l1228t2799r1384b2861],
62	hazard	NN	O	hazard	nn	63	SENT_158	[p12l1421t2799r1659b2861],
63	ratios	NNS	O	ratio	prep_with	6	SENT_158	[p12l1694t2799r1890b2861],
64	of	IN	O	of	_	0	SENT_158	[p12l1930t2799r2008b2861],
65	0.6	CD	PERCENT	0.6	num	69	SENT_158	[p12l2039t2799r2146b2861],
66	(	CD	PERCENT	(	number	67	SENT_158	[p12l17t2908r126b2986],
67	95	CD	PERCENT	95	dep	68	SENT_158	[p12l17t2908r126b2986],
68	%	NN	PERCENT	%	dep	69	SENT_158	[p12l166t2909r231b2972],
69	CI	NN	O	ci	prep_of	6	SENT_158	[p12l274t2909r359b2972],
70	0.4-0	CD	NUMBER	0.4-0	num	71	SENT_158	[p12l398t2909r682b2983],
71	.9	NN	NUMBER	.9	dep	69	SENT_158	[p12l398t2909r682b2983],
72	,	,	O	,	_	0	SENT_158	[p12l398t2909r682b2983],
73	19	CD	NUMBER	19	num	76	SENT_158	[p12l715t2930r764b2989],
74	=	JJ	O	=	amod	76	SENT_158	[p12l801t2937r861b2961],
75	0.007	CD	NUMBER	0.007	tmod	74	SENT_158	[p12l898t2909r1123b2986],
76	)	NN	O	)	conj_and	69	SENT_158	[p12l898t2909r1123b2986],
77	and	CC	O	and	_	0	SENT_158	[p12l1166t2909r1292b2971],
78	0.6	CD	PERCENT	0.6	num	82	SENT_158	[p12l1329t2908r1437b2972],
79	(	CD	PERCENT	(	number	80	SENT_158	[p12l1479t2908r1588b2986],
80	95	CD	PERCENT	95	dep	81	SENT_158	[p12l1479t2908r1588b2986],
81	%	NN	PERCENT	%	dep	82	SENT_158	[p12l1629t2909r1693b2972],
82	CI	NN	O	ci	conj_and	69	SENT_158	[p12l1736t2909r1822b2972],
83	0.4-0	CD	NUMBER	0.4-0	num	84	SENT_158	[p12l1860t2909r2144b2983],
84	.8	CD	NUMBER	.8	dep	82	SENT_158	[p12l1860t2909r2144b2983],
85	,	,	O	,	_	0	SENT_158	[p12l1860t2909r2144b2983],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_159	[p12l52t3064r142b3089],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_159	[p12l155t3064r255b3089],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_159	[p12l267t3064r318b3089],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_159	[p12l331t3064r406b3089],
5	(	CD	NUMBER	(	num	6	SENT_159	[p12l419t3064r510b3094],
6	2013	CD	DATE	2013	dep	4	SENT_159	[p12l419t3064r510b3094],
7	)	CD	NUMBER	)	number	8	SENT_159	[p12l419t3064r510b3094],
8	138:807	CD	NUMBER	138:807	dep	6	SENT_159	[p12l528t3064r709b3089],
9	-816	CD	NUMBER	-816	num	10	SENT_159	[p12l528t3064r709b3089],
10	811	CD	NUMBER	811	dep	4	SENT_159	[p12l2056t3064r2104b3089],

1	Table	NNP	O	Table	dep	2	SENT_160	[p12l53t3175r138b3201],
2	1	CD	NUMBER	1	amod	5	SENT_160	[p12l152t3175r166b3200],
3	Baseline	NN	O	baseline	nn	5	SENT_160	[p12l189t3175r310b3200],
4	patient	NN	O	patient	nn	5	SENT_160	[p12l323t3175r419b3208],
5	characteristics	NNS	O	characteristic	_	0	SENT_160	[p12l432t3175r633b3200],
6	for	IN	O	for	_	0	SENT_160	[p12l647t3175r687b3200],
7	all	DT	O	all	prep_for	5	SENT_160	[p12l700t3175r734b3200],
8	randomized	VBN	O	randomize	partmod	7	SENT_160	[p12l746t3175r921b3205],
9	,	,	O	,	_	0	SENT_160	[p12l746t3175r921b3205],
10	genotyped	VBN	O	genotype	dep	8	SENT_160	[p12l935t3175r1081b3208],
11	patients	NNS	O	patient	dobj	8	SENT_160	[p12l1094t3175r1211b3208],
12	,	,	O	,	_	0	SENT_160	[p12l1094t3175r1211b3208],
13	by	IN	O	by	_	0	SENT_160	[p12l1224t3175r1259b3208],
14	treatment	NN	O	treatment	nn	15	SENT_160	[p12l1272t3179r1406b3200],
15	allocation	NN	O	allocation	agent	8	SENT_160	[p12l1419t3175r1557b3200],
16	and	CC	O	and	_	0	SENT_160	[p12l1570t3175r1620b3200],
17	by	IN	O	by	_	0	SENT_160	[p12l1632t3175r1667b3208],
18	treatment	NN	O	treatment	nn	19	SENT_160	[p12l1680t3179r1813b3200],
19	discontinuation	NN	O	discontinuation	agent	8	SENT_160	[p12l1826t3175r2043b3200],

1	All	DT	O	all	nsubj	2	SENT_161	[p12l422t3242r466b3266],
2	enrolled	VBN	O	enrol	_	0	SENT_161	[p12l480t3242r602b3271],
3	,	,	O	,	_	0	SENT_161	[p12l480t3242r602b3271],
4	genotyped	VBN	O	genotype	dep	2	SENT_161	[p12l617t3242r763b3274],
5	Randomized	NNP	O	Randomized	dobj	4	SENT_161	[p12l806t3242r984b3267],
6	to	TO	O	to	_	0	SENT_161	[p12l996t3246r1023b3267],
7	Randomized	NNP	O	Randomized	prep_to	5	SENT_161	[p12l1128t3242r1306b3267],
8	to	TO	O	to	_	0	SENT_161	[p12l1318t3246r1345b3267],
9	Discontinued	NNP	O	Discontinued	nn	10	SENT_161	[p12l1473t3242r1661b3267],
10	AI	NNP	O	AI	prep_to	4	SENT_161	[p12l1673t3242r1709b3266],
11	because	IN	O	because	_	0	SENT_161	[p12l1721t3242r1832b3267],
12	of	IN	O	of	_	0	SENT_161	[p12l1845t3242r1876b3267],
13	Continued	VBN	O	continue	amod	15	SENT_161	[p12l1910t3242r2057b3267],
14	AI	NN	O	aus	nn	15	SENT_161	[p12l2069t3242r2106b3266],
15	patients	NNS	O	patient	prep_because_of	4	SENT_161	[p12l422t3283r531b3315],
16	(	CD	NUMBER	(	num	17	SENT_161	[p12l545t3283r573b3314],
17	n	NN	O	n	npadvmod	18	SENT_161	[p12l545t3283r573b3314],
18	=	JJ	O	=	amod	15	SENT_161	[p12l587t3294r611b3304],
19	467	CD	NUMBER	467	number	20	SENT_161	[p12l625t3283r688b3314],
20	)	CD	NUMBER	)	dep	2	SENT_161	[p12l625t3283r688b3314],
21	letrozole	NN	O	letrozole	nn	23	SENT_161	[p12l806t3283r928b3308],
22	(	NN	O	(	nn	23	SENT_161	[p12l943t3283r970b3314],
23	n	NN	O	n	nsubj	29	SENT_161	[p12l943t3283r970b3314],
24	=	JJ	O	=	amod	28	SENT_161	[p12l984t3294r1008b3304],
25	232	CD	NUMBER	232	num	28	SENT_161	[p12l1023t3283r1085b3314],
26	)	NN	O	)	nn	28	SENT_161	[p12l1023t3283r1085b3314],
27	exemestane	NN	O	exemestane	nn	28	SENT_161	[p12l1128t3287r1292b3308],
28	symptoms	NNS	O	symptom	dep	23	SENT_161	[p12l1474t3287r1617b3315],
29	(	VBP	O	(	rcmod	20	SENT_161	[p12l1631t3283r1658b3314],
30	n	NN	O	n	nn	38	SENT_161	[p12l1631t3283r1658b3314],
31	=	JJ	O	=	amod	30	SENT_161	[p12l1672t3294r1696b3304],
32	152	CD	NUMBER	152	number	33	SENT_161	[p12l1714t3283r1773b3314],
33	)	CD	NUMBER	)	num	35	SENT_161	[p12l1714t3283r1773b3314],
34	(	NN	O	(	nn	35	SENT_161	[p12l1911t3284r1938b3314],
35	n	NN	O	n	dep	30	SENT_161	[p12l1911t3284r1938b3314],
36	=	JJ	O	=	amod	38	SENT_161	[p12l1952t3294r1977b3304],
37	280	CD	NUMBER	280	tmod	36	SENT_161	[p12l1991t3283r2053b3314],
38	)	NN	O	)	dobj	29	SENT_161	[p12l1991t3283r2053b3314],

1	(	NN	O	(	nn	2	SENT_162	[p12l1129t3325r1156b3356],
2	n	NN	O	n	_	0	SENT_162	[p12l1129t3325r1156b3356],
3	=	JJ	O	=	dep	2	SENT_162	[p12l1170t3336r1194b3346],
4	235	CD	NUMBER	235	num	5	SENT_162	[p12l1209t3325r1271b3355],
5	)	NN	O	)	dep	2	SENT_162	[p12l1209t3325r1271b3355],

1	Median	JJ	MISC	median	dep	2	SENT_163	[p12l6t3436r251b3492],
2	age	NN	O	age	dep	4	SENT_163	[p12l281t3454r406b3509],
3	,	,	O	,	_	0	SENT_163	[p12l281t3454r406b3509],
4	yrs	VBZ	DURATION	yr	_	0	SENT_163	[p12l439t3454r533b3509],
5	59	CD	NUMBER	59	number	6	SENT_163	[p12l851t3436r926b3493],
6	(	CD	NUMBER	(	dobj	4	SENT_163	[p12l959t3436r1207b3505],
7	35-89	CD	NUMBER	35-89	num	8	SENT_163	[p12l959t3436r1207b3505],
8	)	NN	O	)	nsubj	4	SENT_163	[p12l959t3436r1207b3505],
9	59	CD	NUMBER	59	number	10	SENT_163	[p12l1724t3436r1800b3493],
10	(	CD	NUMBER	(	dep	8	SENT_163	[p12l1833t3436r2080b3505],
11	38-89	CD	NUMBER	38-89	num	12	SENT_163	[p12l1833t3436r2080b3505],
12	)	NN	O	)	dep	10	SENT_163	[p12l1833t3436r2080b3505],

1	(	NN	O	(	_	0	SENT_164	[p12l65t3530r291b3602],
2	range	NN	O	range	nn	3	SENT_164	[p12l65t3530r291b3602],
3	)	NN	O	)	dep	1	SENT_164	[p12l65t3530r291b3602],

1	Race	NN	O	race	_	0	SENT_165	[p12l7t3642r165b3697],

1	White	NNP	O	White	nn	2	SENT_166	[p13l58t34r254b90],
2	Black	NNP	O	Black	_	0	SENT_166	[p13l59t146r247b201],
3	Other	JJ	O	other	dep	2	SENT_166	[p13l61t256r242b313],

1	Weight	NNP	O	Weight	nsubj	24	SENT_167	[p13l6t366r259b439],
2	,	,	O	,	_	0	SENT_167	[p13l6t366r259b439],
3	kg	NN	O	kg	nn	5	SENT_167	[p13l291t366r369b439],
4	(	NN	O	(	nn	5	SENT_167	[p13l401t366r550b436],
5	SD	NN	O	sd	appos	1	SENT_167	[p13l401t366r550b436],
6	)	CD	NUMBER	)	num	7	SENT_167	[p13l401t366r550b436],
7	BMI	NN	O	bmus	rcmod	5	SENT_167	[p13l7t479r156b533],
8	(	CD	NUMBER	(	num	9	SENT_167	[p13l187t478r336b547],
9	SD	NN	O	sd	dep	7	SENT_167	[p13l187t478r336b547],
10	)	CD	NUMBER	)	num	12	SENT_167	[p13l187t478r336b547],
11	Prior	JJ	O	prior	amod	12	SENT_167	[p13l7t589r167b645],
12	tamoxifen	NN	O	tamoxifen	npadvmod	13	SENT_167	[p13l194t589r519b645],
13	Prior	RB	O	prior	dep	7	SENT_167	[p13l6t699r167b755],
14	HRT	NNP	O	HRT	pobj	13	SENT_167	[p13l194t700r352b754],
15	Prior	RB	O	prior	advmod	13	SENT_167	[p13l7t809r167b865],
16	chemotherapy	NN	O	chemotherapy	pobj	13	SENT_167	[p13l195t809r648b882],
17	Prior	JJ	O	prior	amod	20	SENT_167	[p13l7t920r167b977],
18	taxane	NN	O	taxane	nn	20	SENT_167	[p13l194t929r402b977],
19	Mean	NN	O	mean	nn	20	SENT_167	[p13l6t1033r188b1088],
20	time	NN	O	time	dep	5	SENT_167	[p13l217t1032r358b1088],
21	since	IN	O	since	_	0	SENT_167	[p13l391t1032r551b1088],
22	chemotherapy	NN	O	chemotherapy	prep_since	20	SENT_167	[p13l64t1125r535b1198],
23	,	,	O	,	_	0	SENT_167	[p13l64t1125r535b1198],
24	yrs	VBZ	DURATION	yr	_	0	SENT_167	[p13l568t1143r662b1198],
25	(	CD	NUMBER	(	num	27	SENT_167	[p13l65t1220r215b1288],
26	SD	NN	O	sd	nn	27	SENT_167	[p13l65t1220r215b1288],
27	)	NN	O	)	dobj	24	SENT_167	[p13l65t1220r215b1288],

1	Assigned	VBN	O	assign	_	0	SENT_168	[p13l6t1330r304b1403],
2	AI	NNP	O	AI	nn	4	SENT_168	[p13l332t1330r415b1385],
3	Letrozole	NNP	O	Letrozole	nn	4	SENT_168	[p13l59t1440r366b1497],
4	Exemestane	NNP	O	Exemestane	dobj	1	SENT_168	[p13l59t1553r446b1608],

1	AI	NN	O	aus	nn	3	SENT_169	[p13l51t3363r88b3387],
2	aromatase	NN	O	aromatase	nn	3	SENT_169	[p13l99t3367r241b3388],
3	inhibitor	NN	O	inhibitor	_	0	SENT_169	[p13l254t3363r383b3392],
4	,	,	O	,	_	0	SENT_169	[p13l254t3363r383b3392],
5	HRT	NN	O	hrt	nn	8	SENT_169	[p13l396t3364r466b3387],
6	hormone	NN	O	hormone	nn	8	SENT_169	[p13l475t3363r600b3388],
7	replacement	NN	O	replacement	nn	8	SENT_169	[p13l612t3363r786b3395],
8	therapy	NN	O	therapy	appos	3	SENT_169	[p13l798t3363r911b3395],
9	,	,	O	,	_	0	SENT_169	[p13l798t3363r911b3395],
10	kg	NN	O	kg	nn	11	SENT_169	[p13l925t3363r957b3395],
11	kilograms	NNS	O	kilogram	appos	3	SENT_169	[p13l970t3363r1118b3395],
12	,	,	O	,	_	0	SENT_169	[p13l970t3363r1118b3395],
13	n	NN	O	n	nn	14	SENT_169	[p13l1132t3371r1149b3388],
14	number	NN	O	number	appos	3	SENT_169	[p13l1162t3363r1276b3392],
15	,	,	O	,	_	0	SENT_169	[p13l1162t3363r1276b3392],
16	SD	NN	O	sd	nn	18	SENT_169	[p13l1291t3363r1333b3388],
17	standard	JJ	O	standard	amod	18	SENT_169	[p13l1346t3363r1464b3388],
18	deviation	NN	O	deviation	appos	3	SENT_169	[p13l1477t3363r1615b3392],
19	,	,	O	,	_	0	SENT_169	[p13l1477t3363r1615b3392],
20	yrs	NNS	DURATION	yr	nn	21	SENT_169	[p13l1628t3371r1671b3394],
21	years	NNS	DURATION	year	appos	3	SENT_169	[p13l1684t3371r1757b3395],

1	[	NN	O	[	_	0	SENT_170	[p13l6t3579r55b3637],
2	9	CD	NUMBER	9	num	1	SENT_170	[p13l6t3579r55b3637],
3	=	JJ	O	=	dep	1	SENT_170	[p13l91t3586r152b3610],
4	0.002	CD	NUMBER	0.002	num	5	SENT_170	[p13l188t3558r435b3634],
5	)	NN	O	)	dep	3	SENT_170	[p13l188t3558r435b3634],
6	,	,	O	,	_	0	SENT_170	[p13l188t3558r435b3634],
7	respectively	RB	O	respectively	advmod	3	SENT_170	[p13l466t3557r917b3638],
8	.	.	O	.	_	0	SENT_170	[p13l466t3557r917b3638],

1	Using	VBG	O	use	partmod	8	SENT_171	[p13l950t3557r1160b3638],
2	the	DT	O	the	det	5	SENT_171	[p13l1190t3557r1296b3620],
3	same	JJ	O	same	amod	5	SENT_171	[p13l1329t3577r1507b3620],
4	statistical	JJ	O	statistical	amod	5	SENT_171	[p13l1540t3557r1873b3620],
5	model	NN	O	model	dobj	1	SENT_171	[p13l1903t3557r2144b3631],
6	,	,	O	,	_	0	SENT_171	[p13l1903t3557r2144b3631],
7	there	EX	O	there	expl	8	SENT_171	[p13l13t3667r190b3729],
8	was	VBD	O	be	_	0	SENT_171	[p13l220t3686r354b3729],
9	a	DT	O	a	det	10	SENT_171	[p13l386t3687r423b3729],
10	trend	NN	O	trend	nsubj	8	SENT_171	[p13l450t3667r633b3729],
11	toward	IN	O	toward	_	0	SENT_171	[p13l660t3667r908b3729],
12	an	DT	O	a	det	13	SENT_171	[p13l937t3686r1017b3729],
13	association	NN	O	association	prep_toward	10	SENT_171	[p13l1047t3667r1442b3729],
14	between	IN	O	between	_	0	SENT_171	[p13l1469t3667r1768b3729],
15	decreased	VBN	O	decrease	amod	16	SENT_171	[p13l1796t3667r2148b3729],
16	likelihood	NN	O	likelihood	prep_between	13	SENT_171	[p14l14t31r377b92],
17	of	IN	O	of	_	0	SENT_171	[p14l428t30r505b92],
18	discontinuation	NN	O	discontinuation	prep_of	16	SENT_171	[p14l551t31r1101b92],
19	of	IN	O	of	_	0	SENT_171	[p14l1153t31r1230b92],
20	exemestane	NN	O	exemestane	prep_of	18	SENT_171	[p14l1275t40r1691b92],
21	because	IN	O	because	_	0	SENT_171	[p14l1742t31r2024b92],
22	of	IN	O	of	_	0	SENT_171	[p14l2076t31r2153b92],
23	toxicity	NN	O	toxicity	prep_of	57	SENT_171	[p14l13t142r285b223],
24	and	CC	O	and	_	0	SENT_171	[p14l366t142r492b205],
25	the	DT	O	the	det	28	SENT_171	[p14l568t142r674b205],
26	same	JJ	O	same	amod	28	SENT_171	[p14l756t162r934b205],
27	two	CD	NUMBER	two	num	28	SENT_171	[p14l1012t152r1143b205],
28	SNPs	NNS	O	snp	conj_and	23	SENT_171	[p14l1223t143r1414b205],
29	(	CD	NUMBER	(	num	30	SENT_171	[p14l1496t142r1940b220],
30	rs11849538	NN	O	rs11849538	dep	28	SENT_171	[p14l1496t142r1940b220],
31	and	CC	O	and	_	0	SENT_171	[p14l2022t142r2148b205],
32	rs2369049	NN	O	rs2369049	nn	33	SENT_171	[p14l12t252r416b328],
33	)	NN	O	)	conj_and	23	SENT_171	[p14l12t252r416b328],
34	with	IN	O	with	_	0	SENT_171	[p14l464t252r621b314],
35	hazard	NN	O	hazard	nn	36	SENT_171	[p14l665t252r903b314],
36	ratios	NNS	O	ratio	prep_with	33	SENT_171	[p14l947t252r1142b314],
37	of	IN	O	of	_	0	SENT_171	[p14l1191t252r1268b314],
38	0.5	CD	PERCENT	0.5	num	42	SENT_171	[p14l1308t252r1412b314],
39	(	CD	PERCENT	(	number	40	SENT_171	[p14l1464t252r1574b328],
40	95	CD	PERCENT	95	dep	41	SENT_171	[p14l1464t252r1574b328],
41	%	NN	PERCENT	%	dep	42	SENT_171	[p14l1614t252r1678b314],
42	CI	NN	O	ci	prep_of	36	SENT_171	[p14l1728t252r1814b314],
43	0.3-0	CD	NUMBER	0.3-0	number	44	SENT_171	[p14l1860t252r2144b325],
44	.8	CD	NUMBER	.8	num	42	SENT_171	[p14l1860t252r2144b325],
45	,	,	O	,	_	0	SENT_171	[p14l1860t252r2144b325],
46	19	CD	NUMBER	19	num	49	SENT_171	[p14l6t383r55b442],
47	=	JJ	O	=	amod	49	SENT_171	[p14l91t390r152b414],
48	0.009	CD	NUMBER	0.009	tmod	47	SENT_171	[p14l188t362r413b439],
49	)	NN	O	)	prep_of	36	SENT_171	[p14l188t362r413b439],
50	and	CC	O	and	_	0	SENT_171	[p14l497t362r623b424],
51	0.5	CD	PERCENT	0.5	num	55	SENT_171	[p14l702t362r807b425],
52	(	CD	PERCENT	(	number	53	SENT_171	[p14l892t361r1002b439],
53	95	CD	PERCENT	95	dep	54	SENT_171	[p14l892t361r1002b439],
54	%	NN	PERCENT	%	dep	55	SENT_171	[p14l1042t362r1106b425],
55	CI	NN	O	ci	prep_of	36	SENT_171	[p14l1190t362r1276b425],
56	0.3-0	CD	NUMBER	0.3-0	number	57	SENT_171	[p14l1356t362r1640b436],
57	.8	CD	NUMBER	.8	prep_because	20	SENT_171	[p14l1356t362r1640b436],
58	,	,	O	,	_	0	SENT_171	[p14l1356t362r1640b436],
59	19	CD	NUMBER	19	num	62	SENT_171	[p14l1715t383r1764b442],
60	=	JJ	O	=	amod	62	SENT_171	[p14l1801t390r1861b414],
61	0.006	CD	NUMBER	0.006	tmod	60	SENT_171	[p14l1897t362r2144b439],
62	)	NN	O	)	appos	57	SENT_171	[p14l1897t362r2144b439],
63	,	,	O	,	_	0	SENT_171	[p14l1897t362r2144b439],
64	respectively	RB	O	respectively	advmod	57	SENT_171	[p14l12t474r464b555],
65	.	.	O	.	_	0	SENT_171	[p14l12t474r464b555],

1	A	DT	O	a	det	3	SENT_172	[p14l511t474r573b536],
2	similar	JJ	O	similar	amod	3	SENT_172	[p14l617t474r864b536],
3	trend	NN	O	trend	nsubjpass	6	SENT_172	[p14l904t474r1087b536],
4	was	VBD	O	be	auxpass	6	SENT_172	[p14l1129t493r1263b537],
5	not	RB	O	not	neg	6	SENT_172	[p14l1307t483r1421b536],
6	seen	VBN	O	see	_	0	SENT_172	[p14l1465t493r1618b536],
7	for	IN	O	for	_	0	SENT_172	[p14l1661t474r1764b536],
8	letrozole	NN	O	letrozole	nn	9	SENT_172	[p14l1805t474r2145b536],
9	—	NN	O	—	prep_for	6	SENT_172	[p14l1805t474r2145b536],
10	treated	VBN	O	treat	partmod	9	SENT_172	[p14l13t585r257b648],
11	patients	NNS	O	patient	dobj	10	SENT_172	[p14l288t585r583b666],
12	.	.	O	.	_	0	SENT_172	[p14l288t585r583b666],

1	Using	VBG	O	use	_	0	SENT_173	[p14l115t696r325b777],
2	data	NNS	O	datum	dobj	1	SENT_173	[p14l365t696r513b759],
3	from	IN	O	from	_	0	SENT_173	[p14l549t696r721b759],
4	a	DT	O	a	det	8	SENT_173	[p14l761t716r797b759],
5	cross	JJ	O	cross	amod	8	SENT_173	[p14l834t696r1364b759],
6	—	NN	O	—	nn	8	SENT_173	[p14l834t696r1364b759],
7	sectional	JJ	O	sectional	amod	8	SENT_173	[p14l834t696r1364b759],
8	trial	NN	O	trial	prep_from	1	SENT_173	[p14l1402t696r1544b759],
9	of	IN	O	of	_	0	SENT_173	[p14l1583t696r1660b759],
10	women	NNS	O	woman	prep_of	8	SENT_173	[p14l1692t716r1953b759],
11	with	IN	O	with	_	0	SENT_173	[p14l1991t696r2148b759],
12	AI	NN	O	aus	nn	13	SENT_173	[p14l13t807r505b870],
13	—	NN	O	—	prep_with	10	SENT_173	[p14l13t807r505b870],
14	associated	VBN	O	associate	partmod	13	SENT_173	[p14l13t807r505b870],
15	arthralgias	NNS	O	arthralgia	dobj	14	SENT_173	[p14l557t807r950b888],
16	,	,	O	,	_	0	SENT_173	[p14l557t807r950b888],
17	others	NNS	O	other	appos	15	SENT_173	[p14l1006t807r1219b870],
18	reported	VBD	O	report	dep	1	SENT_173	[p14l1270t807r1569b888],
19	an	DT	O	a	det	20	SENT_173	[p14l1621t827r1701b870],
20	association	NN	O	association	dobj	18	SENT_173	[p14l1753t807r2148b870],
21	between	IN	O	between	_	0	SENT_173	[p14l12t917r311b979],
22	the	DT	O	the	det	23	SENT_173	[p14l349t917r455b979],
23	presence	NN	O	presence	prep_between	20	SENT_173	[p14l493t936r805b998],
24	of	IN	O	of	_	0	SENT_173	[p14l846t917r922b979],
25	at	IN	O	at	quantmod	27	SENT_173	[p14l957t926r1018b979],
26	least	JJS	O	least	mwe	25	SENT_173	[p14l1056t917r1219b979],
27	one	CD	NUMBER	one	prep_of	23	SENT_173	[p14l1257t936r1382b979],
28	eight	CD	NUMBER	eight	num	31	SENT_173	[p14l1422t917r1850b998],
29	—	NN	O	—	nn	31	SENT_173	[p14l1422t917r1850b998],
30	repeat	NN	O	repeat	nn	31	SENT_173	[p14l1422t917r1850b998],
31	TTTA	NN	O	ttta	dep	27	SENT_173	[p14l1887t917r2147b994],
32	,	,	O	,	_	0	SENT_173	[p14l1887t917r2147b994],
33	,	,	O	,	_	0	SENT_173	[p14l1887t917r2147b994],
34	allele	NN	O	allele	dep	1	SENT_173	[p14l15t1028r206b1090],
35	in	IN	O	in	_	0	SENT_173	[p14l241t1028r308b1089],
36	intron	NN	O	intron	prep_in	34	SENT_173	[p14l342t1028r554b1090],
37	4	CD	NUMBER	4	num	36	SENT_173	[p14l587t1028r629b1089],
38	of	IN	O	of	_	0	SENT_173	[p14l665t1028r742b1090],
39	the	DT	O	the	det	41	SENT_173	[p14l769t1028r876b1090],
40	aromatase	NN	O	aromatase	nn	41	SENT_173	[p14l912t1037r1271b1090],
41	gene	NN	O	gene	prep_of	36	SENT_173	[p14l1308t1047r1472b1109],
42	(	CD	NUMBER	(	num	44	SENT_173	[p14l1510t1027r1984b1105],
43	rs60271534	NN	O	rs60271534	nn	44	SENT_173	[p14l1510t1027r1984b1105],
44	)	NN	O	)	dep	41	SENT_173	[p14l1510t1027r1984b1105],
45	and	CC	O	and	_	0	SENT_173	[p14l2022t1028r2148b1090],
46	decreased	VBD	O	decrease	dep	1	SENT_173	[p14l14t1139r367b1201],
47	likelihood	NN	O	likelihood	dobj	46	SENT_173	[p14l397t1139r759b1201],
48	of	IN	O	of	_	0	SENT_173	[p14l790t1139r867b1201],
49	reporting	VBG	O	report	prepc_of	47	SENT_173	[p14l891t1138r1217b1220],
50	AI	NNP	O	AI	nn	53	SENT_173	[p14l1249t1139r1741b1201],
51	—	NN	O	—	nn	53	SENT_173	[p14l1249t1139r1741b1201],
52	associated	VBN	O	associate	amod	53	SENT_173	[p14l1249t1139r1741b1201],
53	arthralgias	NNS	O	arthralgia	dobj	49	SENT_173	[p14l1773t1139r2145b1220],
54	[	RB	O	[	advmod	55	SENT_173	[p14l20t1251r341b1332],
55	adjusted	VBN	O	adjust	partmod	53	SENT_173	[p14l20t1251r341b1332],
56	odds	NNS	O	odds	nn	57	SENT_173	[p14l371t1251r534b1314],
57	ratio	NN	O	ratio	nn	62	SENT_173	[p14l564t1251r726b1314],
58	0.41	CD	PERCENT	0.41	number	59	SENT_173	[p14l757t1251r902b1314],
59	(	CD	PERCENT	(	dep	57	SENT_173	[p14l943t1251r1052b1328],
60	95	CD	PERCENT	95	number	61	SENT_173	[p14l943t1251r1052b1328],
61	%	NN	PERCENT	%	amod	62	SENT_173	[p14l1092t1251r1157b1314],
62	CI	NN	O	ci	dobj	55	SENT_173	[p14l1190t1251r1276b1314],
63	0.21-0	CD	NUMBER	0.21-0	num	65	SENT_173	[p14l1306t1251r1712b1328],
64	.79	CD	NUMBER	.79	num	65	SENT_173	[p14l1306t1251r1712b1328],
65	)	NN	O	)	dobj	18	SENT_173	[p14l1306t1251r1712b1328],
66	;	:	O	;	_	0	SENT_173	[p14l1306t1251r1712b1328],
67	p	NN	O	p	dobj	18	SENT_173	[p14l1737t1272r1786b1331],
68	=	JJ	O	=	amod	67	SENT_173	[p14l1823t1279r1883b1303],
69	0.008	CD	NUMBER	0.008	tmod	68	SENT_173	[p14l1919t1251r2141b1327],
70	]	CD	NUMBER	]	num	73	SENT_173	[p14l1919t1251r2141b1327],
71	[	NN	O	[	nn	73	SENT_173	[p14l20t1363r178b1438],
72	19	CD	NUMBER	19	num	73	SENT_173	[p14l20t1363r178b1438],
73	]	NN	O	]	nsubj	1	SENT_173	[p14l20t1363r178b1438],
74	.	.	O	.	_	0	SENT_173	[p14l20t1363r178b1438],

1	In	IN	O	in	_	0	SENT_174	[p14l209t1364r281b1424],
2	contrast	NN	O	contrast	prep_in	5	SENT_174	[p14l308t1371r608b1436],
3	,	,	O	,	_	0	SENT_174	[p14l308t1371r608b1436],
4	we	PRP	O	we	nsubj	5	SENT_174	[p14l639t1382r739b1425],
5	observed	VBD	O	observe	_	0	SENT_174	[p14l767t1362r1088b1425],
6	a	DT	O	a	det	11	SENT_174	[p14l1116t1382r1153b1425],
7	non	JJ	O	non	amod	11	SENT_174	[p14l1177t1362r1749b1443],
8	—	NN	O	—	nn	11	SENT_174	[p14l1177t1362r1749b1443],
9	statistically	RB	O	statistically	advmod	10	SENT_174	[p14l1177t1362r1749b1443],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_174	[p14l1779t1362r2149b1443],
11	increase	NN	O	increase	dobj	5	SENT_174	[p14l14t1473r305b1535],
12	in	IN	O	in	_	0	SENT_174	[p14l343t1473r411b1535],
13	AIMSS	NNP	O	AIMSS	prep_in	5	SENT_174	[p14l448t1473r714b1536],
14	when	WRB	O	when	advmod	30	SENT_174	[p14l756t1473r948b1536],
15	at	IN	O	at	advmod	30	SENT_174	[p14l987t1482r1049b1535],
16	least	JJS	O	least	pobj	15	SENT_174	[p14l1086t1473r1249b1535],
17	one	CD	NUMBER	one	dep	15	SENT_174	[p14l1286t1492r1411b1535],
18	8	CD	NUMBER	8	num	21	SENT_174	[p14l1454t1473r1744b1554],
19	—	NN	O	—	nn	21	SENT_174	[p14l1454t1473r1744b1554],
20	repeat	NN	O	repeat	nn	21	SENT_174	[p14l1454t1473r1744b1554],
21	allele	NN	O	allele	nsubj	30	SENT_174	[p14l1782t1473r1972b1535],
22	was	VBD	O	be	cop	30	SENT_174	[p14l2012t1492r2146b1536],
23	present	JJ	DATE	present	amod	30	SENT_174	[p14l12t1594r271b1665],
24	[	CD	NUMBER	[	num	25	SENT_174	[p14l314t1586r460b1660],
25	HR	NN	DURATION	hr	dep	23	SENT_174	[p14l314t1586r460b1660],
26	1.8	CD	PERCENT	1.8	number	27	SENT_174	[p14l505t1585r602b1647],
27	(	CD	PERCENT	(	amod	30	SENT_174	[p14l646t1584r756b1662],
28	95	CD	PERCENT	95	num	29	SENT_174	[p14l646t1584r756b1662],
29	%	NN	PERCENT	%	dep	27	SENT_174	[p14l796t1585r860b1647],
30	CI	NN	O	ci	advcl	5	SENT_174	[p14l902t1585r988b1647],
31	0.8-1	CD	NUMBER	0.8-1	num	33	SENT_174	[p14l1026t1585r1342b1662],
32	.8	CD	NUMBER	.8	num	33	SENT_174	[p14l1026t1585r1342b1662],
33	)	NN	O	)	dep	30	SENT_174	[p14l1026t1585r1342b1662],
34	;	:	O	;	_	0	SENT_174	[p14l1026t1585r1342b1662],
35	p	NN	O	p	dep	30	SENT_174	[p14l1375t1606r1425b1664],
36	=	JJ	O	=	amod	38	SENT_174	[p14l1462t1613r1522b1637],
37	0.49	CD	NUMBER	0.49	tmod	36	SENT_174	[p14l1558t1585r1759b1660],
38	]	NN	O	]	dep	35	SENT_174	[p14l1558t1585r1759b1660],
39	.	.	O	.	_	0	SENT_174	[p14l1558t1585r1759b1660],

1	In	IN	O	in	_	0	SENT_175	[p14l1801t1586r1873b1646],
2	the	DT	O	the	det	6	SENT_175	[p14l1910t1584r2017b1647],
3	letrozole	NN	O	letrozole	nn	6	SENT_175	[p14l2055t1584r2145b1647, p14l13t1695r537b1758],
4	—	NN	O	—	nn	6	SENT_175	[p14l2055t1584r2145b1647, p14l13t1695r537b1758],
5	treated	JJ	O	treated	amod	6	SENT_175	[p14l2055t1584r2145b1647, p14l13t1695r537b1758],
6	subjects	NNS	O	subject	prep_in	15	SENT_175	[p14l572t1695r854b1776],
7	the	DT	O	the	det	9	SENT_175	[p14l889t1695r996b1758],
8	hazard	NN	O	hazard	nn	9	SENT_175	[p14l1029t1695r1267b1758],
9	ratio	NN	O	ratio	nsubj	15	SENT_175	[p14l1299t1695r1461b1758],
10	was	VBD	O	be	cop	15	SENT_175	[p14l1495t1715r1630b1758],
11	1.8	CD	PERCENT	1.8	num	15	SENT_175	[p14l1673t1696r1770b1758],
12	(	CD	PERCENT	(	number	13	SENT_175	[p14l1809t1695r1920b1773],
13	95	CD	PERCENT	95	dep	14	SENT_175	[p14l1809t1695r1920b1773],
14	%	NN	PERCENT	%	dep	15	SENT_175	[p14l1959t1696r2024b1758],
15	CI	NN	O	ci	_	0	SENT_175	[p14l2062t1696r2148b1758],
16	0.96-3	CD	NUMBER	0.96-3	num	17	SENT_175	[p14l14t1805r343b1879],
17	.3	NN	NUMBER	.3	dep	15	SENT_175	[p14l14t1805r343b1879],
18	,	,	O	,	_	0	SENT_175	[p14l14t1805r343b1879],
19	p	NN	O	p	appos	15	SENT_175	[p14l383t1827r432b1885],
20	=	JJ	O	=	amod	22	SENT_175	[p14l469t1834r529b1858],
21	0.065	CD	NUMBER	0.065	tmod	20	SENT_175	[p14l565t1805r812b1882],
22	)	NN	O	)	dep	19	SENT_175	[p14l565t1805r812b1882],
23	,	,	O	,	_	0	SENT_175	[p14l565t1805r812b1882],
24	whereas	IN	O	whereas	mark	39	SENT_175	[p14l859t1805r1148b1868],
25	in	IN	O	in	_	0	SENT_175	[p14l1193t1805r1261b1867],
26	the	DT	O	the	det	30	SENT_175	[p14l1304t1805r1411b1868],
27	eXemestane	NN	O	exemestane	nn	30	SENT_175	[p14l1456t1805r2148b1868],
28	—	NN	O	—	nn	30	SENT_175	[p14l1456t1805r2148b1868],
29	treated	JJ	O	treated	amod	30	SENT_175	[p14l1456t1805r2148b1868],
30	subjects	NNS	O	subject	prep_in	39	SENT_175	[p14l17t1916r299b1997],
31	the	DT	O	the	det	33	SENT_175	[p14l363t1916r469b1978],
32	hazard	NN	O	hazard	nn	33	SENT_175	[p14l531t1916r771b1978],
33	ratio	NN	O	ratio	nsubj	39	SENT_175	[p14l831t1916r993b1978],
34	was	VBD	O	be	cop	39	SENT_175	[p14l1057t1935r1191b1978],
35	0.8	CD	PERCENT	0.8	num	39	SENT_175	[p14l1256t1916r1361b1979],
36	(	CD	PERCENT	(	number	37	SENT_175	[p14l1430t1915r1539b1993],
37	95	CD	PERCENT	95	dep	38	SENT_175	[p14l1430t1915r1539b1993],
38	%	NN	PERCENT	%	dep	39	SENT_175	[p14l1579t1916r1644b1979],
39	CI	NN	O	ci	advcl	15	SENT_175	[p14l1711t1916r1797b1979],
40	0.4-1	CD	NUMBER	0.4-1	num	41	SENT_175	[p14l1860t1915r2144b1990],
41	.5	CD	NUMBER	.5	dep	39	SENT_175	[p14l1860t1915r2144b1990],
42	,	,	O	,	_	0	SENT_175	[p14l1860t1915r2144b1990],
43	p	NN	O	p	appos	39	SENT_175	[p14l6t2048r55b2107],
44	=	JJ	O	=	amod	46	SENT_175	[p14l91t2055r152b2079],
45	0.44	CD	NUMBER	0.44	tmod	44	SENT_175	[p14l188t2027r389b2104],
46	)	NN	O	)	dep	43	SENT_175	[p14l188t2027r389b2104],
47	.	.	O	.	_	0	SENT_175	[p14l188t2027r389b2104],

1	Similarly	RB	O	similarly	advmod	6	SENT_176	[p14l429t2026r778b2108],
2	,	,	O	,	_	0	SENT_176	[p14l429t2026r778b2108],
3	no	DT	O	no	det	4	SENT_176	[p14l814t2046r900b2089],
4	associations	NNS	O	association	nsubjpass	6	SENT_176	[p14l935t2027r1363b2089],
5	were	VBD	O	be	auxpass	6	SENT_176	[p14l1397t2046r1567b2089],
6	noted	VBN	O	note	_	0	SENT_176	[p14l1601t2027r1800b2089],
7	for	IN	O	for	_	0	SENT_176	[p14l1832t2026r1935b2089],
8	other	JJ	O	other	amod	10	SENT_176	[p14l1967t2027r2149b2089],
9	T	NN	O	t	nn	10	SENT_176	[p14l13t2140r66b2200],
10	T	NN	O	t	prep_for	6	SENT_176	[p14l68t2140r121b2200],
11	TA	NNP	O	TA	nn	13	SENT_176	[p14l123t2139r241b2200],
12	repeat	NN	O	repeat	nn	13	SENT_176	[p14l272t2148r491b2220],
13	lengths	NNS	O	length	dep	10	SENT_176	[p14l523t2139r798b2220],
14	.	.	O	.	_	0	SENT_176	[p14l523t2139r798b2220],

1	Discussion	NN	O	discussion	_	0	SENT_177	[p14l13t2382r413b2446],

1	In	IN	O	in	_	0	SENT_178	[p14l14t2608r86b2668],
2	this	DT	O	this	det	3	SENT_178	[p14l121t2606r247b2669],
3	study	NN	O	study	prep_in	6	SENT_178	[p14l287t2606r495b2687],
4	,	,	O	,	_	0	SENT_178	[p14l287t2606r495b2687],
5	we	PRP	O	we	nsubj	6	SENT_178	[p14l535t2626r635b2669],
6	identiﬁed	VBD	O	identiﬁed	_	0	SENT_178	[p14l672t2606r1010b2669],
7	a	DT	O	a	det	11	SENT_178	[p14l1047t2626r1083b2669],
8	potentially	RB	O	potentially	advmod	10	SENT_178	[p14l1117t2606r1500b2687],
9	clinically	RB	O	clinically	advmod	10	SENT_178	[p14l1538t2606r1870b2687],
10	important	JJ	O	important	amod	11	SENT_178	[p14l1905t2606r2145b2687, p14l13t2727r147b2780],
11	association	NN	O	association	dobj	6	SENT_178	[p14l204t2717r599b2780],
12	between	IN	O	between	_	0	SENT_178	[p14l653t2717r950b2780],
13	an	DT	O	a	det	17	SENT_178	[p14l1008t2737r1088b2780],
14	inherited	VBN	O	inherit	amod	17	SENT_178	[p14l1144t2717r1462b2780],
15	germline	NN	O	germline	nn	17	SENT_178	[p14l1518t2717r1833b2798],
16	genetic	JJ	O	genetic	amod	17	SENT_178	[p14l1891t2717r2146b2798],
17	Variation	NN	O	variation	prep_between	11	SENT_178	[p14l8t2828r326b2891],
18	in	IN	O	in	_	0	SENT_178	[p14l360t2828r428b2890],
19	the	DT	O	the	det	22	SENT_178	[p14l462t2828r569b2891],
20	gene	NN	O	gene	nn	22	SENT_178	[p14l605t2848r771b2909],
21	encoding	VBG	O	encode	amod	22	SENT_178	[p14l807t2828r1133b2909],
22	ER	NN	O	er	prep_in	17	SENT_178	[p14l1167t2830r1281b2890],
23	alpha	NN	O	alpha	amod	22	SENT_178	[p14l1316t2828r1508b2909],
24	and	CC	O	and	_	0	SENT_178	[p14l1544t2828r1670b2891],
25	discontinuation	NN	O	discontinuation	amod	22	SENT_178	[p14l1704t2828r2142b2891, p14l8t2939r146b3002],
26	of	IN	O	of	_	0	SENT_178	[p14l190t2939r267b3002],
27	AI	NN	O	aus	nn	28	SENT_178	[p14l305t2940r396b3001],
28	therapy	NN	O	therapy	prep_of	22	SENT_178	[p14l439t2939r706b3020],
29	primarily	RB	O	primarily	advmod	6	SENT_178	[p14l750t2939r1082b3020],
30	because	IN	O	because	_	0	SENT_178	[p14l1125t2939r1408b3002],
31	of	IN	O	of	_	0	SENT_178	[p14l1453t2939r1530b3002],
32	musculoskeletal	JJ	O	musculoskeletal	amod	33	SENT_178	[p14l1568t2939r2145b3002],
33	toxicity	NN	O	toxicity	prep_because_of	6	SENT_178	[p14l8t3049r280b3130],
34	in	IN	O	in	_	0	SENT_178	[p14l309t3049r377b3110],
35	postmenopausal	JJ	O	postmenopausal	amod	36	SENT_178	[p14l403t3049r980b3130],
36	women	NNS	O	woman	prep_in	33	SENT_178	[p14l1008t3068r1269b3112],
37	with	IN	O	with	_	0	SENT_178	[p14l1297t3049r1454b3111],
38	HR	NN	DURATION	hr	nn	40	SENT_178	[p14l1481t3049r1937b3130],
39	—	CD	NUMBER	—	num	40	SENT_178	[p14l1481t3049r1937b3130],
40	positiVe	NN	O	positive	prep_with	6	SENT_178	[p14l1481t3049r1937b3130],
41	,	,	O	,	_	0	SENT_178	[p14l1481t3049r1937b3130],
42	early	JJ	O	early	amod	45	SENT_178	[p14l1968t3049r2144b3130],
43	stage	NN	O	stage	nn	45	SENT_178	[p14l11t3171r189b3242],
44	breast	NN	O	breast	nn	45	SENT_178	[p14l248t3161r463b3224],
45	cancer	NN	O	cancer	appos	40	SENT_178	[p14l521t3181r771b3224],
46	.	.	O	.	_	0	SENT_178	[p14l521t3181r771b3224],

1	Musculoskeletal	JJ	O	musculoskeletal	amod	3	SENT_179	[p14l834t3161r1421b3224],
2	side	JJ	O	side	amod	3	SENT_179	[p14l1484t3161r1622b3224],
3	effects	NNS	O	effect	nsubjpass	7	SENT_179	[p14l1682t3161r1917b3224],
4	have	VBP	O	have	aux	7	SENT_179	[p14l1977t3161r2144b3224],
5	previously	RB	DATE	previously	advmod	7	SENT_179	[p14l7t3272r384b3353],
6	been	VBN	O	be	auxpass	7	SENT_179	[p14l408t3272r576b3335],
7	found	VBN	O	find	_	0	SENT_179	[p14l601t3272r808b3335],
8	to	TO	O	to	aux	9	SENT_179	[p14l832t3281r899b3335],
9	contribute	VB	O	contribute	xcomp	7	SENT_179	[p14l925t3272r1285b3335],
10	to	TO	O	to	_	0	SENT_179	[p14l1310t3282r1377b3335],
11	non-persistence	JJ	O	non-persistence	amod	14	SENT_179	[p14l1402t3272r1962b3353],
12	with	IN	O	with	_	0	SENT_179	[p14l1989t3272r2145b3335],
13	AI	NN	O	aus	prep_with	11	SENT_179	[p14l8t3383r100b3445],
14	therapy	NN	O	therapy	prep_to	9	SENT_179	[p14l154t3383r440b3464],
15	,	,	O	,	_	0	SENT_179	[p14l154t3383r440b3464],
16	which	WDT	O	which	nsubj	19	SENT_179	[p14l498t3383r714b3445],
17	can	MD	O	can	aux	19	SENT_179	[p14l768t3402r890b3445],
18	negatively	RB	O	negatively	advmod	19	SENT_179	[p14l944t3383r1316b3464],
19	impact	VB	O	impact	rcmod	14	SENT_179	[p14l1371t3383r1615b3464],
20	breast	NN	O	breast	nn	21	SENT_179	[p14l1667t3383r2147b3445],
21	—	NN	O	—	dobj	19	SENT_179	[p14l1667t3383r2147b3445],
22	cancer	NN	O	cancer	nn	23	SENT_179	[p14l1667t3383r2147b3445],
23	outcomes	NNS	O	outcome	nsubj	24	SENT_179	[p14l9t3503r349b3556],
24	[	VBP	O	[	rcmod	21	SENT_179	[p14l393t3494r552b3570],
25	14	CD	NUMBER	14	num	26	SENT_179	[p14l393t3494r552b3570],
26	]	CD	NUMBER	]	dobj	24	SENT_179	[p14l393t3494r552b3570],
27	.	.	O	.	_	0	SENT_179	[p14l393t3494r552b3570],

1	In	IN	O	in	_	0	SENT_180	[p14l593t3495r665b3556],
2	addition	NN	O	addition	prep_in	6	SENT_180	[p14l703t3494r1013b3568],
3	,	,	O	,	_	0	SENT_180	[p14l703t3494r1013b3568],
4	this	DT	O	this	det	5	SENT_180	[p14l1053t3494r1179b3556],
5	association	NN	O	association	nsubj	6	SENT_180	[p14l1219t3494r1614b3556],
6	appears	VBZ	O	appear	_	0	SENT_180	[p14l1652t3513r1921b3575],
7	to	TO	O	to	aux	11	SENT_180	[p14l1959t3503r2026b3556],
8	be	VB	O	be	cop	11	SENT_180	[p14l2062t3494r2145b3556],
9	drug	NN	O	drug	nn	11	SENT_180	[p14l9t3605r493b3686],
10	—	NN	O	—	nn	11	SENT_180	[p14l9t3605r493b3686],
11	speciﬁc	NN	O	speciﬁc	xcomp	6	SENT_180	[p14l9t3605r493b3686],
12	,	,	O	,	_	0	SENT_180	[p14l9t3605r493b3686],
13	which	WDT	O	which	nsubj	18	SENT_180	[p14l545t3605r761b3668],
14	could	MD	O	could	aux	18	SENT_180	[p14l809t3605r1006b3668],
15	at	IN	O	at	advmod	18	SENT_180	[p14l1055t3614r1117b3668],
16	least	JJS	O	least	pobj	15	SENT_180	[p14l1163t3605r1327b3668],
17	partially	RB	O	partially	advmod	15	SENT_180	[p14l1372t3605r1670b3686],
18	account	NN	O	account	rcmod	11	SENT_180	[p14l1720t3615r1998b3668],
19	for	IN	O	for	_	0	SENT_180	[p14l2044t3605r2147b3668],
20	differences	NNS	O	difference	prep_for	18	SENT_180	[p14l9t3716r404b3779],
21	in	IN	O	in	_	0	SENT_180	[p14l439t3716r507b3778],
22	inter	NN	O	inter	nn	24	SENT_180	[p14l541t3716r980b3797],
23	—	CD	NUMBER	—	num	24	SENT_180	[p14l541t3716r980b3797],
24	patient	NN	O	patient	prep_in	20	SENT_180	[p14l541t3716r980b3797],
25	and	CC	O	and	_	0	SENT_180	[p14l1015t3716r1141b3779],
26	intra	NN	O	intra	nn	29	SENT_180	[p14l1174t3716r1614b3797],
27	—	CD	NUMBER	—	num	29	SENT_180	[p14l1174t3716r1614b3797],
28	patient	NN	O	patient	nn	29	SENT_180	[p14l1174t3716r1614b3797],
29	tolerability	NN	O	tolerability	prep_for	18	SENT_180	[p14l1645t3716r2038b3797],
30	of	IN	O	of	_	0	SENT_180	[p14l2074t3716r2151b3779],
31	the	DT	O	the	det	33	SENT_180	[p15l8t21r115b83],
32	AIs	NNP	O	AIs	nn	33	SENT_180	[p15l148t22r273b83],
33	[	NN	O	[	prep_of	29	SENT_180	[p15l314t22r398b96],
34	2	CD	NUMBER	2	num	33	SENT_180	[p15l314t22r398b96],
35	,	,	O	,	_	0	SENT_180	[p15l314t22r398b96],
36	14	CD	NUMBER	14	num	37	SENT_180	[p15l443t22r569b96],
37	]	NN	O	]	appos	33	SENT_180	[p15l443t22r569b96],
38	.	.	O	.	_	0	SENT_180	[p15l443t22r569b96],

1	Identiﬁcation	NN	O	identiﬁcation	nsubj	21	SENT_181	[p15l110t131r587b193],
2	of	IN	O	of	_	0	SENT_181	[p15l626t130r703b193],
3	patients	NNS	O	patient	prep_of	1	SENT_181	[p15l734t131r1010b212],
4	who	WP	O	who	nsubj	7	SENT_181	[p15l1050t131r1200b193],
5	are	VBP	O	be	cop	7	SENT_181	[p15l1241t150r1345b193],
6	more	RBR	O	more	advmod	7	SENT_181	[p15l1383t150r1565b193],
7	likely	JJ	O	likely	rcmod	3	SENT_181	[p15l1603t131r1806b212],
8	to	TO	O	to	aux	9	SENT_181	[p15l1843t140r1910b193],
9	experience	VB	O	experience	xcomp	7	SENT_181	[p15l1949t150r2142b212, p15l7t242r225b304],
10	intolerable	JJ	O	intolerable	acomp	9	SENT_181	[p15l260t242r643b304],
11	AI	NN	O	aus	nn	12	SENT_181	[p15l678t242r1170b304],
12	—	NN	O	—	dep	10	SENT_181	[p15l678t242r1170b304],
13	associated	VBN	O	associate	partmod	12	SENT_181	[p15l678t242r1170b304],
14	toxicity	NN	O	toxicity	dobj	13	SENT_181	[p15l1204t242r1475b323],
15	because	IN	O	because	_	0	SENT_181	[p15l1509t242r1792b304],
16	of	IN	O	of	_	0	SENT_181	[p15l1828t242r1905b304],
17	inherited	VBN	O	inherit	amod	19	SENT_181	[p15l1933t242r2143b304, p15l8t354r142b417],
18	genetic	JJ	O	genetic	amod	19	SENT_181	[p15l170t354r425b435],
19	variants	NNS	O	variant	prep_because_of	13	SENT_181	[p15l455t354r735b417],
20	could	MD	O	could	aux	21	SENT_181	[p15l766t354r963b417],
21	permit	VB	O	permit	_	0	SENT_181	[p15l989t354r1224b435],
22	better	JJR	O	better	amod	24	SENT_181	[p15l1249t354r1455b417],
23	treatment	NN	O	treatment	nn	24	SENT_181	[p15l1482t364r1821b417],
24	decision	NN	O	decision	dobj	21	SENT_181	[p15l1849t354r2146b417],
25	making	VBG	O	make	partmod	24	SENT_181	[p15l8t465r274b546],
26	for	IN	O	for	_	0	SENT_181	[p15l321t465r424b528],
27	women	NNS	O	woman	prep_for	25	SENT_181	[p15l467t485r728b528],
28	with	IN	O	with	_	0	SENT_181	[p15l773t465r930b528],
29	breast	NN	O	breast	nn	30	SENT_181	[p15l973t465r1187b528],
30	cancer	NN	O	cancer	prep_with	27	SENT_181	[p15l1231t485r1483b539],
31	,	,	O	,	_	0	SENT_181	[p15l1231t485r1483b539],
32	who	WP	O	who	nsubj	34	SENT_181	[p15l1531t465r1680b528],
33	are	VBP	O	be	aux	34	SENT_181	[p15l1728t485r1833b528],
34	starting	VBG	O	start	rcmod	30	SENT_181	[p15l1881t465r2144b546],
35	adjuvant	JJ	O	adjuvant	amod	37	SENT_181	[p15l10t576r316b657],
36	endocrine	NN	O	endocrine	nn	37	SENT_181	[p15l341t576r692b638],
37	therapy	NN	O	therapy	dobj	34	SENT_181	[p15l717t576r1002b657],
38	.	.	O	.	_	0	SENT_181	[p15l717t576r1002b657],

1	For	IN	O	for	_	0	SENT_182	[p15l1031t577r1155b638],
2	example	NN	O	example	prep_for	32	SENT_182	[p15l1178t576r1500b657],
3	,	,	O	,	_	0	SENT_182	[p15l1178t576r1500b657],
4	if	IN	O	if	mark	10	SENT_182	[p15l1527t576r1586b638],
5	the	DT	O	the	det	6	SENT_182	[p15l1604t576r1711b638],
6	presence	NN	O	presence	nsubj	10	SENT_182	[p15l1735t595r2048b657],
7	of	IN	O	of	_	0	SENT_182	[p15l2074t576r2151b638],
8	a	DT	O	a	det	9	SENT_182	[p15l10t706r47b749],
9	SNP	NN	O	snp	prep_of	6	SENT_182	[p15l82t687r241b750],
10	predicts	VBZ	O	predict	advcl	32	SENT_182	[p15l273t687r554b768],
11	development	NN	O	development	dobj	10	SENT_182	[p15l591t687r1054b768],
12	of	IN	O	of	_	0	SENT_182	[p15l1088t687r1165b749],
13	toxicity	NN	O	toxicity	prep_of	11	SENT_182	[p15l1193t687r1464b768],
14	from	IN	O	from	_	0	SENT_182	[p15l1500t687r1672b749],
15	exemestane	NN	O	exemestane	prep_from	13	SENT_182	[p15l1706t696r2142b761],
16	,	,	O	,	_	0	SENT_182	[p15l1706t696r2142b761],
17	as	IN	O	as	mark	21	SENT_182	[p15l10t818r78b861],
18	may	MD	O	may	aux	21	SENT_182	[p15l104t818r255b879],
19	be	VB	O	be	cop	21	SENT_182	[p15l279t798r362b861],
20	the	DT	O	the	det	21	SENT_182	[p15l386t798r493b861],
21	case	NN	O	case	advcl	10	SENT_182	[p15l518t818r669b861],
22	for	IN	O	for	_	0	SENT_182	[p15l694t798r797b861],
23	the	DT	O	the	det	24	SENT_182	[p15l819t798r926b861],
24	SNP	NN	ORGANIZATION	snp	prep_for	21	SENT_182	[p15l953t799r1112b861],
25	in	IN	O	in	_	0	SENT_182	[p15l1135t798r1203b860],
26	ESRI	NNP	ORGANIZATION	ESRI	prep_in	24	SENT_182	[p15l1225t799r1417b861],
27	,	,	O	,	_	0	SENT_182	[p15l1430t850r1443b872],
28	it	PRP	O	it	nsubjpass	32	SENT_182	[p15l1470t798r1519b861],
29	could	MD	O	could	aux	32	SENT_182	[p15l1542t798r1739b861],
30	potentially	RB	O	potentially	advmod	32	SENT_182	[p15l1761t798r2145b879],
31	be	VB	O	be	auxpass	32	SENT_182	[p15l7t909r90b972],
32	used	VBN	O	use	_	0	SENT_182	[p15l114t909r277b972],
33	to	TO	O	to	_	0	SENT_182	[p15l300t919r366b972],
34	select	JJ	O	select	amod	35	SENT_182	[p15l395t909r596b972],
35	treatment	NN	O	treatment	prep_to	32	SENT_182	[p15l618t919r958b972],
36	with	IN	O	with	_	0	SENT_182	[p15l982t909r1139b972],
37	a	DT	O	a	det	39	SENT_182	[p15l1164t929r1201b972],
38	speciﬁc	NN	O	speciﬁc	nn	39	SENT_182	[p15l1227t909r1493b990],
39	AI	NN	O	aus	prep_with	32	SENT_182	[p15l1520t910r1629b972],
40	.	.	O	.	_	0	SENT_182	[p15l1520t910r1629b972],

1	In	IN	O	in	_	0	SENT_183	[p15l1658t911r1730b971],
2	addition	NN	O	addition	prep_in	31	SENT_183	[p15l1756t909r2066b983],
3	,	,	O	,	_	0	SENT_183	[p15l1756t909r2066b983],
4	if	IN	O	if	mark	10	SENT_183	[p15l2093t909r2152b971],
5	a	DT	O	a	det	7	SENT_183	[p15l10t1040r47b1083],
6	patient	NN	O	patient	nn	7	SENT_183	[p15l76t1020r321b1101],
7	population	NN	O	population	nsubjpass	10	SENT_183	[p15l351t1020r734b1101],
8	could	MD	O	could	aux	10	SENT_183	[p15l767t1020r964b1083],
9	be	VB	O	be	auxpass	10	SENT_183	[p15l993t1020r1076b1083],
10	identiﬁed	VBN	O	identiﬁed	advcl	31	SENT_183	[p15l1109t1020r1446b1083],
11	that	DT	O	that	nsubj	12	SENT_183	[p15l1478t1020r1611b1083],
12	is	VBZ	O	be	ccomp	10	SENT_183	[p15l1642t1020r1697b1083],
13	at	IN	O	at	_	0	SENT_183	[p15l1733t1030r1795b1083],
14	high	JJ	O	high	amod	15	SENT_183	[p15l1824t1020r1982b1101],
15	risk	NN	O	risk	prep_at	12	SENT_183	[p15l2013t1020r2147b1083],
16	for	IN	O	for	_	0	SENT_183	[p15l9t1130r112b1192],
17	development	NN	O	development	prep_for	15	SENT_183	[p15l138t1130r600b1211],
18	of	IN	O	of	_	0	SENT_183	[p15l628t1129r705b1192],
19	a	DT	O	a	det	21	SENT_183	[p15l727t1149r764b1192],
20	speciﬁc	NN	O	speciﬁc	nn	21	SENT_183	[p15l793t1130r1061b1211],
21	toxicity	NN	O	toxicity	prep_of	17	SENT_183	[p15l1089t1130r1381b1211],
22	,	,	O	,	_	0	SENT_183	[p15l1089t1130r1381b1211],
23	such	JJ	O	such	_	0	SENT_183	[p15l1414t1130r1573b1192],
24	as	IN	O	as	_	0	SENT_183	[p15l1602t1149r1670b1192],
25	AIMSS	NNP	O	AIMSS	prep_such_as	17	SENT_183	[p15l1699t1130r1988b1203],
26	,	,	O	,	_	0	SENT_183	[p15l1699t1130r1988b1203],
27	this	DT	O	this	det	28	SENT_183	[p15l2018t1130r2144b1192],
28	cohort	NN	O	cohort	nsubjpass	31	SENT_183	[p15l9t1241r237b1303],
29	could	MD	O	could	aux	31	SENT_183	[p15l265t1241r462b1303],
30	be	VB	O	be	auxpass	31	SENT_183	[p15l489t1241r572b1303],
31	targeted	VBN	O	target	_	0	SENT_183	[p15l601t1241r889b1322],
32	for	IN	O	for	_	0	SENT_183	[p15l918t1240r1021b1303],
33	interventional	JJ	O	interventional	amod	34	SENT_183	[p15l1049t1241r1546b1303],
34	trials	NNS	O	trial	prep_for	31	SENT_183	[p15l1575t1241r1751b1303],
35	to	TO	O	to	aux	36	SENT_183	[p15l1782t1250r1848b1303],
36	prevent	VB	O	prevent	xcomp	31	SENT_183	[p15l1877t1250r2146b1322],
37	or	CC	O	or	_	0	SENT_183	[p15l9t1373r82b1416],
38	reduce	VB	O	reduce	xcomp	31	SENT_183	[p15l113t1353r350b1416],
39	the	DT	O	the	det	40	SENT_183	[p15l385t1353r492b1416],
40	burden	NN	O	burden	dobj	36	SENT_183	[p15l526t1353r774b1416],
41	of	IN	O	of	_	0	SENT_183	[p15l808t1353r886b1416],
42	such	JJ	O	such	amod	43	SENT_183	[p15l916t1353r1075b1416],
43	toxicities	NNS	O	toxicity	prep_of	40	SENT_183	[p15l1109t1353r1455b1416],
44	.	.	O	.	_	0	SENT_183	[p15l1109t1353r1455b1416],

1	In	IN	O	in	_	0	SENT_184	[p15l1493t1355r1565b1415],
2	this	DT	O	this	det	3	SENT_184	[p15l1599t1353r1724b1416],
3	regard	NN	O	regard	prep_in	7	SENT_184	[p15l1759t1353r2007b1434],
4	,	,	O	,	_	0	SENT_184	[p15l1759t1353r2007b1434],
5	we	PRP	O	we	nsubj	7	SENT_184	[p15l2044t1373r2145b1416],
6	have	VBP	O	have	aux	7	SENT_184	[p15l8t1464r174b1527],
7	reported	VBN	O	report	_	0	SENT_184	[p15l214t1464r513b1545],
8	a	DT	O	a	det	10	SENT_184	[p15l553t1484r590b1527],
9	pilot	NN	O	pilot	nn	10	SENT_184	[p15l626t1464r791b1545],
10	phase	NN	O	phase	dobj	7	SENT_184	[p15l827t1464r1029b1545],
11	II	CD	NUMBER	ii	num	12	SENT_184	[p15l1070t1466r1127b1526],
12	trial	NN	O	trial	nsubj	15	SENT_184	[p15l1165t1464r1308b1527],
13	suggesting	VBG	O	suggest	partmod	12	SENT_184	[p15l1351t1464r1727b1545],
14	duloxetine	NN	O	duloxetine	dobj	13	SENT_184	[p15l1769t1464r2144b1527],
15	reduces	VBZ	O	reduce	rcmod	10	SENT_184	[p15l7t1575r278b1637],
16	pain	NN	O	pain	iobj	15	SENT_184	[p15l321t1575r474b1656],
17	related	JJ	O	related	amod	26	SENT_184	[p15l515t1575r760b1637],
18	to	TO	O	to	_	0	SENT_184	[p15l801t1584r867b1637],
19	AIMSS	NN	O	aimss	prep_to	17	SENT_184	[p15l910t1575r1176b1638],
20	by	IN	O	by	_	0	SENT_184	[p15l1221t1575r1308b1656],
21	~	NN	O	~	prep_by	19	SENT_184	[p15l1365t1575r1527b1638],
22	60	CD	PERCENT	60	num	23	SENT_184	[p15l1365t1575r1527b1638],
23	%	NN	PERCENT	%	dep	21	SENT_184	[p15l1563t1575r1627b1638],
24	[	CD	NUMBER	[	number	25	SENT_184	[p15l1680t1575r1837b1651],
25	13	CD	NUMBER	13	num	23	SENT_184	[p15l1680t1575r1837b1651],
26	]	NN	O	]	dobj	15	SENT_184	[p15l1680t1575r1837b1651],
27	.	.	O	.	_	0	SENT_184	[p15l1680t1575r1837b1651],

1	If	IN	O	if	mark	2	SENT_185	[p15l1883t1575r1947b1637],
2	validated	VBN	O	validate	advcl	15	SENT_185	[p15l1983t1575r2142b1637, p15l9t1686r220b1759],
3	,	,	O	,	_	0	SENT_185	[p15l1983t1575r2142b1637, p15l9t1686r220b1759],
4	the	DT	O	the	det	5	SENT_185	[p15l271t1686r378b1748],
5	association	NN	O	association	nsubjpass	15	SENT_185	[p15l429t1686r825b1748],
6	between	IN	O	between	_	0	SENT_185	[p15l872t1686r1170b1748],
7	AIMSS	NNP	O	AIMSS	prep_between	5	SENT_185	[p15l1219t1686r1485b1748],
8	and	CC	O	and	_	0	SENT_185	[p15l1539t1686r1665b1748],
9	the	DT	O	the	det	10	SENT_185	[p15l1713t1686r1820b1748],
10	SNP	NN	ORGANIZATION	snp	nsubjpass	15	SENT_185	[p15l1871t1686r2030b1748],
11	in	IN	O	in	_	0	SENT_185	[p15l2078t1686r2146b1747],
12	ESRI	NNP	ORGANIZATION	ESRI	prep_in	10	SENT_185	[p15l7t1798r199b1860],
13	could	MD	O	could	aux	15	SENT_185	[p15l239t1797r436b1860],
14	be	VB	O	be	auxpass	15	SENT_185	[p15l466t1797r549b1860],
15	used	VBN	O	use	_	0	SENT_185	[p15l583t1797r745b1860],
16	to	TO	O	to	aux	17	SENT_185	[p15l777t1807r843b1860],
17	personalize	VB	O	personalize	xcomp	15	SENT_185	[p15l876t1797r1283b1878],
18	this	DT	O	this	det	19	SENT_185	[p15l1317t1797r1442b1860],
19	strategy	NN	O	strategy	dobj	17	SENT_185	[p15l1480t1807r1777b1878],
20	.	.	O	.	_	0	SENT_185	[p15l1480t1807r1777b1878],

1	The	DT	O	the	det	2	SENT_186	[p15l110t1908r246b1971],
2	mechanism	NN	O	mechanism	nsubj	20	SENT_186	[p15l272t1908r674b1971],
3	by	IN	O	by	_	0	SENT_186	[p15l697t1908r785b1989],
4	which	WDT	O	which	rel	11	SENT_186	[p15l811t1908r1024b1971],
5	the	DT	O	the	det	6	SENT_186	[p15l1050t1908r1155b1971],
6	SNP	NN	ORGANIZATION	snp	nsubj	11	SENT_186	[p15l1185t1909r1342b1971],
7	identiﬁed	VBN	O	identiﬁed	partmod	6	SENT_186	[p15l1367t1908r1699b1971],
8	in	IN	O	in	_	0	SENT_186	[p15l1724t1908r1790b1970],
9	our	PRP$	O	we	poss	10	SENT_186	[p15l1817t1928r1933b1971],
10	study	NN	O	study	prep_in	7	SENT_186	[p15l1961t1908r2145b1989],
11	contributes	VBZ	O	contribute	rcmod	2	SENT_186	[p15l9t2019r395b2082],
12	to	TO	O	to	_	0	SENT_186	[p15l432t2029r497b2082],
13	the	DT	O	the	det	14	SENT_186	[p15l534t2019r639b2082],
14	development	NN	O	development	prep_to	11	SENT_186	[p15l676t2019r1131b2100],
15	of	IN	O	of	_	0	SENT_186	[p15l1165t2019r1242b2082],
16	AI	NN	O	aus	nn	17	SENT_186	[p15l1271t2019r1753b2082],
17	—	NN	O	—	prep_of	14	SENT_186	[p15l1271t2019r1753b2082],
18	associated	VBN	O	associate	partmod	17	SENT_186	[p15l1271t2019r1753b2082],
19	toxicity	NN	O	toxicity	dobj	18	SENT_186	[p15l1787t2019r2054b2100],
20	is	VBZ	O	be	_	0	SENT_186	[p15l2089t2019r2145b2082],

1	@	IN	O	@	_	0	SENT_187	[p15l1777t2262r1855b2357],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_187	[p15l1884t2285r2146b2360],

1	812	CD	NUMBER	812	num	3	SENT_188	[p15l54t2435r104b2460],
2	Breast	NN	ORGANIZATION	breast	nn	3	SENT_188	[p15l1450t2435r1540b2460],
3	Cancer	NN	ORGANIZATION	cancer	dep	8	SENT_188	[p15l1552t2435r1652b2460],
4	Res	NNP	ORGANIZATION	Res	nn	5	SENT_188	[p15l1664t2435r1716b2460],
5	Treat	NNP	ORGANIZATION	Treat	dep	3	SENT_188	[p15l1729t2435r1804b2460],
6	(	CD	NUMBER	(	dep	8	SENT_188	[p15l1817t2435r1908b2465],
7	2013	CD	DATE	2013	num	8	SENT_188	[p15l1817t2435r1908b2465],
8	)	CD	NUMBER	)	dep	12	SENT_188	[p15l1817t2435r1908b2465],
9	l38	NN	O	l38	dep	8	SENT_188	[p15l1925t2435r2107b2460],
10	:807	CD	NUMBER	:807	num	9	SENT_188	[p15l1925t2435r2107b2460],
11	—	CD	NUMBER	—	num	12	SENT_188	[p15l1925t2435r2107b2460],
12	8l6	NN	O	8l6	_	0	SENT_188	[p15l1925t2435r2107b2460],

1	Table2	NN	O	table2	nn	2	SENT_189	[p15l53t2546r167b2572],
2	Associations	NNS	O	association	_	0	SENT_189	[p15l189t2546r368b2571],
3	between	IN	O	between	dep	2	SENT_189	[p15l390t2546r508b2571],
4	ESRI	NNP	ORGANIZATION	ESRI	nn	7	SENT_189	[p15l529t2546r607b2572],
5	single-nucleotide	JJ	O	single-nucleotide	amod	7	SENT_189	[p15l633t2546r875b2579],
6	polymorphism	NN	O	polymorphism	nn	7	SENT_189	[p15l896t2546r1102b2579],
7	rs9322336	NN	O	rs9322336	nsubj	12	SENT_189	[p15l1123t2546r1271b2572],
8	and	CC	O	and	_	0	SENT_189	[p15l1293t2546r1343b2571],
9	toxicity-related	JJ	O	toxicity-related	amod	11	SENT_189	[p15l1364t2546r1580b2579],
10	treatment	NN	O	treatment	nn	11	SENT_189	[p15l1602t2550r1735b2571],
11	discontinuation	NN	O	discontinuation	nsubj	12	SENT_189	[p15l1757t2546r1974b2571],
12	using	VBG	O	use	pcomp	3	SENT_189	[p15l1995t2546r2071b2579],
13	a	DT	O	a	det	16	SENT_189	[p15l2093t2554r2108b2571],
14	recessive	JJ	O	recessive	amod	16	SENT_189	[p15l52t2588r181b2613],
15	statistical	JJ	O	statistical	amod	16	SENT_189	[p15l195t2588r327b2613],
16	model	NN	O	model	dobj	12	SENT_189	[p15l340t2588r427b2613],

1	AI/total	JJ	O	ai/total	_	0	SENT_190	[p15l1142t2713r1250b2738],
2	with	IN	O	with	_	0	SENT_190	[p15l1264t2713r1325b2738],
3	genotype	NN	O	genotype	prep_with	1	SENT_190	[p15l1338t2717r1467b2745],
4	(	CD	PERCENT	(	num	5	SENT_190	[p15l1481t2713r1531b2744],
5	%	NN	PERCENT	%	dep	1	SENT_190	[p15l1481t2713r1531b2744],
6	)	CD	NUMBER	)	dep	5	SENT_190	[p15l1481t2713r1531b2744],

1	Both	DT	O	both	det	2	SENT_191	[p15l8t2822r156b2876],
2	Als	NNP	O	Als	_	0	SENT_191	[p15l184t2822r292b2876],
3	Any	DT	O	any	det	4	SENT_191	[p15l628t2822r758b2892],
4	toxicity	NN	O	toxicity	dep	2	SENT_191	[p15l787t2822r1022b2892],
5	All	DT	O	all	dep	2	SENT_191	[p15l1722t2822r1819b2875],
6	combined	VBN	O	combine	partmod	2	SENT_191	[p15l1848t2822r2153b2876],

1	TT	NN	ORGANIZATION	tt	_	0	SENT_192	[p15l1722t2933r1815b2986],
2	TC	NN	ORGANIZATION	tc	nn	3	SENT_192	[p15l1722t3044r1818b3098],
3	CC	NN	ORGANIZATION	cc	dep	1	SENT_192	[p15l1723t3155r1822b3209],

1	AIMSS	NNP	O	AIMSS	nn	2	SENT_193	[p15l628t3266r858b3320],
2	All	NNP	O	All	nsubj	3	SENT_193	[p15l1722t3266r1819b3319],
3	combined	VBD	O	combine	_	0	SENT_193	[p15l1848t3265r2153b3320],

1	TT	NN	ORGANIZATION	tt	_	0	SENT_194	[p15l1722t3379r1815b3431],
2	TC	NN	ORGANIZATION	tc	nn	3	SENT_194	[p15l1722t3489r1818b3543],
3	CC	NN	ORGANIZATION	cc	dep	1	SENT_194	[p15l1723t3600r1822b3654],

1	Letrozole	NNP	O	Letrozole	_	0	SENT_195	[p15l7t3712r303b3766],
2	Any	DT	O	any	det	3	SENT_195	[p15l628t3712r758b3781],
3	toxicity	NN	O	toxicity	dep	1	SENT_195	[p15l787t3712r1022b3781],
4	All	DT	O	all	dep	1	SENT_195	[p15l1722t3712r1819b3765],
5	combined	VBN	O	combine	partmod	1	SENT_195	[p15l1848t3712r2153b3766],

1	AIMSS	NNS	O	aimss	_	0	SENT_196	[p16l628t361r858b415],

1	Exemestane	NNP	O	Exemestane	_	0	SENT_197	[p16l7t806r381b859],
2	Any	DT	O	any	det	3	SENT_197	[p16l628t806r758b875],
3	toxicity	NN	O	toxicity	dep	1	SENT_197	[p16l787t805r1022b875],

1	AIMSS	NNS	O	aimss	_	0	SENT_198	[p16l628t1251r858b1305],

1	TT	NN	ORGANIZATION	tt	nn	3	SENT_199	[p16l1722t28r1815b81],
2	TC	NN	ORGANIZATION	tc	nn	3	SENT_199	[p16l1722t139r1818b193],
3	CC	NN	O	cc	_	0	SENT_199	[p16l1723t250r1822b304],
4	All	DT	O	all	det	8	SENT_199	[p16l1722t361r1819b414],
5	combined	JJ	O	combined	amod	8	SENT_199	[p16l1848t361r2153b415],
6	TT	NN	ORGANIZATION	tt	nn	8	SENT_199	[p16l1722t474r1815b526],
7	TC	NN	ORGANIZATION	tc	nn	8	SENT_199	[p16l1722t584r1818b638],
8	CC	NN	ORGANIZATION	cc	dep	3	SENT_199	[p16l1723t695r1822b749],
9	All	DT	ORGANIZATION	all	det	13	SENT_199	[p16l1722t805r1819b858],
10	combined	JJ	O	combined	amod	13	SENT_199	[p16l1848t805r2153b859],
11	TT	NN	ORGANIZATION	tt	nn	13	SENT_199	[p16l1722t919r1815b971],
12	TC	NN	ORGANIZATION	tc	nn	13	SENT_199	[p16l1722t1029r1818b1083],
13	CC	NN	ORGANIZATION	cc	dep	8	SENT_199	[p16l1723t1140r1822b1194],
14	All	DT	O	all	det	18	SENT_199	[p16l1722t1251r1819b1304],
15	combined	JJ	O	combined	amod	18	SENT_199	[p16l1848t1251r2153b1305],
16	TT	NN	ORGANIZATION	tt	nn	18	SENT_199	[p16l1722t1363r1815b1416],
17	TC	NN	ORGANIZATION	tc	nn	18	SENT_199	[p16l1722t1474r1818b1528],
18	CC	NN	ORGANIZATION	cc	dep	3	SENT_199	[p16l1723t1585r1822b1639],

1	Number	NN	O	number	nsubjpass	22	SENT_200	[p17l52t717r168b742],
2	of	IN	O	of	_	0	SENT_200	[p17l180t717r211b742],
3	patients	NNS	O	patient	prep_of	1	SENT_200	[p17l221t717r330b749],
4	in	IN	O	in	_	0	SENT_200	[p17l343t717r370b741],
5	total	JJ	O	total	amod	6	SENT_200	[p17l383t717r445b742],
6	cohort	NN	O	cohort	prep_in	3	SENT_200	[p17l458t717r547b742],
7	or	CC	O	or	_	0	SENT_200	[p17l560t725r589b742],
8	divided	VBN	O	divide	amod	12	SENT_200	[p17l601t717r707b742],
9	by	IN	O	by	_	0	SENT_200	[p17l719t717r753b749],
10	aromatase	NN	O	aromatase	nn	11	SENT_200	[p17l767t721r909b742],
11	inhibitor	NN	O	inhibitor	prep_by	8	SENT_200	[p17l922t717r1044b742],
12	(	NN	O	(	conj_or	3	SENT_200	[p17l1057t717r1114b747],
13	AI	NN	O	aus	nn	14	SENT_200	[p17l1057t717r1114b747],
14	)	NN	O	)	dep	12	SENT_200	[p17l1057t717r1114b747],
15	who	WP	O	who	nsubj	16	SENT_200	[p17l1128t717r1187b742],
16	discontinued	VBD	O	discontinue	rcmod	14	SENT_200	[p17l1201t717r1381b742],
17	therapy	NN	O	therapy	dobj	16	SENT_200	[p17l1393t717r1498b749],
18	because	IN	O	because	_	0	SENT_200	[p17l1511t717r1622b742],
19	of	IN	O	of	prepc_because_of	16	SENT_200	[p17l1636t717r1666b742],
20	toxicity	NN	O	toxicity	pobj	16	SENT_200	[p17l1677t717r1784b749],
21	is	VBZ	O	be	auxpass	22	SENT_200	[p17l1797t717r1819b742],
22	given	VBN	O	give	_	0	SENT_200	[p17l1832t717r1910b749],
23	by	IN	O	by	_	0	SENT_200	[p17l1922t717r1956b749],
24	genotype	NN	O	genotype	agent	22	SENT_200	[p17l1970t721r2105b749],
25	.	.	O	.	_	0	SENT_200	[p17l1970t721r2105b749],

1	Hazard	NN	O	hazard	nn	2	SENT_201	[p17l52t760r154b785],
2	ratios	NNS	O	ratio	nsubj	3	SENT_201	[p17l166t760r243b785],
3	(	VBP	O	(	_	0	SENT_201	[p17l258t760r327b791],
4	HR	NN	DURATION	hr	nn	5	SENT_201	[p17l258t760r327b791],
5	)	NN	O	)	nsubjpass	11	SENT_201	[p17l258t760r327b791],
6	and	CC	O	and	_	0	SENT_201	[p17l342t760r392b785],
7	corresponding	JJ	O	corresponding	amod	9	SENT_201	[p17l404t760r605b792],
8	p	NN	O	p	nn	9	SENT_201	[p17l615t769r634b792],
9	values	NNS	O	value	conj_and	5	SENT_201	[p17l647t760r736b785],
10	are	VBP	O	be	auxpass	11	SENT_201	[p17l750t768r792b785],
11	given	VBN	O	give	ccomp	3	SENT_201	[p17l805t760r882b792],
12	for	IN	O	for	mark	16	SENT_201	[p17l895t760r936b785],
13	both	DT	O	both	det	15	SENT_201	[p17l948t760r1010b785],
14	aromatase	NN	O	aromatase	nn	15	SENT_201	[p17l1024t764r1165b785],
15	inhibitors	NNS	O	inhibitor	nsubj	16	SENT_201	[p17l1178t760r1312b785],
16	(	VBP	O	(	dep	11	SENT_201	[p17l1327t760r1385b791],
17	AI	NN	O	aus	nn	18	SENT_201	[p17l1327t760r1385b791],
18	)	NN	O	)	dobj	16	SENT_201	[p17l1327t760r1385b791],
19	combined	VBN	O	combine	partmod	18	SENT_201	[p17l1399t760r1537b785],
20	and	CC	O	and	_	0	SENT_201	[p17l1550t760r1600b785],
21	for	IN	O	for	mark	25	SENT_201	[p17l1613t760r1654b785],
22	each	DT	O	each	det	23	SENT_201	[p17l1666t760r1729b785],
23	AI	NN	O	aus	nsubj	25	SENT_201	[p17l1742t760r1779b785],
24	individually	RB	O	individually	advmod	25	SENT_201	[p17l1791t760r1961b792],
25	AIMSS	VBZ	O	aimss	dep	11	SENT_201	[p17l7t836r215b887],
26	AI	NN	O	aus	nn	27	SENT_201	[p17l239t835r639b886],
27	—	NN	O	—	dobj	25	SENT_201	[p17l239t835r639b886],
28	associated	VBN	O	associate	partmod	27	SENT_201	[p17l239t835r639b886],
29	musculoskeletal	JJ	O	musculoskeletal	amod	30	SENT_201	[p17l665t835r1134b886],
30	syndrome	NN	O	syndrome	dobj	28	SENT_201	[p17l1164t836r1462b901],
31	,	,	O	,	_	0	SENT_201	[p17l1164t836r1462b901],
32	CI	NN	O	ci	nn	34	SENT_201	[p17l1495t837r1568b887],
33	conﬁdence	NN	O	conﬁdence	nn	34	SENT_201	[p17l1590t835r1903b886],
34	interval	NN	O	interval	dep	35	SENT_201	[p17l1930t835r2151b886],
35	unclear	JJ	O	unclear	ccomp	3	SENT_201	[p17l12t1056r276b1115],
36	.	.	O	.	_	0	SENT_201	[p17l12t1056r276b1115],

1	We	PRP	O	we	nsubj	4	SENT_202	[p17l305t1057r423b1115],
2	are	VBP	O	be	cop	4	SENT_202	[p17l452t1074r551b1115],
3	only	RB	O	only	advmod	4	SENT_202	[p17l580t1056r726b1133],
4	aware	JJ	O	aware	_	0	SENT_202	[p17l756t1074r954b1115],
5	of	IN	O	of	_	0	SENT_202	[p17l982t1056r1056b1115],
6	a	DT	O	a	det	8	SENT_202	[p17l1079t1074r1114b1115],
7	single	JJ	O	single	amod	8	SENT_202	[p17l1143t1056r1339b1133],
8	report	NN	O	report	prep_of	4	SENT_202	[p17l1366t1065r1566b1133],
9	regarding	VBG	O	regard	partmod	8	SENT_202	[p17l1592t1056r1913b1133],
10	this	DT	O	this	det	13	SENT_202	[p17l1940t1056r2059b1115],
11	intronic	JJ	O	intronic	amod	13	SENT_202	[p17l12t1162r272b1222],
12	ESR1	NN	O	esr1	nn	13	SENT_202	[p17l297t1162r480b1222],
13	SNP	NN	O	snp	dobj	9	SENT_202	[p17l514t1162r666b1222],
14	(	CD	NUMBER	(	num	15	SENT_202	[p17l694t1161r1118b1236],
15	rs9322336	NN	O	rs9322336	tmod	9	SENT_202	[p17l694t1161r1118b1236],
16	)	CD	NUMBER	)	dep	15	SENT_202	[p17l694t1161r1118b1236],
17	:	:	O	:	_	0	SENT_202	[p17l694t1161r1118b1236],
18	a	DT	O	a	det	20	SENT_202	[p17l1152t1181r1187b1222],
19	possible	JJ	O	possible	amod	20	SENT_202	[p17l1212t1162r1487b1240],
20	association	NN	O	association	dep	15	SENT_202	[p17l1515t1162r1886b1222],
21	with	IN	O	with	_	0	SENT_202	[p17l1912t1162r2060b1222],
22	increased	VBN	O	increase	amod	23	SENT_202	[p17l12t1269r330b1329],
23	risk	NN	O	risk	prep_with	20	SENT_202	[p17l371t1269r498b1329],
24	of	IN	O	of	_	0	SENT_202	[p17l539t1268r613b1329],
25	ovarian	JJ	O	ovarian	amod	26	SENT_202	[p17l650t1269r901b1329],
26	cancer	NN	O	cancer	prep_of	23	SENT_202	[p17l944t1288r1164b1329],
27	[	CD	NUMBER	[	num	29	SENT_202	[p17l1211t1269r1360b1341],
28	23	CD	NUMBER	23	num	29	SENT_202	[p17l1211t1269r1360b1341],
29	]	NN	O	]	dep	15	SENT_202	[p17l1211t1269r1360b1341],
30	.	.	O	.	_	0	SENT_202	[p17l1211t1269r1360b1341],

1	However	RB	O	however	advmod	7	SENT_203	[p17l1406t1270r1732b1340],
2	,	,	O	,	_	0	SENT_203	[p17l1406t1270r1732b1340],
3	estrogen	NN	O	estrogen	nn	4	SENT_203	[p17l1777t1278r2060b1347],
4	receptors	NNS	O	receptor	nsubjpass	7	SENT_203	[p17l12t1385r317b1453],
5	have	VBP	O	have	aux	7	SENT_203	[p17l337t1376r495b1436],
6	been	VBN	O	be	auxpass	7	SENT_203	[p17l512t1376r673b1436],
7	shown	VBN	O	show	dep	30	SENT_203	[p17l693t1376r908b1436],
8	to	TO	O	to	aux	10	SENT_203	[p17l927t1385r989b1436],
9	be	VB	O	be	cop	10	SENT_203	[p17l1007t1376r1087b1436],
10	present	JJ	DATE	present	xcomp	7	SENT_203	[p17l1104t1385r1348b1453],
11	in	IN	O	in	_	0	SENT_203	[p17l1365t1376r1430b1435],
12	multiple	JJ	O	multiple	amod	14	SENT_203	[p17l1447t1376r1726b1453],
13	cell	NN	O	cell	nn	14	SENT_203	[p17l1747t1376r1866b1436],
14	types	NNS	O	type	prep_in	10	SENT_203	[p17l1884t1385r2059b1453],
15	in	IN	O	in	_	0	SENT_203	[p17l12t1482r77b1541],
16	the	DT	O	the	det	19	SENT_203	[p17l94t1482r195b1542],
17	central	JJ	O	central	amod	19	SENT_203	[p17l215t1482r441b1542],
18	nervous	JJ	O	nervous	amod	19	SENT_203	[p17l460t1501r723b1542],
19	system	NN	O	system	prep_in	10	SENT_203	[p17l747t1491r993b1559],
20	,	,	O	,	_	0	SENT_203	[p17l747t1491r993b1559],
21	and	CC	O	and	_	0	SENT_203	[p17l1016t1482r1136b1542],
22	estrogen	NN	O	estrogen	nsubjpass	25	SENT_203	[p17l1154t1491r1438b1559],
23	has	VBZ	O	have	aux	25	SENT_203	[p17l1454t1482r1564b1542],
24	been	VBN	O	be	auxpass	25	SENT_203	[p17l1582t1482r1743b1541],
25	shown	VBN	O	show	dep	30	SENT_203	[p17l1763t1482r1978b1542],
26	to	TO	O	to	aux	27	SENT_203	[p17l1996t1491r2060b1541],
27	have	VB	O	have	xcomp	25	SENT_203	[p17l12t1588r170b1648],
28	antinociceptive	JJ	O	antinociceptive	amod	29	SENT_203	[p17l197t1588r709b1665],
29	effects	NNS	O	effect	dobj	27	SENT_203	[p17l734t1588r954b1648],
30	[	VBP	O	[	_	0	SENT_203	[p17l986t1589r1109b1660],
31	17	CD	NUMBER	17	nsubj	30	SENT_203	[p17l986t1589r1109b1660],
32	,	,	O	,	_	0	SENT_203	[p17l986t1589r1109b1660],
33	27	CD	NUMBER	27	num	34	SENT_203	[p17l1137t1588r1264b1660],
34	]	NN	O	]	appos	31	SENT_203	[p17l1137t1588r1264b1660],
35	.	.	O	.	_	0	SENT_203	[p17l1137t1588r1264b1660],

1	Estrogen	NN	O	estrogen	nsubj	3	SENT_204	[p17l1291t1590r1590b1665],
2	also	RB	O	also	advmod	3	SENT_204	[p17l1616t1588r1747b1648],
3	has	VBZ	O	have	_	0	SENT_204	[p17l1772t1588r1881b1648],
4	antiinﬂammatory	JJ	O	antiinﬂammatory	amod	5	SENT_204	[p17l1909t1588r2057b1648, p17l12t1694r466b1771],
5	effects	NNS	O	effect	dobj	3	SENT_204	[p17l507t1694r747b1765],
6	,	,	O	,	_	0	SENT_204	[p17l507t1694r747b1765],
7	and	CC	O	and	_	0	SENT_204	[p17l791t1694r910b1754],
8	pro	JJ	O	pro	amod	9	SENT_204	[p17l948t1694r1543b1771],
9	—	NN	O	—	nsubj	40	SENT_204	[p17l948t1694r1543b1771],
10	inﬂammatory	JJ	O	inﬂammatory	amod	11	SENT_204	[p17l948t1694r1543b1771],
11	cytokines	NNS	O	cytokine	nsubj	13	SENT_204	[p17l1584t1694r1903b1771],
12	can	MD	O	can	aux	13	SENT_204	[p17l1945t1713r2060b1754],
13	increase	VB	O	increase	rcmod	9	SENT_204	[p17l12t1800r287b1860],
14	during	IN	O	during	_	0	SENT_204	[p17l312t1800r529b1877],
15	menopause	NN	O	menopause	prep_during	13	SENT_204	[p17l553t1819r931b1877],
16	[	CD	NUMBER	[	number	17	SENT_204	[p17l962t1801r1112b1872],
17	22	CD	NUMBER	22	num	18	SENT_204	[p17l962t1801r1112b1872],
18	]	NN	O	]	dobj	13	SENT_204	[p17l962t1801r1112b1872],
19	,	,	O	,	_	0	SENT_204	[p17l962t1801r1112b1872],
20	although	IN	O	although	mark	28	SENT_204	[p17l1141t1800r1433b1877],
21	studies	NNS	O	study	nsubj	28	SENT_204	[p17l1459t1800r1687b1860],
22	of	IN	O	of	_	0	SENT_204	[p17l1713t1800r1787b1860],
23	AIMSS	NN	O	aimss	prep_of	21	SENT_204	[p17l1804t1801r2057b1860],
24	to	TO	O	to	_	0	SENT_204	[p17l12t1915r76b1966],
25	date	NN	O	date	prep_to	23	SENT_204	[p17l97t1906r235b1966],
26	have	VBP	O	have	aux	28	SENT_204	[p17l255t1906r414b1966],
27	not	RB	O	not	neg	28	SENT_204	[p17l434t1915r541b1966],
28	demonstrated	VBN	O	demonstrate	advcl	13	SENT_204	[p17l561t1906r1014b1966],
29	a	DT	O	a	det	31	SENT_204	[p17l1035t1925r1070b1966],
30	direct	JJ	O	direct	amod	31	SENT_204	[p17l1090t1906r1281b1966],
31	effect	NN	O	effect	dobj	28	SENT_204	[p17l1300t1906r1492b1966],
32	of	IN	O	of	_	0	SENT_204	[p17l1511t1906r1585b1966],
33	AI	NN	O	aus	nn	34	SENT_204	[p17l1599t1907r1687b1965],
34	therapy	NN	O	therapy	prep_of	31	SENT_204	[p17l1706t1906r1956b1983],
35	on	IN	O	on	_	0	SENT_204	[p17l1979t1925r2061b1966],
36	systemic	JJ	O	systemic	amod	39	SENT_204	[p17l15t2012r305b2089],
37	inﬂammatory	JJ	O	inﬂammatory	amod	39	SENT_204	[p17l341t2012r794b2089],
38	cytokine	NN	O	cytokine	nn	39	SENT_204	[p17l829t2012r1117b2089],
39	concentrations	NNS	O	concentration	prep_on	28	SENT_204	[p17l1153t2012r1640b2071],
40	[	VBP	O	[	conj_and	3	SENT_204	[p17l1683t2012r1831b2084],
41	12	CD	NUMBER	12	num	42	SENT_204	[p17l1683t2012r1831b2084],
42	]	CD	NUMBER	]	dobj	40	SENT_204	[p17l1683t2012r1831b2084],
43	.	.	O	.	_	0	SENT_204	[p17l1683t2012r1831b2084],

1	However	RB	O	however	advmod	5	SENT_205	[p17l1870t2013r2057b2072, p17l13t2137r173b2189],
2	,	,	O	,	_	0	SENT_205	[p17l1870t2013r2057b2072, p17l13t2137r173b2189],
3	it	PRP	O	it	nsubj	5	SENT_205	[p17l202t2118r249b2178],
4	is	VBZ	O	be	cop	5	SENT_205	[p17l273t2118r326b2178],
5	possible	JJ	O	possible	_	0	SENT_205	[p17l352t2118r626b2196],
6	that	IN	O	that	complm	9	SENT_205	[p17l652t2118r778b2178],
7	estrogen	NN	O	estrogen	nsubj	9	SENT_205	[p17l803t2127r1087b2196],
8	is	VBZ	O	be	aux	9	SENT_205	[p17l1111t2118r1165b2178],
9	exerting	VBG	O	exert	ccomp	5	SENT_205	[p17l1193t2118r1466b2196],
10	an	DT	O	a	det	11	SENT_205	[p17l1494t2137r1571b2178],
11	effect	NN	O	effect	dobj	9	SENT_205	[p17l1596t2117r1787b2178],
12	locally	RB	O	locally	advmod	9	SENT_205	[p17l1812t2118r2058b2196],
13	,	,	O	,	_	0	SENT_205	[p17l1812t2118r2058b2196],
14	such	JJ	O	such	_	0	SENT_205	[p17l15t2225r166b2285],
15	as	IN	O	as	_	0	SENT_205	[p17l201t2244r267b2285],
16	within	IN	O	within	prepc_such_as	9	SENT_205	[p17l302t2225r517b2285],
17	bone	NN	O	bone	pobj	16	SENT_205	[p17l549t2225r730b2296],
18	,	,	O	,	_	0	SENT_205	[p17l549t2225r730b2296],
19	joints	NNS	O	joint	pobj	16	SENT_205	[p17l760t2225r970b2303],
20	,	,	O	,	_	0	SENT_205	[p17l760t2225r970b2303],
21	or	CC	O	or	_	0	SENT_205	[p17l1008t2244r1078b2285],
22	the	DT	O	the	det	25	SENT_205	[p17l1110t2225r1212b2285],
23	central	JJ	O	central	amod	25	SENT_205	[p17l1247t2225r1473b2285],
24	nervous	JJ	O	nervous	amod	25	SENT_205	[p17l1508t2244r1771b2285],
25	system	NN	O	system	conj_or	17	SENT_205	[p17l1810t2234r2056b2303],
26	.	.	O	.	_	0	SENT_205	[p17l1810t2234r2056b2303],

1	Since	IN	O	since	mark	7	SENT_206	[p17l15t2332r198b2392],
2	the	DT	O	the	det	3	SENT_206	[p17l224t2332r324b2392],
3	effect	NN	O	effect	nsubj	7	SENT_206	[p17l352t2332r543b2392],
4	that	IN	O	that	complm	6	SENT_206	[p17l567t2332r694b2392],
5	we	PRP	O	we	nsubj	6	SENT_206	[p17l718t2351r814b2392],
6	identiﬁed	VBD	O	identiﬁed	dep	3	SENT_206	[p17l841t2332r1158b2392],
7	appears	VBZ	O	appear	advcl	18	SENT_206	[p17l1185t2351r1437b2409],
8	to	TO	O	to	aux	9	SENT_206	[p17l1465t2341r1528b2391],
9	be	VB	O	be	xcomp	7	SENT_206	[p17l1553t2332r1632b2392],
10	primarily	RB	O	primarily	advmod	9	SENT_206	[p17l1657t2332r1970b2409],
11	in	IN	O	in	_	0	SENT_206	[p17l1996t2332r2061b2391],
12	exemestane-treated	JJ	O	exemestane-treated	amod	13	SENT_206	[p17l13t2438r663b2498],
13	patients	NNS	O	patient	prep_in	9	SENT_206	[p17l686t2438r965b2515],
14	,	,	O	,	_	0	SENT_206	[p17l686t2438r965b2515],
15	it	PRP	O	it	nsubj	18	SENT_206	[p17l992t2438r1038b2498],
16	is	VBZ	O	be	cop	18	SENT_206	[p17l1061t2438r1114b2497],
17	also	RB	O	also	advmod	18	SENT_206	[p17l1141t2438r1273b2498],
18	possible	JJ	O	possible	_	0	SENT_206	[p17l1296t2438r1571b2515],
19	that	IN	O	that	complm	26	SENT_206	[p17l1595t2438r1721b2497],
20	the	DT	O	the	det	21	SENT_206	[p17l1744t2438r1845b2497],
21	effect	NN	O	effect	nsubj	26	SENT_206	[p17l1871t2438r2062b2498],
22	of	IN	O	of	_	0	SENT_206	[p17l13t2544r87b2604],
23	the	DT	O	the	det	24	SENT_206	[p17l103t2544r204b2603],
24	SNP	NN	ORGANIZATION	snp	prep_of	21	SENT_206	[p17l229t2544r381b2604],
25	could	MD	O	could	aux	26	SENT_206	[p17l403t2544r589b2604],
26	relate	VB	O	relate	ccomp	18	SENT_206	[p17l609t2544r795b2604],
27	to	TO	O	to	_	0	SENT_206	[p17l818t2553r882b2603],
28	an	DT	O	a	det	32	SENT_206	[p17l907t2563r984b2604],
29	off	JJ	O	off	amod	32	SENT_206	[p17l1006t2544r1323b2621],
30	—	CD	NUMBER	—	num	32	SENT_206	[p17l1006t2544r1323b2621],
31	target	NN	O	target	nn	32	SENT_206	[p17l1006t2544r1323b2621],
32	effect	NN	O	effect	prep_to	26	SENT_206	[p17l1344t2544r1535b2604],
33	of	IN	O	of	_	0	SENT_206	[p17l1557t2544r1631b2604],
34	exemestane	NN	O	exemestane	prep_of	32	SENT_206	[p17l1647t2553r2057b2614],
35	,	,	O	,	_	0	SENT_206	[p17l1647t2553r2057b2614],
36	rather	RB	O	rather	_	0	SENT_206	[p17l11t2650r210b2710],
37	than	IN	O	than	_	0	SENT_206	[p17l230t2650r375b2710],
38	a	DT	O	a	det	40	SENT_206	[p17l398t2669r434b2710],
39	direct	JJ	O	direct	amod	40	SENT_206	[p17l456t2650r647b2710],
40	effect	NN	O	effect	prep_to	26	SENT_206	[p17l670t2650r861b2710],
41	on	IN	O	on	_	0	SENT_206	[p17l883t2669r966b2710],
42	ER	NN	O	er	nn	43	SENT_206	[p17l987t2652r1096b2709],
43	function	NN	O	function	prep_on	40	SENT_206	[p17l1118t2650r1413b2710],
44	.	.	O	.	_	0	SENT_206	[p17l1118t2650r1413b2710],

1	Other	JJ	O	other	amod	2	SENT_207	[p17l111t2757r305b2817],
2	associations	NNS	O	association	nsubjpass	17	SENT_207	[p17l349t2757r759b2817],
3	between	IN	O	between	_	0	SENT_207	[p17l803t2757r1090b2817],
4	genetic	JJ	O	genetic	amod	5	SENT_207	[p17l1134t2757r1379b2834],
5	variants	NNS	O	variant	prep_between	2	SENT_207	[p17l1424t2757r1693b2817],
6	in	IN	O	in	_	0	SENT_207	[p17l1739t2757r1803b2816],
7	candidate	NN	O	candidate	nn	8	SENT_207	[p17l1848t2757r2057b2817, p17l13t2863r153b2923],
8	genes	NNS	O	gene	prep_in	5	SENT_207	[p17l198t2882r388b2940],
9	and	CC	O	and	_	0	SENT_207	[p17l436t2863r556b2923],
10	AI	NN	O	aus	nn	11	SENT_207	[p17l599t2863r1070b2923],
11	—	NN	O	—	conj_and	5	SENT_207	[p17l599t2863r1070b2923],
12	associated	VBN	O	associate	partmod	11	SENT_207	[p17l599t2863r1070b2923],
13	musculoskeletal	JJ	O	musculoskeletal	amod	14	SENT_207	[p17l1113t2863r1665b2923],
14	symptoms	NNS	O	symptom	dobj	12	SENT_207	[p17l1712t2872r2058b2940],
15	have	VBP	O	have	aux	17	SENT_207	[p17l12t2969r172b3028],
16	been	VBN	O	be	auxpass	17	SENT_207	[p17l207t2969r369b3028],
17	reported	VBN	O	report	_	0	SENT_207	[p17l404t2969r707b3046],
18	.	.	O	.	_	0	SENT_207	[p17l404t2969r707b3046],

1	In	IN	O	in	dep	6	SENT_208	[p17l747t2970r816b3028],
2	a	DT	O	a	det	4	SENT_208	[p17l854t2987r889b3028],
3	cross	JJ	O	cross	amod	4	SENT_208	[p17l925t2969r1433b3028],
4	—	NN	O	—	pobj	1	SENT_208	[p17l925t2969r1433b3028],
5	sectional	JJ	O	sectional	amod	6	SENT_208	[p17l925t2969r1433b3028],
6	study	NN	O	study	_	0	SENT_208	[p17l1472t2969r1652b3046],
7	of	IN	O	of	_	0	SENT_208	[p17l1690t2969r1764b3028],
8	patients	NNS	O	patient	prep_of	6	SENT_208	[p17l1793t2969r2058b3046],

1	@	IN	O	@	_	0	SENT_209	[p17l11t3201r85b3292],
2	Springer	NNP	PERSON	Springer	nsubj	3	SENT_209	[p17l113t3223r364b3295],
3	receiving	VBG	O	receive	prepc_@	31	SENT_209	[p17l13t3322r346b3403],
4	AI	NN	O	aus	nn	5	SENT_209	[p17l390t3322r482b3383],
5	therapy	NN	O	therapy	dobj	3	SENT_209	[p17l524t3322r811b3403],
6	,	,	O	,	_	0	SENT_209	[p17l524t3322r811b3403],
7	Mao	NNP	PERSON	Mao	iobj	3	SENT_209	[p17l857t3323r1018b3384],
8	et	FW	O	et	nn	10	SENT_209	[p17l1062t3331r1125b3384],
9	al.	FW	O	al.	nn	10	SENT_209	[p17l1168t3322r1247b3384],
10	[	FW	O	[	dobj	3	SENT_209	[p17l1301t3322r1435b3397],
11	19	CD	NUMBER	19	num	12	SENT_209	[p17l1301t3322r1435b3397],
12	]	CD	NUMBER	]	nsubj	31	SENT_209	[p17l1301t3322r1435b3397],
13	explored	VBN	O	explore	partmod	12	SENT_209	[p17l1485t3322r1796b3403],
14	potential	JJ	O	potential	amod	15	SENT_209	[p17l1838t3322r2151b3403],
15	associations	NNS	O	association	dobj	13	SENT_209	[p17l17t3433r445b3495],
16	between	IN	O	between	_	0	SENT_209	[p17l476t3433r775b3495],
17	ﬁve	JJ	O	ﬁve	amod	18	SENT_209	[p17l806t3432r936b3495],
18	polymorphisms	NNS	O	polymorphism	prep_between	15	SENT_209	[p17l966t3433r1521b3514],
19	in	IN	O	in	_	0	SENT_209	[p17l1553t3433r1621b3494],
20	the	DT	O	the	det	25	SENT_209	[p17l1651t3433r1758b3495],
21	aromatase	NN	O	aromatase	nn	25	SENT_209	[p17l1791t3442r2150b3495],
22	gene	NN	O	gene	nn	25	SENT_209	[p17l16t3563r181b3625],
23	(	CD	NUMBER	(	num	25	SENT_209	[p17l224t3544r539b3621],
24	CYP19	NN	O	cyp19	nn	25	SENT_209	[p17l224t3544r539b3621],
25	)	NN	O	)	prep_in	13	SENT_209	[p17l224t3544r539b3621],
26	and	CC	O	and	_	0	SENT_209	[p17l582t3544r708b3606],
27	development	NN	O	development	prep_in	13	SENT_209	[p17l748t3544r1210b3625],
28	of	IN	O	of	_	0	SENT_209	[p17l1249t3543r1326b3606],
29	AI	NNP	O	AI	nn	30	SENT_209	[p17l1359t3544r1851b3606],
30	—	NNP	O	—	prep_of	27	SENT_209	[p17l1359t3544r1851b3606],
31	associated	VBD	O	associate	_	0	SENT_209	[p17l1359t3544r1851b3606],
32	arthral	JJ	O	arthral	amod	34	SENT_209	[p17l1891t3544r2149b3606],
33	—	NN	O	—	nn	34	SENT_209	[p17l1891t3544r2149b3606],
34	gias	NNS	O	gia	dobj	31	SENT_209	[p17l16t3656r174b3737],
35	.	.	O	.	_	0	SENT_209	[p17l16t3656r174b3737],

1	They	PRP	O	they	nsubj	2	SENT_210	[p17l205t3656r387b3737],
2	found	VBD	O	find	_	0	SENT_210	[p17l414t3656r621b3719],
3	that	IN	O	that	_	0	SENT_210	[p17l646t3656r780b3719],
4	carriers	NNS	O	carrier	prep_that	2	SENT_210	[p17l806t3656r1070b3719],
5	of	IN	O	of	_	0	SENT_210	[p17l1100t3656r1177b3719],
6	at	IN	O	at	quantmod	10	SENT_210	[p17l1199t3665r1260b3719],
7	least	JJS	O	least	mwe	6	SENT_210	[p17l1286t3656r1450b3719],
8	one	CD	NUMBER	one	number	10	SENT_210	[p17l1476t3676r1601b3719],
9	eight	CD	NUMBER	eight	number	10	SENT_210	[p17l1629t3656r1806b3737],
10	(	CD	NUMBER	(	num	12	SENT_210	[p17l1835t3657r2152b3733],
11	TTTA	NN	O	ttta	nn	12	SENT_210	[p17l1835t3657r2152b3733],
12	)	NN	O	)	prep_of	4	SENT_210	[p17l1835t3657r2152b3733],
13	,	,	O	,	_	0	SENT_210	[p17l1835t3657r2152b3733],
14	,	,	O	,	_	0	SENT_210	[p17l1835t3657r2152b3733],

1	repeat	NN	O	repeat	nsubj	5	SENT_211	[p18l14t32r234b103],
2	in	IN	O	in	_	0	SENT_211	[p18l275t22r342b84],
3	intron	NN	O	intron	prep_in	1	SENT_211	[p18l384t22r596b85],
4	4	CD	NUMBER	4	num	3	SENT_211	[p18l638t22r680b84],
5	had	VBD	O	have	_	0	SENT_211	[p18l722t22r850b85],
6	decreased	VBN	O	decrease	amod	7	SENT_211	[p18l892t22r1244b85],
7	risk	NN	O	risk	nsubj	12	SENT_211	[p18l1285t22r1420b85],
8	of	IN	O	of	_	0	SENT_211	[p18l1461t22r1538b85],
9	musculoskeletal	JJ	O	musculoskeletal	amod	10	SENT_211	[p18l1574t22r2151b85],
10	toxicity	NN	O	toxicity	prep_of	7	SENT_211	[p18l14t133r286b214],
11	(	RB	O	(	advmod	12	SENT_211	[p18l340t133r666b214],
12	adjusted	VBN	O	adjust	xcomp	5	SENT_211	[p18l340t133r666b214],
13	odds	NNS	O	odds	nn	14	SENT_211	[p18l716t133r880b196],
14	ratio	NN	O	ratio	tmod	5	SENT_211	[p18l931t133r1093b196],
15	0.41	CD	NUMBER	0.41	num	16	SENT_211	[p18l1146t133r1347b210],
16	)	NN	O	)	dep	14	SENT_211	[p18l1146t133r1347b210],
17	.	.	O	.	_	0	SENT_211	[p18l1146t133r1347b210],

1	We	PRP	O	we	nsubj	3	SENT_212	[p18l1400t135r1523b196],
2	were	VBD	O	be	cop	3	SENT_212	[p18l1575t153r1746b196],
3	unable	JJ	O	unable	_	0	SENT_212	[p18l1796t133r2033b196],
4	to	TO	O	to	aux	5	SENT_212	[p18l2084t142r2151b196],
5	conﬁrm	VB	O	conﬁrm	xcomp	3	SENT_212	[p18l15t244r292b307],
6	this	DT	O	this	det	7	SENT_212	[p18l320t244r446b307],
7	ﬁnding	NN	O	ﬁnding	dobj	5	SENT_212	[p18l478t244r727b325],
8	in	IN	O	in	_	0	SENT_212	[p18l757t244r824b306],
9	our	PRP$	O	we	poss	10	SENT_212	[p18l854t264r971b307],
10	cohort	NN	O	cohort	prep_in	7	SENT_212	[p18l999t244r1244b307],
11	.	.	O	.	_	0	SENT_212	[p18l999t244r1244b307],

1	One	CD	NUMBER	one	num	3	SENT_213	[p18l1279t245r1423b307],
2	key	JJ	O	key	amod	3	SENT_213	[p18l1452t244r1579b325],
3	reason	NN	O	reason	nsubj	17	SENT_213	[p18l1608t264r1840b307],
4	why	WRB	O	why	advmod	9	SENT_213	[p18l1870t244r2021b325],
5	we	PRP	O	we	nsubj	9	SENT_213	[p18l2051t264r2151b307],
6	may	MD	O	may	aux	9	SENT_213	[p18l15t375r166b436],
7	have	VB	O	have	aux	9	SENT_213	[p18l204t355r371b418],
8	been	VBN	O	be	cop	9	SENT_213	[p18l409t355r577b418],
9	unable	JJ	O	unable	ccomp	3	SENT_213	[p18l614t355r852b418],
10	to	TO	O	to	aux	11	SENT_213	[p18l890t365r956b418],
11	validate	VB	O	validate	xcomp	9	SENT_213	[p18l995t355r1278b418],
12	the	DT	O	the	det	14	SENT_213	[p18l1316t355r1423b418],
13	previous	JJ	O	previous	amod	14	SENT_213	[p18l1460t355r1766b436],
14	ﬁnding	NN	O	ﬁnding	dobj	11	SENT_213	[p18l1807t355r2056b436],
15	is	VBZ	O	be	cop	17	SENT_213	[p18l2095t355r2150b418],
16	the	DT	O	the	det	17	SENT_213	[p18l14t466r122b529],
17	difference	NN	O	difference	_	0	SENT_213	[p18l177t466r537b529],
18	in	IN	O	in	_	0	SENT_213	[p18l593t466r660b528],
19	phenotypic	JJ	O	phenotypic	amod	20	SENT_213	[p18l712t466r1109b547],
20	endpoint	NN	O	endpoint	prep_in	17	SENT_213	[p18l1165t466r1496b547],
21	,	,	O	,	_	0	SENT_213	[p18l1165t466r1496b547],
22	since	IN	O	since	mark	26	SENT_213	[p18l1557t466r1735b529],
23	our	PRP$	O	we	poss	24	SENT_213	[p18l1791t486r1908b529],
24	study	NN	O	study	nsubj	26	SENT_213	[p18l1963t466r2151b547],
25	prospectively	RB	O	prospectively	advmod	26	SENT_213	[p18l13t577r496b658],
26	evaluated	VBD	O	evaluate	advcl	17	SENT_213	[p18l543t577r886b639],
27	treatment	NN	O	treatment	nn	28	SENT_213	[p18l931t586r1270b639],
28	discontinuation	NN	O	discontinuation	nsubj	29	SENT_213	[p18l1315t577r1866b639],
29	due	JJ	O	due	xcomp	26	SENT_213	[p18l1913t577r2038b639],
30	to	TO	O	to	_	0	SENT_213	[p18l2084t586r2151b639],
31	AIMSS	NNP	O	AIMSS	prep_to	29	SENT_213	[p18l15t687r305b761],
32	,	,	O	,	_	0	SENT_213	[p18l15t687r305b761],
33	whereas	IN	O	whereas	mark	46	SENT_213	[p18l345t687r635b749],
34	the	DT	O	the	det	35	SENT_213	[p18l673t687r780b749],
35	endpoint	NN	O	endpoint	nsubj	46	SENT_213	[p18l818t687r1130b768],
36	in	IN	O	in	_	0	SENT_213	[p18l1167t687r1234b748],
37	the	DT	O	the	det	38	SENT_213	[p18l1271t687r1378b749],
38	study	NN	O	study	prep_in	35	SENT_213	[p18l1419t687r1607b768],
39	by	IN	O	by	_	0	SENT_213	[p18l1643t687r1730b768],
40	Mao	NNP	PERSON	Mao	prep_by	38	SENT_213	[p18l1768t688r1929b749],
41	et	FW	O	et	nn	42	SENT_213	[p18l1968t696r2031b749],
42	al.	FW	O	al.	dep	40	SENT_213	[p18l2069t687r2147b749],
43	was	VBD	O	be	cop	46	SENT_213	[p18l15t817r149b861],
44	a	DT	O	a	det	46	SENT_213	[p18l194t817r230b860],
45	cross	JJ	O	cross	amod	46	SENT_213	[p18l272t798r802b860],
46	—	NN	O	—	advcl	26	SENT_213	[p18l272t798r802b860],
47	sectional	JJ	O	sectional	amod	48	SENT_213	[p18l272t798r802b860],
48	evaluation	NN	O	evaluation	nsubj	52	SENT_213	[p18l845t798r1217b860],
49	of	IN	O	of	_	0	SENT_213	[p18l1259t797r1336b860],
50	patient	NN	O	patient	prep_of	48	SENT_213	[p18l1369t798r1944b879],
51	—	CD	NUMBER	—	num	50	SENT_213	[p18l1369t798r1944b879],
52	reported	VBD	O	report	rcmod	46	SENT_213	[p18l1369t798r1944b879],
53	arthralgias	NNS	O	arthralgia	dobj	52	SENT_213	[p18l1987t798r2149b860, p18l14t910r269b991],
54	.	.	O	.	_	0	SENT_213	[p18l1987t798r2149b860, p18l14t910r269b991],

1	In	IN	O	in	_	0	SENT_214	[p18l324t912r396b972],
2	addition	NN	O	addition	prep_in	14	SENT_214	[p18l447t910r756b984],
3	,	,	O	,	_	0	SENT_214	[p18l447t910r756b984],
4	the	DT	O	the	det	6	SENT_214	[p18l808t910r915b973],
5	possible	JJ	O	possible	amod	6	SENT_214	[p18l964t910r1256b991],
6	effect	NN	O	effect	nsubj	14	SENT_214	[p18l1306t910r1509b973],
7	observed	VBN	O	observe	partmod	6	SENT_214	[p18l1559t910r1880b973],
8	in	IN	O	in	_	0	SENT_214	[p18l1928t910r1996b972],
9	the	DT	O	the	det	11	SENT_214	[p18l2044t910r2151b973],
10	ELPh	NN	MISC	elph	nn	11	SENT_214	[p18l14t1021r217b1083],
11	trial	NN	O	trial	prep_in	7	SENT_214	[p18l259t1021r401b1084],
12	was	VBD	O	be	cop	14	SENT_214	[p18l445t1041r580b1084],
13	more	RBR	O	more	advmod	14	SENT_214	[p18l624t1041r805b1084],
14	prominent	JJ	O	prominent	_	0	SENT_214	[p18l848t1021r1217b1102],
15	in	IN	O	in	_	0	SENT_214	[p18l1259t1021r1326b1083],
16	letrozole	NN	O	letrozole	prep_in	14	SENT_214	[p18l1369t1021r1958b1084],
17	—	CD	NUMBER	—	num	19	SENT_214	[p18l1369t1021r1958b1084],
18	treated	JJ	O	treated	amod	19	SENT_214	[p18l1369t1021r1958b1084],
19	subjects	NNS	O	subject	dep	16	SENT_214	[p18l2003t1021r2149b1084, p18l7t1132r195b1213],
20	.	.	O	.	_	0	SENT_214	[p18l2003t1021r2149b1084, p18l7t1132r195b1213],

1	In	IN	O	in	_	0	SENT_215	[p18l246t1134r319b1194],
2	contrast	NN	O	contrast	prep_in	13	SENT_215	[p18l366t1141r667b1206],
3	,	,	O	,	_	0	SENT_215	[p18l366t1141r667b1206],
4	the	DT	O	the	det	5	SENT_215	[p18l716t1132r823b1195],
5	majority	NN	O	majority	nsubjpass	13	SENT_215	[p18l871t1132r1173b1213],
6	of	IN	O	of	_	0	SENT_215	[p18l1221t1132r1298b1195],
7	subjects	NNS	O	subject	prep_of	5	SENT_215	[p18l1342t1132r1624b1213],
8	in	IN	O	in	_	0	SENT_215	[p18l1673t1132r1740b1194],
9	the	DT	O	the	det	11	SENT_215	[p18l1786t1132r1893b1195],
10	crosssectional	JJ	O	crosssectional	amod	11	SENT_215	[p18l1941t1152r2149b1195, p18l18t1243r332b1306],
11	study	NN	O	study	prep_in	7	SENT_215	[p18l384t1243r572b1324],
12	were	VBD	O	be	auxpass	13	SENT_215	[p18l622t1263r792b1306],
13	treated	VBN	O	treat	_	0	SENT_215	[p18l843t1243r1086b1306],
14	with	IN	O	with	_	0	SENT_215	[p18l1135t1243r1292b1306],
15	anastrozole	NN	O	anastrozole	prep_with	13	SENT_215	[p18l1342t1243r1766b1317],
16	,	,	O	,	_	0	SENT_215	[p18l1342t1243r1766b1317],
17	and	CC	O	and	_	0	SENT_215	[p18l1821t1243r1947b1306],
18	only	RB	O	only	quantmod	19	SENT_215	[p18l1996t1243r2151b1324],
19	20	CD	PERCENT	20	num	20	SENT_215	[p18l16t1355r101b1417],
20	%	NN	PERCENT	%	nsubj	21	SENT_215	[p18l138t1355r202b1417],
21	received	VBD	O	receive	conj_and	13	SENT_215	[p18l283t1354r588b1417],
22	letrozole	NN	O	letrozole	dobj	21	SENT_215	[p18l666t1354r997b1417],
23	.	.	O	.	_	0	SENT_215	[p18l666t1354r997b1417],

1	This	DT	O	this	det	4	SENT_216	[p18l1080t1354r1235b1417],
2	possible	JJ	O	possible	amod	4	SENT_216	[p18l1314t1354r1607b1435],
3	drug	NN	O	drug	nn	4	SENT_216	[p18l1686t1354r2150b1435],
4	—	NN	O	—	nsubj	10	SENT_216	[p18l1686t1354r2150b1435],
5	speciﬁc	JJ	O	speciﬁc	amod	7	SENT_216	[p18l1686t1354r2150b1435],
6	genetic	JJ	O	genetic	amod	7	SENT_216	[p18l16t1465r270b1546],
7	association	NN	O	association	dep	4	SENT_216	[p18l306t1465r702b1528],
8	could	MD	O	could	aux	10	SENT_216	[p18l734t1465r931b1528],
9	also	RB	O	also	advmod	10	SENT_216	[p18l963t1465r1102b1528],
10	result	VB	O	result	_	0	SENT_216	[p18l1134t1465r1334b1528],
11	in	IN	O	in	_	0	SENT_216	[p18l1364t1465r1432b1527],
12	discordant	JJ	O	discordant	amod	13	SENT_216	[p18l1464t1465r1835b1528],
13	ﬁndings	NNS	O	ﬁndings	prep_in	10	SENT_216	[p18l1867t1465r2150b1546],
14	between	IN	O	between	_	0	SENT_216	[p18l13t1576r312b1639],
15	the	DT	O	the	det	17	SENT_216	[p18l344t1576r452b1639],
16	two	CD	NUMBER	two	num	17	SENT_216	[p18l486t1585r617b1639],
17	studies	NNS	O	study	prep_between	13	SENT_216	[p18l654t1576r915b1639],
18	.	.	O	.	_	0	SENT_216	[p18l654t1576r915b1639],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_217	[p18l52t1714r142b1739],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_217	[p18l155t1714r255b1739],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_217	[p18l267t1714r318b1739],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_217	[p18l331t1714r406b1739],
5	(	CD	NUMBER	(	num	4	SENT_217	[p18l419t1714r510b1744],
6	2013	CD	DATE	2013	num	8	SENT_217	[p18l419t1714r510b1744],
7	)	CD	NUMBER	)	num	8	SENT_217	[p18l419t1714r510b1744],
8	l38	NN	O	l38	dep	4	SENT_217	[p18l528t1714r709b1739],
9	:807	CD	NUMBER	:807	number	10	SENT_217	[p18l528t1714r709b1739],
10	—	CD	NUMBER	—	num	11	SENT_217	[p18l528t1714r709b1739],
11	8l6	NN	O	8l6	dep	8	SENT_217	[p18l528t1714r709b1739],
12	813	CD	NUMBER	813	dep	4	SENT_217	[p18l2056t1714r2105b1739],

1	A	DT	O	a	_	0	SENT_218	[p18l40t1893r101b1958],

1	as	IN	O	as	_	0	SENT_219	[p18l307t1904r354b1943],
2	'	''	O	'	_	0	SENT_219	[p18l311t1956r354b1973],
3	I	PRP	O	I	pobj	1	SENT_219	[p18l311t1956r354b1973],
4	—	VBP	O	—	dep	1	SENT_219	[p18l311t1956r354b1973],

1	I13	NN	O	i13	_	0	SENT_220	[p18l307t2090r354b2163],

1	no.	RB	O	no.	dep	2	SENT_221	[p18l307t2279r374b2352],
2	5	CD	NUMBER	5	_	0	SENT_221	[p18l307t2279r374b2352],

1	I14	NN	O	i14	_	0	SENT_222	[p18l307t2464r354b2534],

1	I12	NN	O	i12	_	0	SENT_223	[p18l307t2650r355b2723],

1	Percent	NN	O	percent	_	0	SENT_224	[p18l170t2652r227b2908],
2	continuing	VBG	O	continue	dep	1	SENT_224	[p18l170t2285r242b2627],
3	AI	NN	O	aus	nn	4	SENT_224	[p18l170t2194r226b2259],
4	therapy	NN	O	therapy	dobj	2	SENT_224	[p18l170t1912r242b2166],

1	I	PRP	O	I	nsubj	2	SENT_225	[p18l307t2839r355b2909],
2	]	VBP	O	]	_	0	SENT_225	[p18l307t2839r355b2909],
3	.	.	O	.	_	0	SENT_225	[p18l307t2839r355b2909],

1	t	NN	O	t	_	0	SENT_226	[p18l307t2839r355b2909],
2	:	:	O	:	_	0	SENT_226	[p18l307t2839r355b2909],
3	I	PRP	O	I	dep	1	SENT_226	[p18l307t2839r355b2909],

1	Months	NNS	DURATION	month	_	0	SENT_227	[p18l1075t3062r1317b3119],

1	{	NNP	O	{	nn	2	SENT_228	[p19l307t438r354b508],
2	LE	NNP	O	LE	_	0	SENT_228	[p19l307t438r354b508],

1	D.-I	NN	O	d.-i	_	0	SENT_229	[p19l307t620r354b693],

1	[	NN	O	[	nn	2	SENT_230	[p19l307t999r354b1068],
2	LU	NN	O	lu	_	0	SENT_230	[p19l307t999r354b1068],

1	Percent	NN	O	percent	_	0	SENT_231	[p19l170t827r227b1083],
2	continuing	VBG	O	continue	dep	1	SENT_231	[p19l170t461r242b803],
3	Al	NNP	O	Al	nn	4	SENT_231	[p19l170t370r226b434],
4	therapy	NN	O	therapy	dobj	2	SENT_231	[p19l170t88r242b341],

1	Fig	NN	O	fig	_	0	SENT_232	[p19l13t1393r135b1461],
2	.	.	O	.	_	0	SENT_232	[p19l13t1393r135b1461],

1	2	CD	NUMBER	2	_	0	SENT_233	[p19l164t1393r199b1446],
2	Kaplan	NNP	PERSON	Kaplan	dep	1	SENT_233	[p19l249t1393r688b1462],
3	.	.	O	.	_	0	SENT_233	[p19l249t1393r688b1462],

1	—	NN	O	—	_	0	SENT_234	[p19l249t1393r688b1462],
2	.	.	O	.	_	0	SENT_234	[p19l249t1393r688b1462],

1	Meier	NNP	PERSON	Meier	nn	2	SENT_235	[p19l249t1393r688b1462],
2	plot	NN	O	plot	_	0	SENT_235	[p19l716t1393r834b1462],
3	of	IN	O	of	_	0	SENT_235	[p19l865t1393r930b1446],
4	associations	NNS	O	association	prep_of	2	SENT_235	[p19l957t1393r1320b1446],
5	between	IN	O	between	_	0	SENT_235	[p19l1351t1393r1604b1446],
6	ESR1	NN	O	esr1	nn	8	SENT_235	[p19l1633t1394r1796b1447],
7	rs9322336	CD	NUMBER	rs9322336	num	8	SENT_235	[p19l1832t1393r2150b1447],
8	SNP	NN	ORGANIZATION	snp	prep_between	4	SENT_235	[p19l15t1482r151b1535],
9	and	CC	O	and	_	0	SENT_235	[p19l192t1482r299b1535],
10	aromatase	NN	O	aromatase	nn	12	SENT_235	[p19l340t1490r646b1535],
11	inhibitor	NN	O	inhibitor	nn	12	SENT_235	[p19l687t1482r950b1535],
12	(	NN	O	(	prep_between	4	SENT_235	[p19l990t1483r1115b1548],
13	AI	NN	O	aus	nn	15	SENT_235	[p19l990t1483r1115b1548],
14	)	CD	NUMBER	)	num	15	SENT_235	[p19l990t1483r1115b1548],
15	discontinuation	NN	O	discontinuation	dep	2	SENT_235	[p19l1158t1482r1626b1535],
16	because	IN	O	because	_	0	SENT_235	[p19l1665t1482r1905b1535],
17	of	IN	O	of	prepc_because_of	15	SENT_235	[p19l1947t1482r2013b1535],
18	AIassociated	JJ	O	aiassociated	amod	20	SENT_235	[p19l2048t1483r2149b1535, p19l15t1570r325b1623],
19	musculoskeletal	JJ	O	musculoskeletal	amod	20	SENT_235	[p19l353t1570r842b1623],
20	syndrome	NN	O	syndrome	pobj	15	SENT_235	[p19l874t1570r1184b1639],
21	.	.	O	.	_	0	SENT_235	[p19l874t1570r1184b1639],

1	Percentage	NN	O	percentage	nsubjpass	8	SENT_236	[p19l1216t1572r1548b1639],
2	of	IN	O	of	_	0	SENT_236	[p19l1578t1570r1643b1623],
3	subjects	NNS	O	subject	prep_of	1	SENT_236	[p19l1668t1570r1908b1639],
4	continuing	VBG	O	continue	partmod	3	SENT_236	[p19l1937t1570r2149b1623, p19l13t1658r146b1727],
5	AI	NN	O	aus	nn	6	SENT_236	[p19l172t1659r250b1711],
6	therapy	NN	O	therapy	dobj	4	SENT_236	[p19l275t1658r501b1727],
7	are	VBP	O	be	auxpass	8	SENT_236	[p19l528t1675r617b1711],
8	given	VBN	O	give	_	0	SENT_236	[p19l644t1658r811b1727],
9	over	RP	O	over	prt	8	SENT_236	[p19l836t1675r970b1711],
10	time	NN	O	time	dobj	8	SENT_236	[p19l994t1658r1128b1711],
11	for	IN	O	for	_	0	SENT_236	[p19l1153t1658r1241b1711],
12	subjects	NNS	O	subject	prep_for	8	SENT_236	[p19l1267t1658r1506b1727],
13	with	IN	O	with	_	0	SENT_236	[p19l1533t1658r1667b1711],
14	CC	NN	O	cc	nn	16	SENT_236	[p19l1692t1659r1807b1721],
15	,	,	O	,	_	0	SENT_236	[p19l1692t1659r1807b1721],
16	TC	NN	O	tc	prep_with	12	SENT_236	[p19l1835t1659r1946b1721],
17	,	,	O	,	_	0	SENT_236	[p19l1835t1659r1946b1721],
18	or	CC	O	or	_	0	SENT_236	[p19l1974t1675r2036b1711],
19	TT	NN	O	tt	nn	20	SENT_236	[p19l2060t1659r2151b1711],
20	genotypes	NNS	O	genotype	conj_or	16	SENT_236	[p19l14t1754r335b1815],
21	.	.	O	.	_	0	SENT_236	[p19l14t1754r335b1815],

1	a	DT	O	a	det	3	SENT_237	[p19l377t1762r412b1799],
2	Letrozole-treated	JJ	O	letrozole-treated	amod	3	SENT_237	[p19l448t1746r973b1799],
3	subjects	NNS	O	subject	_	0	SENT_237	[p19l1012t1746r1268b1815],
4	.	.	O	.	_	0	SENT_237	[p19l1012t1746r1268b1815],

1	b	NN	O	b	_	0	SENT_238	[p19l1308t1746r1348b1799],
2	Exemestane-treated	JJ	O	exemestane-treated	amod	3	SENT_238	[p19l1385t1746r1986b1799],
3	subjects	NNS	O	subject	dep	1	SENT_238	[p19l2025t1746r2149b1799, p19l7t1834r167b1903],
4	.	.	O	.	_	0	SENT_238	[p19l2025t1746r2149b1799, p19l7t1834r167b1903],

1	Analysis	NN	O	analysis	nsubjpass	3	SENT_239	[p19l194t1834r457b1903],
2	was	VBD	O	be	auxpass	3	SENT_239	[p19l481t1851r596b1888],
3	performed	VBN	O	perform	_	0	SENT_239	[p19l619t1834r936b1903],
4	using	VBG	O	use	xcomp	3	SENT_239	[p19l959t1834r1121b1903],
5	a	DT	O	a	det	8	SENT_239	[p19l1147t1851r1178b1887],
6	recessive	JJ	O	recessive	amod	8	SENT_239	[p19l1200t1834r1477b1888],
7	statistical	JJ	O	statistical	amod	8	SENT_239	[p19l1504t1834r1788b1887],
8	model	NN	O	model	dobj	4	SENT_239	[p19l1812t1834r2017b1897],
9	,	,	O	,	_	0	SENT_239	[p19l1812t1834r2017b1897],
10	and	CC	O	and	_	0	SENT_239	[p19l2045t1834r2152b1887],
11	p	NN	O	p	nn	12	SENT_239	[p19l7t1941r48b1990],
12	values	NNS	O	value	nsubjpass	14	SENT_239	[p19l76t1923r267b1976],
13	were	VBD	O	be	auxpass	14	SENT_239	[p19l295t1939r440b1976],
14	adjusted	VBN	O	adjust	conj_and	3	SENT_239	[p19l469t1922r720b1991],
15	for	IN	O	for	_	0	SENT_239	[p19l746t1922r834b1976],
16	age	NN	O	age	dep	17	SENT_239	[p19l860t1939r962b1991],
17	>	JJR	O	>	prep_for	14	SENT_239	[p19l990t1922r1130b1986],
18	55	CD	NUMBER	55	dep	17	SENT_239	[p19l990t1922r1130b1986],
19	,	,	O	,	_	0	SENT_239	[p19l990t1922r1130b1986],
20	AI	NN	O	aus	nn	21	SENT_239	[p19l1159t1923r1237b1975],
21	medication	NN	O	medication	appos	18	SENT_239	[p19l1263t1922r1617b1985],
22	,	,	O	,	_	0	SENT_239	[p19l1263t1922r1617b1985],
23	and	CC	O	and	_	0	SENT_239	[p19l1648t1923r1755b1976],
24	prior	RB	O	prior	advmod	26	SENT_239	[p19l1780t1922r1928b1991],
25	taxane	NN	O	taxane	nn	26	SENT_239	[p19l1954t1930r2150b1976],
26	therapy	NN	O	therapy	prep_for	14	SENT_239	[p19l13t2010r240b2079],

1	We	PRP	O	we	nsubj	3	SENT_240	[p19l115t2208r237b2269],
2	also	RB	O	also	advmod	3	SENT_240	[p19l274t2206r413b2269],
3	failed	VBD	O	fail	_	0	SENT_240	[p19l448t2206r651b2269],
4	to	TO	O	to	aux	5	SENT_240	[p19l684t2216r750b2269],
5	validate	VB	O	validate	xcomp	3	SENT_240	[p19l785t2206r1067b2269],
6	the	DT	O	the	det	9	SENT_240	[p19l1102t2206r1209b2269],
7	previously	RB	DATE	previously	advmod	8	SENT_240	[p19l1242t2206r1619b2287],
8	reported	VBN	O	report	amod	9	SENT_240	[p19l1653t2206r1951b2287],
9	ﬁnding	NN	O	ﬁnding	dobj	5	SENT_240	[p19l1986t2206r2148b2269, p19l13t2317r125b2398],
10	of	IN	O	of	_	0	SENT_240	[p19l156t2317r233b2380],
11	a	DT	O	a	det	13	SENT_240	[p19l258t2337r295b2380],
12	potential	JJ	O	potential	amod	13	SENT_240	[p19l321t2317r635b2398],
13	association	NN	O	association	prep_of	9	SENT_240	[p19l667t2317r1062b2380],
14	between	IN	O	between	_	0	SENT_240	[p19l1090t2317r1389b2380],
15	SNPs	NNS	O	snp	prep_between	13	SENT_240	[p19l1420t2318r1611b2380],
16	in	IN	O	in	_	0	SENT_240	[p19l1642t2317r1710b2379],
17	T	NN	O	t	nn	18	SENT_240	[p19l1742t2320r1794b2379],
18	CLIA	NN	ORGANIZATION	clium	prep_in	15	SENT_240	[p19l1792t2318r1991b2381],
19	and	CC	O	and	_	0	SENT_240	[p19l2026t2317r2151b2380],
20	lower	JJR	O	lower	amod	21	SENT_240	[p19l14t2428r217b2491],
21	toxicity	NN	O	toxicity	prep_between	13	SENT_240	[p19l245t2428r517b2509],
22	[	CD	NUMBER	[	number	23	SENT_240	[p19l554t2428r711b2504],
23	16	CD	NUMBER	16	num	24	SENT_240	[p19l554t2428r711b2504],
24	]	NN	O	]	dep	21	SENT_240	[p19l554t2428r711b2504],
25	.	.	O	.	_	0	SENT_240	[p19l554t2428r711b2504],

1	Since	IN	O	since	_	0	SENT_241	[p19l748t2428r941b2491],
2	the	DT	O	the	det	3	SENT_241	[p19l972t2428r1079b2491],
3	ﬁndings	NNS	O	ﬁndings	prep_since	18	SENT_241	[p19l1110t2428r1393b2509],
4	in	IN	O	in	_	0	SENT_241	[p19l1424t2428r1492b2490],
5	neither	CC	O	neither	dep	6	SENT_241	[p19l1520t2428r1769b2491],
6	study	NN	O	study	prep_in	3	SENT_241	[p19l1800t2428r1988b2509],
7	met	VBD	O	meet	partmod	6	SENT_241	[p19l2018t2438r2152b2491],
8	the	DT	O	the	det	10	SENT_241	[p19l13t2539r120b2602],
9	stringent	JJ	O	stringent	amod	10	SENT_241	[p19l194t2539r504b2620],
10	criteria	NNS	O	criterion	nsubj	18	SENT_241	[p19l573t2539r827b2602],
11	for	IN	O	for	_	0	SENT_241	[p19l895t2539r999b2602],
12	statistical	JJ	O	statistical	amod	13	SENT_241	[p19l1070t2539r1404b2602],
13	signiﬁcance	NN	O	signiﬁcance	prep_for	10	SENT_241	[p19l1478t2539r1920b2620],
14	,	,	O	,	_	0	SENT_241	[p19l1478t2539r1920b2620],
15	both	CC	O	both	dep	13	SENT_241	[p19l1992t2539r2151b2602],
16	observations	NNS	O	observation	conj	13	SENT_241	[p19l15t2650r463b2712],
17	may	MD	O	may	aux	18	SENT_241	[p19l492t2669r643b2731],
18	represent	VB	O	represent	_	0	SENT_241	[p19l671t2659r1000b2731],
19	the	DT	O	the	det	20	SENT_241	[p19l1026t2650r1133b2712],
20	play	NN	O	play	dobj	18	SENT_241	[p19l1160t2650r1312b2731],
21	of	IN	O	of	_	0	SENT_241	[p19l1341t2650r1419b2712],
22	chance	NN	O	chance	prep_of	20	SENT_241	[p19l1440t2650r1705b2712],
23	.	.	O	.	_	0	SENT_241	[p19l1440t2650r1705b2712],

1	In	IN	O	in	_	0	SENT_242	[p19l1737t2651r1809b2712],
2	addition	NN	O	addition	prep_in	9	SENT_242	[p19l1838t2650r2147b2724],
3	,	,	O	,	_	0	SENT_242	[p19l1838t2650r2147b2724],
4	the	DT	O	the	det	6	SENT_242	[p19l13t2761r120b2823],
5	phenotypic	JJ	O	phenotypic	amod	6	SENT_242	[p19l157t2761r553b2842],
6	endpoints	NNS	O	endpoint	nsubj	9	SENT_242	[p19l592t2761r936b2842],
7	were	VBD	O	be	cop	9	SENT_242	[p19l974t2780r1145b2824],
8	not	RB	O	not	neg	9	SENT_242	[p19l1182t2770r1295b2823],
9	identical	JJ	O	identical	_	0	SENT_242	[p19l1330t2761r1656b2823],
10	.	.	O	.	_	0	SENT_242	[p19l1330t2761r1656b2823],

1	In	IN	O	in	_	0	SENT_243	[p19l1697t2762r1769b2823],
2	the	DT	O	the	det	4	SENT_243	[p19l1805t2761r1912b2823],
3	ELPh	NN	MISC	elph	nn	4	SENT_243	[p19l1948t2761r2151b2823],
4	study	NN	O	study	prep_in	7	SENT_243	[p19l17t2871r224b2952],
5	,	,	O	,	_	0	SENT_243	[p19l17t2871r224b2952],
6	we	PRP	O	we	nsubj	7	SENT_243	[p19l258t2890r359b2933],
7	evaluated	VBD	O	evaluate	_	0	SENT_243	[p19l391t2871r734b2933],
8	discontinuation	NN	O	discontinuation	dobj	7	SENT_243	[p19l765t2871r1316b2933],
9	of	IN	O	of	_	0	SENT_243	[p19l1347t2871r1424b2933],
10	AI	NN	O	aus	nn	11	SENT_243	[p19l1449t2871r1541b2932],
11	therapy	NN	O	therapy	prep_of	8	SENT_243	[p19l1571t2871r1837b2952],
12	because	IN	O	because	_	0	SENT_243	[p19l1867t2871r2150b2933],
13	of	IN	O	of	prepc_because_of	7	SENT_243	[p19l15t2983r92b3046],
14	intolerable	JJ	O	intolerable	amod	15	SENT_243	[p19l124t2983r506b3046],
15	toxicity	NN	O	toxicity	pobj	7	SENT_243	[p19l544t2983r837b3064],
16	,	,	O	,	_	0	SENT_243	[p19l544t2983r837b3064],
17	whereas	IN	O	whereas	mark	23	SENT_243	[p19l878t2983r1168b3046],
18	in	IN	O	in	_	0	SENT_243	[p19l1207t2983r1275b3045],
19	MA	NNP	O	MA	prep_in	23	SENT_243	[p19l1312t2984r1563b3046],
20	.27	CD	NUMBER	.27	num	19	SENT_243	[p19l1312t2984r1563b3046],
21	the	DT	O	the	det	22	SENT_243	[p19l1604t2983r1710b3046],
22	researchers	NNS	O	researcher	nsubj	23	SENT_243	[p19l1748t2983r2149b3046],
23	evaluated	VBD	O	evaluate	advcl	7	SENT_243	[p19l14t3094r358b3157],
24	a	DT	O	a	det	26	SENT_243	[p19l392t3114r429b3157],
25	composite	JJ	O	composite	amod	26	SENT_243	[p19l462t3094r827b3175],
26	endpoint	NN	O	endpoint	dobj	23	SENT_243	[p19l862t3094r1175b3175],
27	of	IN	O	of	_	0	SENT_243	[p19l1208t3094r1285b3157],
28	CTCAE	NNP	O	CTCAE	prep_of	26	SENT_243	[p19l1314t3094r1603b3157],
29	grade	NN	O	grade	npadvmod	23	SENT_243	[p19l1639t3094r1834b3175],
30	three	CD	NUMBER	three	num	29	SENT_243	[p19l1867t3094r2044b3157],
31	or	CC	O	or	_	0	SENT_243	[p19l2080t3114r2152b3157],
32	four	CD	NUMBER	four	num	34	SENT_243	[p19l14t3205r162b3268],
33	musculoskeletal	JJ	O	musculoskeletal	amod	34	SENT_243	[p19l196t3205r772b3268],
34	toxicity	NN	O	toxicity	conj_or	29	SENT_243	[p19l809t3205r1081b3286],
35	or	CC	O	or	_	0	SENT_243	[p19l1119t3225r1191b3268],
36	treatment	NN	O	treatment	nn	37	SENT_243	[p19l1224t3214r1564b3268],
37	discontinuation	NN	O	discontinuation	npadvmod	23	SENT_243	[p19l1600t3205r2151b3268],
38	because	IN	O	because	_	0	SENT_243	[p19l12t3316r295b3379],
39	of	IN	O	of	_	0	SENT_243	[p19l328t3316r405b3379],
40	musculoskeletal	JJ	O	musculoskeletal	amod	41	SENT_243	[p19l430t3316r1007b3379],
41	toxicity	NN	O	toxicity	prep_of	43	SENT_243	[p19l1039t3316r1311b3397],
42	[	CD	NUMBER	[	number	43	SENT_243	[p19l1349t3316r1507b3392],
43	16	CD	NUMBER	16	prep_because	23	SENT_243	[p19l1349t3316r1507b3392],
44	]	NN	O	]	dep	43	SENT_243	[p19l1349t3316r1507b3392],
45	.	.	O	.	_	0	SENT_243	[p19l1349t3316r1507b3392],

1	Furthermore	RB	O	furthermore	advmod	14	SENT_244	[p19l1543t3316r2009b3390],
2	,	,	O	,	_	0	SENT_244	[p19l1543t3316r2009b3390],
3	the	DT	O	the	det	5	SENT_244	[p19l2043t3316r2150b3379],
4	GWAS	NNP	ORGANIZATION	GWAS	nn	5	SENT_244	[p19l15t3428r270b3490],
5	approach	NN	O	approach	nsubj	14	SENT_244	[p19l309t3427r635b3508],
6	taken	VBN	O	take	partmod	5	SENT_244	[p19l667t3427r860b3490],
7	in	IN	O	in	_	0	SENT_244	[p19l892t3427r960b3489],
8	the	DT	O	the	det	11	SENT_244	[p19l993t3428r1100b3490],
9	MA	NNP	O	MA	nn	11	SENT_244	[p19l1133t3428r1384b3490],
10	.27	CD	NUMBER	.27	num	11	SENT_244	[p19l1133t3428r1384b3490],
11	study	NN	O	study	prep_in	6	SENT_244	[p19l1423t3427r1610b3508],
12	is	VBZ	O	be	cop	14	SENT_244	[p19l1644t3427r1699b3490],
13	more	RBR	O	more	advmod	14	SENT_244	[p19l1734t3447r1915b3490],
14	prone	JJ	O	prone	_	0	SENT_244	[p19l1948t3447r2150b3508],
15	to	TO	O	to	_	0	SENT_244	[p19l13t3548r80b3601],
16	false	JJ	O	false	amod	17	SENT_244	[p19l125t3538r291b3601],
17	discovery	NN	O	discovery	prep_to	14	SENT_244	[p19l337t3538r682b3619],
18	than	IN	O	than	_	0	SENT_244	[p19l726t3538r879b3601],
19	the	DT	O	the	det	24	SENT_244	[p19l922t3538r1029b3601],
20	more	RBR	O	more	advmod	21	SENT_244	[p19l1073t3558r1255b3601],
21	limited	JJ	O	limited	amod	24	SENT_244	[p19l1300t3538r1554b3601],
22	candidate	NN	O	candidate	nn	24	SENT_244	[p19l1597t3538r1939b3601],
23	gene	NN	O	gene	nn	24	SENT_244	[p19l1985t3558r2150b3619],
24	strategy	NN	O	strategy	prep_than	17	SENT_244	[p19l17t3658r295b3730],
25	used	VBN	O	use	partmod	24	SENT_244	[p19l327t3649r490b3711],
26	in	IN	O	in	_	0	SENT_244	[p19l522t3649r590b3711],
27	our	PRP$	O	we	poss	28	SENT_244	[p19l623t3668r741b3711],
28	study	NN	O	study	prep_in	25	SENT_244	[p19l775t3649r981b3730],
29	.	.	O	.	_	0	SENT_244	[p19l775t3649r981b3730],

1	Regardless	RB	O	regardless	advmod	24	SENT_245	[p19l1017t3649r1428b3730],
2	,	,	O	,	_	0	SENT_245	[p19l1017t3649r1428b3730],
3	a	DT	O	a	det	6	SENT_245	[p19l1466t3668r1502b3711],
4	recently	RB	DATE	recently	advmod	5	SENT_245	[p19l1533t3649r1820b3730],
5	reported	VBN	O	report	amod	6	SENT_245	[p19l1852t3649r2152b3730],
6	analysis	NN	O	analysis	nsubj	24	SENT_245	[p20l15t22r299b103],
7	from	IN	O	from	_	0	SENT_245	[p20l375t22r547b84],
8	the	DT	O	the	det	22	SENT_245	[p20l620t22r727b84],
9	randomized	VBN	O	randomize	dep	22	SENT_245	[p20l800t22r1225b84],
10	Arimidex	NNP	MISC	Arimidex	dep	9	SENT_245	[p20l1298t22r1659b96],
11	,	,	O	,	_	0	SENT_245	[p20l1298t22r1659b96],
12	Tamoxifen	NN	MISC	tamoxifen	appos	10	SENT_245	[p20l1736t22r2147b96],
13	,	,	O	,	_	0	SENT_245	[p20l1736t22r2147b96],
14	Alone	RB	O	alone	advmod	12	SENT_245	[p20l13t133r249b207],
15	,	,	O	,	_	0	SENT_245	[p20l13t133r249b207],
16	or	CC	O	or	_	0	SENT_245	[p20l312t152r385b195],
17	in	IN	O	in	dep	22	SENT_245	[p20l440t133r509b195],
18	Combination	NN	O	combination	nn	20	SENT_245	[p20l567t133r1034b196],
19	(	CD	NUMBER	(	num	20	SENT_245	[p20l1094t133r1389b210],
20	ATAC	NN	O	atac	pobj	17	SENT_245	[p20l1094t133r1389b210],
21	)	CD	NUMBER	)	num	20	SENT_245	[p20l1094t133r1389b210],
22	Trial	NN	O	trial	prep_from	6	SENT_245	[p20l1450t133r1642b207],
23	,	,	O	,	_	0	SENT_245	[p20l1450t133r1642b207],
24	revealed	VBD	O	reveal	_	0	SENT_245	[p20l1702t133r2007b196],
25	no	DT	O	no	det	26	SENT_245	[p20l2064t152r2150b195],
26	association	NN	O	association	dobj	24	SENT_245	[p20l15t245r411b308],
27	between	IN	O	between	_	0	SENT_245	[p20l457t245r756b308],
28	the	DT	O	the	det	32	SENT_245	[p20l803t245r910b308],
29	rsll849538	NN	O	rsll849538	nn	32	SENT_245	[p20l956t245r1375b309],
30	T	NN	O	t	nn	32	SENT_245	[p20l1429t248r1481b307],
31	CLIA	NN	ORGANIZATION	clium	nn	32	SENT_245	[p20l1479t246r1678b309],
32	variant	NN	O	variant	prep_between	26	SENT_245	[p20l1729t245r1977b308],
33	and	CC	O	and	_	0	SENT_245	[p20l2026t245r2151b308],
34	CT	NN	O	ct	nn	35	SENT_245	[p20l14t357r126b420],
35	CAE	NN	O	ca	prep_between	26	SENT_245	[p20l129t357r581b438],
36	—	CD	NUMBER	—	tmod	24	SENT_245	[p20l129t357r581b438],
37	graded	VBN	O	grade	partmod	36	SENT_245	[p20l129t357r581b438],
38	musculoskeletal	JJ	O	musculoskeletal	amod	39	SENT_245	[p20l662t357r1239b420],
39	toxicity	NN	O	toxicity	dobj	37	SENT_245	[p20l1322t357r1594b438],
40	[	CD	NUMBER	[	num	42	SENT_245	[p20l1684t357r1842b433],
41	24	CD	NUMBER	24	num	42	SENT_245	[p20l1684t357r1842b433],
42	]	NN	O	]	dep	36	SENT_245	[p20l1684t357r1842b433],
43	.	.	O	.	_	0	SENT_245	[p20l1684t357r1842b433],

1	Taken	VBN	O	take	partmod	6	SENT_246	[p20l1929t357r2151b420],
2	together	RB	O	together	advmod	1	SENT_246	[p20l13t468r325b549],
3	,	,	O	,	_	0	SENT_246	[p20l13t468r325b549],
4	these	DT	O	these	det	5	SENT_246	[p20l354t468r536b531],
5	data	NNS	O	datum	nsubj	6	SENT_246	[p20l563t468r711b531],
6	do	VBP	O	do	_	0	SENT_246	[p20l737t468r821b531],
7	not	RB	O	not	dep	9	SENT_246	[p20l849t478r962b531],
8	strongly	RB	O	strongly	advmod	9	SENT_246	[p20l989t468r1277b549],
9	suggest	VBP	O	suggest	ccomp	6	SENT_246	[p20l1307t477r1572b549],
10	that	IN	O	that	complm	14	SENT_246	[p20l1595t468r1729b531],
11	this	DT	O	this	det	12	SENT_246	[p20l1754t468r1880b531],
12	SNP	NN	O	snp	nsubjpass	14	SENT_246	[p20l1910t468r2069b531],
13	is	VBZ	O	be	auxpass	14	SENT_246	[p20l2094t468r2149b531],
14	involved	VBN	O	involve	ccomp	9	SENT_246	[p20l13t579r326b642],
15	in	IN	O	in	_	0	SENT_246	[p20l375t579r442b641],
16	the	DT	O	the	det	17	SENT_246	[p20l490t579r597b642],
17	development	NN	O	development	prep_in	14	SENT_246	[p20l648t579r1111b660],
18	of	IN	O	of	_	0	SENT_246	[p20l1159t579r1236b642],
19	AI	NN	O	aus	nn	20	SENT_246	[p20l1279t579r1771b642],
20	—	NN	O	—	prep_of	17	SENT_246	[p20l1279t579r1771b642],
21	associated	VBN	O	associate	partmod	20	SENT_246	[p20l1279t579r1771b642],
22	musculoskeletal	JJ	O	musculoskeletal	amod	23	SENT_246	[p20l1819t579r2148b642, p20l17t690r286b753],
23	toxicity	NN	O	toxicity	dobj	21	SENT_246	[p20l319t690r610b771],
24	.	.	O	.	_	0	SENT_246	[p20l319t690r610b771],

1	The	DT	O	the	det	2	SENT_247	[p20l109t801r246b864],
2	strength	NN	O	strength	nsubjpass	7	SENT_247	[p20l296t801r580b882],
3	of	IN	O	of	_	0	SENT_247	[p20l627t801r704b864],
4	our	PRP$	O	we	poss	5	SENT_247	[p20l746t821r864b864],
5	observations	NNS	O	observation	prep_of	2	SENT_247	[p20l909t801r1357b864],
6	is	VBZ	O	be	auxpass	7	SENT_247	[p20l1406t801r1461b864],
7	supported	VBN	O	support	_	0	SENT_247	[p20l1512t801r1862b882],
8	by	IN	O	by	_	0	SENT_247	[p20l1906t801r1993b882],
9	the	DT	O	the	det	10	SENT_247	[p20l2040t801r2147b864],
10	derivation	NN	O	derivation	agent	7	SENT_247	[p20l8t912r371b975],
11	of	IN	O	of	_	0	SENT_247	[p20l426t912r503b975],
12	the	DT	O	the	det	13	SENT_247	[p20l551t912r658b975],
13	data	NNS	O	datum	prep_of	10	SENT_247	[p20l714t912r862b975],
14	from	IN	O	from	_	0	SENT_247	[p20l916t912r1089b975],
15	a	DT	O	a	det	20	SENT_247	[p20l1144t932r1181b975],
16	prospective	JJ	O	prospective	amod	20	SENT_247	[p20l1234t912r1667b993],
17	,	,	O	,	_	0	SENT_247	[p20l1234t912r1667b993],
18	randomized	JJ	O	randomized	amod	20	SENT_247	[p20l1723t912r2148b975],
19	clinical	JJ	O	clinical	amod	20	SENT_247	[p20l8t1023r270b1085],
20	trial	NN	O	trial	prep_from	7	SENT_247	[p20l298t1023r440b1085],
21	of	IN	O	of	_	0	SENT_247	[p20l470t1023r547b1085],
22	patients	NNS	O	patient	prep_of	20	SENT_247	[p20l567t1023r844b1104],
23	treated	VBN	O	treat	partmod	22	SENT_247	[p20l873t1023r1117b1085],
24	with	IN	O	with	_	0	SENT_247	[p20l1144t1023r1301b1086],
25	AIs	NNS	O	ai	prep_with	23	SENT_247	[p20l1328t1023r1452b1085],
26	from	IN	O	from	_	0	SENT_247	[p20l1482t1023r1654b1085],
27	two	CD	NUMBER	two	num	29	SENT_247	[p20l1680t1032r1811b1086],
28	different	JJ	O	different	amod	29	SENT_247	[p20l1841t1023r2149b1085],
29	classes	NNS	O	class	nsubj	30	SENT_247	[p20l8t1134r252b1196],
30	(	VBP	O	(	dep	36	SENT_247	[p20l290t1134r625b1211],
31	steroidal	JJ	O	steroidal	amod	34	SENT_247	[p20l290t1134r625b1211],
32	and	CC	O	and	_	0	SENT_247	[p20l661t1134r787b1196],
33	non	JJ	O	non	amod	34	SENT_247	[p20l819t1134r1340b1211],
34	—	NN	O	—	dobj	30	SENT_247	[p20l819t1134r1340b1211],
35	steroidal	JJ	O	steroidal	amod	36	SENT_247	[p20l819t1134r1340b1211],
36	)	NN	O	)	prep_from	25	SENT_247	[p20l819t1134r1340b1211],
37	.	.	O	.	_	0	SENT_247	[p20l819t1134r1340b1211],

1	Furthermore	RB	O	furthermore	advmod	9	SENT_248	[p20l1377t1134r1844b1208],
2	,	,	O	,	_	0	SENT_248	[p20l1377t1134r1844b1208],
3	reasons	NNS	O	reason	nsubjpass	9	SENT_248	[p20l1880t1153r2146b1196],
4	for	IN	O	for	_	0	SENT_248	[p20l8t1244r111b1307],
5	treatment	NN	O	treatment	nn	6	SENT_248	[p20l141t1254r480b1307],
6	discontinuation	NN	O	discontinuation	prep_for	3	SENT_248	[p20l511t1245r1064b1307],
7	were	VBD	O	be	auxpass	9	SENT_248	[p20l1096t1264r1266b1307],
8	prospectively	RB	O	prospectively	advmod	9	SENT_248	[p20l1297t1245r1781b1326],
9	recorded	VBN	O	record	_	0	SENT_248	[p20l1811t1245r2143b1307],
10	.	.	O	.	_	0	SENT_248	[p20l1811t1245r2143b1307],

1	We	PRP	O	we	nsubj	4	SENT_249	[p20l6t1359r129b1420],
2	were	VBD	O	be	cop	4	SENT_249	[p20l170t1377r341b1420],
3	therefore	RB	O	therefore	advmod	4	SENT_249	[p20l382t1357r704b1420],
4	able	JJ	O	able	_	0	SENT_249	[p20l747t1357r891b1420],
5	to	TO	O	to	aux	6	SENT_249	[p20l932t1367r999b1420],
6	evaluate	VB	O	evaluate	xcomp	4	SENT_249	[p20l1040t1357r1337b1420],
7	associations	NNS	O	association	dobj	6	SENT_249	[p20l1380t1357r1808b1420],
8	between	IN	O	between	_	0	SENT_249	[p20l1848t1357r2148b1420],
9	inherited	VBN	O	inherit	amod	11	SENT_249	[p20l7t1469r327b1532],
10	genetic	JJ	O	genetic	amod	11	SENT_249	[p20l357t1469r612b1550],
11	variants	NNS	O	variant	prep_between	7	SENT_249	[p20l644t1469r924b1532],
12	involved	VBN	O	involve	partmod	11	SENT_249	[p20l957t1469r1270b1532],
13	in	IN	O	in	_	0	SENT_249	[p20l1299t1469r1367b1531],
14	estrogen	NN	O	estrogen	nn	15	SENT_249	[p20l1397t1479r1699b1550],
15	metabolism	NN	O	metabolism	prep_in	12	SENT_249	[p20l1729t1469r2149b1532],
16	and	CC	O	and	_	0	SENT_249	[p20l9t1580r135b1643],
17	activity	NN	O	activity	conj_and	15	SENT_249	[p20l171t1580r457b1661],
18	,	,	O	,	_	0	SENT_249	[p20l171t1580r457b1661],
19	and	CC	O	and	_	0	SENT_249	[p20l497t1580r623b1643],
20	reasonably	RB	O	reasonably	advmod	21	SENT_249	[p20l656t1580r1044b1661],
21	accurate	JJ	O	accurate	amod	22	SENT_249	[p20l1080t1590r1377b1643],
22	measures	NNS	O	measure	dobj	6	SENT_249	[p20l1412t1600r1743b1643],
23	of	IN	O	of	_	0	SENT_249	[p20l1780t1580r1857b1643],
24	discontinuation	NN	O	discontinuation	prep_of	22	SENT_249	[p20l1886t1580r2144b1643, p20l7t1691r325b1754],
25	of	IN	O	of	_	0	SENT_249	[p20l359t1691r436b1754],
26	AI	NN	O	aus	nn	27	SENT_249	[p20l463t1692r555b1753],
27	therapy	NN	O	therapy	prep_of	24	SENT_249	[p20l588t1691r855b1772],
28	because	IN	O	because	_	0	SENT_249	[p20l888t1691r1170b1754],
29	of	IN	O	of	prepc_because_of	6	SENT_249	[p20l1205t1691r1283b1754],
30	either	CC	O	either	dep	6	SENT_249	[p20l1310t1691r1514b1754],
31	any	DT	O	any	det	32	SENT_249	[p20l1547t1711r1672b1772],
32	drug	NN	O	drug	conj	6	SENT_249	[p20l1707t1691r2145b1772],
33	—	NN	O	—	nn	34	SENT_249	[p20l1707t1691r2145b1772],
34	associ	NNS	O	assocus	nsubj	35	SENT_249	[p20l1707t1691r2145b1772],
35	—	VBP	O	—	rcmod	32	SENT_249	[p20l1707t1691r2145b1772],
36	ated	JJ	O	ated	amod	37	SENT_249	[p20l9t1802r156b1865],
37	toxicity	NN	O	toxicity	dobj	35	SENT_249	[p20l188t1802r460b1883],
38	or	CC	O	or	_	0	SENT_249	[p20l495t1822r585b1876],
39	,	,	O	,	_	0	SENT_249	[p20l495t1822r585b1876],
40	speciﬁcally	RB	O	speciﬁcally	dep	37	SENT_249	[p20l624t1802r1048b1883],
41	,	,	O	,	_	0	SENT_249	[p20l624t1802r1048b1883],
42	AIMSS	NN	O	aimss	dobj	35	SENT_249	[p20l1084t1803r1372b1865],
43	.	.	O	.	_	0	SENT_249	[p20l1084t1803r1372b1865],

1	Nonetheless	RB	O	nonetheless	advmod	15	SENT_250	[p20l109t1913r565b1987],
2	,	,	O	,	_	0	SENT_250	[p20l109t1913r565b1987],
3	given	VBN	O	give	prep	15	SENT_250	[p20l613t1913r809b1994],
4	the	DT	O	the	det	6	SENT_250	[p20l852t1913r959b1975],
5	large	JJ	O	large	amod	6	SENT_250	[p20l1003t1913r1180b1994],
6	number	NN	O	number	dep	3	SENT_250	[p20l1224t1913r1498b1975],
7	of	IN	O	of	_	0	SENT_250	[p20l1540t1913r1617b1975],
8	gene	NN	O	gene	nn	9	SENT_250	[p20l1655t1932r1821b1994],
9	variants	NNS	O	variant	prep_of	6	SENT_250	[p20l1865t1913r2146b1976],
10	that	IN	O	that	dep	12	SENT_250	[p20l7t2024r141b2086],
11	we	PRP	O	we	nsubj	12	SENT_250	[p20l173t2043r274b2087],
12	analyzed	VBD	O	analyze	dep	6	SENT_250	[p20l310t2024r646b2105],
13	,	,	O	,	_	0	SENT_250	[p20l310t2024r646b2105],
14	we	PRP	O	we	nsubj	15	SENT_250	[p20l682t2043r783b2086],
15	applied	VBD	O	apply	_	0	SENT_250	[p20l818t2024r1081b2105],
16	a	DT	O	a	det	19	SENT_250	[p20l1114t2043r1151b2086],
17	stringent	JJ	O	stringent	amod	19	SENT_250	[p20l1186t2024r1497b2105],
18	statistical	JJ	O	statistical	amod	19	SENT_250	[p20l1532t2024r1867b2086],
19	threshold	NN	O	threshold	dobj	15	SENT_250	[p20l1900t2024r2145b2086, p20l8t2134r121b2196],
20	to	TO	O	to	aux	21	SENT_250	[p20l147t2143r214b2196],
21	account	VB	O	account	xcomp	15	SENT_250	[p20l245t2143r522b2196],
22	for	IN	O	for	_	0	SENT_250	[p20l550t2133r653b2196],
23	multiple	JJ	O	multiple	amod	24	SENT_250	[p20l680t2134r978b2215],
24	comparisons	NNS	O	comparison	prep_for	21	SENT_250	[p20l1007t2134r1477b2215],
25	.	.	O	.	_	0	SENT_250	[p20l1007t2134r1477b2215],

1	These	DT	O	these	det	2	SENT_251	[p20l1509t2134r1721b2196],
2	corrections	NNS	O	correction	nsubj	8	SENT_251	[p20l1750t2134r2146b2196],
3	in	IN	O	in	_	0	SENT_251	[p20l7t2246r75b2308],
4	this	DT	O	this	det	7	SENT_251	[p20l106t2246r232b2309],
5	relatively	RB	O	relatively	advmod	6	SENT_251	[p20l265t2246r604b2327],
6	small	JJ	O	small	amod	7	SENT_251	[p20l640t2246r829b2309],
7	data	NNS	O	datum	prep_in	2	SENT_251	[p20l863t2246r1011b2309],
8	set	VBN	O	set	_	0	SENT_251	[p20l1045t2255r1140b2309],
9	(	CD	NUMBER	(	num	10	SENT_251	[p20l1174t2247r1243b2323],
10	n	NN	O	n	dobj	8	SENT_251	[p20l1174t2247r1243b2323],
11	=	JJ	O	=	amod	13	SENT_251	[p20l1279t2275r1340b2298],
12	467	CD	NUMBER	467	num	13	SENT_251	[p20l1375t2246r1535b2323],
13	)	NN	O	)	nsubj	14	SENT_251	[p20l1375t2246r1535b2323],
14	limit	NN	O	limit	rcmod	10	SENT_251	[p20l1570t2246r1739b2309],
15	our	PRP$	O	we	poss	16	SENT_251	[p20l1771t2266r1889b2309],
16	ability	NN	O	ability	dobj	14	SENT_251	[p20l1921t2246r2146b2327],
17	to	TO	O	to	aux	18	SENT_251	[p20l7t2366r74b2420],
18	detect	VB	O	detect	infmod	16	SENT_251	[p20l108t2357r322b2420],
19	statistically	RB	O	statistically	advmod	20	SENT_251	[p20l356t2357r761b2438],
20	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_251	[p20l798t2357r1169b2438],
21	associations	NNS	O	association	dobj	18	SENT_251	[p20l1202t2357r1650b2420],
22	.	.	O	.	_	0	SENT_251	[p20l1202t2357r1650b2420],

1	An	DT	O	a	det	3	SENT_252	[p20l109t2469r216b2530],
2	additional	JJ	O	additional	amod	3	SENT_252	[p20l262t2468r617b2531],
3	limitation	NN	O	limitation	nsubj	6	SENT_252	[p20l662t2468r1011b2531],
4	is	VBZ	O	be	cop	6	SENT_252	[p20l1054t2468r1110b2531],
5	the	DT	O	the	det	6	SENT_252	[p20l1155t2468r1262b2531],
6	lack	NN	O	lack	_	0	SENT_252	[p20l1306t2468r1456b2531],
7	of	IN	O	of	_	0	SENT_252	[p20l1499t2468r1576b2531],
8	a	DT	O	a	det	10	SENT_252	[p20l1615t2488r1652b2531],
9	standardized	JJ	O	standardized	amod	10	SENT_252	[p20l1698t2468r2148b2531],
10	deﬁnition	NN	O	deﬁnition	prep_of	6	SENT_252	[p20l8t2580r350b2643],
11	of	IN	O	of	_	0	SENT_252	[p20l374t2580r452b2643],
12	AIMSS	NNP	O	AIMSS	prep_of	10	SENT_252	[p20l469t2581r759b2655],
13	,	,	O	,	_	0	SENT_252	[p20l469t2581r759b2655],
14	and	CC	O	and	_	0	SENT_252	[p20l789t2580r915b2643],
15	therefore	RB	O	therefore	advmod	10	SENT_252	[p20l938t2580r1260b2643],
16	the	DT	O	the	det	17	SENT_252	[p20l1285t2581r1392b2643],
17	absence	NN	O	absence	prep_of	6	SENT_252	[p20l1418t2580r1698b2643],
18	of	IN	O	of	_	0	SENT_252	[p20l1724t2580r1801b2643],
19	objective	JJ	O	objective	amod	20	SENT_252	[p20l1820t2580r2146b2661],
20	criteria	NNS	O	criterion	prep_of	17	SENT_252	[p20l8t2691r262b2754],
21	on	IN	O	on	_	0	SENT_252	[p20l297t2711r384b2754],
22	which	WDT	O	which	nsubj	25	SENT_252	[p20l418t2691r636b2754],
23	to	TO	O	to	aux	25	SENT_252	[p20l670t2701r737b2754],
24	base	NN	O	base	nn	25	SENT_252	[p20l772t2691r930b2754],
25	decisions	NNS	O	decision	prepc_on	6	SENT_252	[p20l966t2691r1295b2754],
26	to	TO	O	to	aux	27	SENT_252	[p20l1332t2701r1399b2754],
27	continue	VB	O	continue	xcomp	25	SENT_252	[p20l1436t2691r1742b2754],
28	or	CC	O	or	_	0	SENT_252	[p20l1779t2711r1852b2754],
29	discontinue	VB	O	discontinue	conj_or	27	SENT_252	[p20l1886t2691r2144b2754, p20l7t2803r184b2866],

1	therapy	NN	O	therapy	_	0	SENT_253	[p20l213t2803r499b2884],
2	.	.	O	.	_	0	SENT_253	[p20l213t2803r499b2884],

1	Pain	NN	O	pain	nsubj	9	SENT_254	[p20l531t2803r689b2866],
2	is	VBZ	O	be	cop	6	SENT_254	[p20l717t2803r772b2866],
3	an	DT	O	a	det	6	SENT_254	[p20l803t2823r884b2866],
4	inherently	RB	O	inherently	advmod	5	SENT_254	[p20l912t2803r1275b2884],
5	subjective	JJ	O	subjective	amod	6	SENT_254	[p20l1306t2803r1665b2884],
6	measure	NN	O	measure	_	0	SENT_254	[p20l1695t2823r1991b2866],
7	and	CC	O	and	_	0	SENT_254	[p20l2022t2803r2148b2866],
8	can	MD	O	can	aux	9	SENT_254	[p20l8t2933r130b2976],
9	have	VB	O	have	conj_and	6	SENT_254	[p20l172t2914r339b2976],
10	a	DT	O	a	det	11	SENT_254	[p20l385t2933r422b2976],
11	myriad	JJ	O	myriad	dobj	9	SENT_254	[p20l464t2914r717b2995],
12	of	IN	O	of	_	0	SENT_254	[p20l760t2914r837b2976],
13	etiologies	NNS	O	etiology	prep_of	11	SENT_254	[p20l874t2914r1240b2995],
14	.	.	O	.	_	0	SENT_254	[p20l874t2914r1240b2995],

1	Therefore	RB	O	therefore	advmod	3	SENT_255	[p20l1287t2914r1659b2988],
2	,	,	O	,	_	0	SENT_255	[p20l1287t2914r1659b2988],
3	deﬁning	VBG	O	deﬁning	conj_and	3	SENT_255	[p20l1706t2914r1996b2995],
4	the	DT	O	the	det	6	SENT_255	[p20l2040t2914r2147b2976],
5	primary	JJ	O	primary	amod	6	SENT_255	[p20l6t3025r289b3106],
6	endpoint	NN	O	endpoint	dobj	3	SENT_255	[p20l318t3025r632b3106],
7	as	IN	O	as	_	0	SENT_255	[p20l660t3044r729b3087],
8	change	NN	O	change	prep_as	3	SENT_255	[p20l759t3025r1009b3106],
9	in	IN	O	in	_	0	SENT_255	[p20l1038t3025r1106b3087],
10	pain	NN	O	pain	nn	11	SENT_255	[p20l1133t3025r1287b3106],
11	score	NN	NUMBER	score	prep_in	8	SENT_255	[p20l1317t3044r1501b3087],
12	between	IN	O	between	_	0	SENT_255	[p20l1528t3025r1827b3088],
13	baseline	NN	O	baseline	prep_between	11	SENT_255	[p20l1853t3025r2147b3087],
14	and	CC	O	and	_	0	SENT_255	[p20l9t3135r135b3197],
15	on	IN	O	on	_	0	SENT_255	[p20l160t3144r619b3197],
16	—	NN	O	—	nn	19	SENT_255	[p20l160t3144r619b3197],
17	treatment	NN	O	treatment	nn	19	SENT_255	[p20l160t3144r619b3197],
18	study	NN	O	study	nn	19	SENT_255	[p20l645t3135r833b3216],
19	visit	NN	O	visit	prep_on	3	SENT_255	[p20l859t3135r1012b3197],
20	can	MD	O	can	aux	22	SENT_255	[p20l1037t3154r1159b3197],
21	be	VB	O	be	auxpass	22	SENT_255	[p20l1182t3135r1265b3197],
22	confounded	VBN	O	confound	dep	3	SENT_255	[p20l1291t3135r1713b3197],
23	by	IN	O	by	_	0	SENT_255	[p20l1736t3135r1824b3216],
24	multiple	JJ	O	multiple	amod	25	SENT_255	[p20l1848t3135r2147b3216],
25	factors	NNS	O	factor	agent	22	SENT_255	[p20l8t3247r248b3310],
26	including	VBG	O	include	_	0	SENT_255	[p20l291t3247r628b3328],
27	recent	JJ	O	recent	amod	30	SENT_255	[p20l670t3257r890b3310],
28	breast	NN	O	breast	nn	30	SENT_255	[p20l928t3247r1144b3310],
29	cancer	NN	O	cancer	nn	30	SENT_255	[p20l1185t3267r1418b3310],
30	surgery	NN	O	surgery	prep_including	25	SENT_255	[p20l1461t3267r1724b3328],
31	or	CC	O	or	_	0	SENT_255	[p20l1767t3267r1841b3310],
32	chemotherapy	NN	O	chemotherapy	nn	33	SENT_255	[p20l1881t3247r2144b3310, p20l7t3358r274b3439],
33	(	NN	O	(	conj_or	30	SENT_255	[p20l308t3359r399b3435],
34	at	IN	O	at	_	0	SENT_255	[p20l308t3359r399b3435],
35	baseline	NN	O	baseline	nn	36	SENT_255	[p20l428t3358r771b3435],
36	)	NN	O	)	prep_at	30	SENT_255	[p20l428t3358r771b3435],
37	,	,	O	,	_	0	SENT_255	[p20l428t3358r771b3435],
38	lymphedema	NN	O	lymphedema	nn	39	SENT_255	[p20l806t3358r1270b3439],
39	exacerbations	NNS	O	exacerbation	conj_or	30	SENT_255	[p20l1301t3358r1812b3432],
40	,	,	O	,	_	0	SENT_255	[p20l1301t3358r1812b3432],
41	and	CC	O	and	_	0	SENT_255	[p20l1848t3358r1975b3421],
42	preexisting	VBG	O	preexist	amod	43	SENT_255	[p20l2004t3378r2145b3439, p20l8t3469r288b3550],
43	arthritis	NN	O	arthritis	conj_and	30	SENT_255	[p20l329t3469r623b3532],
44	.	.	O	.	_	0	SENT_255	[p20l329t3469r623b3532],

1	To	TO	O	to	aux	2	SENT_256	[p20l665t3471r761b3532],
2	minimize	VB	O	minimize	purpcl	8	SENT_256	[p20l799t3469r1136b3532],
3	these	DT	O	these	det	5	SENT_256	[p20l1174t3469r1355b3532],
4	confounding	JJ	O	confounding	amod	5	SENT_256	[p20l1394t3469r1844b3550],
5	factors	NNS	O	factor	dobj	2	SENT_256	[p20l1883t3469r2144b3543],
6	,	,	O	,	_	0	SENT_256	[p20l1883t3469r2144b3543],
7	we	PRP	O	we	nsubj	8	SENT_256	[p20l8t3600r109b3643],
8	chose	VBD	O	choose	_	0	SENT_256	[p20l145t3580r345b3643],
9	to	TO	O	to	aux	10	SENT_256	[p20l380t3590r447b3643],
10	use	VB	O	use	xcomp	8	SENT_256	[p20l482t3600r598b3643],
11	persistence	NN	O	persistence	nsubj	15	SENT_256	[p20l632t3580r1031b3661],
12	of	IN	O	of	_	0	SENT_256	[p20l1067t3580r1144b3643],
13	patient	NN	O	patient	prep_of	11	SENT_256	[p20l1171t3580r1747b3661],
14	—	CD	NUMBER	—	num	13	SENT_256	[p20l1171t3580r1747b3661],
15	reported	VBD	O	report	ccomp	10	SENT_256	[p20l1171t3580r1747b3661],
16	symptoms	NNS	O	symptom	dobj	15	SENT_256	[p20l1784t3590r2146b3661],
17	despite	IN	O	despite	_	0	SENT_256	[p20l8t3691r259b3772],
18	conservative	JJ	O	conservative	amod	20	SENT_256	[p20l288t3691r739b3754],
19	symptom	NN	O	symptom	nn	20	SENT_256	[p20l769t3701r1100b3772],
20	management	NN	O	management	prep_despite	15	SENT_256	[p20l1126t3701r1584b3772],
21	as	IN	O	as	_	0	SENT_256	[p20l1613t3711r1681b3754],
22	the	DT	O	the	det	23	SENT_256	[p20l1710t3691r1817b3754],
23	criterion	NN	O	criterion	prep_as	15	SENT_256	[p20l1845t3691r2148b3754],
24	on	IN	O	on	_	0	SENT_256	[p21l8t42r95b85],
25	which	WDT	O	which	det	26	SENT_256	[p21l128t22r344b85],
26	treatment	NN	O	treatment	rel	30	SENT_256	[p21l376t32r717b85],
27	discontinuation	NN	O	discontinuation	nn	28	SENT_256	[p21l749t22r1302b85],
28	decisions	NNS	O	decision	nsubjpass	30	SENT_256	[p21l1335t22r1665b85],
29	were	VBD	O	be	auxpass	30	SENT_256	[p21l1699t42r1870b85],
30	made	VBN	O	make	rcmod	23	SENT_256	[p21l1903t22r2114b85],
31	.	.	O	.	_	0	SENT_256	[p21l1903t22r2114b85],

1	Non	JJ	O	non	amod	3	SENT_257	[p21l109t134r656b196],
2	—	NN	O	—	nn	3	SENT_257	[p21l109t134r656b196],
3	adherence	NN	O	adherence	nsubj	7	SENT_257	[p21l109t134r656b196],
4	to	TO	O	to	_	0	SENT_257	[p21l689t143r756b196],
5	therapy	NN	O	therapy	prep_to	3	SENT_257	[p21l789t134r1056b215],
6	could	MD	O	could	aux	7	SENT_257	[p21l1090t134r1288b196],
7	confound	VB	O	confound	_	0	SENT_257	[p21l1320t134r1658b196],
8	our	PRP$	O	we	poss	9	SENT_257	[p21l1690t153r1808b196],
9	ﬁndings	NNS	O	ﬁndings	dobj	7	SENT_257	[p21l1840t134r2143b215],
10	.	.	O	.	_	0	SENT_257	[p21l1840t134r2143b215],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_258	[p21l7t245r289b307],
2	were	VBD	O	be	auxpass	3	SENT_258	[p21l328t264r498b308],
3	queried	VBN	O	query	_	0	SENT_258	[p21l537t245r804b326],
4	about	IN	O	about	_	0	SENT_258	[p21l843t245r1040b307],
5	adherence	NN	O	adherence	prep_about	3	SENT_258	[p21l1077t245r1437b307],
6	to	TO	O	to	_	0	SENT_258	[p21l1476t254r1542b307],
7	therapy	NN	O	therapy	prep_to	3	SENT_258	[p21l1580t245r1847b326],
8	at	IN	O	at	_	0	SENT_258	[p21l1887t254r1949b307],
9	each	DT	O	each	det	11	SENT_258	[p21l1985t245r2147b307],
10	study	NN	O	study	nn	11	SENT_258	[p21l10t355r198b436],
11	visit	NN	O	visit	prep_at	3	SENT_258	[p21l239t355r412b429],
12	,	,	O	,	_	0	SENT_258	[p21l239t355r412b429],
13	but	CC	O	but	_	0	SENT_258	[p21l454t355r568b417],
14	no	DT	O	no	det	17	SENT_258	[p21l607t374r693b417],
15	formal	JJ	O	formal	amod	17	SENT_258	[p21l735t355r972b417],
16	adherence	NN	O	adherence	nn	17	SENT_258	[p21l1015t355r1374b417],
17	data	NNS	O	datum	nsubjpass	19	SENT_258	[p21l1417t355r1565b417],
18	were	VBD	O	be	auxpass	19	SENT_258	[p21l1605t374r1776b417],
19	obtained	VBN	O	obtain	conj_but	3	SENT_258	[p21l1818t355r2143b417],
20	.	.	O	.	_	0	SENT_258	[p21l1818t355r2143b417],

1	The	DT	O	the	det	2	SENT_259	[p21l7t467r144b530],
2	majority	NN	O	majority	nsubj	5	SENT_259	[p21l176t467r479b548],
3	of	IN	O	of	_	0	SENT_259	[p21l512t467r589b530],
4	patients	NNS	O	patient	prep_of	2	SENT_259	[p21l613t467r890b548],
5	reported	VBD	O	report	_	0	SENT_259	[p21l923t467r1222b548],
6	high	JJ	O	high	amod	7	SENT_259	[p21l1252t467r1410b548],
7	levels	NNS	O	level	dobj	5	SENT_259	[p21l1442t467r1647b530],
8	of	IN	O	of	_	0	SENT_259	[p21l1682t467r1759b530],
9	adherence	NN	O	adherence	prep_of	7	SENT_259	[p21l1786t467r2146b530],
10	to	TO	O	to	_	0	SENT_259	[p21l7t587r74b641],
11	therapy	NN	O	therapy	prep_to	5	SENT_259	[p21l100t578r386b659],
12	,	,	O	,	_	0	SENT_259	[p21l100t578r386b659],
13	which	WDT	O	which	nsubjpass	15	SENT_259	[p21l416t578r633b641],
14	was	VBD	O	be	auxpass	15	SENT_259	[p21l659t598r793b641],
15	provided	VBN	O	provide	rcmod	11	SENT_259	[p21l819t578r1139b659],
16	free	JJ	O	free	advmod	15	SENT_259	[p21l1164t578r1300b641],
17	of	IN	O	of	_	0	SENT_259	[p21l1328t578r1405b641],
18	charge	NN	O	charge	prep_of	16	SENT_259	[p21l1425t578r1661b659],
19	by	IN	O	by	_	0	SENT_259	[p21l1686t578r1774b659],
20	the	DT	O	the	det	21	SENT_259	[p21l1800t578r1907b641],
21	study	NN	O	study	agent	15	SENT_259	[p21l1937t578r2143b659],
22	.	.	O	.	_	0	SENT_259	[p21l1937t578r2143b659],

1	Because	IN	O	because	mark	33	SENT_260	[p21l7t691r304b752],
2	of	IN	O	of	_	0	SENT_260	[p21l365t689r443b752],
3	the	DT	O	the	det	6	SENT_260	[p21l495t689r602b752],
4	predeﬁned	JJ	O	predeﬁned	amod	6	SENT_260	[p21l661t689r1041b770],
5	cross	NN	O	cross	nn	6	SENT_260	[p21l1100t709r1472b752],
6	—	NN	O	—	prep_of	15	SENT_260	[p21l1100t709r1472b752],
7	over	IN	O	over	prep	6	SENT_260	[p21l1100t709r1472b752],
8	in	IN	O	in	pcomp	7	SENT_260	[p21l1530t689r1598b751],
9	the	DT	O	the	det	10	SENT_260	[p21l1656t689r1763b752],
10	event	NN	O	event	pobj	8	SENT_260	[p21l1824t699r2017b752],
11	of	IN	O	of	_	0	SENT_260	[p21l2076t689r2153b752],
12	treatment-emergent	JJ	O	treatment-emergent	amod	14	SENT_260	[p21l7t810r713b881],
13	side	JJ	O	side	amod	14	SENT_260	[p21l750t800r888b863],
14	effects	NNS	O	effect	prep_of	10	SENT_260	[p21l924t800r1159b863],
15	from	IN	O	from	nsubj	33	SENT_260	[p21l1196t800r1369b863],
16	one	CD	NUMBER	one	num	17	SENT_260	[p21l1404t820r1529b863],
17	treatment	NN	O	treatment	pobj	15	SENT_260	[p21l1564t810r1905b863],
18	to	TO	O	to	_	0	SENT_260	[p21l1938t810r2004b863],
19	the	DT	O	the	det	25	SENT_260	[p21l2040t800r2147b863],
20	other	JJ	O	other	amod	25	SENT_260	[p21l8t911r192b974],
21	with	IN	O	with	_	0	SENT_260	[p21l224t911r381b974],
22	continued	JJ	O	continued	amod	24	SENT_260	[p21l415t911r768b974],
23	clinical	JJ	O	clinical	amod	24	SENT_260	[p21l801t911r1063b974],
24	trial	NN	O	trial	prep_with	20	SENT_260	[p21l1098t911r1240b974],
25	participation	NN	O	participation	prep_to	17	SENT_260	[p21l1273t911r1747b992],
26	,	,	O	,	_	0	SENT_260	[p21l1273t911r1747b992],
27	as	RB	O	as	_	0	SENT_260	[p21l1786t931r1854b974],
28	well	RB	O	well	_	0	SENT_260	[p21l1890t911r2041b974],
29	as	IN	O	as	_	0	SENT_260	[p21l2077t931r2146b974],
30	the	DT	O	the	det	31	SENT_260	[p21l7t1022r114b1085],
31	patient	NN	O	patient	conj_and	15	SENT_260	[p21l148t1022r724b1103],
32	—	RB	O	—	advmod	33	SENT_260	[p21l148t1022r724b1103],
33	reported	VBD	O	report	advcl	42	SENT_260	[p21l148t1022r724b1103],
34	high	JJ	O	high	amod	35	SENT_260	[p21l758t1022r916b1103],
35	adherence	NN	O	adherence	dobj	33	SENT_260	[p21l952t1022r1312b1085],
36	to	TO	O	to	_	0	SENT_260	[p21l1348t1032r1415b1085],
37	therapy	NN	O	therapy	prep_to	33	SENT_260	[p21l1451t1022r1737b1103],
38	,	,	O	,	_	0	SENT_260	[p21l1451t1022r1737b1103],
39	we	PRP	O	we	nsubj	42	SENT_260	[p21l1777t1042r1878b1085],
40	do	VBP	O	do	aux	42	SENT_260	[p21l1914t1022r1999b1085],
41	not	RB	O	not	neg	42	SENT_260	[p21l2035t1032r2149b1085],
42	believe	VB	O	believe	_	0	SENT_260	[p21l6t1133r264b1196],
43	that	IN	O	that	complm	48	SENT_260	[p21l290t1133r424b1195],
44	poor	JJ	O	poor	amod	45	SENT_260	[p21l447t1152r612b1214],
45	adherence	NN	O	adherence	nsubj	48	SENT_260	[p21l636t1133r997b1195],
46	likely	JJ	O	likely	amod	45	SENT_260	[p21l1022t1133r1225b1214],
47	substantially	RB	O	substantially	advmod	46	SENT_260	[p21l1253t1133r1702b1214],
48	impacts	VBZ	O	impact	ccomp	42	SENT_260	[p21l1728t1133r2003b1214],
49	our	PRP$	O	we	poss	50	SENT_260	[p21l2031t1152r2149b1195],
50	results	NNS	O	result	dobj	48	SENT_260	[p21l6t1244r257b1307],
51	.	.	O	.	_	0	SENT_260	[p21l6t1244r257b1307],

1	In	IN	O	in	_	0	SENT_261	[p21l109t1356r182b1416],
2	summary	NN	O	summary	prep_in	12	SENT_261	[p21l209t1374r558b1436],
3	,	,	O	,	_	0	SENT_261	[p21l209t1374r558b1436],
4	discontinuation	NN	O	discontinuation	nsubj	12	SENT_261	[p21l587t1354r1139b1417],
5	of	IN	O	of	_	0	SENT_261	[p21l1165t1355r1242b1417],
6	AI	NN	O	aus	nn	7	SENT_261	[p21l1260t1355r1352b1416],
7	therapy	NN	O	therapy	prep_of	4	SENT_261	[p21l1376t1355r1643b1436],
8	is	VBZ	O	be	cop	12	SENT_261	[p21l1669t1354r1724b1417],
9	a	DT	O	a	det	12	SENT_261	[p21l1753t1374r1790b1417],
10	clinically	RB	O	clinically	advmod	11	SENT_261	[p21l1814t1355r2146b1436],
11	important	JJ	O	important	amod	12	SENT_261	[p21l7t1467r356b1548],
12	problem	NN	O	problem	_	0	SENT_261	[p21l410t1467r709b1548],
13	for	IN	O	for	_	0	SENT_261	[p21l764t1467r868b1530],
14	women	NNS	O	woman	prep_for	12	SENT_261	[p21l922t1487r1183b1530],
15	with	IN	O	with	_	0	SENT_261	[p21l1239t1467r1396b1530],
16	ER	NN	O	er	nn	17	SENT_261	[p21l1451t1467r1879b1548],
17	—	NN	O	—	prep_with	14	SENT_261	[p21l1451t1467r1879b1548],
18	positive	JJ	O	positive	amod	20	SENT_261	[p21l1451t1467r1879b1548],
19	breast	NN	O	breast	nn	20	SENT_261	[p21l1934t1467r2149b1530],
20	cancer	NN	O	cancer	nsubj	37	SENT_261	[p21l8t1598r259b1652],
21	,	,	O	,	_	0	SENT_261	[p21l8t1598r259b1652],
22	since	IN	O	since	mark	31	SENT_261	[p21l291t1578r469b1641],
23	decreased	VBN	O	decrease	amod	24	SENT_261	[p21l496t1578r849b1641],
24	persistence	NN	O	persistence	nsubj	31	SENT_261	[p21l872t1578r1270b1659],
25	with	IN	O	with	prep	24	SENT_261	[p21l1296t1578r1453b1641],
26	or	CC	O	or	_	0	SENT_261	[p21l1479t1598r1552b1641],
27	adherence	NN	O	adherence	nsubj	31	SENT_261	[p21l1577t1578r1936b1641],
28	to	TO	O	to	_	0	SENT_261	[p21l1963t1587r2030b1641],
29	AI	NN	O	aus	nn	30	SENT_261	[p21l2056t1579r2148b1640],
30	therapy	NN	O	therapy	prep_to	27	SENT_261	[p21l7t1689r274b1770],
31	leads	VBZ	O	lead	dep	20	SENT_261	[p21l315t1689r495b1752],
32	to	TO	O	to	_	0	SENT_261	[p21l536t1698r603b1752],
33	worse	JJR	O	worse	amod	36	SENT_261	[p21l644t1709r854b1752],
34	breast	NN	O	breast	nn	36	SENT_261	[p21l893t1689r1108b1752],
35	cancer	NN	O	cancer	nn	36	SENT_261	[p21l1147t1709r1381b1752],
36	outcomes	NNS	O	outcome	prep_to	31	SENT_261	[p21l1420t1698r1760b1752],
37	[	VBP	O	[	rcmod	12	SENT_261	[p21l1807t1689r1966b1765],
38	15	CD	NUMBER	15	number	39	SENT_261	[p21l1807t1689r1966b1765],
39	]	CD	NUMBER	]	dobj	37	SENT_261	[p21l1807t1689r1966b1765],
40	.	.	O	.	_	0	SENT_261	[p21l1807t1689r1966b1765],

1	The	DT	O	the	det	2	SENT_262	[p21l2010t1689r2147b1752],
2	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_262	[p21l8t1800r292b1881],
3	presented	VBN	O	present	partmod	2	SENT_262	[p21l337t1800r682b1881],
4	here	RB	O	here	advmod	3	SENT_262	[p21l726t1800r878b1863],
5	suggest	VBP	O	suggest	_	0	SENT_262	[p21l927t1810r1191b1881],
6	that	IN	O	that	complm	16	SENT_262	[p21l1235t1800r1369b1863],
7	variants	NNS	O	variant	nsubjpass	16	SENT_262	[p21l1413t1800r1693b1863],
8	in	IN	O	in	_	0	SENT_262	[p21l1740t1800r1808b1862],
9	the	DT	O	the	det	13	SENT_262	[p21l1853t1800r1960b1863],
10	biologically	RB	O	biologically	advmod	11	SENT_262	[p21l2004t1800r2145b1863, p21l7t1911r320b1992],
11	relevant	JJ	O	relevant	amod	13	SENT_262	[p21l354t1911r644b1974],
12	ESR1	NN	O	esr1	nn	13	SENT_262	[p21l675t1912r868b1975],
13	gene	NN	O	gene	prep_in	7	SENT_262	[p21l910t1931r1075b1992],
14	may	MD	O	may	aux	16	SENT_262	[p21l1110t1931r1262b1992],
15	be	VB	O	be	auxpass	16	SENT_262	[p21l1295t1911r1378b1974],
16	associated	VBN	O	associate	ccomp	5	SENT_262	[p21l1414t1911r1781b1974],
17	with	IN	O	with	_	0	SENT_262	[p21l1815t1911r1972b1974],
18	premature	JJ	O	premature	amod	19	SENT_262	[p21l2004t1931r2145b1992, p21l7t2032r255b2085],
19	discontinuation	NN	O	discontinuation	prep_with	16	SENT_262	[p21l348t2022r900b2085],
20	of	IN	O	of	_	0	SENT_262	[p21l994t2022r1071b2085],
21	AI	NN	O	aus	nn	22	SENT_262	[p21l1157t2023r1248b2084],
22	therapy	NN	O	therapy	prep_of	19	SENT_262	[p21l1341t2022r1608b2103],
23	because	IN	O	because	_	0	SENT_262	[p21l1699t2022r1982b2085],
24	of	IN	O	of	prepc_because_of	16	SENT_262	[p21l2076t2022r2153b2085],
25	musculoskeletal	JJ	O	musculoskeletal	amod	26	SENT_262	[p21l7t2133r585b2195],
26	toxicity	NN	O	toxicity	pobj	16	SENT_262	[p21l618t2133r910b2214],
27	.	.	O	.	_	0	SENT_262	[p21l618t2133r910b2214],

1	Ability	NN	O	ability	nsubj	17	SENT_263	[p21l948t2133r1199b2214],
2	to	TO	O	to	aux	3	SENT_263	[p21l1233t2142r1300b2195],
3	identify	VB	O	identify	infmod	1	SENT_263	[p21l1333t2133r1611b2214],
4	patients	NNS	O	patient	dobj	3	SENT_263	[p21l1643t2133r1920b2214],
5	using	VBG	O	use	partmod	4	SENT_263	[p21l1955t2133r2147b2214],
6	genetic	JJ	O	genetic	amod	7	SENT_263	[p21l8t2244r263b2325],
7	testing	NN	O	testing	dobj	5	SENT_263	[p21l313t2244r549b2325],
8	who	WP	O	who	nsubj	9	SENT_263	[p21l600t2244r749b2307],
9	are	VBP	O	be	rcmod	7	SENT_263	[p21l800t2263r905b2306],
10	at	IN	O	at	_	0	SENT_263	[p21l955t2253r1018b2306],
11	increased	VBN	O	increase	amod	12	SENT_263	[p21l1064t2244r1402b2306],
12	risk	NN	O	risk	prep_at	9	SENT_263	[p21l1449t2244r1584b2306],
13	of	IN	O	of	_	0	SENT_263	[p21l1631t2244r1708b2306],
14	developing	VBG	O	develop	amod	15	SENT_263	[p21l1750t2244r2147b2325],
15	toxicity	NN	O	toxicity	prep_of	12	SENT_263	[p21l7t2354r279b2435],
16	may	MD	O	may	aux	17	SENT_263	[p21l316t2373r468b2435],
17	enable	VB	O	enable	_	0	SENT_263	[p21l505t2354r736b2416],
18	improved	JJ	O	improved	amod	20	SENT_263	[p21l773t2354r1116b2435],
19	patient	NN	O	patient	nn	20	SENT_263	[p21l1150t2354r1395b2435],
20	management	NN	O	management	dobj	17	SENT_263	[p21l1430t2363r1906b2435],
21	.	.	O	.	_	0	SENT_263	[p21l1430t2363r1906b2435],

1	However	RB	O	however	advmod	12	SENT_264	[p21l1946t2355r2144b2416, p21l8t2486r179b2540],
2	,	,	O	,	_	0	SENT_264	[p21l1946t2355r2144b2416, p21l8t2486r179b2540],
3	conﬁrmation	NN	O	conﬁrmation	nsubj	12	SENT_264	[p21l209t2466r667b2529],
4	of	IN	O	of	_	0	SENT_264	[p21l694t2466r771b2529],
5	this	DT	O	this	det	6	SENT_264	[p21l791t2466r917b2529],
6	result	NN	O	result	prep_of	3	SENT_264	[p21l944t2466r1144b2529],
7	in	IN	O	in	_	0	SENT_264	[p21l1169t2466r1237b2528],
8	an	DT	O	a	det	10	SENT_264	[p21l1265t2486r1345b2529],
9	independent	JJ	O	independent	amod	10	SENT_264	[p21l1372t2466r1811b2547],
10	cohort	NN	O	cohort	prep_in	6	SENT_264	[p21l1837t2466r2066b2529],
11	is	VBZ	O	be	cop	12	SENT_264	[p21l2090t2466r2146b2529],
12	important	JJ	O	important	_	0	SENT_264	[p21l7t2577r356b2658],
13	before	IN	O	before	mark	17	SENT_264	[p21l393t2577r620b2640],
14	it	PRP	O	it	nsubjpass	17	SENT_264	[p21l660t2577r709b2640],
15	can	MD	O	can	aux	17	SENT_264	[p21l747t2597r869b2640],
16	be	VB	O	be	auxpass	17	SENT_264	[p21l907t2577r989b2640],
17	incorporated	VBN	O	incorporate	advcl	12	SENT_264	[p21l1029t2577r1483b2658],
18	into	IN	O	into	_	0	SENT_264	[p21l1520t2577r1657b2640],
19	clinical	JJ	O	clinical	amod	23	SENT_264	[p21l1698t2577r1960b2640],
20	care	NN	O	care	nn	23	SENT_264	[p21l2001t2597r2147b2640],
21	[	NN	O	[	nn	23	SENT_264	[p21l13t2688r172b2764],
22	26	CD	NUMBER	26	num	23	SENT_264	[p21l13t2688r172b2764],
23	]	NN	O	]	prep_into	17	SENT_264	[p21l13t2688r172b2764],
24	.	.	O	.	_	0	SENT_264	[p21l13t2688r172b2764],

1	@	IN	O	@	_	0	SENT_265	[p21l1779t2926r1856b3021],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_265	[p21l1886t2949r2148b3024],

1	814	CD	NUMBER	814	num	3	SENT_266	[p21l54t3099r105b3124],
2	Breast	NN	ORGANIZATION	breast	nn	3	SENT_266	[p21l1450t3099r1540b3124],
3	Cancer	NN	ORGANIZATION	cancer	dep	8	SENT_266	[p21l1553t3099r1652b3124],
4	Res	NNP	ORGANIZATION	Res	nn	5	SENT_266	[p21l1664t3099r1716b3124],
5	Treat	NNP	ORGANIZATION	Treat	dep	3	SENT_266	[p21l1729t3099r1804b3124],
6	(	CD	NUMBER	(	dep	8	SENT_266	[p21l1817t3099r1908b3129],
7	2013	CD	DATE	2013	num	8	SENT_266	[p21l1817t3099r1908b3129],
8	)	CD	NUMBER	)	dep	12	SENT_266	[p21l1817t3099r1908b3129],
9	l38	NN	O	l38	dep	8	SENT_266	[p21l1925t3099r2107b3124],
10	:807	CD	NUMBER	:807	num	9	SENT_266	[p21l1925t3099r2107b3124],
11	—	CD	NUMBER	—	num	12	SENT_266	[p21l1925t3099r2107b3124],
12	8l6	NN	O	8l6	_	0	SENT_266	[p21l1925t3099r2107b3124],

1	Fig	NN	O	fig	_	0	SENT_267	[p22l53t33r109b65],
2	.	.	O	.	_	0	SENT_267	[p22l53t33r109b65],

1	3	CD	NUMBER	3	num	3	SENT_268	[p22l123t33r139b58],
2	Manhattan	NNP	LOCATION	Manhattan	nn	3	SENT_268	[p22l161t34r312b58],
3	plots	NNS	O	plot	_	0	SENT_268	[p22l325t34r392b66],
4	depicting	VBG	O	depict	partmod	3	SENT_268	[p22l53t75r184b107],
5	associations	NNS	O	association	dobj	4	SENT_268	[p22l197t75r366b100],
6	between	IN	O	between	_	0	SENT_268	[p22l379t75r496b100],
7	A	DT	O	a	det	10	SENT_268	[p22l676t65r705b95],
8	8	CD	NUMBER	8	num	10	SENT_268	[p22l765t57r781b81],
9	candidate	NN	O	candidate	nn	10	SENT_268	[p22l53t117r188b141],
10	SNPs	NNS	O	snp	nsubj	15	SENT_268	[p22l202t117r277b142],
11	and	CC	O	and	_	0	SENT_268	[p22l291t117r341b141],
12	treatment	NN	O	treatment	nn	14	SENT_268	[p22l353t121r487b141],
13	AIMSS	NN	O	aimss	nn	14	SENT_268	[p22l830t111r930b136],
14	discontinuation	NN	O	discontinuation	conj_and	10	SENT_268	[p22l53t158r270b183],
15	using	VBG	O	use	dep	20	SENT_268	[p22l283t158r358b190],
16	a	DT	O	a	det	17	SENT_268	[p22l372t166r387b183],
17	Exemestane	NN	O	exemestane	nsubj	18	SENT_268	[p22l833t152r1011b176],
18	recessive	JJ	O	recessive	xcomp	15	SENT_268	[p22l53t200r181b224],
19	statistical	JJ	O	statistical	amod	20	SENT_268	[p22l196t200r327b224],
20	model	NN	O	model	prep_between	5	SENT_268	[p22l340t199r435b224],
21	.	.	O	.	_	0	SENT_268	[p22l340t199r435b224],

1	Horizontal	JJ	O	horizontal	amod	3	SENT_269	[p22l52t241r205b268],
2	line	NN	O	line	nn	3	SENT_269	[p22l216t241r267b266],
3	signiﬁes	NNS	O	signiﬁes	_	0	SENT_269	[p22l279t241r394b273],
4	level	NN	O	level	dep	3	SENT_269	[p22l406t241r473b266],
5	of	IN	O	of	_	0	SENT_269	[p22l485t241r515b266],
6	5	CD	NUMBER	5	num	8	SENT_269	[p22l765t253r781b279],
7	statistical	JJ	O	statistical	amod	8	SENT_269	[p22l54t282r186b307],
8	signiﬁcance	NN	O	signiﬁcance	prep_of	4	SENT_269	[p22l200t282r367b315],
9	after	IN	O	after	_	0	SENT_269	[p22l380t282r444b307],
10	Bonferroni	NNP	PERSON	Bonferroni	prep_after	8	SENT_269	[p22l53t324r206b349],
11	correction	NN	O	correction	nn	13	SENT_269	[p22l220t324r362b349],
12	(	NN	O	(	nn	13	SENT_269	[p22l54t366r81b398],
13	p	NN	O	p	dep	3	SENT_269	[p22l54t366r81b398],
14	=	JJ	O	=	amod	16	SENT_269	[p22l95t377r120b387],
15	0.00036	CD	NUMBER	0.00036	tmod	14	SENT_269	[p22l134t366r266b396],
16	)	NN	O	)	dep	13	SENT_269	[p22l134t366r266b396],
17	.	.	O	.	_	0	SENT_269	[p22l134t366r266b396],

1	AIMSS	NNP	O	AIMSS	nn	2	SENT_270	[p22l278t366r378b391],
2	Aromatase	NNP	O	Aromatase	_	0	SENT_270	[p22l53t408r205b432],
3	inhibitor-associated	JJ	O	inhibitor-associated	amod	6	SENT_270	[p22l218t407r496b432],
4	ESR1	NN	O	esr1	nn	6	SENT_270	[p22l1117t400r1183b422],
5	musculoskeletal	JJ	O	musculoskeletal	amod	6	SENT_270	[p22l53t449r280b473],
6	syndrome	NN	O	syndrome	dep	2	SENT_270	[p22l294t449r438b481],
7	.	.	O	.	_	0	SENT_270	[p22l294t449r438b481],

1	4	CD	NUMBER	4	_	0	SENT_271	[p22l764t451r782b475],
2	,	,	O	,	_	0	SENT_271	[p22l1057t446r1101b481],
3	/	:	O	/	punct	4	SENT_271	[p22l1057t446r1101b481],
4	$	$	MONEY	$	dep	1	SENT_271	[p22l1117t432r1247b453],
5	932336	CD	MONEY	932336	num	4	SENT_271	[p22l1117t432r1247b453],
6	a	DT	O	a	det	11	SENT_271	[p22l53t498r70b515],
7	Treatment	NN	O	treatment	nn	11	SENT_271	[p22l82t491r228b515],
8	discontinuation	NN	O	discontinuation	nn	11	SENT_271	[p22l240t490r457b515],
9	p	NN	O	p	nn	11	SENT_271	[p22l586t496r748b528],
10	=	JJ	O	=	amod	11	SENT_271	[p22l586t496r748b528],
11	0_0oo35	NN	O	0_0oo35	dep	1	SENT_271	[p22l586t496r748b528],
12	because	IN	O	because	prep	11	SENT_271	[p22l53t532r164b557],
13	of	IN	O	of	_	0	SENT_271	[p22l177t532r208b557],
14	AIMSS	NNP	O	AIMSS	prep_of	11	SENT_271	[p22l218t532r323b557],
15	for	IN	O	for	_	0	SENT_271	[p22l337t532r378b557],
16	patients	NNS	O	patient	prep_for	11	SENT_271	[p22l390t532r499b564],
17	treated	VBN	O	treat	partmod	1	SENT_271	[p22l53t574r149b598],
18	with	IN	O	with	_	0	SENT_271	[p22l162t573r223b598],
19	exemestane	NN	O	exemestane	prep_with	17	SENT_271	[p22l236t577r407b598],
20	.	.	O	.	_	0	SENT_271	[p22l236t577r407b598],

1	.	.	O	.	_	0	SENT_272	[p22l2011t589r2023b602],

1	b	NN	O	b	nn	4	SENT_273	[p22l53t615r71b640],
2	Treatment	NN	O	treatment	nn	4	SENT_273	[p22l84t615r229b640],
3	discontinuation	NN	O	discontinuation	nn	4	SENT_273	[p22l242t615r459b640],
4	_	NN	O	_	_	0	SENT_273	[p22l1037t635r1050b649],
5	because	IN	O	because	_	0	SENT_273	[p22l53t656r164b681],
6	of	IN	O	of	_	0	SENT_273	[p22l177t656r208b681],
7	any	DT	O	any	det	8	SENT_273	[p22l219t664r268b688],
8	toxicity	NN	O	toxicity	prep_because_of	4	SENT_273	[p22l281t656r388b688],
9	for	IN	O	for	_	0	SENT_273	[p22l401t656r442b681],
10	2	CD	NUMBER	2	num	11	SENT_273	[p22l764t649r781b673],
11	patients	NNS	O	patient	prep_for	8	SENT_273	[p22l52t698r162b730],
12	treated	VBN	O	treat	partmod	8	SENT_273	[p22l172t698r268b723],
13	with	IN	O	with	_	0	SENT_273	[p22l277t698r339b723],
14	exemestane	NN	O	exemestane	prep_with	12	SENT_273	[p22l349t702r512b723],

1	§	SYM	O	§	dep	3	SENT_274	[p22l701t763r735b817],
2	-	:	O	-	_	0	SENT_274	[p22l893t771r904b783],
3	:	:	O	:	_	0	SENT_274	[p22l1117t771r1173b801],
4	.	.	O	.	_	0	SENT_274	[p22l1117t771r1173b801],

1	.	.	O	.	_	0	SENT_275	[p22l2047t791r2061b803],

1	—	NN	O	—	_	0	SENT_276	[p22l716t821r735b827],
2	I	CD	NUMBER	i	num	1	SENT_276	[p22l890t817r902b829],
3	I	PRP	O	I	nsubj	4	SENT_276	[p22l1113t815r1125b827],
4	_	VBP	O	_	rcmod	1	SENT_276	[p22l1252t829r1256b830],
5	*	CD	NUMBER	*	dobj	4	SENT_276	[p22l1853t820r1859b821],
6	I	PRP	O	I	nsubj	7	SENT_276	[p22l2047t817r2059b829],
7	E	NN	O	e	rcmod	5	SENT_276	[p22l704t829r735b867],
8	I	PRP	O	I	nsubj	9	SENT_276	[p22l765t845r781b869],
9	]	VBP	O	]	rcmod	7	SENT_276	[p22l765t845r781b869],
10	Jr	NNP	O	Jr	dobj	9	SENT_276	[p22l882t831r936b863],
11	6	CD	NUMBER	6	num	10	SENT_276	[p22l1098t829r1131b863],
12	:	:	O	:	_	0	SENT_276	[p22l1098t829r1131b863],
13	E	NN	O	e	dep	17	SENT_276	[p22l1156t813r1192b863],
14	‘	CD	NUMBER	‘	num	13	SENT_276	[p22l1216t831r1263b863],
15	If	IN	O	if	dep	17	SENT_276	[p22l1216t831r1263b863],
16	I	PRP	O	I	nsubj	17	SENT_276	[p22l1322t851r1335b863],
17	‘	VBP	O	‘	parataxis	9	SENT_276	[p22l1837t825r1867b863],
18	:	:	O	:	_	0	SENT_276	[p22l1837t825r1867b863],
19	o	NN	O	o	dep	23	SENT_276	[p22l1891t851r1903b863],
20	II	CD	NUMBER	ii	num	19	SENT_276	[p22l1935t851r1947b863],
21	I	PRP	O	I	dep	22	SENT_276	[p22l1984t855r1985b859],
22	n	NN	O	n	dep	19	SENT_276	[p22l2049t851r2061b863],
23	I	PRP	O	I	parataxis	7	SENT_276	[p22l718t871r722b889],

1	u.	NNP	O	u.	nn	2	SENT_277	[p22l838t909r964b927],
2	|	NNP	O	|	_	0	SENT_277	[p22l838t909r964b927],
3	.	.	O	.	_	0	SENT_277	[p22l838t909r964b927],

1	—	NN	O	—	nn	4	SENT_278	[p22l838t909r964b927],
2	. . .	CD	NUMBER	. . .	num	4	SENT_278	[p22l1063t915r1088b923],[p22l838t909r964b927],
3	N	NN	O	n	nn	4	SENT_278	[p22l1152t909r1178b925],
4	u	NN	O	u	_	0	SENT_278	[p22l1230t909r1391b929],
5	:	:	O	:	_	0	SENT_278	[p22l1230t909r1391b929],
6	I3c	NN	O	i3c	dep	4	SENT_278	[p22l1230t909r1391b929],
7	\	CD	NUMBER	\	number	8	SENT_278	[p22l1230t909r1391b929],
8	|	CD	NUMBER	|	dep	6	SENT_278	[p22l1230t909r1391b929],
9	SE	NN	O	se	dep	8	SENT_278	[p22l1449t909r1473b945],
10	21	CD	NUMBER	21	num	9	SENT_278	[p22l1549t909r1611b945],
11	-	:	O	-	_	0	SENT_278	[p22l1549t909r1611b945],
12	m.	NN	O	m.	dep	8	SENT_278	[p22l1663t909r2067b946],
13	.	.	O	.	_	0	SENT_278	[p22l1663t909r2067b946],

1	—	NN	O	—	_	0	SENT_279	[p22l1663t909r2067b946],
2	. . .	CD	NUMBER	. . .	num	3	SENT_279	[p22l1663t909r2067b946],[p22l1663t909r2067b946],
3	—	NN	O	—	dep	1	SENT_279	[p22l1663t909r2067b946],
4	.	.	O	.	_	0	SENT_279	[p22l1663t909r2067b946],

1	¢	NN	O	¢	_	0	SENT_280	[p22l1663t909r2067b946],
2	¢	CD	NUMBER	¢	num	1	SENT_280	[p22l1663t909r2067b946],
3	a	DT	O	a	det	4	SENT_280	[p22l1663t909r2067b946],
4	«	NN	O	«	dep	1	SENT_280	[p22l1663t909r2067b946],
5	:	:	O	:	_	0	SENT_280	[p22l1663t909r2067b946],
6	|	SYM	O	|	dep	8	SENT_280	[p22l1663t909r2067b946],
7	-	:	O	-	_	0	SENT_280	[p22l1663t909r2067b946],
8	|	NN	O	|	dep	4	SENT_280	[p22l1663t909r2067b946],
9	.	.	O	.	_	0	SENT_280	[p22l1663t909r2067b946],

1	—	NN	O	—	_	0	SENT_281	[p22l1663t909r2067b946],
2	.	.	O	.	_	0	SENT_281	[p22l1663t909r2067b946],

1	.	.	O	.	_	0	SENT_282	[p22l1663t909r2067b946],

1	-	:	O	-	_	0	SENT_283	[p22l1663t909r2067b946],
2	ma	NN	O	ma	_	0	SENT_283	[p22l1663t909r2067b946],
3	:	:	O	:	_	0	SENT_283	[p22l1663t909r2067b946],
4	Q	NNP	O	Q	dep	2	SENT_283	[p22l838t925r964b951],
5	-	:	O	-	_	0	SENT_283	[p22l838t925r964b951],
6	_	NN	O	_	dep	4	SENT_283	[p22l838t925r964b951],
7	§	SYM	O	§	dep	6	SENT_283	[p22l838t925r964b951],
8	-	:	O	-	_	0	SENT_283	[p22l838t925r964b951],
9	:	:	O	:	_	0	SENT_283	[p22l838t925r964b951],
10	u	NN	O	u	dep	4	SENT_283	[p22l1063t927r1088b945],
11	:	:	O	:	_	0	SENT_283	[p22l1063t927r1088b945],
12	n	NN	O	n	dep	10	SENT_283	[p22l1152t927r1178b945],
13	:	:	O	:	_	0	SENT_283	[p22l1152t927r1178b945],
14	(	CD	NUMBER	(	number	15	SENT_283	[p22l1230t925r1391b953],
15	5131	CD	NUMBER	5131	dep	12	SENT_283	[p22l1230t925r1391b953],
16	:	:	O	:	_	0	SENT_283	[p22l1230t925r1391b953],
17	:	:	O	:	_	0	SENT_283	[p22l1230t925r1391b953],
18	n	NN	O	n	dep	2	SENT_283	[p22l1585t927r1611b945],
19	:	:	O	:	_	0	SENT_283	[p22l1585t927r1611b945],
20	|	CD	NUMBER	|	num	22	SENT_283	[p22l1663t927r1815b951],
21	:	:	O	:	_	0	SENT_283	[p22l1663t927r1815b951],
22	|	CD	NUMBER	|	dep	18	SENT_283	[p22l1663t927r1815b951],
23	:	:	O	:	_	0	SENT_283	[p22l1663t927r1815b951],
24	En	NN	O	en	dep	22	SENT_283	[p22l1663t927r1815b951],
25	.	.	O	.	_	0	SENT_283	[p22l1663t927r1815b951],

1	.	.	O	.	_	0	SENT_284	[p22l1663t927r1815b951],

1	n	NN	O	n	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
2	:	:	O	:	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
3	r	NN	O	r	dep	1	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
4	;	:	O	;	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
5	I	PRP	O	I	dep	3	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
6	:	:	O	:	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
7	|	CD	NUMBER	|	dep	5	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
8	:	:	O	:	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
9	|	CD	NUMBER	|	num	11	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
10	:	:	O	:	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
11	|	CD	NUMBER	|	dep	7	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
12	:	:	O	:	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],
13	.	.	O	.	_	0	SENT_285	[p22l1893t925r2065b947, p22l838t947r898b967],

1	—	NN	O	—	_	0	SENT_286	[p22l1893t925r2065b947, p22l838t947r898b967],
2	.	.	O	.	_	0	SENT_286	[p22l1893t925r2065b947, p22l838t947r898b967],

1	1	CD	NUMBER	1	_	0	SENT_287	[p22l1893t925r2065b947, p22l838t947r898b967],
2	*	CD	NUMBER	*	dep	1	SENT_287	[p22l1893t925r2065b947, p22l838t947r898b967],
3	"	``	O	"	punct	4	SENT_287	[p22l1893t925r2065b947, p22l838t947r898b967],
4	9	CD	NUMBER	9	rcmod	2	SENT_287	[p22l938t945r964b975],
5	-	:	O	-	_	0	SENT_287	[p22l938t945r964b975],
6	’	CD	NUMBER	’	number	7	SENT_287	[p22l938t945r964b975],
7	‘	CD	NUMBER	‘	dep	4	SENT_287	[p22l1063t947r1087b965],
8	°	NN	O	°	dep	7	SENT_287	[p22l1063t947r1087b965],
9	“’	CD	NUMBER	“’	num	8	SENT_287	[p22l1152t947r1177b965],
10	IIERJ	NN	O	iierj	nn	13	SENT_287	[p22l1230t943r1341b983],
11	*	CD	NUMBER	*	num	13	SENT_287	[p22l1585t947r1611b969],
12	o	NN	O	o	nn	13	SENT_287	[p22l1585t947r1611b969],
13	°	NN	O	°	dep	7	SENT_287	[p22l1663t945r2065b983],
14	'	''	O	'	_	0	SENT_287	[p22l1663t945r2065b983],
15	Iﬁ	NN	O	iﬁ	dep	4	SENT_287	[p22l1663t945r2065b983],
16	'	''	O	'	_	0	SENT_287	[p22l1663t945r2065b983],
17	;	:	O	;	_	0	SENT_287	[p22l1663t945r2065b983],
18	E3	NN	O	e3	dep	4	SENT_287	[p22l1663t945r2065b983],
19	°	CD	NUMBER	°	rcmod	18	SENT_287	[p22l1663t945r2065b983],
20	"	``	O	"	punct	19	SENT_287	[p22l1663t945r2065b983],
21	n	NN	O	n	nn	22	SENT_287	[p22l1663t945r2065b983],
22	’	NN	O	’	dep	19	SENT_287	[p22l1663t945r2065b983],
23	:	:	O	:	_	0	SENT_287	[p22l1663t945r2065b983],
24	'	''	O	'	_	0	SENT_287	[p22l1663t945r2065b983],
25	Eﬁ	NNP	O	Eﬁ	dep	4	SENT_287	[p22l1663t945r2065b983],
26	$	$	MONEY	$	amod	25	SENT_287	[p22l838t955r964b1037],
27	35	CD	MONEY	35	number	26	SENT_287	[p22l838t955r964b1037],
28	"	``	O	"	punct	25	SENT_287	[p22l1063t967r1088b983],
29	‘	CD	NUMBER	‘	dep	25	SENT_287	[p22l1063t967r1088b983],
30	"	``	O	"	punct	29	SENT_287	[p22l1152t967r1178b983],
31	‘	NN	O	‘	nn	32	SENT_287	[p22l1152t967r1178b983],
32	w	NN	O	w	dep	29	SENT_287	[p22l1280t979r1305b997],
33	§	CD	PERCENT	§	number	34	SENT_287	[p22l1365t947r1391b1009],
34	§	CD	PERCENT	§	dep	38	SENT_287	[p22l1449t947r1473b1009],
35	§	CD	PERCENT	§	number	36	SENT_287	[p22l1549t947r1611b1011],
36	%	NN	PERCENT	%	num	37	SENT_287	[p22l1549t947r1611b1011],
37	%	NN	PERCENT	%	npadvmod	38	SENT_287	[p22l1663t964r2065b1025],
38	=	JJ	O	=	amod	29	SENT_287	[p22l1663t964r2065b1025],
39	m	NN	O	m	nn	41	SENT_287	[p22l1663t964r2065b1025],
40	'	''	O	'	_	0	SENT_287	[p22l1663t964r2065b1025],
41	iIaIgg	NN	O	iiaigg	dep	29	SENT_287	[p22l1663t964r2065b1025],
42	'	''	O	'	_	0	SENT_287	[p22l1663t964r2065b1025],
43	=	JJ	O	=	dep	4	SENT_287	[p22l1663t964r2065b1025],

1	B	NN	O	b	_	0	SENT_288	[p22l678t1123r703b1154],

1	Anytoxicity	NNP	O	Anytoxicity	nn	2	SENT_289	[p22l833t1171r1015b1205],
2	Exemestane	NNP	O	Exemestane	_	0	SENT_289	[p22l835t1211r1032b1238],

1	ESR1	NN	O	esr1	nn	2	SENT_290	[p22l1121t1471r1187b1493],
2	rs9322336	NN	O	rs9322336	_	0	SENT_290	[p22l1121t1503r1251b1524],

1	p	NN	O	p	_	0	SENT_291	[p22l594t1564r756b1596],
2	=	JJ	O	=	amod	4	SENT_291	[p22l594t1564r756b1596],
3	0.0	CD	NUMBER	0.0	tmod	2	SENT_291	[p22l594t1564r756b1596],
4	O036	NN	O	o036	dep	1	SENT_291	[p22l594t1564r756b1596],
5	I	PRP	O	I	dep	4	SENT_291	[p22l1038t1571r1053b1584, p22l1849t1709r1863b1723],

1	I	PRP	O	I	nsubj	2	SENT_292	[p22l1120t1765r1132b1779],
2	D	NN	O	d	_	0	SENT_292	[p22l1631t1793r1643b1807],
3	.	.	O	.	_	0	SENT_292	[p22l1841t1781r1853b1793],

1	an	DT	O	a	det	5	SENT_293	[p22l703t1827r737b1837],
2	‘	NN	O	‘	nn	5	SENT_293	[p22l1058t1823r1084b1853],
3	g.	NN	O	g.	nn	5	SENT_293	[p22l1405t1829r1417b1841],
4	‘	CD	NUMBER	‘	num	5	SENT_293	[p22l1553t1847r1554b1851],
5	‘	NN	O	‘	nsubj	7	SENT_293	[p22l1606t1853r1607b1856],
6	I	PRP	O	I	nsubj	7	SENT_293	[p22l1763t1835r1775b1847],
7	‘	VBP	O	‘	_	0	SENT_293	[p22l1864t1851r1865b1855],
8	.	.	O	.	_	0	SENT_293	[p22l1901t1831r1913b1841],

1	I	CD	PERCENT	i	nsubj	2	SENT_294	[p22l2049t1825r2063b1837],
2	%	NN	PERCENT	%	_	0	SENT_294	[p22l703t1839r737b1891],
3	.	.	O	.	_	0	SENT_294	[p22l848t1843r1301b1915],
4	'	''	O	'	_	0	SENT_294	[p22l848t1843r1301b1915],

1	;	:	O	;	_	0	SENT_295	[p22l848t1843r1301b1915],
2	§	NN	O	§	_	0	SENT_295	[p22l848t1843r1301b1915],
3	.	.	O	.	_	0	SENT_295	[p22l848t1843r1301b1915],

1	!	.	O	!	_	0	SENT_296	[p22l848t1843r1301b1915],

1	.	.	O	.	_	0	SENT_297	[p22l848t1843r1301b1915],

1	.	.	O	.	_	0	SENT_298	[p22l848t1843r1301b1915],
2	'	''	O	'	_	0	SENT_298	[p22l848t1843r1301b1915],

1	[	SYM	O	[	dep	3	SENT_299	[p22l848t1843r1301b1915],
2	-	:	O	-	_	0	SENT_299	[p22l848t1843r1301b1915],
3	"	``	O	"	_	0	SENT_299	[p22l848t1843r1301b1915],
4	-	:	O	-	_	0	SENT_299	[p22l848t1843r1301b1915],
5	b	NN	O	b	dep	3	SENT_299	[p22l1361t1849r1453b1903],
6	+	CC	O	+	_	0	SENT_299	[p22l1361t1849r1453b1903],
7	+	CC	O	+	dep	3	SENT_299	[p22l1517t1843r1605b1905],
8	-	:	O	-	_	0	SENT_299	[p22l1669t1883r1739b1901],
9	.	.	O	.	_	0	SENT_299	[p22l1669t1883r1739b1901],

1	1	CD	NUMBER	1	_	0	SENT_300	[p22l1835t1847r1869b1899],
2	'	''	O	'	_	0	SENT_300	[p22l1835t1847r1869b1899],
3	.	.	O	.	_	0	SENT_300	[p22l1835t1847r1869b1899],

1	:	:	O	:	_	0	SENT_301	[p22l1975t1873r1989b1901],
2	:	:	O	:	_	0	SENT_301	[p22l1975t1873r1989b1901],
3	'	''	O	'	_	0	SENT_301	[p22l2049t1849r2061b1861],
4	E	NN	O	e	dep	3	SENT_301	[p22l706t1893r737b1931],
5	I	PRP	O	I	dobj	4	SENT_301	[p22l853t1904r856b1905],
6	'	''	O	'	_	0	SENT_301	[p22l893t1907r905b1917],
7	'	''	O	'	_	0	SENT_301	[p22l956t1899r991b1921],
8	.	.	O	.	_	0	SENT_301	[p22l956t1899r991b1921],

1	o	NN	O	o	_	0	SENT_302	[p22l1014t1887r1133b1927],
2	e	SYM	O	e	dep	4	SENT_302	[p22l1014t1887r1133b1927],
3	+	CC	O	+	nsubj	4	SENT_302	[p22l1014t1887r1133b1927],
4	it	PRP	O	it	dep	1	SENT_302	[p22l1158t1909r1194b1927],
5	@	SYM	O	@	dep	18	SENT_302	[p22l1227t1899r1265b1927],
6	2	CD	NUMBER	2	nsubj	18	SENT_302	[p22l1227t1899r1265b1927],
7	+	CC	O	+	cc	6	SENT_302	[p22l1227t1899r1265b1927],
8	I	PRP	O	I	dep	6	SENT_302	[p22l1324t1915r1337b1927],
9	'	''	O	'	_	0	SENT_302	[p22l1459t1911r1471b1921],
10	I	PRP	O	I	advmod	8	SENT_302	[p22l1555t1915r1567b1927],
11	"	``	O	"	punct	18	SENT_302	[p22l1641t1907r1655b1919],
12	"	``	O	"	punct	13	SENT_302	[p22l1689t1905r1703b1917],
13	D	NN	O	d	nsubj	18	SENT_302	[p22l1799t1899r1811b1911],
14	`	``	O	`	_	0	SENT_302	[p22l1837t1900r1869b1927],
15	ݒ	NN	O	ݒ	dep	13	SENT_302	[p22l1837t1900r1869b1927],
16	+	CC	O	+	_	0	SENT_302	[p22l1837t1900r1869b1927],
17	I	PRP	O	I	dep	13	SENT_302	[p22l1893t1915r1905b1927],
18	‘	VBP	O	‘	dep	4	SENT_302	[p22l1937t1915r1949b1927],
19	I	PRP	O	I	nsubj	20	SENT_302	[p22l1937t1915r1949b1927],
20	I	PRP	O	I	xcomp	18	SENT_302	[p22l1973t1915r1987b1927],
21	I	PRP	O	I	dep	20	SENT_302	[p22l2051t1915r2063b1927],
22	I	PRP	O	I	dep	20	SENT_302	[p22l720t1935r724b1953],

1	u.	NNP	O	u.	dep	3	SENT_303	[p22l840t1973r966b1991],
2	|	NNP	O	|	dep	3	SENT_303	[p22l840t1973r966b1991],
3	1	LS	NUMBER	1	dep	5	SENT_303	[p22l1065t1979r1090b1987],
4	-	:	O	-	_	0	SENT_303	[p22l1065t1979r1090b1987],
5	as	IN	O	as	_	0	SENT_303	[p22l1154t1973r1179b1989],
6	géuxl	NN	O	géuxl	pobj	5	SENT_303	[p22l1232t1973r1393b1996],
7	-	:	O	-	_	0	SENT_303	[p22l1232t1973r1393b1996],
8	.	.	O	.	_	0	SENT_303	[p22l1232t1973r1393b1996],

1	.	.	O	.	_	0	SENT_304	[p22l1587t1979r1613b1987],

1	mu	NN	O	mu	_	0	SENT_305	[p22l1665t1973r1817b2002],
2	‘	NN	O	‘	dep	1	SENT_305	[p22l1665t1973r1817b2002],
3	.	.	O	.	_	0	SENT_305	[p22l1665t1973r1817b2002],

1	—	NN	O	—	_	0	SENT_306	[p22l1665t1973r1817b2002],
2	.	.	O	.	_	0	SENT_306	[p22l1665t1973r1817b2002],

1	.	.	O	.	_	0	SENT_307	[p22l1665t1973r1817b2002],

1	-4	CD	NUMBER	-4	num	2	SENT_308	[p22l1665t1973r1817b2002],
2	-1	CD	NUMBER	-1	_	0	SENT_308	[p22l1895t1973r2069b2001],
3	‘	SYM	O	‘	dep	5	SENT_308	[p22l1895t1973r2069b2001],
4	-	:	O	-	_	0	SENT_308	[p22l1895t1973r2069b2001],
5	\	NN	O	\	dep	2	SENT_308	[p22l1895t1973r2069b2001],
6	[	NN	O	[	dep	5	SENT_308	[p22l1895t1973r2069b2001],
7	.	.	O	.	_	0	SENT_308	[p22l1895t1973r2069b2001],

1	—	NN	O	—	_	0	SENT_309	[p22l1895t1973r2069b2001],
2	.	.	O	.	_	0	SENT_309	[p22l1895t1973r2069b2001],

1	-	:	O	-	_	0	SENT_310	[p22l1895t1973r2069b2001],
2	N4	NN	O	n4	_	0	SENT_310	[p22l1895t1973r2069b2001],
3	`	``	O	`	_	0	SENT_310	[p22l840t1989r966b2061],
4	+	CC	O	+	cc	5	SENT_310	[p22l840t1989r966b2061],
5	E	NN	O	e	rcmod	2	SENT_310	[p22l1065t1973r1475b2053],
6	ésaaaaéaattaa	JJ	O	ésaaaaéaattaa	amod	5	SENT_310	[p22l1551t1973r2069b2053],
7	$	$	MONEY	$	dep	6	SENT_310	[p22l840t2031r966b2101],
8	3	CD	MONEY	3	num	7	SENT_310	[p22l840t2031r966b2101],
9	"	``	O	"	punct	5	SENT_310	[p22l1282t2043r1307b2059],
10	4	CD	PERCENT	4	dep	5	SENT_310	[p22l1282t2043r1307b2059],
11	22	CD	PERCENT	22	number	12	SENT_310	[p22l1367t2055r1477b2073],
12	2	CD	PERCENT	2	num	13	SENT_310	[p22l1551t2034r1613b2075],
13	%	NN	PERCENT	%	rcmod	10	SENT_310	[p22l1551t2034r1613b2075],
14	92	CD	NUMBER	92	dep	13	SENT_310	[p22l1663t2034r1919b2081],
15	°	SYM	O	°	dep	13	SENT_310	[p22l1663t2034r1919b2081],
16	-	:	O	-	_	0	SENT_310	[p22l1663t2034r1919b2081],
17	I13	NN	O	i13	dep	5	SENT_310	[p22l1663t2034r1919b2081],
18	33	CD	NUMBER	33	num	17	SENT_310	[p22l1971t2045r2069b2089, p22l6t2251r600b2320],
19	'	''	O	'	_	0	SENT_310	[p22l1971t2045r2069b2089, p22l6t2251r600b2320],
20	Acknowledgments	NNS	O	acknowledgment	dep	2	SENT_310	[p22l1971t2045r2069b2089, p22l6t2251r600b2320],

1	We	PRP	O	we	nsubj	2	SENT_311	[p22l679t2253r783b2305],
2	thank	VBP	O	thank	_	0	SENT_311	[p22l817t2252r987b2305],
3	the	DT	O	the	det	4	SENT_311	[p22l1018t2252r1109b2305],
4	patients	NNS	O	patient	dobj	2	SENT_311	[p22l1141t2252r1377b2320],
5	who	WP	O	who	nsubj	6	SENT_311	[p22l1412t2252r1539b2305],
6	participated	VBD	O	participate	rcmod	4	SENT_311	[p22l1572t2252r1933b2320],
7	in	IN	O	in	_	0	SENT_311	[p22l1966t2252r2024b2304],
8	the	DT	O	the	det	9	SENT_311	[p22l2056t2252r2147b2305],
9	study	NN	O	study	prep_in	6	SENT_311	[p22l9t2340r186b2409],
10	,	,	O	,	_	0	SENT_311	[p22l9t2340r186b2409],
11	and	CC	O	and	_	0	SENT_311	[p22l215t2340r322b2393],
12	the	DT	O	the	det	14	SENT_311	[p22l346t2340r437b2393],
13	treating	VBG	O	treat	amod	14	SENT_311	[p22l462t2340r693b2409],
14	physicians	NNS	O	physician	conj_and	4	SENT_311	[p22l717t2340r1054b2409],
15	,	,	O	,	_	0	SENT_311	[p22l717t2340r1054b2409],
16	research	NN	O	research	nn	17	SENT_311	[p22l1080t2340r1334b2393],
17	nurses	NNS	O	nurse	conj_and	4	SENT_311	[p22l1358t2357r1549b2393],
18	and	CC	O	and	_	0	SENT_311	[p22l1577t2340r1684b2393],
19	data	NNS	O	datum	nn	20	SENT_311	[p22l1708t2340r1834b2393],
20	managers	NNS	O	manager	conj_and	4	SENT_311	[p22l1857t2357r2146b2409],
21	at	IN	O	at	_	0	SENT_311	[p22l9t2436r61b2481],
22	the	DT	O	the	det	24	SENT_311	[p22l94t2428r185b2481],
23	three	CD	NUMBER	three	num	24	SENT_311	[p22l219t2427r369b2481],
24	sites	NNS	O	site	prep_at	2	SENT_311	[p22l406t2427r552b2481],
25	.	.	O	.	_	0	SENT_311	[p22l406t2427r552b2481],

1	Supported	VBN	O	support	_	0	SENT_312	[p22l591t2427r901b2496],
2	in	IN	O	in	_	0	SENT_312	[p22l934t2427r991b2480],
3	part	NN	O	part	prep_in	1	SENT_312	[p22l1023t2436r1142b2496],
4	by	IN	O	by	_	0	SENT_312	[p22l1173t2428r1248b2496],
5	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	nn	10	SENT_312	[p22l1282t2427r1835b2496],
6	Research	NNP	ORGANIZATION	Research	nn	10	SENT_312	[p22l1870t2428r2148b2481],
7	Network	NNP	ORGANIZATION	Network	nn	10	SENT_312	[p22l7t2516r273b2569],
8	Grant	NNP	ORGANIZATION	Grant	nn	10	SENT_312	[p22l295t2516r466b2569],
9	#	#	ORGANIZATION	#	dep	10	SENT_312	[p22l487t2517r525b2568],
10	U	NNP	ORGANIZATION	U	prep_by	1	SENT_312	[p22l546t2516r693b2569],
11	.	.	O	.	_	0	SENT_312	[p22l546t2516r693b2569],

1	—	NN	O	—	_	0	SENT_313	[p22l546t2516r693b2569],
2	.	.	O	.	_	0	SENT_313	[p22l546t2516r693b2569],

1	Ol	JJ	O	ol	amod	2	SENT_314	[p22l546t2516r693b2569],
2	GM06l373	NN	O	gm06l373	_	0	SENT_314	[p22l723t2516r1067b2569],
3	(	CD	NUMBER	(	num	5	SENT_314	[p22l1095t2516r1291b2581],
4	DAF	NNP	ORGANIZATION	DAF	nn	5	SENT_314	[p22l1095t2516r1291b2581],
5	)	NN	O	)	dep	2	SENT_314	[p22l1095t2516r1291b2581],
6	and	CC	O	and	_	0	SENT_314	[p22l1317t2516r1424b2569],
7	Clinical	JJ	O	clinical	amod	9	SENT_314	[p22l1447t2516r1686b2569],
8	Pharmacology	NN	O	pharmacology	nn	9	SENT_314	[p22l1709t2516r2147b2584],
9	training	NN	O	training	dep	2	SENT_314	[p22l7t2604r242b2673],
10	Grant	NNP	O	Grant	dep	2	SENT_314	[p22l270t2604r456b2657],
11	:	:	O	:	_	0	SENT_314	[p22l270t2604r456b2657],
12	ST32-GM08425	NN	O	st32-gm08425	dep	10	SENT_314	[p22l488t2604r981b2657],
13	(	CD	NUMBER	(	num	14	SENT_314	[p22l1013t2604r1208b2670],
14	DAF	NNP	ORGANIZATION	DAF	dep	2	SENT_314	[p22l1013t2604r1208b2670],
15	)	CD	NUMBER	)	num	14	SENT_314	[p22l1013t2604r1208b2670],
16	from	IN	O	from	_	0	SENT_314	[p22l1236t2604r1383b2657],
17	the	DT	O	the	det	19	SENT_314	[p22l1408t2604r1499b2657],
18	National	NNP	ORGANIZATION	National	nn	19	SENT_314	[p22l1524t2604r1786b2657],
19	Institute	NNP	ORGANIZATION	Institute	prep_from	14	SENT_314	[p22l1812t2604r2060b2657],
20	of	IN	ORGANIZATION	of	_	0	SENT_314	[p22l2088t2604r2153b2657],
21	General	NNP	ORGANIZATION	General	nn	23	SENT_314	[p22l8t2693r247b2746],
22	Medical	NNP	ORGANIZATION	Medical	nn	23	SENT_314	[p22l298t2693r547b2746],
23	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	19	SENT_314	[p22l601t2693r881b2756],
24	,	,	O	,	_	0	SENT_314	[p22l601t2693r881b2756],
25	National	NNP	ORGANIZATION	National	nn	26	SENT_314	[p22l935t2693r1197b2746],
26	Institutes	NNPS	ORGANIZATION	Institutes	appos	2	SENT_314	[p22l1249t2693r1525b2746],
27	of	IN	ORGANIZATION	of	_	0	SENT_314	[p22l1579t2693r1645b2746],
28	Health	NNP	ORGANIZATION	Health	nn	40	SENT_314	[p22l1692t2693r1894b2746],
29	(	CD	NUMBER	(	num	31	SENT_314	[p22l1947t2694r2145b2759],
30	NIH	NNP	ORGANIZATION	NIH	nn	31	SENT_314	[p22l1947t2694r2145b2759],
31	)	NN	O	)	nn	40	SENT_314	[p22l1947t2694r2145b2759],
32	,	,	O	,	_	0	SENT_314	[p22l1947t2694r2145b2759],
33	Bethesda	NNP	LOCATION	Bethesda	appos	31	SENT_314	[p22l7t2781r301b2844],
34	,	,	O	,	_	0	SENT_314	[p22l7t2781r301b2844],
35	MD	NNP	O	MD	appos	31	SENT_314	[p22l336t2782r455b2833],
36	and	CC	O	and	_	0	SENT_314	[p22l490t2781r597b2834],
37	by	IN	O	by	conj_and	31	SENT_314	[p22l627t2781r702b2849],
38	Grant	NNP	PERSON	Grant	nn	39	SENT_314	[p22l735t2781r907b2834],
39	numbers	NNS	O	number	pobj	37	SENT_314	[p22l938t2781r1197b2834],
40	M0l	NN	O	m0l	prep_of	26	SENT_314	[p22l1230t2781r1727b2834],
41	.	.	O	.	_	0	SENT_314	[p22l1230t2781r1727b2834],

1	—	NN	O	—	_	0	SENT_315	[p22l1230t2781r1727b2834],
2	.	.	O	.	_	0	SENT_315	[p22l1230t2781r1727b2834],

1	RRO00042	NN	O	rro00042	nn	4	SENT_316	[p22l1230t2781r1727b2834],
2	(	CD	NUMBER	(	num	4	SENT_316	[p22l1762t2781r1946b2846],
3	UM	NN	O	um	nn	4	SENT_316	[p22l1762t2781r1946b2846],
4	)	NN	O	)	_	0	SENT_316	[p22l1762t2781r1946b2846],
5	,	,	O	,	_	0	SENT_316	[p22l1762t2781r1946b2846],
6	M01RROO750	NN	O	m01rroo750	nn	9	SENT_316	[p22l1981t2781r2146b2834, p22l7t2870r297b2923],
7	(	CD	NUMBER	(	num	9	SENT_316	[p22l330t2871r473b2935],
8	IU	NN	MISC	iu	nn	9	SENT_316	[p22l330t2871r473b2935],
9	)	NN	O	)	conj_and	4	SENT_316	[p22l330t2871r473b2935],
10	,	,	O	,	_	0	SENT_316	[p22l330t2871r473b2935],
11	and	CC	O	and	_	0	SENT_316	[p22l508t2870r615b2923],
12	M01-RR00O52	NN	O	m01-rr00o52	conj_and	4	SENT_316	[p22l645t2870r1104b2923],
13	(	CD	NUMBER	(	num	14	SENT_316	[p22l1138t2871r1321b2936],
14	JHU	NN	O	jhu	dep	12	SENT_316	[p22l1138t2871r1321b2936],
15	)	CD	NUMBER	)	dep	4	SENT_316	[p22l1138t2871r1321b2936],
16	from	IN	O	from	_	0	SENT_316	[p22l1354t2870r1501b2923],
17	the	DT	O	the	det	19	SENT_316	[p22l1531t2870r1622b2923],
18	National	NNP	ORGANIZATION	National	nn	19	SENT_316	[p22l1653t2870r1915b2923],
19	Center	NNP	ORGANIZATION	Center	prep_from	15	SENT_316	[p22l1947t2870r2149b2923],
20	for	IN	ORGANIZATION	for	_	0	SENT_316	[p22l7t2958r95b3011],
21	Research	NNP	ORGANIZATION	Research	nn	22	SENT_316	[p22l125t2958r403b3011],
22	Resources	NNPS	ORGANIZATION	Resources	prep_for	19	SENT_316	[p22l434t2959r744b3011],
23	(	CD	NUMBER	(	num	25	SENT_316	[p22l778t2958r1047b3023],
24	NCRR	NN	O	ncrr	nn	25	SENT_316	[p22l778t2958r1047b3023],
25	)	NN	O	)	dep	4	SENT_316	[p22l778t2958r1047b3023],
26	,	,	O	,	_	0	SENT_316	[p22l778t2958r1047b3023],
27	a	DT	O	a	det	28	SENT_316	[p22l1083t2975r1114b3011],
28	component	NN	O	component	appos	25	SENT_316	[p22l1145t2966r1482b3027],
29	of	IN	O	of	_	0	SENT_316	[p22l1513t2958r1579b3011],
30	the	DT	O	the	det	31	SENT_316	[p22l1605t2958r1695b3011],
31	NIH	NNP	ORGANIZATION	NIH	prep_of	28	SENT_316	[p22l1727t2959r1875b3011],
32	.	.	O	.	_	0	SENT_316	[p22l1727t2959r1875b3011],

1	Its	PRP$	O	its	poss	2	SENT_317	[p22l1909t2959r1982b3011],
2	contents	NNS	O	contents	nsubj	14	SENT_317	[p22l2015t2975r2146b3011, p22l7t3053r148b3098],
3	are	VBP	O	be	cop	6	SENT_317	[p22l172t3062r261b3098],
4	solely	RB	O	solely	advmod	6	SENT_317	[p22l285t3045r462b3114],
5	the	DT	O	the	det	6	SENT_317	[p22l484t3045r575b3098],
6	responsibility	NN	O	responsibility	_	0	SENT_317	[p22l596t3045r1009b3114],
7	of	IN	O	of	_	0	SENT_317	[p22l1033t3045r1098b3098],
8	the	DT	O	the	det	9	SENT_317	[p22l1114t3045r1205b3098],
9	authors	NNS	O	author	prep_of	6	SENT_317	[p22l1227t3045r1447b3098],
10	and	CC	O	and	_	0	SENT_317	[p22l1471t3045r1579b3098],
11	do	VBP	O	do	aux	14	SENT_317	[p22l1600t3045r1672b3098],
12	not	RB	O	not	neg	14	SENT_317	[p22l1694t3053r1790b3098],
13	necessarily	RB	O	necessarily	advmod	14	SENT_317	[p22l1810t3045r2147b3114],
14	represent	VB	O	represent	conj_and	6	SENT_317	[p22l6t3142r286b3203],
15	the	DT	O	the	det	17	SENT_317	[p22l326t3134r417b3187],
16	ofﬁcial	JJ	O	ofﬁcial	amod	17	SENT_317	[p22l458t3134r672b3187],
17	Views	NNS	O	view	dobj	14	SENT_317	[p22l712t3134r886b3187],
18	of	IN	O	of	_	0	SENT_317	[p22l929t3134r995b3187],
19	NCRR	NN	O	ncrr	prep_of	17	SENT_317	[p22l1030t3134r1236b3187],
20	or	CC	O	or	_	0	SENT_317	[p22l1276t3151r1338b3187],
21	NIH	NNP	O	NIH	conj_or	19	SENT_317	[p22l1376t3135r1525b3187],
22	.	.	O	.	_	0	SENT_317	[p22l1376t3135r1525b3187],

1	NLH	NN	O	nlh	nsubj	7	SENT_318	[p22l1569t3135r1724b3187],
2	is	VBZ	O	be	cop	7	SENT_318	[p22l1764t3134r1811b3187],
3	a	DT	O	a	det	7	SENT_318	[p22l1855t3151r1886b3187],
4	Damon	NNP	MISC	Damon	nn	7	SENT_318	[p22l1925t3135r2148b3187],
5	Runyon-Lilly	NNP	MISC	Runyon-Lilly	nn	7	SENT_318	[p22l7t3222r420b3291],
6	Clinical	JJ	MISC	clinical	amod	7	SENT_318	[p22l448t3222r688b3275],
7	Investigator	NN	MISC	investigator	dep	8	SENT_318	[p22l715t3222r1079b3291],
8	supported	VBD	O	support	_	0	SENT_318	[p22l1106t3222r1403b3291],
9	(	CD	NUMBER	(	dobj	8	SENT_318	[p22l1431t3222r1512b3288],
10	in	IN	O	in	_	0	SENT_318	[p22l1431t3222r1512b3288],
11	part	NN	O	part	prep_in	8	SENT_318	[p22l1537t3223r1678b3291],
12	)	CD	NUMBER	)	num	11	SENT_318	[p22l1537t3223r1678b3291],
13	by	IN	O	by	_	0	SENT_318	[p22l1706t3222r1781b3291],
14	the	DT	O	the	det	19	SENT_318	[p22l1808t3222r1898b3275],
15	Damon	NNP	ORGANIZATION	Damon	nn	19	SENT_318	[p22l1925t3223r2148b3275],
16	Runyon	NNP	ORGANIZATION	Runyon	nn	19	SENT_318	[p22l7t3310r246b3378],
17	Cancer	NNP	ORGANIZATION	Cancer	nn	19	SENT_318	[p22l278t3309r493b3362],
18	Research	NNP	ORGANIZATION	Research	nn	19	SENT_318	[p22l523t3309r801b3362],
19	Foundation	NNP	ORGANIZATION	Foundation	prep_by	8	SENT_318	[p22l833t3309r1179b3362],
20	(	CD	NUMBER	(	num	21	SENT_318	[p22l1212t3309r1566b3375],
21	CI	NN	O	ci	nsubj	8	SENT_318	[p22l1212t3309r1566b3375],
22	#	#	O	#	prep	21	SENT_318	[p22l1212t3309r1566b3375],
23	53-l0	JJ	O	53-l0	amod	24	SENT_318	[p22l1212t3309r1566b3375],
24	)	NN	O	)	dep	22	SENT_318	[p22l1212t3309r1566b3375],
25	.	.	O	.	_	0	SENT_318	[p22l1212t3309r1566b3375],

1	In	IN	O	in	_	0	SENT_319	[p22l1601t3310r1663b3362],
2	addition	NN	O	addition	pobj	1	SENT_319	[p22l1695t3309r1959b3372],
3	,	,	O	,	_	0	SENT_319	[p22l1695t3309r1959b3372],
4	these	DT	O	these	appos	2	SENT_319	[p22l1993t3309r2147b3362],

1	@	SYM	O	@	dep	3	SENT_320	[p22l6t3540r83b3635],
2	Springer	NN	O	springer	nn	3	SENT_320	[p22l113t3563r375b3638],
3	studies	NNS	O	study	_	0	SENT_320	[p22l11t3652r217b3705],
4	were	VBD	O	be	auxpass	5	SENT_320	[p22l249t3668r395b3705],
5	supported	VBN	O	support	rcmod	3	SENT_320	[p22l429t3652r726b3720],
6	by	IN	O	by	_	0	SENT_320	[p22l754t3652r829b3720],
7	Grants	NNPS	O	Grants	agent	5	SENT_320	[p22l862t3652r1061b3705],
8	from	IN	O	from	_	0	SENT_320	[p22l1093t3652r1240b3705],
9	Pﬁzer	NNP	LOCATION	Pﬁzer	nn	11	SENT_320	[p22l1270t3652r1462b3715],
10	,	,	O	,	_	0	SENT_320	[p22l1270t3652r1462b3715],
11	Inc.	NNP	ORGANIZATION	Inc.	prep_from	5	SENT_320	[p22l1496t3653r1606b3705],
12	(	CD	NUMBER	(	num	14	SENT_320	[p22l1643t3652r1858b3717],
13	DFH	NN	O	dfh	nn	14	SENT_320	[p22l1643t3652r1858b3717],
14	)	NN	O	)	dep	11	SENT_320	[p22l1643t3652r1858b3717],
15	,	,	O	,	_	0	SENT_320	[p22l1643t3652r1858b3717],
16	Novartis	NNP	ORGANIZATION	Novartis	appos	11	SENT_320	[p22l1891t3652r2151b3705],

1	Pharma	NNP	ORGANIZATION	Pharma	nn	2	SENT_321	[p23l8t17r241b70],
2	AG	NNP	ORGANIZATION	AG	nsubj	15	SENT_321	[p23l273t17r381b70],
3	(	CD	NUMBER	(	num	5	SENT_321	[p23l416t18r630b83],
4	DFH	NN	O	dfh	nn	5	SENT_321	[p23l416t18r630b83],
5	)	NN	O	)	dep	2	SENT_321	[p23l416t18r630b83],
6	,	,	O	,	_	0	SENT_321	[p23l416t18r630b83],
7	and	CC	O	and	_	0	SENT_321	[p23l668t17r775b70],
8	the	DT	O	the	det	11	SENT_321	[p23l807t17r899b70],
9	Fashion	NNP	ORGANIZATION	Fashion	nn	11	SENT_321	[p23l932t17r1172b70],
10	Footwear	NNP	ORGANIZATION	Footwear	nn	11	SENT_321	[p23l1204t18r1492b70],
11	Association	NNP	ORGANIZATION	Association	conj_and	2	SENT_321	[p23l1524t17r1883b70],
12	of	IN	ORGANIZATION	of	_	0	SENT_321	[p23l1917t17r1982b70],
13	New	NNP	ORGANIZATION	New	nn	14	SENT_321	[p23l2010t18r2151b70],
14	York/QVC	NNP	ORGANIZATION	York/QVC	prep_of	11	SENT_321	[p23l8t107r343b172],
15	Presents	VBZ	O	present	_	0	SENT_321	[p23l374t108r625b160],
16	Shoes	NNS	O	shoe	dobj	15	SENT_321	[p23l657t107r834b160],
17	on	IN	O	on	_	0	SENT_321	[p23l866t123r940b160],
18	SaleTM	NN	O	saletm	nn	21	SENT_321	[p23l970t91r1184b160],
19	(	CD	NUMBER	(	num	21	SENT_321	[p23l1215t107r1430b172],
20	DFH	NN	O	dfh	nn	21	SENT_321	[p23l1215t107r1430b172],
21	)	NN	O	)	prep_on	16	SENT_321	[p23l1215t107r1430b172],
22	.	.	O	.	_	0	SENT_321	[p23l1215t107r1430b172],

1	Study	NNP	O	Study	nn	2	SENT_322	[p23l1464t106r1638b175],
2	medication	NN	O	medication	nsubjpass	4	SENT_322	[p23l1667t107r2006b160],
3	was	VBD	O	be	auxpass	4	SENT_322	[p23l2036t123r2151b160],
4	provided	VBN	O	provide	_	0	SENT_322	[p23l7t195r278b263],
5	by	IN	O	by	_	0	SENT_322	[p23l304t195r379b263],
6	Pﬁzer	NNP	ORGANIZATION	Pﬁzer	nn	12	SENT_322	[p23l407t195r599b258],
7	,	,	ORGANIZATION	,	_	0	SENT_322	[p23l407t195r599b258],
8	Inc.	NNP	ORGANIZATION	Inc.	nn	12	SENT_322	[p23l630t196r741b248],
9	and	CC	O	and	_	0	SENT_322	[p23l774t195r881b248],
10	Novartis	NNP	ORGANIZATION	Novartis	nn	12	SENT_322	[p23l908t195r1168b248],
11	Pharma	NNP	ORGANIZATION	Pharma	nn	12	SENT_322	[p23l1197t195r1429b248],
12	AG	NNP	ORGANIZATION	AG	agent	4	SENT_322	[p23l1456t195r1579b248],
13	.	.	O	.	_	0	SENT_322	[p23l1456t195r1579b248],

1	Conﬂict	NN	O	conﬂict	nsubj	5	SENT_323	[p23l10t372r266b427],
2	of	IN	O	of	_	0	SENT_323	[p23l301t372r367b426],
3	interest	NN	O	interest	nn	4	SENT_323	[p23l397t372r643b426],
4	NLH	NN	O	nlh	prep_of	1	SENT_323	[p23l720t374r875b426],
5	receives	VBZ	O	receive	_	0	SENT_323	[p23l915t373r1163b426],
6	research	NN	O	research	nn	7	SENT_323	[p23l1204t373r1459b426],
7	funding	NN	O	funding	dobj	5	SENT_323	[p23l1500t373r1735b442],
8	from	IN	O	from	_	0	SENT_323	[p23l1777t373r1924b426],
9	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	5	SENT_323	[p23l1964t374r2150b426, p23l8t463r244b524],
10	,	,	O	,	_	0	SENT_323	[p23l1964t374r2150b426, p23l8t463r244b524],
11	Eli	NNP	PERSON	Eli	nn	12	SENT_323	[p23l302t461r389b514],
12	Lilly	NNP	PERSON	Lilly	prep_from	5	SENT_323	[p23l445t461r609b530],
13	,	,	O	,	_	0	SENT_323	[p23l445t461r609b530],
14	and	CC	O	and	_	0	SENT_323	[p23l669t461r776b514],
15	Sanoﬁ	NNP	PERSON	Sanoﬁ	nn	16	SENT_323	[p23l833t461r1023b515],
16	Aventis	NNP	PERSON	Aventis	prep_from	5	SENT_323	[p23l1079t461r1330b514],
17	.	.	O	.	_	0	SENT_323	[p23l1079t461r1330b514],

1	DFH	NN	O	dfh	nsubj	2	SENT_324	[p23l1389t463r1539b514],
2	receives	VBZ	O	receive	_	0	SENT_324	[p23l1594t461r1842b514],
3	research	NN	O	research	nn	4	SENT_324	[p23l1898t461r2152b514],
4	funding	NN	O	funding	dobj	2	SENT_324	[p23l8t550r243b619],
5	from	IN	O	from	_	0	SENT_324	[p23l281t550r428b603],
6	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	12	SENT_324	[p23l465t550r866b613],
7	,	,	O	,	_	0	SENT_324	[p23l465t550r866b613],
8	Novartis	NNP	ORGANIZATION	Novartis	appos	12	SENT_324	[p23l906t550r1184b613],
9	,	,	O	,	_	0	SENT_324	[p23l906t550r1184b613],
10	Pﬁzer	NNP	O	Pﬁzer	appos	12	SENT_324	[p23l1224t550r1416b613],
11	,	,	O	,	_	0	SENT_324	[p23l1224t550r1416b613],
12	Veridex	NNP	ORGANIZATION	Veridex	prep_from	2	SENT_324	[p23l1456t550r1716b613],
13	,	,	O	,	_	0	SENT_324	[p23l1456t550r1716b613],
14	and	CC	O	and	_	0	SENT_324	[p23l1758t550r1866b603],
15	Janssen	NNP	PERSON	Janssen	conj_and	12	SENT_324	[p23l1902t551r2148b603],
16	.	.	O	.	_	0	SENT_324	[p23l1902t551r2148b603],

1	DAF	NNP	ORGANIZATION	DAF	nsubj	2	SENT_325	[p23l8t638r159b690],
2	receives	VBZ	O	receive	_	0	SENT_325	[p23l213t637r461b690],
3	research	NN	O	research	nn	4	SENT_325	[p23l519t637r773b690],
4	funding	NN	O	funding	dobj	2	SENT_325	[p23l829t637r1064b706],
5	from	IN	O	from	_	0	SENT_325	[p23l1121t637r1268b690],
6	Novartis	NNP	ORGANIZATION	Novartis	prep_from	2	SENT_325	[p23l1323t637r1583b690],
7	and	CC	O	and	_	0	SENT_325	[p23l1643t637r1750b690],
8	Pﬁzer	NNP	O	Pﬁzer	prep_from	2	SENT_325	[p23l1806t637r1997b690],
9	.	.	O	.	_	0	SENT_325	[p23l1806t637r1997b690],

1	VS	NN	O	v	nsubj	2	SENT_326	[p23l2057t638r2149b690],
2	receives	VBZ	O	receive	_	0	SENT_326	[p23l7t725r255b778],
3	research	NN	O	research	nn	4	SENT_326	[p23l296t725r549b778],
4	funding	NN	O	funding	dobj	2	SENT_326	[p23l589t725r824b794],
5	from	IN	O	from	_	0	SENT_326	[p23l864t725r1012b778],
6	Abbott	NNP	PERSON	Abbott	nn	12	SENT_326	[p23l1050t725r1276b788],
7	,	,	O	,	_	0	SENT_326	[p23l1050t725r1276b788],
8	Abraxis	NNP	ORGANIZATION	Abraxis	appos	12	SENT_326	[p23l1318t725r1574b788],
9	,	,	O	,	_	0	SENT_326	[p23l1318t725r1574b788],
10	Merck	NNP	PERSON	Merck	appos	12	SENT_326	[p23l1616t725r1830b788],
11	,	,	O	,	_	0	SENT_326	[p23l1616t725r1830b788],
12	Novartis	NNP	ORGANIZATION	Novartis	prep_from	2	SENT_326	[p23l1872t725r2149b788],
13	,	,	O	,	_	0	SENT_326	[p23l1872t725r2149b788],
14	and	CC	O	and	_	0	SENT_326	[p23l9t815r117b868],
15	Pﬁzer	NNP	PERSON	Pﬁzer	conj_and	12	SENT_326	[p23l154t815r345b868],
16	.	.	O	.	_	0	SENT_326	[p23l154t815r345b868],

1	JMR	NN	O	jmr	nsubj	2	SENT_327	[p23l388t816r535b868],
2	received	VBD	O	receive	_	0	SENT_327	[p23l570t815r829b868],
3	a	DT	O	a	det	4	SENT_327	[p23l869t832r900b868],
4	research	NN	O	research	iobj	2	SENT_327	[p23l936t815r1191b868],
5	Grant	NNP	O	Grant	dobj	2	SENT_327	[p23l1229t815r1401b868],
6	from	IN	O	from	_	0	SENT_327	[p23l1439t815r1586b868],
7	Pﬁzer	NNP	LOCATION	Pﬁzer	prep_from	5	SENT_327	[p23l1623t815r1814b868],
8	.	.	O	.	_	0	SENT_327	[p23l1623t815r1814b868],

1	TCS	NNP	ORGANIZATION	TCS	nn	15	SENT_328	[p23l1856t815r2010b878],
2	,	,	O	,	_	0	SENT_328	[p23l1856t815r2010b878],
3	JD	NNP	O	JD	appos	15	SENT_328	[p23l2051t816r2150b878],
4	,	,	O	,	_	0	SENT_328	[p23l2051t816r2150b878],
5	LL	NNP	O	LL	appos	15	SENT_328	[p23l8t903r116b965],
6	,	,	O	,	_	0	SENT_328	[p23l8t903r116b965],
7	KK	NNP	ORGANIZATION	KK	appos	15	SENT_328	[p23l154t903r277b965],
8	,	,	O	,	_	0	SENT_328	[p23l154t903r277b965],
9	CG	NNP	O	CG	appos	15	SENT_328	[p23l314t902r433b965],
10	,	,	O	,	_	0	SENT_328	[p23l314t902r433b965],
11	ATN	NNP	ORGANIZATION	ATN	appos	15	SENT_328	[p23l469t903r640b965],
12	,	,	O	,	_	0	SENT_328	[p23l469t903r640b965],
13	ZD	NNP	O	ZD	appos	15	SENT_328	[p23l676t903r793b965],
14	,	,	O	,	_	0	SENT_328	[p23l676t903r793b965],
15	SO	NNP	O	SO	nsubj	23	SENT_328	[p23l831t903r941b965],
16	,	,	O	,	_	0	SENT_328	[p23l831t903r941b965],
17	SP	NN	O	sp	nsubj	23	SENT_328	[p23l979t902r1076b965],
18	,	,	O	,	_	0	SENT_328	[p23l979t902r1076b965],
19	JSC	NNP	ORGANIZATION	JSC	nsubj	23	SENT_328	[p23l1111t902r1248b965],
20	,	,	O	,	_	0	SENT_328	[p23l1111t902r1248b965],
21	and	CC	O	and	_	0	SENT_328	[p23l1287t902r1394b955],
22	AMS	NNP	O	AMS	nsubj	23	SENT_328	[p23l1427t902r1586b955],
23	reported	VBD	O	report	_	0	SENT_328	[p23l1623t902r1877b971],
24	no	DT	O	no	det	25	SENT_328	[p23l1911t919r1984b955],
25	conﬂicts	NNS	O	conﬂicts	dobj	23	SENT_328	[p23l2019t919r2150b955, p23l9t991r153b1044],
26	of	IN	O	of	_	0	SENT_328	[p23l189t991r254b1044],
27	interest	NN	O	interest	prep_of	25	SENT_328	[p23l281t991r520b1044],
28	.	.	O	.	_	0	SENT_328	[p23l281t991r520b1044],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_329	[p23l52t1120r142b1144],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_329	[p23l155t1119r255b1145],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_329	[p23l267t1120r318b1144],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_329	[p23l331t1120r406b1144],
5	(	CD	NUMBER	(	num	4	SENT_329	[p23l419t1119r510b1150],
6	2013	CD	DATE	2013	num	8	SENT_329	[p23l419t1119r510b1150],
7	)	CD	NUMBER	)	num	8	SENT_329	[p23l419t1119r510b1150],
8	l38	NN	O	l38	dep	4	SENT_329	[p23l528t1119r709b1145],
9	:807	CD	NUMBER	:807	number	10	SENT_329	[p23l528t1119r709b1145],
10	—	CD	NUMBER	—	num	11	SENT_329	[p23l528t1119r709b1145],
11	8l6	NN	O	8l6	dep	8	SENT_329	[p23l528t1119r709b1145],
12	815	CD	NUMBER	815	dep	4	SENT_329	[p23l2056t1119r2106b1145],

1	References	NNS	O	reference	_	0	SENT_330	[p23l7t1288r423b1351],

1	1	LS	NUMBER	1	_	0	SENT_331	[p23l51t1500r95b1553],
2	.	.	O	.	_	0	SENT_331	[p23l51t1500r95b1553],

1	Amir	NNP	PERSON	Amir	nn	2	SENT_332	[p23l137t1500r298b1552],
2	E	NNP	O	E	nsubj	15	SENT_332	[p23l341t1501r402b1563],
3	,	,	O	,	_	0	SENT_332	[p23l341t1501r402b1563],
4	Seruga	NNP	PERSON	Seruga	nn	5	SENT_332	[p23l451t1500r660b1569],
5	B	NNP	PERSON	B	appos	2	SENT_332	[p23l704t1501r769b1563],
6	,	,	O	,	_	0	SENT_332	[p23l704t1501r769b1563],
7	Niraula	NNP	LOCATION	Niraula	nn	8	SENT_332	[p23l816t1500r1045b1553],
8	S	NNP	LOCATION	S	appos	2	SENT_332	[p23l1091t1500r1145b1563],
9	,	,	O	,	_	0	SENT_332	[p23l1091t1500r1145b1563],
10	Carlsson	NNP	PERSON	Carlsson	nn	11	SENT_332	[p23l1193t1500r1457b1553],
11	L	NNP	PERSON	L	appos	2	SENT_332	[p23l1502t1501r1563b1563],
12	,	,	O	,	_	0	SENT_332	[p23l1502t1501r1563b1563],
13	Ocana	NNP	PERSON	Ocana	nn	14	SENT_332	[p23l1612t1500r1804b1553],
14	A	NNP	O	A	appos	2	SENT_332	[p23l1848t1500r1902b1552],
15	(	VBD	O	(	_	0	SENT_332	[p23l1949t1500r2145b1565],
16	2011	CD	DATE	2011	num	18	SENT_332	[p23l1949t1500r2145b1565],
17	)	CD	NUMBER	)	num	18	SENT_332	[p23l1949t1500r2145b1565],
18	Toxicity	NN	O	toxicity	dobj	15	SENT_332	[p23l137t1587r394b1656],
19	of	IN	O	of	_	0	SENT_332	[p23l421t1587r487b1640],
20	adjuvant	JJ	O	adjuvant	amod	22	SENT_332	[p23l507t1587r768b1656],
21	endocrine	NN	O	endocrine	nn	22	SENT_332	[p23l793t1587r1091b1640],
22	therapy	NN	O	therapy	prep_of	18	SENT_332	[p23l1117t1587r1343b1656],
23	in	IN	O	in	_	0	SENT_332	[p23l1369t1587r1426b1640],
24	postmenopausal	JJ	O	postmenopausal	amod	27	SENT_332	[p23l1451t1587r1941b1656],
25	breast	NN	O	breast	nn	27	SENT_332	[p23l1965t1587r2148b1640],
26	cancer	NN	O	cancer	nn	27	SENT_332	[p23l138t1692r336b1729],
27	patients	NNS	O	patient	prep_in	22	SENT_332	[p23l371t1676r624b1744],
28	:	:	O	:	_	0	SENT_332	[p23l371t1676r624b1744],
29	a	DT	O	a	det	31	SENT_332	[p23l667t1692r699b1729],
30	systematic	JJ	O	systematic	amod	31	SENT_332	[p23l737t1676r1054b1744],
31	review	NN	O	review	dep	18	SENT_332	[p23l1091t1676r1297b1729],
32	and	CC	O	and	_	0	SENT_332	[p23l1335t1676r1443b1729],
33	meta	NN	O	meta	nn	35	SENT_332	[p23l1479t1676r1912b1744],
34	—	NN	O	—	nn	35	SENT_332	[p23l1479t1676r1912b1744],
35	analysis	NN	O	analysis	conj_and	31	SENT_332	[p23l1479t1676r1912b1744],
36	.	.	O	.	_	0	SENT_332	[p23l1479t1676r1912b1744],

1	J	NNP	O	J	nn	6	SENT_333	[p23l1953t1677r1981b1729],
2	Natl	NNP	O	Natl	nn	6	SENT_333	[p23l2017t1676r2147b1729],
3	Cancer	NNP	O	Cancer	nn	6	SENT_333	[p23l138t1764r353b1817],
4	Inst	NN	O	inst	nn	6	SENT_333	[p23l379t1765r492b1817],
5	103	CD	NUMBER	103	num	6	SENT_333	[p23l527t1764r1138b1830],
6	(	NN	O	(	_	0	SENT_333	[p23l527t1764r1138b1830],
7	17	CD	NUMBER	17	dep	6	SENT_333	[p23l527t1764r1138b1830],
8	)	CD	NUMBER	)	number	9	SENT_333	[p23l527t1764r1138b1830],
9	:1299	CD	NUMBER	:1299	num	11	SENT_333	[p23l527t1764r1138b1830],
10	—	CD	NUMBER	—	number	11	SENT_333	[p23l527t1764r1138b1830],
11	1309	CD	DATE	1309	dep	7	SENT_333	[p23l527t1764r1138b1830],
12	.	.	O	.	_	0	SENT_333	[p23l527t1764r1138b1830],

1	doi	FW	O	doi	nn	2	SENT_334	[p23l1170t1764r1891b1833],
2	:10	FW	O	:10	_	0	SENT_334	[p23l1170t1764r1891b1833],
3	.	.	O	.	_	0	SENT_334	[p23l1170t1764r1891b1833],

1	l093/jnci/djr242	NN	O	l093/jnci/djr242	_	0	SENT_335	[p23l1170t1764r1891b1833],

1	2	LS	NUMBER	2	_	0	SENT_336	[p23l45t1852r95b1905],
2	.	.	O	.	_	0	SENT_336	[p23l45t1852r95b1905],

1	Briot	NNP	PERSON	Briot	nn	2	SENT_337	[p23l137t1852r293b1905],
2	K	NNP	PERSON	K	_	0	SENT_337	[p23l331t1853r399b1915],
3	,	,	O	,	_	0	SENT_337	[p23l331t1853r399b1915],
4	Tubiana-Hulin	NNP	O	Tubiana-Hulin	nn	5	SENT_337	[p23l439t1852r887b1905],
5	M	NNP	O	M	appos	2	SENT_337	[p23l925t1853r1006b1915],
6	,	,	O	,	_	0	SENT_337	[p23l925t1853r1006b1915],
7	Bastit	NNP	PERSON	Bastit	nn	8	SENT_337	[p23l1046t1852r1223b1905],
8	L	NNP	PERSON	L	appos	2	SENT_337	[p23l1260t1853r1322b1915],
9	,	,	O	,	_	0	SENT_337	[p23l1260t1853r1322b1915],
10	Kloos	NNP	PERSON	Kloos	nn	11	SENT_337	[p23l1363t1852r1540b1905],
11	I	NNP	O	I	appos	2	SENT_337	[p23l1579t1853r1619b1915],
12	,	,	O	,	_	0	SENT_337	[p23l1579t1853r1619b1915],
13	Roux	NNP	PERSON	Roux	nn	14	SENT_337	[p23l1659t1853r1822b1905],
14	C	NNP	O	C	appos	2	SENT_337	[p23l1860t1853r1907b1905],
15	(	JJ	O	(	amod	14	SENT_337	[p23l1949t1852r2145b1918],
16	2010	CD	DATE	2010	tmod	15	SENT_337	[p23l1949t1852r2145b1918],
17	)	CD	NUMBER	)	num	18	SENT_337	[p23l1949t1852r2145b1918],
18	Effect	NN	O	effect	dep	2	SENT_337	[p23l137t1941r323b1994],
19	of	IN	O	of	_	0	SENT_337	[p23l362t1941r427b1994],
20	a	DT	O	a	det	21	SENT_337	[p23l463t1958r494b1994],
21	switch	NN	O	switch	prep_of	18	SENT_337	[p23l534t1941r729b1995],
22	of	IN	O	of	_	0	SENT_337	[p23l768t1941r834b1994],
23	aromatase	NN	O	aromatase	nn	24	SENT_337	[p23l869t1950r1175b1994],
24	inhibitors	NNS	O	inhibitor	prep_of	21	SENT_337	[p23l1214t1941r1503b1994],
25	on	IN	O	on	_	0	SENT_337	[p23l1544t1958r1617b1994],
26	musculoskeletal	JJ	O	musculoskeletal	amod	27	SENT_337	[p23l1656t1941r2146b1994],
27	symptoms	NNS	O	symptom	prep_on	24	SENT_337	[p23l140t2039r447b2100],
28	in	IN	O	in	_	0	SENT_337	[p23l493t2031r551b2083],
29	postmenopausal	JJ	O	postmenopausal	amod	30	SENT_337	[p23l594t2031r1085b2100],
30	women	NNS	O	woman	prep_in	27	SENT_337	[p23l1130t2048r1353b2084],
31	with	IN	O	with	_	0	SENT_337	[p23l1398t2031r1531b2084],
32	hormone	NN	O	hormone	nn	33	SENT_337	[p23l1575t2031r2144b2100, p23l136t2118r377b2187],
33	—	NN	O	—	prep_with	30	SENT_337	[p23l1575t2031r2144b2100, p23l136t2118r377b2187],
34	receptorpositive	JJ	O	receptorpositive	amod	36	SENT_337	[p23l1575t2031r2144b2100, p23l136t2118r377b2187],
35	breast	NN	O	breast	nn	36	SENT_337	[p23l435t2118r617b2171],
36	cancer	NN	O	cancer	dep	2	SENT_337	[p23l676t2135r889b2171],
37	:	:	O	:	_	0	SENT_337	[p23l676t2135r889b2171],
38	the	DT	O	the	det	42	SENT_337	[p23l953t2118r1045b2171],
39	ATOLL	NNP	O	ATOLL	nn	42	SENT_337	[p23l1103t2119r1352b2171],
40	(	CD	NUMBER	(	num	42	SENT_337	[p23l1412t2118r1690b2184],
41	articular	JJ	O	articular	amod	42	SENT_337	[p23l1412t2118r1690b2184],
42	tolerance	NN	O	tolerance	dep	36	SENT_337	[p23l1748t2118r2026b2171],
43	of	IN	O	of	_	0	SENT_337	[p23l2086t2118r2152b2171],
44	letrozole	NN	O	letrozole	nn	46	SENT_337	[p23l138t2206r426b2272],
45	)	CD	NUMBER	)	num	46	SENT_337	[p23l138t2206r426b2272],
46	study	NN	O	study	prep_of	42	SENT_337	[p23l464t2206r640b2275],
47	.	.	O	.	_	0	SENT_337	[p23l464t2206r640b2275],

1	Breast	NN	O	breast	nn	4	SENT_338	[p23l677t2208r871b2259],
2	Cancer	NN	O	cancer	nn	4	SENT_338	[p23l904t2207r1119b2260],
3	Res	NNP	O	Res	nn	4	SENT_338	[p23l1151t2208r1261b2259],
4	Treat	NNP	O	Treat	_	0	SENT_338	[p23l1296t2208r1457b2259],
5	120	CD	NUMBER	120	num	6	SENT_338	[p23l1496t2207r1993b2272],
6	(	NN	O	(	dep	4	SENT_338	[p23l1496t2207r1993b2272],
7	1	CD	NUMBER	1	number	8	SENT_338	[p23l1496t2207r1993b2272],
8	)	CD	NUMBER	)	dep	6	SENT_338	[p23l1496t2207r1993b2272],
9	:127	CD	NUMBER	:127	num	10	SENT_338	[p23l1496t2207r1993b2272],
10	—	NN	O	—	dep	4	SENT_338	[p23l1496t2207r1993b2272],
11	134	CD	NUMBER	134	dep	10	SENT_338	[p23l1496t2207r1993b2272],
12	.	.	O	.	_	0	SENT_338	[p23l1496t2207r1993b2272],

1	doi	FW	O	doi	_	0	SENT_339	[p23l2031t2206r2141b2259],
2	:	:	O	:	_	0	SENT_339	[p23l2031t2206r2141b2259],
3	10.1007	CD	NUMBER	10.1007	dep	1	SENT_339	[p23l144t2296r1003b2350],
4	/	:	O	/	punct	5	SENT_339	[p23l144t2296r1003b2350],
5	s10549-009-0692-7	NN	O	s10549-009-0692-7	dep	3	SENT_339	[p23l144t2296r1003b2350],

1	3	LS	NUMBER	3	_	0	SENT_340	[p23l46t2384r96b2438],
2	.	.	O	.	_	0	SENT_340	[p23l46t2384r96b2438],

1	Burstein	NNP	PERSON	Burstein	nn	2	SENT_341	[p23l137t2384r394b2437],
2	HJ	NNP	O	HJ	nsubj	43	SENT_341	[p23l425t2385r523b2447],
3	,	,	O	,	_	0	SENT_341	[p23l425t2385r523b2447],
4	Prestrud	NNP	O	Prestrud	nn	5	SENT_341	[p23l556t2384r809b2437],
5	AA	NNP	O	AA	appos	2	SENT_341	[p23l839t2385r963b2447],
6	,	,	O	,	_	0	SENT_341	[p23l839t2385r963b2447],
7	Seidenfeld	NNP	PERSON	Seidenfeld	nn	8	SENT_341	[p23l998t2384r1322b2438],
8	J	NNP	PERSON	J	appos	5	SENT_341	[p23l1352t2385r1380b2438],
9	,	,	O	,	_	0	SENT_341	[p23l1384t2428r1396b2447],
10	Anderson	NNP	PERSON	Anderson	nn	11	SENT_341	[p23l1429t2384r1723b2437],
11	H	NNP	O	H	appos	5	SENT_341	[p23l1753t2385r1823b2447],
12	,	,	O	,	_	0	SENT_341	[p23l1753t2385r1823b2447],
13	Buchholz	NNP	ORGANIZATION	Buchholz	nn	14	SENT_341	[p23l1856t2384r2146b2437],
14	TA	NNP	ORGANIZATION	TA	appos	5	SENT_341	[p23l137t2474r253b2536],
15	,	,	O	,	_	0	SENT_341	[p23l137t2474r253b2536],
16	Davidson	NNP	PERSON	Davidson	nn	17	SENT_341	[p23l282t2473r572b2527],
17	NE	NNS	O	ne	appos	5	SENT_341	[p23l599t2475r715b2536],
18	,	,	O	,	_	0	SENT_341	[p23l599t2475r715b2536],
19	Gelmon	NNP	PERSON	Gelmon	nn	20	SENT_341	[p23l745t2473r988b2527],
20	KE	NNP	PERSON	KE	appos	5	SENT_341	[p23l1015t2475r1129b2536],
21	,	,	O	,	_	0	SENT_341	[p23l1015t2475r1129b2536],
22	Giordano	NNP	PERSON	Giordano	nn	23	SENT_341	[p23l1160t2473r1444b2527],
23	SH	NNP	O	SH	appos	5	SENT_341	[p23l1474t2474r1582b2536],
24	,	,	O	,	_	0	SENT_341	[p23l1474t2474r1582b2536],
25	Hudis	NNP	PERSON	Hudis	nn	26	SENT_341	[p23l1611t2473r1789b2527],
26	CA	NNP	O	CA	appos	5	SENT_341	[p23l1818t2474r1937b2536],
27	,	,	O	,	_	0	SENT_341	[p23l1818t2474r1937b2536],
28	Malin	NNP	PERSON	Malin	nn	29	SENT_341	[p23l1966t2473r2147b2527],
29	J	NNP	PERSON	J	appos	5	SENT_341	[p23l137t2563r165b2615],
30	,	,	O	,	_	0	SENT_341	[p23l169t2605r180b2624],
31	Mamounas	NNP	O	Mamounas	nn	32	SENT_341	[p23l210t2563r546b2614],
32	EP	NNP	O	EP	appos	5	SENT_341	[p23l574t2563r677b2624],
33	,	,	O	,	_	0	SENT_341	[p23l574t2563r677b2624],
34	Rowden	NNP	PERSON	Rowden	nn	35	SENT_341	[p23l707t2561r959b2614],
35	D	NNP	O	D	appos	5	SENT_341	[p23l985t2563r1055b2624],
36	,	,	O	,	_	0	SENT_341	[p23l985t2563r1055b2624],
37	Solky	NNP	O	Solky	nn	38	SENT_341	[p23l1087t2561r1260b2630],
38	AJ	NNP	O	AJ	appos	5	SENT_341	[p23l1287t2562r1385b2624],
39	,	,	O	,	_	0	SENT_341	[p23l1287t2562r1385b2624],
40	Sowers	NNP	PERSON	Sowers	nn	41	SENT_341	[p23l1417t2562r1635b2615],
41	MR	NN	PERSON	mr	appos	5	SENT_341	[p23l1663t2563r1796b2624],
42	,	,	O	,	_	0	SENT_341	[p23l1663t2563r1796b2624],
43	Steams	VBZ	O	steam	_	0	SENT_341	[p23l1828t2562r2046b2615],
44	V	NN	O	v	dobj	43	SENT_341	[p23l2075t2563r2144b2624],
45	,	,	O	,	_	0	SENT_341	[p23l2075t2563r2144b2624],
46	Winer	NNP	PERSON	Winer	nn	47	SENT_341	[p23l136t2649r328b2702],
47	EP	NNP	O	EP	appos	44	SENT_341	[p23l348t2650r451b2712],
48	,	,	O	,	_	0	SENT_341	[p23l348t2650r451b2712],
49	Somerﬁeld	NNP	ORGANIZATION	Somerﬁeld	nn	50	SENT_341	[p23l478t2649r809b2702],
50	MR	NN	ORGANIZATION	mr	appos	44	SENT_341	[p23l830t2650r963b2712],
51	,	,	O	,	_	0	SENT_341	[p23l830t2650r963b2712],
52	Griggs	NNP	PERSON	Griggs	appos	44	SENT_341	[p23l988t2649r1191b2718],
53	JJ	NN	PERSON	jj	nn	58	SENT_341	[p23l1214t2650r1271b2702],
54	(	CD	NUMBER	(	num	58	SENT_341	[p23l1295t2650r1491b2715],
55	2010	CD	DATE	2010	num	58	SENT_341	[p23l1295t2650r1491b2715],
56	)	NNP	O	)	nn	58	SENT_341	[p23l1295t2650r1491b2715],
57	American	NNP	ORGANIZATION	American	nn	58	SENT_341	[p23l1515t2649r1815b2702],
58	Society	NNP	ORGANIZATION	Society	dep	52	SENT_341	[p23l1839t2649r2064b2718],
59	of	IN	ORGANIZATION	of	_	0	SENT_341	[p23l2087t2649r2152b2702],
60	Clinical	JJ	ORGANIZATION	clinical	amod	64	SENT_341	[p23l138t2737r377b2790],
61	Oncology	NN	ORGANIZATION	oncology	nn	64	SENT_341	[p23l403t2737r699b2806],
62	clinical	JJ	O	clinical	amod	64	SENT_341	[p23l724t2737r947b2790],
63	practice	NN	O	practice	nn	64	SENT_341	[p23l970t2737r1211b2806],
64	guideline	NN	O	guideline	prep_of	58	SENT_341	[p23l1236t2737r1534b2806],
65	:	:	O	:	_	0	SENT_341	[p23l1236t2737r1534b2806],
66	update	VB	O	update	dep	43	SENT_341	[p23l1562t2737r1764b2806],
67	on	IN	O	on	_	0	SENT_341	[p23l1789t2754r1862b2790],
68	adjuvant	JJ	O	adjuvant	amod	70	SENT_341	[p23l1887t2737r2148b2806],
69	endocrine	NN	O	endocrine	nn	70	SENT_341	[p23l138t2825r436b2878],
70	therapy	NN	O	therapy	prep_on	66	SENT_341	[p23l479t2825r706b2894],
71	for	IN	O	for	_	0	SENT_341	[p23l749t2825r837b2878],
72	women	NNS	O	woman	prep_for	70	SENT_341	[p23l878t2842r1100b2878],
73	with	IN	O	with	_	0	SENT_341	[p23l1143t2825r1276b2879],
74	hormone	NN	O	hormone	nn	77	SENT_341	[p23l1318t2825r1587b2878],
75	receptor-positive	JJ	O	receptor-positive	amod	77	SENT_341	[p23l1630t2825r2146b2894],
76	breast	NN	O	breast	nn	77	SENT_341	[p23l136t2915r318b2968],
77	cancer	NN	O	cancer	prep_with	72	SENT_341	[p23l368t2931r581b2968],
78	.	.	O	.	_	0	SENT_341	[p23l368t2931r581b2968],

1	J	NNP	O	J	nn	3	SENT_342	[p23l634t2916r662b2968],
2	Clin	NNP	O	Clin	nn	3	SENT_342	[p23l713t2914r842b2968],
3	Oncol	NNP	O	Oncol	_	0	SENT_342	[p23l893t2915r1076b2968],
4	28	CD	NUMBER	28	number	5	SENT_342	[p23l1127t2914r1706b2980],
5	(	CD	NUMBER	(	dep	3	SENT_342	[p23l1127t2914r1706b2980],
6	23	CD	NUMBER	23	num	7	SENT_342	[p23l1127t2914r1706b2980],
7	)	NN	O	)	dep	5	SENT_342	[p23l1127t2914r1706b2980],
8	:3784	CD	NUMBER	:3784	number	9	SENT_342	[p23l1127t2914r1706b2980],
9	—	CD	NUMBER	—	dep	3	SENT_342	[p23l1127t2914r1706b2980],
10	3796	CD	DATE	3796	dep	9	SENT_342	[p23l1127t2914r1706b2980],
11	.	.	O	.	_	0	SENT_342	[p23l1127t2914r1706b2980],

1	doi	FW	O	doi	_	0	SENT_343	[p23l1762t2914r2148b2968],
2	:10.1200	CD	NUMBER	:10.1200	dep	1	SENT_343	[p23l1762t2914r2148b2968],
3	/	:	O	/	punct	4	SENT_343	[p23l1762t2914r2148b2968],
4	JCO	NNP	O	JCO	dep	2	SENT_343	[p23l137t3003r707b3057],
5	.2009.26.3756	CD	NUMBER	.2009.26.3756	num	4	SENT_343	[p23l137t3003r707b3057],

1	4	LS	NUMBER	4	_	0	SENT_344	[p23l44t3092r95b3144],
2	.	.	O	.	_	0	SENT_344	[p23l44t3092r95b3144],

1	Colomer	NNP	PERSON	Colomer	nn	2	SENT_345	[p23l138t3091r404b3145],
2	R	NNP	PERSON	R	nsubj	7	SENT_345	[p23l423t3093r488b3154],
3	,	,	O	,	_	0	SENT_345	[p23l423t3093r488b3154],
4	Monzo	NNP	O	Monzo	nn	5	SENT_345	[p23l512t3093r725b3144],
5	M	NNP	O	M	appos	2	SENT_345	[p23l747t3093r828b3154],
6	,	,	O	,	_	0	SENT_345	[p23l747t3093r828b3154],
7	Tusquets	VBZ	O	tusquet	_	0	SENT_345	[p23l852t3093r1124b3160],
8	I	PRP	O	I	nsubjpass	59	SENT_345	[p23l1146t3093r1186b3154],
9	,	,	O	,	_	0	SENT_345	[p23l1146t3093r1186b3154],
10	Rifa	NNP	PERSON	Rifa	nn	11	SENT_345	[p23l1210t3091r1340b3144],
11	J	NNP	PERSON	J	dep	50	SENT_345	[p23l1360t3093r1388b3145],
12	,	,	O	,	_	0	SENT_345	[p23l1393t3135r1404b3154],
13	Baena	NNP	PERSON	Baena	nn	14	SENT_345	[p23l1427t3093r1618b3144],
14	JM	NN	O	jm	appos	11	SENT_345	[p23l1638t3093r1749b3154],
15	,	,	O	,	_	0	SENT_345	[p23l1638t3093r1749b3154],
16	Bamadas	NNP	O	Bamadas	nn	17	SENT_345	[p23l1772t3091r2053b3144],
17	A	NNP	O	A	appos	11	SENT_345	[p23l2075t3092r2144b3154],
18	,	,	O	,	_	0	SENT_345	[p23l2075t3092r2144b3154],
19	Calvo	NNP	PERSON	Calvo	nn	20	SENT_345	[p23l138t3179r317b3233],
20	L	NNP	O	L	appos	11	SENT_345	[p23l345t3181r407b3242],
21	,	,	O	,	_	0	SENT_345	[p23l345t3181r407b3242],
22	Carabantes	NNP	O	Carabantes	nn	23	SENT_345	[p23l438t3180r773b3233],
23	F	NN	O	f	appos	11	SENT_345	[p23l803t3181r859b3242],
24	,	,	O	,	_	0	SENT_345	[p23l803t3181r859b3242],
25	Crespo	NNP	PERSON	Crespo	nn	26	SENT_345	[p23l890t3180r1102b3248],
26	C	NNP	O	C	appos	11	SENT_345	[p23l1132t3180r1196b3242],
27	,	,	O	,	_	0	SENT_345	[p23l1132t3180r1196b3242],
28	Munoz	NNP	PERSON	Munoz	nn	29	SENT_345	[p23l1227t3181r1440b3233],
29	M	NNP	O	M	appos	11	SENT_345	[p23l1468t3181r1551b3242],
30	,	,	O	,	_	0	SENT_345	[p23l1468t3181r1551b3242],
31	Llombart	NNP	O	Llombart	nn	32	SENT_345	[p23l1581t3180r1865b3233],
32	A	NNP	O	A	appos	11	SENT_345	[p23l1893t3180r1961b3242],
33	,	,	O	,	_	0	SENT_345	[p23l1893t3180r1961b3242],
34	Plazaola	NNP	O	Plazaola	nn	35	SENT_345	[p23l1992t3180r2145b3233, p23l139t3269r264b3322],
35	A	NNP	O	A	appos	11	SENT_345	[p23l302t3269r371b3332],
36	,	,	O	,	_	0	SENT_345	[p23l302t3269r371b3332],
37	Artells	NNP	O	Artells	nn	38	SENT_345	[p23l412t3269r616b3322],
38	R	NNP	O	R	appos	11	SENT_345	[p23l657t3270r722b3332],
39	,	,	O	,	_	0	SENT_345	[p23l657t3270r722b3332],
40	Gilabert	NNP	O	Gilabert	nn	41	SENT_345	[p23l765t3269r1013b3322],
41	M	NNP	O	M	appos	11	SENT_345	[p23l1051t3270r1133b3332],
42	,	,	O	,	_	0	SENT_345	[p23l1051t3270r1133b3332],
43	Lloveras	NNP	O	Lloveras	nn	44	SENT_345	[p23l1174t3269r1438b3322],
44	B	NNP	O	B	appos	11	SENT_345	[p23l1479t3270r1544b3332],
45	,	,	O	,	_	0	SENT_345	[p23l1479t3270r1544b3332],
46	Alba	NNP	ORGANIZATION	Alba	nn	47	SENT_345	[p23l1586t3269r1733b3322],
47	E	NNP	ORGANIZATION	E	appos	11	SENT_345	[p23l1770t3270r1815b3321],
48	(	CD	NUMBER	(	dep	50	SENT_345	[p23l1856t3269r2053b3334],
49	2008	CD	DATE	2008	num	50	SENT_345	[p23l1856t3269r2053b3334],
50	)	NN	O	)	dep	59	SENT_345	[p23l1856t3269r2053b3334],
51	A	DT	O	a	det	53	SENT_345	[p23l2094t3269r2148b3321],
52	single-nucleotide	JJ	O	single-nucleotide	amod	53	SENT_345	[p23l140t3356r661b3425],
53	polymorphism	NN	O	polymorphism	dep	50	SENT_345	[p23l695t3356r1140b3425],
54	in	IN	O	in	_	0	SENT_345	[p23l1174t3356r1232b3409],
55	the	DT	O	the	det	56	SENT_345	[p23l1265t3356r1356b3409],
56	aromatase	NN	O	aromatase	prep_in	53	SENT_345	[p23l1393t3364r1698b3409],
57	gene	NN	O	gene	nsubjpass	59	SENT_345	[p23l1734t3373r1875b3425],
58	is	VBZ	O	be	auxpass	59	SENT_345	[p23l1910t3356r1957b3409],
59	associated	VBN	O	associate	ccomp	7	SENT_345	[p23l1994t3373r2144b3409, p23l138t3444r319b3498],
60	with	IN	O	with	_	0	SENT_345	[p23l355t3444r488b3498],
61	the	DT	O	the	det	62	SENT_345	[p23l522t3445r613b3498],
62	efﬁcacy	NN	O	efﬁcacy	prep_with	59	SENT_345	[p23l650t3444r888b3513],
63	of	IN	O	of	_	0	SENT_345	[p23l925t3444r991b3498],
64	the	DT	O	the	det	67	SENT_345	[p23l1021t3445r1112b3498],
65	aromatase	NN	O	aromatase	nn	67	SENT_345	[p23l1150t3453r1455b3498],
66	inhibitor	NN	O	inhibitor	nn	67	SENT_345	[p23l1491t3444r1754b3498],
67	letrozole	NN	O	letrozole	prep_of	62	SENT_345	[p23l1789t3444r2054b3498],
68	in	IN	O	in	_	0	SENT_345	[p23l2089t3444r2147b3497],
69	advanced	JJ	O	advanced	amod	71	SENT_345	[p23l139t3534r424b3587],
70	breast	NN	O	breast	nn	71	SENT_345	[p23l469t3534r652b3587],
71	carcinoma	NN	O	carcinoma	prep_in	67	SENT_345	[p23l698t3534r1030b3587],
72	.	.	O	.	_	0	SENT_345	[p23l698t3534r1030b3587],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_346	[p23l1081t3534r1211b3587],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_346	[p23l1257t3534r1473b3587],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_346	[p23l1518t3535r1628b3587],
4	14	CD	NUMBER	14	number	5	SENT_346	[p23l1684t3534r2143b3599],
5	(	CD	NUMBER	(	dep	3	SENT_346	[p23l1684t3534r2143b3599],
6	3	CD	NUMBER	3	num	7	SENT_346	[p23l1684t3534r2143b3599],
7	)	NN	O	)	dep	5	SENT_346	[p23l1684t3534r2143b3599],
8	:811	CD	NUMBER	:811	num	9	SENT_346	[p23l1684t3534r2143b3599],
9	—	NN	O	—	dep	3	SENT_346	[p23l1684t3534r2143b3599],
10	816	CD	NUMBER	816	dep	9	SENT_346	[p23l1684t3534r2143b3599],
11	.	.	O	.	_	0	SENT_346	[p23l1684t3534r2143b3599],

1	doi	FW	O	doi	_	0	SENT_347	[p23l138t3622r1301b3676],
2	:10.1158	CD	NUMBER	:10.1158	dep	1	SENT_347	[p23l138t3622r1301b3676],
3	/	:	O	/	punct	4	SENT_347	[p23l138t3622r1301b3676],
4	1078-0432	CD	DURATION	1078-0432	dep	2	SENT_347	[p23l138t3622r1301b3676],
5	.	.	O	.	_	0	SENT_347	[p23l138t3622r1301b3676],

1	CCR-07-1923	NN	O	ccr-07-1923	_	0	SENT_348	[p23l138t3622r1301b3676],

1	ll	NN	O	ll	_	0	SENT_349	[p24l13t3201r95b3253],
2	.	.	O	.	_	0	SENT_349	[p24l13t3201r95b3253],

1	.	.	O	.	_	0	SENT_350	[p24l87t69r95b78],

1	Crew	NNP	O	Crew	nn	2	SENT_351	[p24l138t25r300b78],
2	KD	NN	O	kd	nsubj	24	SENT_351	[p24l322t26r445b88],
3	,	,	O	,	_	0	SENT_351	[p24l322t26r445b88],
4	Greenlee	NNP	PERSON	Greenlee	nn	5	SENT_351	[p24l470t25r743b78],
5	H	NNP	PERSON	H	appos	2	SENT_351	[p24l765t26r833b87],
6	,	,	O	,	_	0	SENT_351	[p24l765t26r833b87],
7	Capodice	NNP	O	Capodice	nn	8	SENT_351	[p24l858t24r1143b93],
8	J	NNP	O	J	appos	2	SENT_351	[p24l1165t26r1193b78],
9	,	,	O	,	_	0	SENT_351	[p24l1197t69r1209b87],
10	Raptis	NNP	PERSON	Raptis	nn	11	SENT_351	[p24l1233t24r1424b93],
11	G	NNP	O	G	appos	2	SENT_351	[p24l1449t25r1516b87],
12	,	,	O	,	_	0	SENT_351	[p24l1449t25r1516b87],
13	Brafman	NNP	PERSON	Brafman	nn	14	SENT_351	[p24l1540t24r1806b78],
14	L	NNP	O	L	appos	2	SENT_351	[p24l1826t26r1888b87],
15	,	,	O	,	_	0	SENT_351	[p24l1826t26r1888b87],
16	Fuentes	NNP	PERSON	Fuentes	nn	17	SENT_351	[p24l1911t26r2146b78],
17	D	NNP	PERSON	D	appos	2	SENT_351	[p24l137t114r206b176],
18	,	,	O	,	_	0	SENT_351	[p24l137t114r206b176],
19	Sierra	NNP	LOCATION	Sierra	nn	20	SENT_351	[p24l237t112r416b166],
20	A	NNP	LOCATION	A	appos	2	SENT_351	[p24l440t113r509b175],
21	,	,	O	,	_	0	SENT_351	[p24l440t113r509b175],
22	Hershman	NNP	PERSON	Hershman	nn	23	SENT_351	[p24l537t113r849b166],
23	DL	NNP	O	DL	appos	2	SENT_351	[p24l874t114r974b165],
24	(	VBD	O	(	_	0	SENT_351	[p24l1001t113r1198b178],
25	2007	CD	DATE	2007	num	27	SENT_351	[p24l1001t113r1198b178],
26	)	CD	NUMBER	)	num	27	SENT_351	[p24l1001t113r1198b178],
27	Prevalence	NN	O	prevalence	dobj	24	SENT_351	[p24l1225t112r1558b166],
28	of	IN	O	of	_	0	SENT_351	[p24l1586t112r1651b166],
29	joint	JJ	O	joint	amod	30	SENT_351	[p24l1665t112r1811b181],
30	symptoms	NNS	O	symptom	prep_of	27	SENT_351	[p24l1838t121r2145b181],
31	in	IN	O	in	_	0	SENT_351	[p24l137t201r195b253],
32	postmenopausal	JJ	O	postmenopausal	amod	33	SENT_351	[p24l220t201r710b269],
33	women	NNS	O	woman	prep_in	24	SENT_351	[p24l739t217r962b254],
34	taking	VBG	O	take	partmod	33	SENT_351	[p24l988t201r1176b269],
35	aromatase	NN	O	aromatase	nn	36	SENT_351	[p24l1206t209r1512b254],
36	inhibitors	NNS	O	inhibitor	dobj	34	SENT_351	[p24l1539t201r1829b254],
37	for	IN	O	for	_	0	SENT_351	[p24l1857t201r1945b254],
38	earlystage	JJ	O	earlystage	amod	40	SENT_351	[p24l1971t201r2145b269, p24l140t297r291b357],
39	breast	NN	O	breast	nn	40	SENT_351	[p24l319t289r501b342],
40	cancer	NN	O	cancer	prep_for	34	SENT_351	[p24l529t305r741b342],
41	.	.	O	.	_	0	SENT_351	[p24l529t305r741b342],

1	J	NNP	O	J	nn	3	SENT_352	[p24l772t290r800b342],
2	Clin	NNP	O	Clin	nn	3	SENT_352	[p24l829t288r957b342],
3	Oncol	NNP	O	Oncol	_	0	SENT_352	[p24l986t289r1168b342],
4	25	CD	NUMBER	25	number	5	SENT_352	[p24l1197t288r1758b354],
5	(	CD	NUMBER	(	dep	3	SENT_352	[p24l1197t288r1758b354],
6	25	CD	NUMBER	25	num	7	SENT_352	[p24l1197t288r1758b354],
7	)	NN	O	)	dep	3	SENT_352	[p24l1197t288r1758b354],
8	:3877	CD	NUMBER	:3877	number	9	SENT_352	[p24l1197t288r1758b354],
9	—	CD	NUMBER	—	num	10	SENT_352	[p24l1197t288r1758b354],
10	3883	CD	DATE	3883	dep	7	SENT_352	[p24l1197t288r1758b354],

1	.	.	O	.	_	0	SENT_353	[p24l87t421r95b430],

1	Desta	NNP	O	Desta	nn	2	SENT_354	[p24l137t378r310b430],
2	Z	NNP	O	Z	nsubj	39	SENT_354	[p24l343t378r404b439],
3	,	,	O	,	_	0	SENT_354	[p24l343t378r404b439],
4	Kreutz	NNP	PERSON	Kreutz	nn	5	SENT_354	[p24l442t378r646b430],
5	Y	NN	PERSON	y	appos	2	SENT_354	[p24l682t378r750b439],
6	,	,	O	,	_	0	SENT_354	[p24l682t378r750b439],
7	Nguyen	NNP	ORGANIZATION	Nguyen	nn	8	SENT_354	[p24l787t378r1027b445],
8	AT	NNP	O	AT	appos	5	SENT_354	[p24l1061t377r1176b440],
9	,	,	O	,	_	0	SENT_354	[p24l1061t377r1176b440],
10	Li	NNP	PERSON	Li	nn	11	SENT_354	[p24l1213t376r1279b429],
11	L	NNP	PERSON	L	appos	5	SENT_354	[p24l1314t378r1375b439],
12	,	,	O	,	_	0	SENT_354	[p24l1314t378r1375b439],
13	Skaar	NNP	ORGANIZATION	Skaar	nn	14	SENT_354	[p24l1414t377r1585b430],
14	T	NN	ORGANIZATION	t	appos	5	SENT_354	[p24l1618t378r1679b439],
15	,	,	O	,	_	0	SENT_354	[p24l1618t378r1679b439],
16	Kamdem	NNP	ORGANIZATION	Kamdem	nn	17	SENT_354	[p24l1717t377r1995b430],
17	LK	NNP	ORGANIZATION	LK	appos	5	SENT_354	[p24l2028t378r2144b439],
18	,	,	O	,	_	0	SENT_354	[p24l2028t378r2144b439],
19	Henry	NNP	ORGANIZATION	Henry	nn	20	SENT_354	[p24l137t466r325b533],
20	NL	NNP	ORGANIZATION	NL	appos	5	SENT_354	[p24l360t466r476b528],
21	,	,	O	,	_	0	SENT_354	[p24l360t466r476b528],
22	Hayes	NNP	PERSON	Hayes	nn	23	SENT_354	[p24l513t466r700b533],
23	DF	NNP	O	DF	appos	5	SENT_354	[p24l735t466r846b528],
24	,	,	O	,	_	0	SENT_354	[p24l735t466r846b528],
25	Storniolo	NNP	ORGANIZATION	Storniolo	nn	26	SENT_354	[p24l886t465r1165b518],
26	AM	NNP	ORGANIZATION	AM	appos	5	SENT_354	[p24l1200t465r1337b528],
27	,	,	O	,	_	0	SENT_354	[p24l1200t465r1337b528],
28	Stearns	NNP	PERSON	Stearns	nn	29	SENT_354	[p24l1376t465r1595b518],
29	V	NNP	PERSON	V	appos	5	SENT_354	[p24l1631t466r1700b528],
30	,	,	O	,	_	0	SENT_354	[p24l1631t466r1700b528],
31	Hoffmann	NNP	PERSON	Hoffmann	nn	32	SENT_354	[p24l1737t465r2049b518],
32	E	NNP	O	E	appos	5	SENT_354	[p24l2083t466r2144b527],
33	,	,	O	,	_	0	SENT_354	[p24l2083t466r2144b527],
34	Tyndale	NNP	ORGANIZATION	Tyndale	nn	35	SENT_354	[p24l137t553r385b622],
35	RF	NNP	O	RF	appos	5	SENT_354	[p24l421t554r528b616],
36	,	,	O	,	_	0	SENT_354	[p24l421t554r528b616],
37	Flockhart	NNP	ORGANIZATION	Flockhart	nn	38	SENT_354	[p24l566t553r858b606],
38	DA	NNP	ORGANIZATION	DA	appos	5	SENT_354	[p24l892t553r1000b605],
39	(	VBD	O	(	dep	52	SENT_354	[p24l1037t553r1233b618],
40	2011	CD	DATE	2011	num	44	SENT_354	[p24l1037t553r1233b618],
41	)	CD	NUMBER	)	num	44	SENT_354	[p24l1037t553r1233b618],
42	Plasma	NN	O	plasma	nn	44	SENT_354	[p24l1271t553r1490b606],
43	letrozole	NN	O	letrozole	nn	44	SENT_354	[p24l1524t553r1790b606],
44	concentrations	NNS	O	concentration	dobj	39	SENT_354	[p24l1827t561r2145b606, p24l137t640r282b694],
45	in	IN	O	in	_	0	SENT_354	[p24l306t640r364b693],
46	postmenopausal	JJ	O	postmenopausal	amod	47	SENT_354	[p24l384t641r874b709],
47	women	NNS	O	woman	prep_in	39	SENT_354	[p24l898t657r1121b694],
48	with	IN	O	with	_	0	SENT_354	[p24l1143t640r1276b694],
49	breast	NN	O	breast	nn	50	SENT_354	[p24l1297t641r1479b694],
50	cancer	NN	O	cancer	prep_with	39	SENT_354	[p24l1502t657r1700b694],
51	are	VBP	O	be	auxpass	52	SENT_354	[p24l1722t657r1812b694],
52	associated	VBN	O	associate	_	0	SENT_354	[p24l1836t641r2147b694],
53	with	IN	O	with	_	0	SENT_354	[p24l138t729r271b782],
54	CYP2A6	NN	O	cyp2a6	prep_with	52	SENT_354	[p24l302t729r577b782],
55	genetic	JJ	O	genetic	amod	56	SENT_354	[p24l609t729r826b797],
56	variants	NNS	O	variant	nsubjpass	52	SENT_354	[p24l858t729r1114b791],
57	,	,	O	,	_	0	SENT_354	[p24l858t729r1114b791],
58	body	NN	O	body	nn	60	SENT_354	[p24l1146t729r1297b797],
59	mass	NN	O	mass	nn	60	SENT_354	[p24l1328t745r1476b782],
60	index	NN	O	index	appos	56	SENT_354	[p24l1508t729r1692b792],
61	,	,	O	,	_	0	SENT_354	[p24l1508t729r1692b792],
62	and	CC	O	and	_	0	SENT_354	[p24l1726t729r1834b782],
63	age	NN	O	age	conj_and	60	SENT_354	[p24l1865t745r1983b797],
64	.	.	O	.	_	0	SENT_354	[p24l1865t745r1983b797],

1	Clin	NNP	O	Clin	nn	3	SENT_355	[p24l2018t729r2148b782],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_355	[p24l137t817r461b870],
3	Ther	NNP	O	Ther	_	0	SENT_355	[p24l490t817r634b870],
4	90	CD	NUMBER	90	number	5	SENT_355	[p24l661t817r1126b883],
5	(	CD	NUMBER	(	dep	3	SENT_355	[p24l661t817r1126b883],
6	5	CD	NUMBER	5	num	7	SENT_355	[p24l661t817r1126b883],
7	)	NN	O	)	dep	5	SENT_355	[p24l661t817r1126b883],
8	:693	CD	NUMBER	:693	num	9	SENT_355	[p24l661t817r1126b883],
9	—	NN	O	—	dep	3	SENT_355	[p24l661t817r1126b883],
10	700	CD	NUMBER	700	dep	9	SENT_355	[p24l661t817r1126b883],
11	.	.	O	.	_	0	SENT_355	[p24l661t817r1126b883],

1	doi	FW	O	doi	nn	2	SENT_356	[p24l1158t817r1963b886],
2	:10	FW	O	:10	_	0	SENT_356	[p24l1158t817r1963b886],
3	.	.	O	.	_	0	SENT_356	[p24l1158t817r1963b886],

1	l038/clpt	JJ	O	l038/clpt	amod	2	SENT_357	[p24l1158t817r1963b886],
2	.2011.174	NN	O	.2011.174	_	0	SENT_357	[p24l1158t817r1963b886],

1	.	.	O	.	_	0	SENT_358	[p24l87t949r95b958],

1	Dowsett	NNP	PERSON	Dowsett	nn	2	SENT_359	[p24l137t906r390b958],
2	M	NNP	O	M	nsubj	58	SENT_359	[p24l414t906r496b967],
3	,	,	O	,	_	0	SENT_359	[p24l414t906r496b967],
4	Cuzick	NNP	PERSON	Cuzick	nn	5	SENT_359	[p24l524t904r739b958],
5	J	NNP	PERSON	J	appos	2	SENT_359	[p24l762t906r806b967],
6	,	,	O	,	_	0	SENT_359	[p24l762t906r806b967],
7	Ingle	NNP	PERSON	Ingle	nn	8	SENT_359	[p24l834t905r988b973],
8	J	NNP	PERSON	J	appos	5	SENT_359	[p24l1013t906r1057b967],
9	,	,	O	,	_	0	SENT_359	[p24l1013t906r1057b967],
10	Coates	NNP	O	Coates	nn	11	SENT_359	[p24l1086t905r1289b958],
11	A	NNP	O	A	appos	5	SENT_359	[p24l1315t905r1384b967],
12	,	,	O	,	_	0	SENT_359	[p24l1315t905r1384b967],
13	Forbes	NNP	PERSON	Forbes	nn	14	SENT_359	[p24l1411t905r1615b958],
14	J	NNP	PERSON	J	appos	5	SENT_359	[p24l1641t906r1685b967],
15	,	,	O	,	_	0	SENT_359	[p24l1641t906r1685b967],
16	Bliss	NNP	PERSON	Bliss	nn	17	SENT_359	[p24l1712t904r1861b958],
17	J	NNP	PERSON	J	appos	5	SENT_359	[p24l1887t906r1931b968],
18	,	,	O	,	_	0	SENT_359	[p24l1887t906r1931b968],
19	Buyse	NNP	PERSON	Buyse	nn	20	SENT_359	[p24l1959t906r2146b973],
20	M	NNP	O	M	appos	5	SENT_359	[p24l136t995r219b1057],
21	,	,	O	,	_	0	SENT_359	[p24l136t995r219b1057],
22	Baum	NNP	PERSON	Baum	nn	23	SENT_359	[p24l253t995r435b1047],
23	M	NNP	O	M	appos	5	SENT_359	[p24l465t995r547b1057],
24	,	,	O	,	_	0	SENT_359	[p24l465t995r547b1057],
25	Buzdar	NNP	PERSON	Buzdar	nn	26	SENT_359	[p24l581t994r801b1047],
26	A	NNP	O	A	appos	5	SENT_359	[p24l832t994r901b1057],
27	,	,	O	,	_	0	SENT_359	[p24l832t994r901b1057],
28	Colleoni	NNP	O	Colleoni	nn	29	SENT_359	[p24l937t994r1196b1047],
29	M	NNP	O	M	appos	5	SENT_359	[p24l1228t995r1310b1057],
30	,	,	O	,	_	0	SENT_359	[p24l1228t995r1310b1057],
31	Coombes	NNP	PERSON	Coombes	nn	32	SENT_359	[p24l1346t994r1629b1047],
32	C	NNP	O	C	appos	5	SENT_359	[p24l1664t994r1728b1057],
33	,	,	O	,	_	0	SENT_359	[p24l1664t994r1728b1057],
34	Snowdon	NNP	PERSON	Snowdon	nn	35	SENT_359	[p24l1764t994r2048b1047],
35	C	NNP	O	C	appos	5	SENT_359	[p24l2080t994r2144b1057],
36	,	,	O	,	_	0	SENT_359	[p24l2080t994r2144b1057],
37	Gnant	NNP	PERSON	Gnant	nn	38	SENT_359	[p24l138t1083r323b1136],
38	M	NNP	O	M	appos	5	SENT_359	[p24l343t1084r425b1146],
39	,	,	O	,	_	0	SENT_359	[p24l343t1084r425b1146],
40	J	NNP	O	J	nn	42	SENT_359	[p24l450t1084r478b1136],
41	akesz	NN	O	akesz	nn	42	SENT_359	[p24l481t1083r647b1136],
42	R	NN	O	r	appos	5	SENT_359	[p24l670t1084r735b1146],
43	,	,	O	,	_	0	SENT_359	[p24l670t1084r735b1146],
44	Kaufmann	NNP	PERSON	Kaufmann	nn	45	SENT_359	[p24l761t1083r1080b1136],
45	M	NNP	O	M	appos	5	SENT_359	[p24l1102t1084r1184b1146],
46	,	,	O	,	_	0	SENT_359	[p24l1102t1084r1184b1146],
47	Boccardo	NNP	PERSON	Boccardo	nn	48	SENT_359	[p24l1209t1083r1499b1136],
48	F	NN	O	f	appos	5	SENT_359	[p24l1521t1084r1578b1146],
49	,	,	O	,	_	0	SENT_359	[p24l1521t1084r1578b1146],
50	Godwin	NNP	PERSON	Godwin	nn	51	SENT_359	[p24l1604t1083r1847b1136],
51	J	NNP	PERSON	J	appos	5	SENT_359	[p24l1868t1084r1912b1146],
52	,	,	O	,	_	0	SENT_359	[p24l1868t1084r1912b1146],
53	Davies	NNP	PERSON	Davies	nn	54	SENT_359	[p24l1937t1083r2146b1137],
54	C	NNP	O	C	appos	5	SENT_359	[p24l138t1171r202b1234],
55	,	,	O	,	_	0	SENT_359	[p24l138t1171r202b1234],
56	Peto	NNP	PERSON	Peto	nn	57	SENT_359	[p24l243t1172r376b1224],
57	R	NNP	PERSON	R	appos	5	SENT_359	[p24l415t1172r465b1223],
58	(	VBD	O	(	_	0	SENT_359	[p24l505t1171r701b1236],
59	2010	CD	DATE	2010	num	61	SENT_359	[p24l505t1171r701b1236],
60	)	CD	NUMBER	)	num	61	SENT_359	[p24l505t1171r701b1236],
61	Meta-analysis	NN	O	meta-analysis	dobj	58	SENT_359	[p24l741t1171r1166b1240],
62	of	IN	O	of	_	0	SENT_359	[p24l1207t1171r1273b1224],
63	breast	NN	O	breast	nn	65	SENT_359	[p24l1304t1171r1487b1224],
64	cancer	NN	O	cancer	nn	65	SENT_359	[p24l1525t1188r1724b1224],
65	outcomes	NNS	O	outcome	prep_of	61	SENT_359	[p24l1761t1179r2049b1224],
66	in	IN	O	in	_	0	SENT_359	[p24l2089t1171r2147b1223],
67	adjuvant	JJ	O	adjuvant	amod	68	SENT_359	[p24l139t1259r399b1327],
68	trials	NNS	O	trial	prep_in	58	SENT_359	[p24l431t1259r581b1312],
69	of	IN	O	of	_	0	SENT_359	[p24l616t1259r681b1312],
70	aromatase	NN	O	aromatase	nn	71	SENT_359	[p24l710t1267r1016b1312],
71	inhibitors	NNS	O	inhibitor	prep_of	68	SENT_359	[p24l1049t1259r1339b1312],
72	versus	CC	O	versus	prep	71	SENT_359	[p24l1373t1275r1564b1312],
73	tamoxifen	NN	O	tamoxifen	dep	72	SENT_359	[p24l1598t1259r1921b1312],
74	.	.	O	.	_	0	SENT_359	[p24l1598t1259r1921b1312],

1	J	NNP	O	J	nn	3	SENT_360	[p24l1957t1260r1985b1312],
2	Clin	NNP	O	Clin	nn	3	SENT_360	[p24l2018t1259r2148b1312],
3	Oncol	NNP	O	Oncol	_	0	SENT_360	[p24l139t1348r321b1401],
4	28	CD	NUMBER	28	number	5	SENT_360	[p24l350t1348r816b1413],
5	(	CD	NUMBER	(	dep	3	SENT_360	[p24l350t1348r816b1413],
6	3	CD	NUMBER	3	num	7	SENT_360	[p24l350t1348r816b1413],
7	)	NN	O	)	dep	5	SENT_360	[p24l350t1348r816b1413],
8	:509	CD	NUMBER	:509	num	9	SENT_360	[p24l350t1348r816b1413],
9	—	NN	O	—	dep	3	SENT_360	[p24l350t1348r816b1413],
10	518	CD	NUMBER	518	dep	9	SENT_360	[p24l350t1348r816b1413],
11	.	.	O	.	_	0	SENT_360	[p24l350t1348r816b1413],

1	doi	FW	O	doi	_	0	SENT_361	[p24l848t1348r959b1401],
2	:	:	O	:	_	0	SENT_361	[p24l848t1348r959b1401],
3	10.1200	CD	NUMBER	10.1200	dep	1	SENT_361	[p24l974t1348r1650b1402],
4	/	:	O	/	punct	5	SENT_361	[p24l974t1348r1650b1402],
5	JCO	NNP	O	JCO	dep	3	SENT_361	[p24l974t1348r1650b1402],
6	.2009.23	CD	NUMBER	.2009.23	num	5	SENT_361	[p24l974t1348r1650b1402],
7	.	.	O	.	_	0	SENT_361	[p24l974t1348r1650b1402],

1	1274	CD	DATE	1274	_	0	SENT_362	[p24l1664t1348r1806b1401],

1	.	.	O	.	_	0	SENT_363	[p24l87t1480r95b1489],

1	Goss	NNP	ORGANIZATION	Goss	nn	2	SENT_364	[p24l138t1436r285b1489],
2	PE	NNP	ORGANIZATION	PE	nsubj	54	SENT_364	[p24l312t1437r415b1499],
3	,	,	O	,	_	0	SENT_364	[p24l312t1437r415b1499],
4	Ingle	NNP	ORGANIZATION	Ingle	nn	5	SENT_364	[p24l443t1436r598b1505],
5	JN	NN	ORGANIZATION	jn	appos	2	SENT_364	[p24l623t1437r722b1499],
6	,	,	O	,	_	0	SENT_364	[p24l623t1437r722b1499],
7	Martino	NNP	PERSON	Martino	nn	8	SENT_364	[p24l750t1436r993b1489],
8	S	NNP	O	S	appos	5	SENT_364	[p24l1022t1436r1076b1499],
9	,	,	O	,	_	0	SENT_364	[p24l1022t1436r1076b1499],
10	Robert	NNP	PERSON	Robert	nn	11	SENT_364	[p24l1104t1436r1311b1489],
11	NJ	NNP	PERSON	NJ	appos	5	SENT_364	[p24l1335t1437r1433b1499],
12	,	,	O	,	_	0	SENT_364	[p24l1335t1437r1433b1499],
13	Muss	NNP	ORGANIZATION	Muss	nn	14	SENT_364	[p24l1462t1437r1622b1489],
14	HB	NNP	ORGANIZATION	HB	appos	5	SENT_364	[p24l1649t1437r1769b1499],
15	,	,	O	,	_	0	SENT_364	[p24l1649t1437r1769b1499],
16	Piccart	NNP	ORGANIZATION	Piccart	nn	17	SENT_364	[p24l1797t1436r2008b1489],
17	MJ	NNP	ORGANIZATION	MJ	appos	5	SENT_364	[p24l2033t1437r2144b1499],
18	,	,	O	,	_	0	SENT_364	[p24l2033t1437r2144b1499],
19	Castiglione	NNP	PERSON	Castiglione	nn	20	SENT_364	[p24l138t1523r483b1592],
20	M	NNP	O	M	appos	5	SENT_364	[p24l506t1524r588b1586],
21	,	,	O	,	_	0	SENT_364	[p24l506t1524r588b1586],
22	Tu	NNP	O	Tu	nn	23	SENT_364	[p24l614t1524r696b1576],
23	D	NNP	O	D	appos	5	SENT_364	[p24l719t1524r788b1586],
24	,	,	O	,	_	0	SENT_364	[p24l719t1524r788b1586],
25	Shepherd	NNP	ORGANIZATION	Shepherd	nn	26	SENT_364	[p24l816t1523r1100b1592],
26	LE	NNP	ORGANIZATION	LE	appos	5	SENT_364	[p24l1122t1524r1230b1586],
27	,	,	O	,	_	0	SENT_364	[p24l1122t1524r1230b1586],
28	Pritchard	NNP	PERSON	Pritchard	nn	29	SENT_364	[p24l1256t1523r1535b1576],
29	KI	NNP	PERSON	KI	appos	5	SENT_364	[p24l1558t1524r1651b1586],
30	,	,	O	,	_	0	SENT_364	[p24l1558t1524r1651b1586],
31	Livingston	NNP	ORGANIZATION	Livingston	nn	32	SENT_364	[p24l1676t1523r2005b1592],
32	RB	NN	ORGANIZATION	rb	appos	5	SENT_364	[p24l2028t1524r2144b1586],
33	,	,	O	,	_	0	SENT_364	[p24l2028t1524r2144b1586],
34	Davidson	NNP	PERSON	Davidson	nn	35	SENT_364	[p24l137t1613r427b1666],
35	NE	NNS	O	ne	appos	5	SENT_364	[p24l469t1614r586b1676],
36	,	,	O	,	_	0	SENT_364	[p24l469t1614r586b1676],
37	Norton	NNP	ORGANIZATION	Norton	nn	38	SENT_364	[p24l630t1614r845b1666],
38	L	NNP	ORGANIZATION	L	appos	5	SENT_364	[p24l886t1614r948b1676],
39	,	,	O	,	_	0	SENT_364	[p24l886t1614r948b1676],
40	Perez	NNP	ORGANIZATION	Perez	nn	41	SENT_364	[p24l993t1614r1160b1666],
41	EA	NN	ORGANIZATION	ea	appos	5	SENT_364	[p24l1202t1613r1318b1676],
42	,	,	O	,	_	0	SENT_364	[p24l1202t1613r1318b1676],
43	Abrams	NNP	PERSON	Abrams	nn	44	SENT_364	[p24l1363t1613r1601b1666],
44	JS	NNP	O	JS	appos	5	SENT_364	[p24l1645t1613r1731b1676],
45	,	,	O	,	_	0	SENT_364	[p24l1645t1613r1731b1676],
46	Therasse	NNP	O	Therasse	nn	47	SENT_364	[p24l1776t1613r2044b1666],
47	P	NN	O	p	appos	5	SENT_364	[p24l2087t1614r2144b1676],
48	,	,	O	,	_	0	SENT_364	[p24l2087t1614r2144b1676],
49	Palmer	NNP	ORGANIZATION	Palmer	nn	50	SENT_364	[p24l137t1702r353b1755],
50	MJ	NNP	ORGANIZATION	MJ	appos	5	SENT_364	[p24l385t1703r496b1765],
51	,	,	O	,	_	0	SENT_364	[p24l385t1703r496b1765],
52	Pater	NNP	O	Pater	nn	53	SENT_364	[p24l532t1703r689b1755],
53	JL	NNP	O	JL	appos	5	SENT_364	[p24l720t1703r795b1755],
54	(	VBP	O	(	_	0	SENT_364	[p24l830t1702r1027b1768],
55	2003	CD	DATE	2003	num	56	SENT_364	[p24l830t1702r1027b1768],
56	)	CD	NUMBER	)	nsubj	59	SENT_364	[p24l830t1702r1027b1768],
57	A	DT	O	a	det	59	SENT_364	[p24l1062t1702r1115b1754],
58	randomized	JJ	O	randomized	amod	59	SENT_364	[p24l1147t1702r1507b1755],
59	trial	NN	O	trial	xcomp	54	SENT_364	[p24l1540t1702r1662b1755],
60	of	IN	O	of	_	0	SENT_364	[p24l1696t1702r1762b1755],
61	letrozole	NN	O	letrozole	prep_of	59	SENT_364	[p24l1790t1702r2055b1755],
62	in	IN	O	in	_	0	SENT_364	[p24l2089t1702r2147b1754],
63	postmenopausal	JJ	O	postmenopausal	amod	64	SENT_364	[p24l136t1789r626b1858],
64	women	NNS	O	woman	prep_in	61	SENT_364	[p24l654t1806r876b1842],
65	after	IN	O	after	_	0	SENT_364	[p24l902t1789r1041b1842],
66	ﬁve	NN	O	ﬁve	nn	67	SENT_364	[p24l1066t1789r1176b1842],
67	years	NNS	DURATION	year	prep_after	54	SENT_364	[p24l1202t1806r1360b1858],
68	of	IN	O	of	_	0	SENT_364	[p24l1388t1789r1453b1842],
69	tamoxifen	NN	O	tamoxifen	nn	70	SENT_364	[p24l1473t1789r1782b1842],
70	therapy	NN	O	therapy	prep_of	67	SENT_364	[p24l1807t1789r2034b1858],
71	for	IN	O	for	_	0	SENT_364	[p24l2061t1789r2149b1842],
72	early-stage	JJ	O	early-stage	amod	74	SENT_364	[p24l138t1877r470b1946],
73	breast	NN	O	breast	nn	74	SENT_364	[p24l497t1877r679b1930],
74	cancer	NN	O	cancer	prep_for	70	SENT_364	[p24l707t1894r920b1930],
75	.	.	O	.	_	0	SENT_364	[p24l707t1894r920b1930],

1	N	NN	O	n	nn	3	SENT_365	[p24l951t1879r1004b1930],
2	Engl	NNP	O	Engl	nn	3	SENT_365	[p24l1031t1877r1173b1946],
3	J	NNP	O	J	nsubj	4	SENT_365	[p24l1201t1879r1229b1931],
4	Med	VBD	O	med	_	0	SENT_365	[p24l1256t1877r1394b1930],
5	349	CD	NUMBER	349	num	6	SENT_365	[p24l1424t1878r2025b1943],
6	(	CD	NUMBER	(	dep	4	SENT_365	[p24l1424t1878r2025b1943],
7	19	CD	NUMBER	19	num	8	SENT_365	[p24l1424t1878r2025b1943],
8	)	NN	O	)	dep	6	SENT_365	[p24l1424t1878r2025b1943],
9	:1793	CD	NUMBER	:1793	number	10	SENT_365	[p24l1424t1878r2025b1943],
10	—	CD	NUMBER	—	num	11	SENT_365	[p24l1424t1878r2025b1943],
11	l802	NN	O	l802	dep	8	SENT_365	[p24l1424t1878r2025b1943],

1	.	.	O	.	_	0	SENT_366	[p24l87t2010r95b2019],

1	Goss	NNP	ORGANIZATION	Goss	nn	2	SENT_367	[p24l138t1966r285b2019],
2	PE	NNP	ORGANIZATION	PE	nsubj	60	SENT_367	[p24l315t1967r418b2029],
3	,	,	O	,	_	0	SENT_367	[p24l315t1967r418b2029],
4	Ingle	NNP	ORGANIZATION	Ingle	nn	5	SENT_367	[p24l450t1966r604b2035],
5	JN	NN	ORGANIZATION	jn	appos	2	SENT_367	[p24l633t1967r732b2029],
6	,	,	O	,	_	0	SENT_367	[p24l633t1967r732b2029],
7	Ales-Martinez	NNP	PERSON	Ales-Martinez	nn	8	SENT_367	[p24l763t1966r1201b2019],
8	JE	NNP	O	JE	appos	5	SENT_367	[p24l1231t1967r1322b2029],
9	,	,	O	,	_	0	SENT_367	[p24l1231t1967r1322b2029],
10	Cheung	NNP	ORGANIZATION	Cheung	nn	11	SENT_367	[p24l1354t1966r1587b2035],
11	AM	NNP	ORGANIZATION	AM	appos	5	SENT_367	[p24l1617t1966r1753b2029],
12	,	,	O	,	_	0	SENT_367	[p24l1617t1966r1753b2029],
13	Chlebowski	NNP	ORGANIZATION	Chlebowski	nn	14	SENT_367	[p24l1786t1966r2146b2019],
14	RT	NN	ORGANIZATION	rt	appos	5	SENT_367	[p24l137t2055r249b2117],
15	,	,	O	,	_	0	SENT_367	[p24l137t2055r249b2117],
16	Wactawski-Wende	NNP	O	Wactawski-Wende	nn	17	SENT_367	[p24l275t2054r855b2108],
17	J	NNP	O	J	appos	5	SENT_367	[p24l879t2055r907b2108],
18	,	,	O	,	_	0	SENT_367	[p24l912t2098r923b2117],
19	McTiernan	NNP	PERSON	McTiernan	nn	20	SENT_367	[p24l950t2054r1288b2107],
20	A	NNP	O	A	appos	5	SENT_367	[p24l1311t2055r1381b2117],
21	,	,	O	,	_	0	SENT_367	[p24l1311t2055r1381b2117],
22	Robbins	NNP	PERSON	Robbins	nn	23	SENT_367	[p24l1407t2054r1658b2107],
23	J	NNP	PERSON	J	appos	5	SENT_367	[p24l1683t2055r1711b2108],
24	,	,	O	,	_	0	SENT_367	[p24l1716t2098r1727b2117],
25	Johnson	NNP	PERSON	Johnson	nn	26	SENT_367	[p24l1753t2054r2001b2108],
26	KC	NNP	O	KC	appos	5	SENT_367	[p24l2026t2054r2144b2117],
27	,	,	O	,	_	0	SENT_367	[p24l2026t2054r2144b2117],
28	Martin	NNP	PERSON	Martin	nn	29	SENT_367	[p24l137t2142r343b2195],
29	LW	NNP	PERSON	LW	appos	5	SENT_367	[p24l363t2144r497b2205],
30	,	,	O	,	_	0	SENT_367	[p24l363t2144r497b2205],
31	Winquist	NNP	ORGANIZATION	Winquist	nn	32	SENT_367	[p24l519t2142r799b2211],
32	E	NNP	ORGANIZATION	E	appos	5	SENT_367	[p24l818t2144r879b2205],
33	,	,	O	,	_	0	SENT_367	[p24l818t2144r879b2205],
34	Sarto	NNP	ORGANIZATION	Sarto	nn	35	SENT_367	[p24l904t2143r1060b2196],
35	GE	NNP	ORGANIZATION	GE	appos	5	SENT_367	[p24l1083t2143r1198b2205],
36	,	,	O	,	_	0	SENT_367	[p24l1083t2143r1198b2205],
37	Garber	NNP	PERSON	Garber	nn	38	SENT_367	[p24l1222t2142r1432b2196],
38	JE	NNP	O	JE	appos	5	SENT_367	[p24l1451t2144r1541b2205],
39	,	,	O	,	_	0	SENT_367	[p24l1451t2144r1541b2205],
40	Fabian	NNP	PERSON	Fabian	nn	41	SENT_367	[p24l1564t2142r1771b2195],
41	CJ	NNP	PERSON	CJ	appos	5	SENT_367	[p24l1792t2143r1885b2205],
42	,	,	O	,	_	0	SENT_367	[p24l1792t2143r1885b2205],
43	Pujol	NNP	PERSON	Pujol	nn	44	SENT_367	[p24l1909t2142r2067b2211],
44	P	NN	PERSON	p	appos	5	SENT_367	[p24l2088t2144r2144b2205],
45	,	,	O	,	_	0	SENT_367	[p24l2088t2144r2144b2205],
46	Maunsell	NN	ORGANIZATION	maunsell	nn	47	SENT_367	[p24l136t2232r419b2285],
47	E	NN	ORGANIZATION	e	appos	5	SENT_367	[p24l445t2233r507b2295],
48	,	,	O	,	_	0	SENT_367	[p24l445t2233r507b2295],
49	Farmer	NNP	PERSON	Farmer	nn	50	SENT_367	[p24l535t2233r756b2285],
50	P	NN	PERSON	p	appos	5	SENT_367	[p24l780t2233r836b2295],
51	,	,	O	,	_	0	SENT_367	[p24l780t2233r836b2295],
52	Gelmon	NNP	O	Gelmon	nn	53	SENT_367	[p24l867t2232r1110b2285],
53	KA	NN	O	ka	appos	5	SENT_367	[p24l1137t2232r1259b2295],
54	,	,	O	,	_	0	SENT_367	[p24l1137t2232r1259b2295],
55	Tu	NN	O	tu	nn	56	SENT_367	[p24l1288t2233r1371b2285],
56	D	NN	O	d	appos	5	SENT_367	[p24l1397t2233r1466b2295],
57	,	,	O	,	_	0	SENT_367	[p24l1397t2233r1466b2295],
58	Richardson	NNP	PERSON	Richardson	nn	59	SENT_367	[p24l1495t2232r1841b2285],
59	H	NNP	PERSON	H	appos	5	SENT_367	[p24l1867t2233r1920b2284],
60	(	VBD	O	(	_	0	SENT_367	[p24l1949t2232r2145b2298],
61	2011	CD	DATE	2011	num	63	SENT_367	[p24l1949t2232r2145b2298],
62	)	CD	NUMBER	)	num	63	SENT_367	[p24l1949t2232r2145b2298],
63	Exemestane	NN	O	exemestane	dobj	60	SENT_367	[p24l137t2320r504b2372],
64	for	IN	O	for	_	0	SENT_367	[p24l561t2319r649b2372],
65	breast	NN	O	breast	nn	68	SENT_367	[p24l701t2319r1109b2372],
66	—	NN	O	—	nn	68	SENT_367	[p24l701t2319r1109b2372],
67	cancer	NN	O	cancer	nn	68	SENT_367	[p24l701t2319r1109b2372],
68	prevention	NN	O	prevention	prep_for	60	SENT_367	[p24l1163t2319r1489b2388],
69	in	IN	O	in	_	0	SENT_367	[p24l1544t2319r1601b2372],
70	postmenopausal	JJ	O	postmenopausal	amod	71	SENT_367	[p24l1656t2319r2146b2388],
71	women	NNS	O	woman	prep_in	60	SENT_367	[p24l138t2424r374b2460],
72	.	.	O	.	_	0	SENT_367	[p24l138t2424r374b2460],

1	N	NN	O	n	nn	3	SENT_368	[p24l423t2408r477b2460],
2	Engl	NNP	O	Engl	nn	3	SENT_368	[p24l520t2407r663b2476],
3	J	NNP	O	J	nsubj	4	SENT_368	[p24l708t2408r736b2460],
4	Med	VBD	O	med	_	0	SENT_368	[p24l779t2407r918b2460],
5	364	CD	NUMBER	364	num	6	SENT_368	[p24l964t2407r1581b2473],
6	(	CD	NUMBER	(	dep	4	SENT_368	[p24l964t2407r1581b2473],
7	25	CD	NUMBER	25	num	8	SENT_368	[p24l964t2407r1581b2473],
8	)	NN	O	)	dep	6	SENT_368	[p24l964t2407r1581b2473],
9	:2381	CD	NUMBER	:2381	number	10	SENT_368	[p24l964t2407r1581b2473],
10	—	CD	NUMBER	—	num	11	SENT_368	[p24l964t2407r1581b2473],
11	239l	NN	O	239l	dep	8	SENT_368	[p24l964t2407r1581b2473],
12	.	.	O	.	_	0	SENT_368	[p24l964t2407r1581b2473],

1	doi	FW	O	doi	nn	4	SENT_369	[p24l1630t2407r2147b2460],
2	:10.1056	FW	O	:10.1056	nn	4	SENT_369	[p24l1630t2407r2147b2460],
3	ﬂ	FW	O	ﬂ	nn	4	SENT_369	[p24l1630t2407r2147b2460],
4	\	FW	O	\	_	0	SENT_369	[p24l1630t2407r2147b2460],
5	IEJ	NN	O	iej	dep	4	SENT_369	[p24l1630t2407r2147b2460],
6	Moal	JJ	O	moal	amod	7	SENT_369	[p24l137t2497r306b2549],
7	103507	CD	NUMBER	103507	dep	4	SENT_369	[p24l322t2496r539b2550],

1	Goss	NNP	ORGANIZATION	Goss	nn	2	SENT_370	[p24l138t2584r285b2637],
2	PE	NNP	ORGANIZATION	PE	dep	66	SENT_370	[p24l308t2585r412b2647],
3	,	,	O	,	_	0	SENT_370	[p24l308t2585r412b2647],
4	Ingle	NNP	ORGANIZATION	Ingle	nn	5	SENT_370	[p24l436t2584r590b2653],
5	JN	NN	ORGANIZATION	jn	appos	2	SENT_370	[p24l612t2585r711b2647],
6	,	,	O	,	_	0	SENT_370	[p24l612t2585r711b2647],
7	Pritchard	NNP	PERSON	Pritchard	nn	8	SENT_370	[p24l736t2584r1014b2637],
8	KI	NNP	PERSON	KI	appos	2	SENT_370	[p24l1037t2585r1130b2647],
9	,	,	O	,	_	0	SENT_370	[p24l1037t2585r1130b2647],
10	Ellis	NNP	PERSON	Ellis	nn	11	SENT_370	[p24l1154t2584r1291b2637],
11	MJ	NNP	PERSON	MJ	appos	2	SENT_370	[p24l1315t2585r1426b2647],
12	,	,	O	,	_	0	SENT_370	[p24l1315t2585r1426b2647],
13	Sledge	NNP	ORGANIZATION	Sledge	nn	14	SENT_370	[p24l1452t2584r1655b2653],
14	GW	NNP	ORGANIZATION	GW	appos	2	SENT_370	[p24l1679t2584r1819b2647],
15	,	,	O	,	_	0	SENT_370	[p24l1679t2584r1819b2647],
16	Budd	NNP	PERSON	Budd	nn	17	SENT_370	[p24l1843t2584r2007b2637],
17	GT	NN	O	gt	appos	2	SENT_370	[p24l2029t2584r2144b2647],
18	,	,	O	,	_	0	SENT_370	[p24l2029t2584r2144b2647],
19	Rabaglio	NN	O	rabaglio	nn	20	SENT_370	[p24l137t2672r410b2741],
20	M	NN	O	m	appos	2	SENT_370	[p24l448t2673r530b2735],
21	,	,	O	,	_	0	SENT_370	[p24l448t2673r530b2735],
22	Ansari	NNP	PERSON	Ansari	nn	23	SENT_370	[p24l570t2672r771b2725],
23	RH	NNP	O	RH	appos	2	SENT_370	[p24l808t2673r928b2735],
24	,	,	O	,	_	0	SENT_370	[p24l808t2673r928b2735],
25	Johnson	NNP	PERSON	Johnson	nn	26	SENT_370	[p24l968t2672r1216b2725],
26	DB	NNP	O	DB	appos	2	SENT_370	[p24l1252t2673r1372b2735],
27	,	,	O	,	_	0	SENT_370	[p24l1252t2673r1372b2735],
28	Tozer	NNP	PERSON	Tozer	nn	29	SENT_370	[p24l1413t2673r1591b2725],
29	R	NNP	PERSON	R	appos	2	SENT_370	[p24l1626t2673r1691b2735],
30	,	,	O	,	_	0	SENT_370	[p24l1626t2673r1691b2735],
31	D’Souza	NNP	O	D’Souza	nn	32	SENT_370	[p24l1731t2672r1997b2725],
32	DP	NN	O	dp	appos	2	SENT_370	[p24l2033t2673r2144b2735],
33	,	,	O	,	_	0	SENT_370	[p24l2033t2673r2144b2735],
34	Chalchal	JJ	PERSON	chalchal	amod	35	SENT_370	[p24l138t2760r407b2814],
35	H	NN	PERSON	h	appos	2	SENT_370	[p24l432t2762r501b2823],
36	,	,	O	,	_	0	SENT_370	[p24l432t2762r501b2823],
37	Spadafora	NNP	PERSON	Spadafora	nn	38	SENT_370	[p24l531t2760r837b2829],
38	S	NNP	O	S	appos	2	SENT_370	[p24l863t2761r917b2823],
39	,	,	O	,	_	0	SENT_370	[p24l863t2761r917b2823],
40	Stearns	NNP	PERSON	Stearns	nn	41	SENT_370	[p24l947t2761r1166b2814],
41	V	NNP	PERSON	V	appos	2	SENT_370	[p24l1193t2762r1262b2823],
42	,	,	O	,	_	0	SENT_370	[p24l1193t2762r1262b2823],
43	Perez	NNP	ORGANIZATION	Perez	nn	44	SENT_370	[p24l1289t2762r1456b2813],
44	EA	NN	ORGANIZATION	ea	appos	2	SENT_370	[p24l1481t2761r1598b2823],
45	,	,	O	,	_	0	SENT_370	[p24l1481t2761r1598b2823],
46	Liedke	NNP	ORGANIZATION	Liedke	nn	47	SENT_370	[p24l1625t2760r1836b2813],
47	PE	NNP	ORGANIZATION	PE	appos	2	SENT_370	[p24l1861t2762r1964b2823],
48	,	,	O	,	_	0	SENT_370	[p24l1861t2762r1964b2823],
49	Lang	NNP	PERSON	Lang	appos	2	SENT_370	[p24l1991t2762r2146b2829],
50	1	CD	NUMBER	1	num	49	SENT_370	[p24l137t2850r177b2911],
51	,	,	O	,	_	0	SENT_370	[p24l137t2850r177b2911],
52	Elliott	NNP	PERSON	Elliott	nn	53	SENT_370	[p24l220t2848r411b2902],
53	C	NNP	O	C	appos	2	SENT_370	[p24l452t2849r516b2912],
54	,	,	O	,	_	0	SENT_370	[p24l452t2849r516b2912],
55	Gelmon	NNP	O	Gelmon	nn	56	SENT_370	[p24l561t2849r804b2902],
56	KA	NN	O	ka	appos	2	SENT_370	[p24l846t2849r968b2911],
57	,	,	O	,	_	0	SENT_370	[p24l846t2849r968b2911],
58	Chapman	NNP	PERSON	Chapman	nn	59	SENT_370	[p24l1013t2848r1303b2917],
59	JA	NNP	O	JA	appos	2	SENT_370	[p24l1344t2849r1443b2911],
60	,	,	O	,	_	0	SENT_370	[p24l1344t2849r1443b2911],
61	Shepherd	NNP	ORGANIZATION	Shepherd	nn	63	SENT_370	[p24l1488t2849r1773b2917],
62	LE	NNP	ORGANIZATION	LE	nn	63	SENT_370	[p24l1813t2850r1905b2901],
63	(	NNP	O	(	appos	2	SENT_370	[p24l1949t2849r2145b2914],
64	2013	CD	DATE	2013	dep	66	SENT_370	[p24l1949t2849r2145b2914],
65	)	CD	NUMBER	)	num	66	SENT_370	[p24l1949t2849r2145b2914],
66	Exemestane	NN	O	exemestane	dep	79	SENT_370	[p24l137t2937r504b2989],
67	versus	CC	O	versus	prep	66	SENT_370	[p24l538t2953r729b2989],
68	anastrozole	NN	O	anastrozole	dep	67	SENT_370	[p24l765t2936r1109b2989],
69	in	IN	O	in	_	0	SENT_370	[p24l1143t2936r1201b2989],
70	postmenopausal	JJ	O	postmenopausal	amod	71	SENT_370	[p24l1233t2936r1723b3005],
71	women	NNS	O	woman	prep_in	68	SENT_370	[p24l1758t2953r1980b2989],
72	with	IN	O	with	_	0	SENT_370	[p24l2014t2936r2147b2989],
73	early	JJ	O	early	amod	75	SENT_370	[p24l138t3024r288b3093],
74	breast	NN	O	breast	nn	75	SENT_370	[p24l331t3024r514b3077],
75	cancer	NN	O	cancer	prep_with	71	SENT_370	[p24l558t3041r771b3077],
76	:	:	O	:	_	0	SENT_370	[p24l558t3041r771b3077],
77	NCIC	NNP	ORGANIZATION	NCIC	nn	79	SENT_370	[p24l820t3025r999b3078],
78	CTG	NNP	O	CTG	nn	79	SENT_370	[p24l1046t3025r1196b3078],
79	MA	NNP	O	MA	_	0	SENT_370	[p24l1239t3025r1567b3077],
80	.27	CD	NUMBER	.27	number	81	SENT_370	[p24l1239t3025r1567b3077],
81	—	CD	NUMBER	—	num	82	SENT_370	[p24l1239t3025r1567b3077],
82	a	DT	O	a	dep	79	SENT_370	[p24l1239t3025r1567b3077],
83	randomized	VBN	O	randomize	partmod	79	SENT_370	[p24l1609t3024r1969b3077],
84	controlled	JJ	O	controlled	ccomp	83	SENT_370	[p24l2014t3041r2145b3077, p24l137t3112r335b3166],
85	phase	NN	O	phase	iobj	84	SENT_370	[p24l362t3113r533b3181],
86	III	CD	NUMBER	iii	num	87	SENT_370	[p24l562t3114r636b3165],
87	trial	NN	O	trial	dobj	84	SENT_370	[p24l664t3112r800b3166],
88	.	.	O	.	_	0	SENT_370	[p24l664t3112r800b3166],

1	J	NNP	O	J	nn	3	SENT_371	[p24l832t3114r859b3166],
2	Clin	NNP	O	Clin	nn	3	SENT_371	[p24l887t3112r1017b3166],
3	Oncol	NNP	O	Oncol	_	0	SENT_371	[p24l1045t3113r1243b3166],
4	.	.	O	.	_	0	SENT_371	[p24l1045t3113r1243b3166],

1	Epub	NN	O	epub	nsubj	66	SENT_372	[p24l1275t3112r1433b3181],
2	ahead	RB	O	ahead	_	0	SENT_372	[p24l1463t3113r1639b3166],
3	of	IN	O	of	_	0	SENT_372	[p24l1667t3112r1732b3166],
4	print	NN	O	print	prep_ahead_of	1	SENT_372	[p24l1753t3112r1898b3181],
5	Henry	NNP	ORGANIZATION	Henry	nn	6	SENT_372	[p24l137t3201r325b3269],
6	NL	NNP	ORGANIZATION	NL	dep	56	SENT_372	[p24l349t3201r466b3263],
7	,	,	O	,	_	0	SENT_372	[p24l349t3201r466b3263],
8	Giles	NNP	PERSON	Giles	nn	9	SENT_372	[p24l493t3200r650b3253],
9	JT	NNP	O	JT	appos	6	SENT_372	[p24l675t3201r765b3263],
10	,	,	O	,	_	0	SENT_372	[p24l675t3201r765b3263],
11	Ang	NNP	O	Ang	nn	12	SENT_372	[p24l792t3201r921b3269],
12	D	NNP	O	D	appos	6	SENT_372	[p24l946t3201r1015b3263],
13	,	,	O	,	_	0	SENT_372	[p24l946t3201r1015b3263],
14	Mohan	NNP	PERSON	Mohan	nn	15	SENT_372	[p24l1041t3200r1256b3253],
15	M	NNP	PERSON	M	appos	6	SENT_372	[p24l1279t3201r1361b3263],
16	,	,	O	,	_	0	SENT_372	[p24l1279t3201r1361b3263],
17	Dadabhoy	NNP	PERSON	Dadabhoy	nn	18	SENT_372	[p24l1388t3200r1699b3269],
18	D	NNP	PERSON	D	appos	6	SENT_372	[p24l1724t3201r1793b3263],
19	,	,	O	,	_	0	SENT_372	[p24l1724t3201r1793b3263],
20	Robarge	NNP	PERSON	Robarge	nn	21	SENT_372	[p24l1820t3200r2076b3269],
21	J	NNP	PERSON	J	appos	6	SENT_372	[p24l2100t3201r2128b3253],
22	,	,	O	,	_	0	SENT_372	[p24l2133t3244r2144b3263],
23	Hayden	NNP	PERSON	Hayden	nn	24	SENT_372	[p24l137t3288r372b3357],
24	J	NNP	PERSON	J	appos	6	SENT_372	[p24l399t3290r427b3342],
25	,	,	O	,	_	0	SENT_372	[p24l432t3332r443b3351],
26	Lemler	NNP	PERSON	Lemler	nn	27	SENT_372	[p24l472t3288r694b3341],
27	S	NNP	O	S	appos	6	SENT_372	[p24l721t3289r776b3351],
28	,	,	O	,	_	0	SENT_372	[p24l721t3289r776b3351],
29	Shahverdi	NNP	PERSON	Shahverdi	nn	30	SENT_372	[p24l807t3288r1111b3342],
30	K	NNP	PERSON	K	appos	6	SENT_372	[p24l1141t3290r1209b3351],
31	,	,	O	,	_	0	SENT_372	[p24l1141t3290r1209b3351],
32	Powers	NNP	O	Powers	nn	33	SENT_372	[p24l1239t3290r1459b3342],
33	P	NN	O	p	appos	6	SENT_372	[p24l1487t3290r1543b3351],
34	,	,	O	,	_	0	SENT_372	[p24l1487t3290r1543b3351],
35	Li	NNP	PERSON	Li	nn	36	SENT_372	[p24l1573t3288r1639b3341],
36	L	NNP	PERSON	L	appos	6	SENT_372	[p24l1666t3290r1727b3351],
37	,	,	O	,	_	0	SENT_372	[p24l1666t3290r1727b3351],
38	Flockhart	NNP	ORGANIZATION	Flockhart	nn	39	SENT_372	[p24l1757t3288r2049b3341],
39	D	NNP	ORGANIZATION	D	appos	6	SENT_372	[p24l2075t3290r2144b3351],
40	,	,	O	,	_	0	SENT_372	[p24l2075t3290r2144b3351],
41	Stearns	NNP	PERSON	Stearns	nn	42	SENT_372	[p24l139t3377r358b3430],
42	V	NNP	PERSON	V	appos	6	SENT_372	[p24l402t3378r471b3439],
43	,	,	O	,	_	0	SENT_372	[p24l402t3378r471b3439],
44	Hayes	NNP	PERSON	Hayes	nn	45	SENT_372	[p24l517t3378r703b3445],
45	DF	NNP	O	DF	appos	6	SENT_372	[p24l747t3378r858b3439],
46	,	,	O	,	_	0	SENT_372	[p24l747t3378r858b3439],
47	Storniolo	NNP	ORGANIZATION	Storniolo	nn	48	SENT_372	[p24l905t3376r1185b3430],
48	AM	NNP	ORGANIZATION	AM	appos	6	SENT_372	[p24l1228t3377r1365b3440],
49	,	,	O	,	_	0	SENT_372	[p24l1228t3377r1365b3440],
50	Clauw	NNP	PERSON	Clauw	nn	52	SENT_372	[p24l1411t3377r1607b3430],
51	DJ	NNP	O	DJ	nn	52	SENT_372	[p24l1650t3378r1732b3430],
52	(	NNP	O	(	appos	6	SENT_372	[p24l1777t3377r1973b3442],
53	2008	CD	DATE	2008	dep	56	SENT_372	[p24l1777t3377r1973b3442],
54	)	CD	NUMBER	)	num	56	SENT_372	[p24l1777t3377r1973b3442],
55	Prospective	JJ	O	prospective	amod	56	SENT_372	[p24l2018t3378r2145b3430, p24l140t3464r385b3533],
56	characterization	NN	O	characterization	dep	1	SENT_372	[p24l420t3464r907b3517],
57	of	IN	O	of	_	0	SENT_372	[p24l942t3464r1007b3517],
58	musculoskeletal	JJ	O	musculoskeletal	amod	59	SENT_372	[p24l1036t3464r1526b3517],
59	symptoms	NNS	O	symptom	prep_of	56	SENT_372	[p24l1562t3472r1870b3533],
60	in	IN	O	in	_	0	SENT_372	[p24l1905t3464r1963b3517],
61	early	JJ	O	early	amod	65	SENT_372	[p24l1996t3464r2146b3533],
62	stage	NN	O	stage	nn	65	SENT_372	[p24l140t3561r291b3621],
63	breast	NN	O	breast	nn	65	SENT_372	[p24l331t3552r514b3605],
64	cancer	NN	O	cancer	nn	65	SENT_372	[p24l553t3569r752b3605],
65	patients	NNS	O	patient	prep_in	1	SENT_372	[p24l790t3552r1026b3621],
66	treated	VBN	O	treat	_	0	SENT_372	[p24l1068t3552r1275b3605],
67	with	IN	O	with	_	0	SENT_372	[p24l1315t3552r1449b3606],
68	aromatase	NN	O	aromatase	nn	69	SENT_372	[p24l1490t3561r1796b3605],
69	inhibitors	NNS	O	inhibitor	prep_with	66	SENT_372	[p24l1837t3552r2143b3605],
70	.	.	O	.	_	0	SENT_372	[p24l1837t3552r2143b3605],

1	Breast	NN	O	breast	nn	4	SENT_373	[p24l137t3643r331b3695],
2	Cancer	NN	O	cancer	nn	4	SENT_373	[p24l359t3642r574b3695],
3	Res	NNP	O	Res	nn	4	SENT_373	[p24l600t3643r710b3695],
4	Treat	NNP	O	Treat	_	0	SENT_373	[p24l739t3643r900b3695],
5	111	CD	NUMBER	111	num	6	SENT_373	[p24l934t3641r1416b3707],
6	(	NN	O	(	dep	4	SENT_373	[p24l934t3641r1416b3707],
7	2	CD	NUMBER	2	number	8	SENT_373	[p24l934t3641r1416b3707],
8	)	CD	NUMBER	)	dep	6	SENT_373	[p24l934t3641r1416b3707],
9	:365	CD	NUMBER	:365	num	10	SENT_373	[p24l934t3641r1416b3707],
10	—	NN	O	—	dep	8	SENT_373	[p24l934t3641r1416b3707],
11	372	CD	NUMBER	372	dep	4	SENT_373	[p24l934t3641r1416b3707],

1	Henry	NNP	PERSON	Henry	nn	2	SENT_374	[p25l137t20r325b87],
2	NL	NNP	PERSON	NL	_	0	SENT_374	[p25l366t20r482b81],
3	,	,	O	,	_	0	SENT_374	[p25l366t20r482b81],
4	Pchejetski	NNP	PERSON	Pchejetski	nn	5	SENT_374	[p25l527t18r838b87],
5	D	NNP	PERSON	D	appos	2	SENT_374	[p25l880t20r949b81],
6	,	,	O	,	_	0	SENT_374	[p25l880t20r949b81],
7	A’Hern	NNP	O	A’Hern	nn	8	SENT_374	[p25l994t19r1224b71],
8	R	NNP	O	R	appos	2	SENT_374	[p25l1265t20r1330b81],
9	,	,	O	,	_	0	SENT_374	[p25l1265t20r1330b81],
10	Nguyen	NNP	ORGANIZATION	Nguyen	nn	11	SENT_374	[p25l1374t20r1613b87],
11	AT	NNP	O	AT	appos	8	SENT_374	[p25l1655t19r1771b81],
12	,	,	O	,	_	0	SENT_374	[p25l1655t19r1771b81],
13	Charles	NNP	PERSON	Charles	nn	14	SENT_374	[p25l1816t18r2045b72],
14	P	NN	PERSON	p	appos	8	SENT_374	[p25l2088t20r2144b81],
15	,	,	O	,	_	0	SENT_374	[p25l2088t20r2144b81],
16	Waxman	NNP	PERSON	Waxman	nn	17	SENT_374	[p25l136t108r411b160],
17	J	NNP	PERSON	J	appos	8	SENT_374	[p25l457t108r486b160],
18	,	,	O	,	_	0	SENT_374	[p25l491t150r502b169],
19	Li	NNP	PERSON	Li	nn	20	SENT_374	[p25l550t106r616b159],
20	L	NNP	PERSON	L	appos	8	SENT_374	[p25l663t108r724b169],
21	,	,	O	,	_	0	SENT_374	[p25l663t108r724b169],
22	Storniolo	NNP	ORGANIZATION	Storniolo	nn	23	SENT_374	[p25l775t106r1055b160],
23	AM	NNP	ORGANIZATION	AM	appos	8	SENT_374	[p25l1102t107r1238b169],
24	,	,	O	,	_	0	SENT_374	[p25l1102t107r1238b169],
25	Hayes	NNP	PERSON	Hayes	nn	26	SENT_374	[p25l1288t108r1475b175],
26	DF	NNP	O	DF	appos	8	SENT_374	[p25l1523t108r1634b169],
27	,	,	O	,	_	0	SENT_374	[p25l1523t108r1634b169],
28	Flockhart	NNP	ORGANIZATION	Flockhart	nn	29	SENT_374	[p25l1683t106r1975b159],
29	DA	NNP	ORGANIZATION	DA	appos	8	SENT_374	[p25l2020t107r2144b169],
30	,	,	O	,	_	0	SENT_374	[p25l2020t107r2144b169],
31	Stearns	NNP	PERSON	Stearns	nn	32	SENT_374	[p25l139t195r358b248],
32	V	NNP	PERSON	V	appos	8	SENT_374	[p25l395t196r464b257],
33	,	,	O	,	_	0	SENT_374	[p25l395t196r464b257],
34	Stebbing	VBG	O	stebb	partmod	2	SENT_374	[p25l505t194r771b263],
35	J	NN	O	j	dobj	34	SENT_374	[p25l806t196r835b248],
36	(	CD	NUMBER	(	num	40	SENT_374	[p25l872t195r1069b260],
37	2010	CD	DATE	2010	num	40	SENT_374	[p25l872t195r1069b260],
38	)	CD	NUMBER	)	num	40	SENT_374	[p25l872t195r1069b260],
39	Inﬂammatory	JJ	O	inﬂammatory	amod	40	SENT_374	[p25l1107t194r1520b263],
40	cytokines	NNS	O	cytokine	dep	35	SENT_374	[p25l1557t194r1845b263],
41	and	CC	O	and	_	0	SENT_374	[p25l1884t195r1991b248],
42	aromatase	NN	O	aromatase	nn	44	SENT_374	[p25l2028t211r2145b248, p25l137t291r347b336],
43	inhibitor	NN	O	inhibitor	nn	44	SENT_374	[p25l387t283r989b336],
44	—	NN	O	—	dobj	34	SENT_374	[p25l387t283r989b336],
45	associated	VBN	O	associate	partmod	44	SENT_374	[p25l387t283r989b336],
46	musculoskeletal	JJ	O	musculoskeletal	amod	47	SENT_374	[p25l1029t283r1519b336],
47	syndrome	NN	O	syndrome	dobj	45	SENT_374	[p25l1562t283r1874b351],
48	:	:	O	:	_	0	SENT_374	[p25l1562t283r1874b351],
49	a	DT	O	a	det	51	SENT_374	[p25l1922t299r1953b336],
50	casecontrol	NN	O	casecontrol	nn	51	SENT_374	[p25l1992t299r2145b336, p25l138t370r351b423],
51	study	NN	O	study	dep	47	SENT_374	[p25l382t370r558b439],
52	.	.	O	.	_	0	SENT_374	[p25l382t370r558b439],

1	Br	NN	O	br	nn	3	SENT_375	[p25l589t372r665b423],
2	J	NN	O	j	nn	3	SENT_375	[p25l690t372r718b424],
3	Cancer	NN	O	cancer	_	0	SENT_375	[p25l746t371r961b424],
4	103	CD	NUMBER	103	num	5	SENT_375	[p25l995t370r1476b436],
5	(	NN	O	(	dep	3	SENT_375	[p25l995t370r1476b436],
6	3	CD	NUMBER	3	num	7	SENT_375	[p25l995t370r1476b436],
7	)	NN	O	)	dep	5	SENT_375	[p25l995t370r1476b436],
8	:291	CD	NUMBER	:291	num	9	SENT_375	[p25l995t370r1476b436],
9	—	NN	O	—	dep	3	SENT_375	[p25l995t370r1476b436],
10	296	CD	NUMBER	296	dep	9	SENT_375	[p25l995t370r1476b436],
11	Henry	NNP	ORGANIZATION	Henry	nn	12	SENT_375	[p25l137t460r325b527],
12	NL	NNP	ORGANIZATION	NL	dep	3	SENT_375	[p25l354t460r470b521],
13	,	,	O	,	_	0	SENT_375	[p25l354t460r470b521],
14	Banerjee	NNP	PERSON	Banerjee	nn	15	SENT_375	[p25l502t458r771b527],
15	M	NNP	O	M	appos	12	SENT_375	[p25l801t460r882b521],
16	,	,	O	,	_	0	SENT_375	[p25l801t460r882b521],
17	Wicha	NNP	PERSON	Wicha	nn	18	SENT_375	[p25l913t458r1112b512],
18	M	NNP	O	M	appos	12	SENT_375	[p25l1140t460r1222b521],
19	,	,	O	,	_	0	SENT_375	[p25l1140t460r1222b521],
20	Van	NNP	PERSON	Van	nn	22	SENT_375	[p25l1254t460r1379b512],
21	Poznak	NNP	PERSON	Poznak	nn	22	SENT_375	[p25l1408t459r1632b512],
22	C	NNP	O	C	appos	12	SENT_375	[p25l1660t459r1724b521],
23	,	,	O	,	_	0	SENT_375	[p25l1660t459r1724b521],
24	Smerage	NNP	O	Smerage	nn	25	SENT_375	[p25l1758t459r2020b527],
25	JB	NNP	O	JB	appos	12	SENT_375	[p25l2049t460r2144b521],
26	,	,	O	,	_	0	SENT_375	[p25l2049t460r2144b521],
27	Schott	NNP	PERSON	Schott	nn	28	SENT_375	[p25l139t547r331b600],
28	AF	NNP	O	AF	appos	12	SENT_375	[p25l356t547r466b609],
29	,	,	O	,	_	0	SENT_375	[p25l356t547r466b609],
30	Griggs	NNP	PERSON	Griggs	nn	31	SENT_375	[p25l495t547r698b615],
31	JJ	NN	PERSON	jj	appos	12	SENT_375	[p25l724t548r797b610],
32	,	,	O	,	_	0	SENT_375	[p25l724t548r797b610],
33	Hayes	NNP	PERSON	Hayes	nn	34	SENT_375	[p25l825t548r1012b615],
34	DF	NN	O	df	appos	12	SENT_375	[p25l1038t548r1134b599],
35	(	CD	NUMBER	(	num	34	SENT_375	[p25l1160t547r1357b612],
36	2011	CD	DATE	2011	num	39	SENT_375	[p25l1160t547r1357b612],
37	)	NNP	O	)	nn	39	SENT_375	[p25l1160t547r1357b612],
38	Pilot	NN	O	pilot	nn	39	SENT_375	[p25l1384t547r1527b600],
39	study	NN	O	study	dep	3	SENT_375	[p25l1554t547r1714b615],
40	of	IN	O	of	_	0	SENT_375	[p25l1740t547r1806b600],
41	duloxetine	NN	O	duloxetine	prep_of	39	SENT_375	[p25l1827t547r2147b600],
42	for	IN	O	for	_	0	SENT_375	[p25l137t636r225b689],
43	treatment	NN	O	treatment	prep_for	41	SENT_375	[p25l259t644r547b689],
44	of	IN	O	of	_	0	SENT_375	[p25l582t636r648b689],
45	aromatase	NN	O	aromatase	prep_of	43	SENT_375	[p25l679t644r985b689],
46	inhibitor-associated	JJ	O	inhibitor-associated	amod	48	SENT_375	[p25l1020t636r1621b689],
47	musculoskeletal	JJ	O	musculoskeletal	amod	48	SENT_375	[p25l1656t636r2146b689],
48	symptoms	NNS	O	symptom	dep	39	SENT_375	[p25l140t732r464b792],
49	.	.	O	.	_	0	SENT_375	[p25l140t732r464b792],

1	Cancer	NNP	O	Cancer	_	0	SENT_376	[p25l496t724r711b777],
2	117	CD	NUMBER	117	number	3	SENT_376	[p25l745t724r847b777],
3	(	CD	NUMBER	(	dep	1	SENT_376	[p25l854t723r1338b789],
4	24	CD	NUMBER	24	num	5	SENT_376	[p25l854t723r1338b789],
5	)	NN	O	)	dep	3	SENT_376	[p25l854t723r1338b789],
6	:5469	CD	NUMBER	:5469	num	10	SENT_376	[p25l854t723r1338b789],
7	—	CD	NUMBER	—	num	10	SENT_376	[p25l854t723r1338b789],
8	5475	CD	DATE	5475	num	10	SENT_376	[p25l854t723r1338b789],
9	Henry	NNP	ORGANIZATION	Henry	nn	10	SENT_376	[p25l137t813r325b880],
10	NL	NNP	ORGANIZATION	NL	dep	1	SENT_376	[p25l363t813r479b874],
11	,	,	O	,	_	0	SENT_376	[p25l363t813r479b874],
12	Azzouz	NNP	PERSON	Azzouz	nn	13	SENT_376	[p25l519t812r749b865],
13	F	NN	PERSON	f	appos	10	SENT_376	[p25l787t813r844b874],
14	,	,	O	,	_	0	SENT_376	[p25l787t813r844b874],
15	Desta	NNP	PERSON	Desta	nn	16	SENT_376	[p25l884t813r1056b865],
16	Z	NNP	O	Z	appos	10	SENT_376	[p25l1092t813r1154b874],
17	,	,	O	,	_	0	SENT_376	[p25l1092t813r1154b874],
18	Li	NNP	PERSON	Li	nn	19	SENT_376	[p25l1194t812r1259b864],
19	L	NNP	PERSON	L	appos	10	SENT_376	[p25l1297t813r1358b874],
20	,	,	O	,	_	0	SENT_376	[p25l1297t813r1358b874],
21	Nguyen	NNP	ORGANIZATION	Nguyen	nn	22	SENT_376	[p25l1398t813r1638b881],
22	AT	NNP	O	AT	appos	10	SENT_376	[p25l1675t812r1790b874],
23	,	,	O	,	_	0	SENT_376	[p25l1675t812r1790b874],
24	Lemler	NNP	PERSON	Lemler	nn	25	SENT_376	[p25l1831t812r2052b865],
25	S	NNP	O	S	appos	10	SENT_376	[p25l2090t812r2144b875],
26	,	,	O	,	_	0	SENT_376	[p25l2090t812r2144b875],
27	Hayden	NNP	PERSON	Hayden	nn	28	SENT_376	[p25l137t900r372b968],
28	J	NNP	PERSON	J	appos	10	SENT_376	[p25l414t901r458b963],
29	,	,	O	,	_	0	SENT_376	[p25l414t901r458b963],
30	Tarpinian	NNP	PERSON	Tarpinian	nn	31	SENT_376	[p25l503t900r799b968],
31	K	NNP	PERSON	K	appos	10	SENT_376	[p25l842t901r909b963],
32	,	,	O	,	_	0	SENT_376	[p25l842t901r909b963],
33	Yakim	NNP	O	Yakim	nn	34	SENT_376	[p25l955t900r1161b953],
34	E	NNP	O	E	appos	10	SENT_376	[p25l1202t901r1264b962],
35	,	,	O	,	_	0	SENT_376	[p25l1202t901r1264b962],
36	Flockhart	NNP	ORGANIZATION	Flockhart	nn	37	SENT_376	[p25l1308t900r1600b953],
37	DA	NNP	ORGANIZATION	DA	appos	10	SENT_376	[p25l1642t900r1765b962],
38	,	,	O	,	_	0	SENT_376	[p25l1642t900r1765b962],
39	Stearns	NNP	PERSON	Stearns	nn	40	SENT_376	[p25l1812t900r2031b953],
40	V	NNP	PERSON	V	appos	10	SENT_376	[p25l2075t901r2144b963],
41	,	,	O	,	_	0	SENT_376	[p25l2075t901r2144b963],
42	Hayes	NNP	PERSON	Hayes	nn	43	SENT_376	[p25l137t989r324b1057],
43	DF	NNP	O	DF	appos	10	SENT_376	[p25l346t989r457b1051],
44	,	,	O	,	_	0	SENT_376	[p25l346t989r457b1051],
45	Stomiolo	NNP	ORGANIZATION	Stomiolo	nn	46	SENT_376	[p25l482t988r762b1041],
46	AM	NNP	ORGANIZATION	AM	appos	10	SENT_376	[p25l783t988r904b1040],
47	(	JJ	O	(	amod	50	SENT_376	[p25l927t988r1123b1053],
48	2012	CD	DATE	2012	num	50	SENT_376	[p25l927t988r1123b1053],
49	)	CD	NUMBER	)	num	50	SENT_376	[p25l927t988r1123b1053],
50	Predictors	NNS	O	predictor	dep	1	SENT_376	[p25l1146t988r1452b1041],
51	of	IN	O	of	_	0	SENT_376	[p25l1476t988r1541b1041],
52	aromatase	NN	O	aromatase	nn	54	SENT_376	[p25l1558t996r1864b1041],
53	inhibitor	NN	O	inhibitor	nn	54	SENT_376	[p25l1885t988r2148b1041],
54	discontinuation	NN	O	discontinuation	prep_of	50	SENT_376	[p25l138t1076r607b1129],
55	due	JJ	O	due	_	0	SENT_376	[p25l646t1076r753b1129],
56	to	TO	O	to	_	0	SENT_376	[p25l792t1084r848b1129],
57	treatment	NN	O	treatment	nn	58	SENT_376	[p25l888t1083r1486b1144],
58	—	NN	O	—	prep_due_to	60	SENT_376	[p25l888t1083r1486b1144],
59	emergent	NN	O	emergent	nn	60	SENT_376	[p25l888t1083r1486b1144],
60	symptoms	NNS	O	symptom	dep	1	SENT_376	[p25l1527t1084r1835b1144],
61	in	IN	O	in	_	0	SENT_376	[p25l1874t1076r1932b1128],
62	earlystage	JJ	O	earlystage	amod	64	SENT_376	[p25l1971t1076r2145b1144, p25l140t1172r291b1232],
63	breast	NN	O	breast	nn	64	SENT_376	[p25l319t1164r501b1217],
64	cancer	NN	O	cancer	prep_in	60	SENT_376	[p25l529t1180r741b1217],
65	.	.	O	.	_	0	SENT_376	[p25l529t1180r741b1217],

1	J	NNP	O	J	nn	9	SENT_377	[p25l772t1165r800b1217],
2	Clin	NNP	O	Clin	nn	9	SENT_377	[p25l828t1164r957b1217],
3	Oncol	NNP	O	Oncol	nn	9	SENT_377	[p25l985t1164r1168b1217],
4	30	CD	NUMBER	30	num	9	SENT_377	[p25l1198t1164r1647b1229],
5	(	CD	NUMBER	(	num	9	SENT_377	[p25l1198t1164r1647b1229],
6	9	CD	NUMBER	9	num	9	SENT_377	[p25l1198t1164r1647b1229],
7	)	NN	O	)	nn	9	SENT_377	[p25l1198t1164r1647b1229],
8	:936	CD	NUMBER	:936	num	9	SENT_377	[p25l1198t1164r1647b1229],
9	—	NN	O	—	nsubj	51	SENT_377	[p25l1198t1164r1647b1229],
10	942	CD	NUMBER	942	num	12	SENT_377	[p25l1198t1164r1647b1229],
11	Hershman	NNP	O	Hershman	nn	12	SENT_377	[p25l137t1253r449b1306],
12	DL	NNP	O	DL	dep	44	SENT_377	[p25l482t1254r598b1316],
13	,	,	O	,	_	0	SENT_377	[p25l482t1254r598b1316],
14	Kushi	NNP	ORGANIZATION	Kushi	nn	15	SENT_377	[p25l635t1253r813b1306],
15	LH	NNP	ORGANIZATION	LH	appos	12	SENT_377	[p25l847t1254r963b1316],
16	,	,	O	,	_	0	SENT_377	[p25l847t1254r963b1316],
17	Shao	NNP	PERSON	Shao	nn	18	SENT_377	[p25l1002t1253r1149b1307],
18	T	NN	PERSON	t	appos	12	SENT_377	[p25l1183t1254r1244b1316],
19	,	,	O	,	_	0	SENT_377	[p25l1183t1254r1244b1316],
20	Buono	NNP	PERSON	Buono	nn	21	SENT_377	[p25l1280t1254r1480b1306],
21	D	NNP	PERSON	D	appos	12	SENT_377	[p25l1515t1254r1584b1316],
22	,	,	O	,	_	0	SENT_377	[p25l1515t1254r1584b1316],
23	Kershenbaum	NNP	O	Kershenbaum	nn	24	SENT_377	[p25l1621t1253r2043b1306],
24	A	NNP	O	A	appos	12	SENT_377	[p25l2075t1253r2144b1316],
25	,	,	O	,	_	0	SENT_377	[p25l2075t1253r2144b1316],
26	Tsai	NNP	ORGANIZATION	Tsai	nn	27	SENT_377	[p25l137t1341r266b1394],
27	WY	NN	ORGANIZATION	wy	appos	12	SENT_377	[p25l286t1342r428b1403],
28	,	,	O	,	_	0	SENT_377	[p25l286t1342r428b1403],
29	Fehrenbacher	NNP	PERSON	Fehrenbacher	nn	30	SENT_377	[p25l451t1341r866b1394],
30	L	NNP	PERSON	L	appos	12	SENT_377	[p25l885t1342r946b1404],
31	,	,	O	,	_	0	SENT_377	[p25l885t1342r946b1404],
32	Gomez	NNP	PERSON	Gomez	nn	33	SENT_377	[p25l970t1341r1186b1394],
33	SL	NNP	O	SL	appos	12	SENT_377	[p25l1209t1341r1311b1403],
34	,	,	O	,	_	0	SENT_377	[p25l1209t1341r1311b1403],
35	Miles	NNP	O	Miles	nn	36	SENT_377	[p25l1333t1340r1504b1394],
36	S	NNP	O	S	appos	12	SENT_377	[p25l1528t1341r1582b1403],
37	,	,	O	,	_	0	SENT_377	[p25l1528t1341r1582b1403],
38	Neugut	NNP	PERSON	Neugut	appos	12	SENT_377	[p25l1604t1342r1828b1409],
39	A1	NN	O	a1	dep	44	SENT_377	[p25l1847t1341r1925b1393],
40	(	CD	NUMBER	(	num	39	SENT_377	[p25l1949t1341r2145b1406],
41	2010	CD	DATE	2010	num	44	SENT_377	[p25l1949t1341r2145b1406],
42	)	NNP	O	)	nn	44	SENT_377	[p25l1949t1341r2145b1406],
43	Early	NNP	O	Early	nn	44	SENT_377	[p25l137t1429r300b1497],
44	discontinuation	NN	O	discontinuation	dep	51	SENT_377	[p25l341t1429r810b1482],
45	and	CC	O	and	_	0	SENT_377	[p25l850t1429r958b1482],
46	nonadherence	NN	O	nonadherence	dep	51	SENT_377	[p25l996t1429r1418b1482],
47	to	TO	O	to	_	0	SENT_377	[p25l1459t1437r1515b1482],
48	adjuvant	JJ	O	adjuvant	amod	50	SENT_377	[p25l1557t1429r1817b1497],
49	hormonal	JJ	O	hormonal	amod	50	SENT_377	[p25l1856t1429r2147b1482],
50	therapy	NN	O	therapy	prep_to	44	SENT_377	[p25l137t1517r363b1586],
51	in	IN	O	in	_	0	SENT_377	[p25l398t1517r455b1569],
52	a	DT	O	a	det	53	SENT_377	[p25l491t1534r522b1570],
53	cohort	NN	O	cohort	pobj	51	SENT_377	[p25l555t1517r748b1570],
54	of	IN	O	of	_	0	SENT_377	[p25l782t1517r847b1570],
55	8,769	CD	NUMBER	8,769	num	59	SENT_377	[p25l879t1517r1044b1580],
56	early-stage	JJ	O	early-stage	amod	59	SENT_377	[p25l1079t1517r1412b1586],
57	breast	NN	O	breast	nn	59	SENT_377	[p25l1445t1517r1627b1570],
58	cancer	NN	O	cancer	nn	59	SENT_377	[p25l1661t1534r1859b1570],
59	patients	NNS	O	patient	prep_of	53	SENT_377	[p25l1891t1517r2143b1586],
60	.	.	O	.	_	0	SENT_377	[p25l1891t1517r2143b1586],

1	J	NNP	O	J	nn	3	SENT_378	[p25l137t1606r165b1658],
2	Clin	NNP	O	Clin	nn	3	SENT_378	[p25l193t1605r322b1658],
3	Oncol	NNP	O	Oncol	_	0	SENT_378	[p25l350t1605r533b1658],
4	28	CD	NUMBER	28	number	5	SENT_378	[p25l562t1605r1142b1671],
5	(	CD	NUMBER	(	dep	3	SENT_378	[p25l562t1605r1142b1671],
6	27	CD	NUMBER	27	num	7	SENT_378	[p25l562t1605r1142b1671],
7	)	NN	O	)	dep	5	SENT_378	[p25l562t1605r1142b1671],
8	:4120	CD	NUMBER	:4120	number	9	SENT_378	[p25l562t1605r1142b1671],
9	—	CD	NUMBER	—	dep	3	SENT_378	[p25l562t1605r1142b1671],
10	4128	CD	NUMBER	4128	dep	9	SENT_378	[p25l562t1605r1142b1671],
11	.	.	O	.	_	0	SENT_378	[p25l562t1605r1142b1671],

1	doi	FW	O	doi	_	0	SENT_379	[p25l1174t1605r2129b1659],
2	:10.1200	CD	NUMBER	:10.1200	dep	1	SENT_379	[p25l1174t1605r2129b1659],
3	/	:	O	/	punct	4	SENT_379	[p25l1174t1605r2129b1659],
4	JCO	NNP	ORGANIZATION	JCO	dep	2	SENT_379	[p25l1174t1605r2129b1659],
5	.2009.25.9655	CD	NUMBER	.2009.25.9655	num	7	SENT_379	[p25l1174t1605r2129b1659],
6	Ingle	NNP	ORGANIZATION	Ingle	nn	7	SENT_379	[p25l137t1694r291b1762],
7	JN	NN	ORGANIZATION	jn	dep	69	SENT_379	[p25l324t1695r423b1757],
8	,	,	O	,	_	0	SENT_379	[p25l324t1695r423b1757],
9	Schaid	NNP	O	Schaid	nn	10	SENT_379	[p25l459t1694r663b1747],
10	DJ	NNP	O	DJ	appos	7	SENT_379	[p25l695t1695r793b1757],
11	,	,	O	,	_	0	SENT_379	[p25l695t1695r793b1757],
12	Goss	NNP	PERSON	Goss	nn	13	SENT_379	[p25l829t1694r976b1747],
13	PE	NNP	O	PE	appos	7	SENT_379	[p25l1009t1695r1113b1757],
14	,	,	O	,	_	0	SENT_379	[p25l1009t1695r1113b1757],
15	Liu	NNP	ORGANIZATION	Liu	nn	16	SENT_379	[p25l1147t1694r1251b1747],
16	M	NNP	ORGANIZATION	M	appos	7	SENT_379	[p25l1283t1695r1365b1757],
17	,	,	O	,	_	0	SENT_379	[p25l1283t1695r1365b1757],
18	Mushiroda	NNP	ORGANIZATION	Mushiroda	nn	19	SENT_379	[p25l1400t1694r1729b1747],
19	T	NN	ORGANIZATION	t	appos	7	SENT_379	[p25l1760t1695r1821b1757],
20	,	,	O	,	_	0	SENT_379	[p25l1760t1695r1821b1757],
21	Chapman	NNP	PERSON	Chapman	nn	22	SENT_379	[p25l1857t1694r2147b1762],
22	JA	NNP	O	JA	appos	7	SENT_379	[p25l137t1782r235b1845],
23	,	,	O	,	_	0	SENT_379	[p25l137t1782r235b1845],
24	Kubo	NNP	PERSON	Kubo	nn	25	SENT_379	[p25l265t1782r430b1835],
25	M	NNP	O	M	appos	7	SENT_379	[p25l456t1783r538b1845],
26	,	,	O	,	_	0	SENT_379	[p25l456t1783r538b1845],
27	Jenkins	NNP	PERSON	Jenkins	nn	28	SENT_379	[p25l566t1782r791b1835],
28	GD	NN	MISC	gd	appos	7	SENT_379	[p25l819t1782r942b1845],
29	,	,	O	,	_	0	SENT_379	[p25l819t1782r942b1845],
30	Batzler	NNP	O	Batzler	nn	31	SENT_379	[p25l970t1782r1191b1835],
31	A	NNP	O	A	appos	7	SENT_379	[p25l1215t1782r1285b1845],
32	,	,	O	,	_	0	SENT_379	[p25l1215t1782r1285b1845],
33	Shepherd	NNP	ORGANIZATION	Shepherd	nn	34	SENT_379	[p25l1315t1782r1599b1851],
34	L	NNP	ORGANIZATION	L	appos	7	SENT_379	[p25l1624t1783r1686b1845],
35	,	,	O	,	_	0	SENT_379	[p25l1624t1783r1686b1845],
36	Pater	NNP	PERSON	Pater	nn	37	SENT_379	[p25l1714t1783r1870b1835],
37	J	NNP	PERSON	J	appos	7	SENT_379	[p25l1894t1783r1922b1835],
38	,	,	O	,	_	0	SENT_379	[p25l1927t1826r1938b1845],
39	Wang	NNP	PERSON	Wang	nn	40	SENT_379	[p25l1965t1783r2146b1851],
40	L	NNP	PERSON	L	appos	7	SENT_379	[p25l136t1871r198b1933],
41	,	,	O	,	_	0	SENT_379	[p25l136t1871r198b1933],
42	Ellis	NNP	PERSON	Ellis	nn	43	SENT_379	[p25l239t1870r376b1923],
43	MJ	NNP	PERSON	MJ	appos	7	SENT_379	[p25l416t1871r527b1933],
44	,	,	O	,	_	0	SENT_379	[p25l416t1871r527b1933],
45	Stearns	NNP	PERSON	Stearns	nn	46	SENT_379	[p25l571t1870r790b1924],
46	V	NNP	PERSON	V	appos	7	SENT_379	[p25l829t1871r898b1933],
47	,	,	O	,	_	0	SENT_379	[p25l829t1871r898b1933],
48	Rohrer	NNP	ORGANIZATION	Rohrer	nn	49	SENT_379	[p25l940t1870r1151b1923],
49	DC	NNP	ORGANIZATION	DC	appos	7	SENT_379	[p25l1188t1870r1308b1933],
50	,	,	O	,	_	0	SENT_379	[p25l1188t1870r1308b1933],
51	Goetz	NNP	PERSON	Goetz	nn	52	SENT_379	[p25l1350t1870r1528b1924],
52	MP	NNP	O	MP	appos	7	SENT_379	[p25l1568t1871r1692b1933],
53	,	,	O	,	_	0	SENT_379	[p25l1568t1871r1692b1933],
54	Pritchard	NNP	PERSON	Pritchard	nn	55	SENT_379	[p25l1733t1870r2012b1923],
55	KI	NNP	PERSON	KI	appos	7	SENT_379	[p25l2051t1871r2144b1933],
56	,	,	O	,	_	0	SENT_379	[p25l2051t1871r2144b1933],
57	Flockhart	NNP	ORGANIZATION	Flockhart	nn	58	SENT_379	[p25l137t1959r429b2012],
58	DA	NNP	ORGANIZATION	DA	appos	7	SENT_379	[p25l450t1960r574b2022],
59	,	,	O	,	_	0	SENT_379	[p25l450t1960r574b2022],
60	Nakamura	NNP	PERSON	Nakamura	nn	61	SENT_379	[p25l599t1959r916b2012],
61	Y	NN	PERSON	y	appos	7	SENT_379	[p25l938t1960r1007b2022],
62	,	,	O	,	_	0	SENT_379	[p25l938t1960r1007b2022],
63	Weinshilboum	NNP	O	Weinshilboum	appos	7	SENT_379	[p25l1031t1959r1481b2012],
64	RM	NN	O	rm	dep	69	SENT_379	[p25l1503t1960r1619b2012],
65	(	CD	NUMBER	(	num	64	SENT_379	[p25l1644t1959r1840b2025],
66	2010	CD	DATE	2010	num	69	SENT_379	[p25l1644t1959r1840b2025],
67	)	NNP	O	)	nn	69	SENT_379	[p25l1644t1959r1840b2025],
68	Genomewide	NNP	O	Genomewide	nn	69	SENT_379	[p25l1866t1959r2145b2012, p25l138t2048r283b2101],
69	associations	NNS	O	association	dep	2	SENT_379	[p25l323t2048r687b2101],
70	and	CC	O	and	_	0	SENT_379	[p25l728t2048r835b2101],
71	functional	JJ	O	functional	amod	72	SENT_379	[p25l872t2048r1180b2101],
72	genomic	JJ	O	genomic	amod	73	SENT_379	[p25l1219t2048r1478b2117],
73	studies	NNS	O	study	conj_and	69	SENT_379	[p25l1520t2048r1726b2101],
74	of	IN	O	of	_	0	SENT_379	[p25l1766t2048r1832b2101],
75	musculoskeletal	JJ	O	musculoskeletal	amod	77	SENT_379	[p25l1865t2048r2145b2101, p25l140t2135r368b2188],
76	adverse	JJ	O	adverse	amod	77	SENT_379	[p25l395t2135r624b2188],
77	events	NNS	O	event	prep_of	69	SENT_379	[p25l651t2143r841b2188],
78	in	IN	O	in	_	0	SENT_379	[p25l867t2135r925b2188],
79	women	NNS	O	woman	prep_in	2	SENT_379	[p25l950t2152r1172b2188],
80	receiving	VBG	O	receive	partmod	1	SENT_379	[p25l1196t2135r1478b2204],
81	aromatase	NN	O	aromatase	nn	82	SENT_379	[p25l1506t2143r1812b2188],
82	inhibitors	NNS	O	inhibitor	dobj	80	SENT_379	[p25l1837t2135r2143b2188],
83	.	.	O	.	_	0	SENT_379	[p25l1837t2135r2143b2188],

1	J	NNP	O	J	nn	3	SENT_380	[p25l137t2225r165b2278],
2	Clin	NNP	O	Clin	nn	3	SENT_380	[p25l193t2224r322b2277],
3	Oncol	NNP	O	Oncol	_	0	SENT_380	[p25l350t2224r533b2277],
4	28	CD	NUMBER	28	number	5	SENT_380	[p25l562t2224r1142b2290],
5	(	CD	NUMBER	(	dep	3	SENT_380	[p25l562t2224r1142b2290],
6	31	CD	NUMBER	31	num	7	SENT_380	[p25l562t2224r1142b2290],
7	)	NN	O	)	dep	5	SENT_380	[p25l562t2224r1142b2290],
8	:4674	CD	NUMBER	:4674	number	9	SENT_380	[p25l562t2224r1142b2290],
9	—	CD	NUMBER	—	dep	3	SENT_380	[p25l562t2224r1142b2290],
10	4682	CD	NUMBER	4682	dep	9	SENT_380	[p25l562t2224r1142b2290],
11	.	.	O	.	_	0	SENT_380	[p25l562t2224r1142b2290],

1	doi	FW	O	doi	dep	17	SENT_381	[p25l1174t2224r2132b2278],
2	:10.1200	CD	NUMBER	:10.1200	dep	1	SENT_381	[p25l1174t2224r2132b2278],
3	/	:	O	/	punct	1	SENT_381	[p25l1174t2224r2132b2278],
4	JCO	NNP	ORGANIZATION	JCO	nn	7	SENT_381	[p25l1174t2224r2132b2278],
5	.2010.28.5064	CD	NUMBER	.2010.28.5064	num	7	SENT_381	[p25l1174t2224r2132b2278],
6	Maggi	NNP	O	Maggi	nn	7	SENT_381	[p25l137t2313r333b2382],
7	A	NNP	O	A	dep	1	SENT_381	[p25l365t2313r434b2376],
8	,	,	O	,	_	0	SENT_381	[p25l365t2313r434b2376],
9	Ciana	NNP	PERSON	Ciana	nn	10	SENT_381	[p25l468t2313r645b2366],
10	P	NN	PERSON	p	appos	7	SENT_381	[p25l675t2314r731b2376],
11	,	,	O	,	_	0	SENT_381	[p25l675t2314r731b2376],
12	Belcredito	NNP	O	Belcredito	nn	13	SENT_381	[p25l765t2313r1081b2366],
13	S	NNP	O	S	appos	7	SENT_381	[p25l1115t2313r1169b2376],
14	,	,	O	,	_	0	SENT_381	[p25l1115t2313r1169b2376],
15	Vegeto	NNP	O	Vegeto	nn	16	SENT_381	[p25l1202t2314r1420b2382],
16	E	NNP	O	E	nsubj	17	SENT_381	[p25l1452t2314r1497b2365],
17	(	VBD	O	(	_	0	SENT_381	[p25l1530t2313r1727b2379],
18	2004	CD	DATE	2004	num	20	SENT_381	[p25l1530t2313r1727b2379],
19	)	CD	NUMBER	)	num	20	SENT_381	[p25l1530t2313r1727b2379],
20	Estrogens	NNS	O	estrogen	dobj	17	SENT_381	[p25l1759t2314r2057b2382],
21	in	IN	O	in	_	0	SENT_381	[p25l2089t2313r2147b2365],
22	the	DT	O	the	det	24	SENT_381	[p25l137t2401r228b2454],
23	nervous	JJ	O	nervous	amod	24	SENT_381	[p25l256t2418r494b2454],
24	system	NN	O	system	prep_in	17	SENT_381	[p25l525t2409r748b2470],
25	:	:	O	:	_	0	SENT_381	[p25l525t2409r748b2470],
26	mechanisms	NNS	O	mechanism	dep	24	SENT_381	[p25l781t2401r1155b2454],
27	and	CC	O	and	_	0	SENT_381	[p25l1186t2401r1293b2454],
28	nonreproductive	JJ	O	nonreproductive	amod	29	SENT_381	[p25l1319t2401r1817b2470],
29	functions	NNS	O	function	conj_and	26	SENT_381	[p25l1846t2401r2143b2454],
30	.	.	O	.	_	0	SENT_381	[p25l1846t2401r2143b2454],

1	Annu	NNP	PERSON	Annu	nn	3	SENT_382	[p25l137t2489r304b2541],
2	Rev	NN	PERSON	rev	nn	3	SENT_382	[p25l335t2489r455b2541],
3	Physiol	NN	PERSON	physiol	_	0	SENT_382	[p25l486t2488r713b2557],
4	66:291	CD	NUMBER	66:291	number	5	SENT_382	[p25l746t2488r1122b2542],
5	-313	CD	NUMBER	-313	num	3	SENT_382	[p25l746t2488r1122b2542],
6	.	.	O	.	_	0	SENT_382	[p25l746t2488r1122b2542],

1	doi	FW	O	doi	_	0	SENT_383	[p25l1157t2488r2142b2557],
2	:10.1146	CD	NUMBER	:10.1146	dep	1	SENT_383	[p25l1157t2488r2142b2557],
3	/	:	O	/	punct	4	SENT_383	[p25l1157t2488r2142b2557],
4	annurev	NN	O	annurev	dep	2	SENT_383	[p25l1157t2488r2142b2557],
5	.	.	O	.	_	0	SENT_383	[p25l1157t2488r2142b2557],

1	physio1	NN	O	physio1	_	0	SENT_384	[p25l1157t2488r2142b2557],
2	.66	CD	NUMBER	.66	dep	1	SENT_384	[p25l1157t2488r2142b2557],
3	.	.	O	.	_	0	SENT_384	[p25l1157t2488r2142b2557],

1	032802.154945	CD	NUMBER	032802.154945	_	0	SENT_385	[p25l138t2577r608b2631],

1	Mao	NNP	PERSON	Mao	nn	2	SENT_386	[p25l137t2668r274b2720],
2	JJ	NN	PERSON	jj	nsubj	24	SENT_386	[p25l306t2668r379b2730],
3	,	,	O	,	_	0	SENT_386	[p25l306t2668r379b2730],
4	Stricker	NNP	PERSON	Stricker	nn	5	SENT_386	[p25l416t2667r655b2720],
5	C	NNP	O	C	appos	2	SENT_386	[p25l686t2667r750b2730],
6	,	,	O	,	_	0	SENT_386	[p25l686t2667r750b2730],
7	Bruner	NNP	PERSON	Bruner	nn	8	SENT_386	[p25l785t2668r996b2720],
8	D	NNP	O	D	appos	2	SENT_386	[p25l1027t2668r1096b2730],
9	,	,	O	,	_	0	SENT_386	[p25l1027t2668r1096b2730],
10	Xie	NNP	O	Xie	nn	11	SENT_386	[p25l1130t2667r1238b2720],
11	S	NNP	O	S	appos	2	SENT_386	[p25l1272t2667r1327b2730],
12	,	,	O	,	_	0	SENT_386	[p25l1272t2667r1327b2730],
13	Bowman	NNP	PERSON	Bowman	nn	14	SENT_386	[p25l1361t2668r1635b2720],
14	MA	NNP	PERSON	MA	appos	2	SENT_386	[p25l1666t2667r1803b2730],
15	,	,	O	,	_	0	SENT_386	[p25l1666t2667r1803b2730],
16	Farrar	NNP	PERSON	Farrar	nn	17	SENT_386	[p25l1837t2668r2023b2720],
17	JT	NNP	O	JT	appos	2	SENT_386	[p25l2053t2668r2144b2730],
18	,	,	O	,	_	0	SENT_386	[p25l2053t2668r2144b2730],
19	Greene	NNP	PERSON	Greene	nn	20	SENT_386	[p25l138t2755r355b2808],
20	BT	NNP	O	BT	appos	2	SENT_386	[p25l386t2756r497b2818],
21	,	,	O	,	_	0	SENT_386	[p25l386t2756r497b2818],
22	Demichele	NNP	PERSON	Demichele	nn	23	SENT_386	[p25l530t2755r859b2808],
23	A	NNP	O	A	appos	2	SENT_386	[p25l889t2756r943b2808],
24	(	VBD	O	(	_	0	SENT_386	[p25l974t2756r1170b2821],
25	2009	CD	DATE	2009	num	26	SENT_386	[p25l974t2756r1170b2821],
26	)	CD	NUMBER	)	dobj	24	SENT_386	[p25l974t2756r1170b2821],
27	Patterns	NN	O	pattern	nn	30	SENT_386	[p25l1203t2756r1446b2808],
28	and	CC	O	and	_	0	SENT_386	[p25l1479t2755r1586b2808],
29	risk	NN	O	risk	nn	30	SENT_386	[p25l1614t2755r1729b2808],
30	factors	NNS	O	factor	nsubj	31	SENT_386	[p25l1757t2755r1961b2808],
31	associated	VBN	O	associate	dep	24	SENT_386	[p25l1994t2772r2144b2808, p25l138t2843r319b2896],
32	with	IN	O	with	_	0	SENT_386	[p25l354t2843r488b2897],
33	aromatase	NN	O	aromatase	nn	35	SENT_386	[p25l524t2852r830b2896],
34	inhibitor-related	JJ	O	inhibitor-related	amod	35	SENT_386	[p25l867t2843r1363b2896],
35	arthralgia	NN	O	arthralgium	prep_with	31	SENT_386	[p25l1399t2843r1690b2912],
36	among	IN	O	among	_	0	SENT_386	[p25l1726t2860r1930b2912],
37	breast	NN	O	breast	nn	39	SENT_386	[p25l1965t2843r2148b2896],
38	cancer	NN	O	cancer	nn	39	SENT_386	[p25l138t2949r336b2986],
39	survivors	NNS	O	survivor	prep_among	35	SENT_386	[p25l365t2932r659b2986],
40	.	.	O	.	_	0	SENT_386	[p25l365t2932r659b2986],

1	Cancer	NNP	O	Cancer	dep	7	SENT_387	[p25l692t2933r907b2986],
2	115	CD	NUMBER	115	number	3	SENT_387	[p25l940t2932r1534b2998],
3	(	CD	NUMBER	(	dep	1	SENT_387	[p25l940t2932r1534b2998],
4	16	CD	NUMBER	16	dep	3	SENT_387	[p25l940t2932r1534b2998],
5	)	NN	O	)	dep	7	SENT_387	[p25l940t2932r1534b2998],
6	:3631	CD	NUMBER	:3631	num	5	SENT_387	[p25l940t2932r1534b2998],
7	—	CD	NUMBER	—	dep	45	SENT_387	[p25l940t2932r1534b2998],
8	3639	CD	NUMBER	3639	num	10	SENT_387	[p25l940t2932r1534b2998],
9	Mao	NNP	PERSON	Mao	nn	10	SENT_387	[p25l137t3021r274b3073],
10	JJ	NN	PERSON	jj	dep	7	SENT_387	[p25l303t3021r376b3083],
11	,	,	O	,	_	0	SENT_387	[p25l303t3021r376b3083],
12	Su	FW	O	su	nn	13	SENT_387	[p25l410t3020r485b3073],
13	HI	FW	O	hi	dep	35	SENT_387	[p25l515t3021r609b3083],
14	,	,	O	,	_	0	SENT_387	[p25l515t3021r609b3083],
15	Feng	NNP	O	Feng	nn	16	SENT_387	[p25l640t3021r790b3089],
16	R	NNP	O	R	appos	13	SENT_387	[p25l819t3021r884b3083],
17	,	,	O	,	_	0	SENT_387	[p25l819t3021r884b3083],
18	Donelson	NNP	PERSON	Donelson	nn	19	SENT_387	[p25l915t3020r1206b3073],
19	ML	NNP	O	ML	appos	13	SENT_387	[p25l1234t3021r1363b3083],
20	,	,	O	,	_	0	SENT_387	[p25l1234t3021r1363b3083],
21	Aplenc	NNP	ORGANIZATION	Aplenc	nn	22	SENT_387	[p25l1394t3020r1611b3089],
22	R	NNP	ORGANIZATION	R	appos	13	SENT_387	[p25l1642t3021r1707b3083],
23	,	,	O	,	_	0	SENT_387	[p25l1642t3021r1707b3083],
24	Rebbeck	NNP	ORGANIZATION	Rebbeck	nn	25	SENT_387	[p25l1738t3020r2005b3073],
25	TR	NN	ORGANIZATION	tr	appos	13	SENT_387	[p25l2032t3021r2144b3083],
26	,	,	O	,	_	0	SENT_387	[p25l2032t3021r2144b3083],
27	Stanczyk	NNP	PERSON	Stanczyk	nn	28	SENT_387	[p25l139t3108r416b3177],
28	F	NN	O	f	appos	13	SENT_387	[p25l466t3110r523b3171],
29	,	,	O	,	_	0	SENT_387	[p25l466t3110r523b3171],
30	Demichele	NNP	PERSON	Demichele	nn	31	SENT_387	[p25l577t3108r906b3161],
31	A	NNP	O	A	appos	13	SENT_387	[p25l958t3109r1012b3161],
32	(	CD	NUMBER	(	dep	35	SENT_387	[p25l1065t3109r1262b3174],
33	2011	CD	DATE	2011	num	35	SENT_387	[p25l1065t3109r1262b3174],
34	)	NNP	O	)	nn	35	SENT_387	[p25l1065t3109r1262b3174],
35	Association	NNP	O	Association	dep	45	SENT_387	[p25l1316t3108r1674b3161],
36	of	IN	O	of	_	0	SENT_387	[p25l1726t3108r1792b3161],
37	functional	JJ	O	functional	amod	38	SENT_387	[p25l1839t3108r2146b3161],
38	polymorphisms	NNS	O	polymorphism	prep_of	35	SENT_387	[p25l136t3196r608b3265],
39	in	IN	O	in	_	0	SENT_387	[p25l635t3196r692b3249],
40	CYP19A1	NN	O	cyp19a1	prep_in	38	SENT_387	[p25l718t3197r1024b3250],
41	with	IN	O	with	_	0	SENT_387	[p25l1057t3196r1190b3250],
42	aromatase	NN	O	aromatase	nn	43	SENT_387	[p25l1217t3205r1523b3249],
43	inhibitor	NN	O	inhibitor	prep_with	40	SENT_387	[p25l1548t3196r1812b3249],
44	associated	VBN	O	associate	amod	45	SENT_387	[p25l1836t3196r2147b3249],
45	arthralgia	NN	O	arthralgium	_	0	SENT_387	[p25l139t3284r429b3353],
46	in	IN	O	in	_	0	SENT_387	[p25l450t3285r507b3337],
47	breast	NN	O	breast	nn	49	SENT_387	[p25l527t3285r710b3338],
48	cancer	NN	O	cancer	nn	49	SENT_387	[p25l731t3301r929b3338],
49	survivors	NNS	O	survivor	prep_in	45	SENT_387	[p25l952t3284r1246b3338],
50	.	.	O	.	_	0	SENT_387	[p25l952t3284r1246b3338],

1	Breast	NN	O	breast	nn	2	SENT_388	[p25l1271t3286r1465b3338],
2	Cancer	NN	O	cancer	_	0	SENT_388	[p25l1486t3285r1701b3338],
3	Res	NNP	O	Res	dep	2	SENT_388	[p25l1721t3286r1832b3338],
4	13	CD	NUMBER	13	num	3	SENT_388	[p25l1862t3285r2143b3350],
5	(	CD	NUMBER	(	number	6	SENT_388	[p25l1862t3285r2143b3350],
6	1	CD	NUMBER	1	num	7	SENT_388	[p25l1862t3285r2143b3350],
7	)	NN	O	)	dep	3	SENT_388	[p25l1862t3285r2143b3350],
8	:	:	O	:	_	0	SENT_388	[p25l1862t3285r2143b3350],
9	R8	NN	O	r8	dep	2	SENT_388	[p25l1862t3285r2143b3350],
10	.	.	O	.	_	0	SENT_388	[p25l1862t3285r2143b3350],

1	doi	FW	O	doi	_	0	SENT_389	[p25l138t3373r770b3427],
2	:10.1186	CD	NUMBER	:10.1186	dep	1	SENT_389	[p25l138t3373r770b3427],
3	/	:	O	/	punct	4	SENT_389	[p25l138t3373r770b3427],
4	bcr2813	CD	NUMBER	bcr2813	dep	2	SENT_389	[p25l138t3373r770b3427],

1	McShane	NNP	PERSON	McShane	nn	2	SENT_390	[p25l137t3462r422b3516],
2	LM	NNP	O	LM	nsubj	29	SENT_390	[p25l459t3464r588b3525],
3	,	,	O	,	_	0	SENT_390	[p25l459t3464r588b3525],
4	Altman	NNP	PERSON	Altman	nn	5	SENT_390	[p25l627t3462r855b3516],
5	DG	NNS	O	dg	dep	20	SENT_390	[p25l891t3463r1015b3525],
6	,	,	O	,	_	0	SENT_390	[p25l891t3463r1015b3525],
7	Sauerbrei	NNP	O	Sauerbrei	nn	8	SENT_390	[p25l1057t3462r1344b3516],
8	W	NNP	O	W	appos	5	SENT_390	[p25l1381t3464r1468b3525],
9	,	,	O	,	_	0	SENT_390	[p25l1381t3464r1468b3525],
10	T	NN	O	t	nn	12	SENT_390	[p25l1507t3464r1552b3515],
11	aube	NN	O	aube	nn	12	SENT_390	[p25l1556t3462r1696b3516],
12	SE	NN	O	se	appos	5	SENT_390	[p25l1735t3463r1836b3525],
13	,	,	O	,	_	0	SENT_390	[p25l1735t3463r1836b3525],
14	Gion	NNP	ORGANIZATION	Gion	nn	15	SENT_390	[p25l1877t3462r2026b3516],
15	M	NNP	ORGANIZATION	M	appos	5	SENT_390	[p25l2062t3464r2144b3525],
16	,	,	O	,	_	0	SENT_390	[p25l2062t3464r2144b3525],
17	Clark	NNP	PERSON	Clark	nn	18	SENT_390	[p25l138t3550r306b3604],
18	GM	NNP	PERSON	GM	appos	5	SENT_390	[p25l366t3551r484b3604],
19	(	CD	NUMBER	(	dep	20	SENT_390	[p25l547t3550r743b3616],
20	2005	CD	DATE	2005	dep	29	SENT_390	[p25l547t3550r743b3616],
21	)	CD	NUMBER	)	num	23	SENT_390	[p25l547t3550r743b3616],
22	REporting	NN	O	reporting	nn	23	SENT_390	[p25l805t3550r1120b3619],
23	recommendations	NNS	O	recommendation	dep	20	SENT_390	[p25l1180t3550r1720b3604],
24	for	IN	O	for	_	0	SENT_390	[p25l1782t3550r1870b3604],
25	tumour	NN	O	tumour	nn	26	SENT_390	[p25l1928t3559r2148b3604],
26	MARKer	NN	O	marker	prep_for	23	SENT_390	[p25l137t3639r424b3691],
27	prognostic	JJ	O	prognostic	amod	28	SENT_390	[p25l503t3638r822b3707],
28	studies	NNS	O	study	nsubj	29	SENT_390	[p25l907t3638r1113b3691],
29	(	VBP	O	(	_	0	SENT_390	[p25l1197t3639r1584b3704],
30	REMARK	NN	O	remark	dobj	29	SENT_390	[p25l1197t3639r1584b3704],
31	)	CD	NUMBER	)	num	30	SENT_390	[p25l1197t3639r1584b3704],
32	.	.	O	.	_	0	SENT_390	[p25l1197t3639r1584b3704],

1	Br	NN	O	br	nn	3	SENT_391	[p25l1669t3640r1745b3691],
2	J	NN	O	j	nn	3	SENT_391	[p25l1824t3640r1852b3692],
3	Cancer	NN	O	cancer	_	0	SENT_391	[p25l1933t3639r2148b3692],
4	93	CD	NUMBER	93	num	5	SENT_391	[p25l138t3728r582b3793],
5	(	NN	O	(	dep	3	SENT_391	[p25l138t3728r582b3793],
6	4	CD	NUMBER	4	number	7	SENT_391	[p25l138t3728r582b3793],
7	)	CD	NUMBER	)	dep	5	SENT_391	[p25l138t3728r582b3793],
8	:387	CD	NUMBER	:387	num	9	SENT_391	[p25l138t3728r582b3793],
9	—	NN	O	—	dep	7	SENT_391	[p25l138t3728r582b3793],
10	391	CD	NUMBER	391	dep	3	SENT_391	[p25l138t3728r582b3793],

1	Park	NNP	O	Park	nn	2	SENT_392	[p26l137t18r276b72],
2	IH	NN	O	ih	nsubj	27	SENT_392	[p26l296t20r391b81],
3	,	,	O	,	_	0	SENT_392	[p26l296t20r391b81],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_392	[p26l414t20r527b72],
5	YS	NNP	O	YS	appos	2	SENT_392	[p26l549t19r660b81],
6	,	,	O	,	_	0	SENT_392	[p26l549t19r660b81],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_392	[p26l684t20r796b72],
8	KS	NN	O	k	appos	2	SENT_392	[p26l820t19r930b81],
9	,	,	O	,	_	0	SENT_392	[p26l820t19r930b81],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_392	[p26l955t18r1088b71],
11	SY	NNP	PERSON	SY	appos	2	SENT_392	[p26l1111t19r1220b81],
12	,	,	O	,	_	0	SENT_392	[p26l1111t19r1220b81],
13	Hong	NNP	LOCATION	Hong	nn	14	SENT_392	[p26l1245t20r1410b87],
14	SH	NNP	LOCATION	SH	appos	2	SENT_392	[p26l1435t19r1544b81],
15	,	,	O	,	_	0	SENT_392	[p26l1435t19r1544b81],
16	Jeong	NNP	PERSON	Jeong	nn	17	SENT_392	[p26l1567t20r1743b87],
17	J	NNP	PERSON	J	appos	2	SENT_392	[p26l1764t20r1808b81],
18	,	,	O	,	_	0	SENT_392	[p26l1764t20r1808b81],
19	Lee	NNP	PERSON	Lee	nn	20	SENT_392	[p26l1832t20r1945b72],
20	H	NNP	O	H	appos	2	SENT_392	[p26l1967t20r2036b81],
21	,	,	O	,	_	0	SENT_392	[p26l1967t20r2036b81],
22	Ro	NN	O	ro	nn	23	SENT_392	[p26l2060t20r2146b72],
23	J	NN	O	j	appos	2	SENT_392	[p26l137t108r180b170],
24	,	,	O	,	_	0	SENT_392	[p26l137t108r180b170],
25	Nam	NNP	O	Nam	nn	26	SENT_392	[p26l250t108r398b160],
26	BH	NNP	O	BH	appos	2	SENT_392	[p26l464t108r567b159],
27	(	VBD	O	(	_	0	SENT_392	[p26l636t107r833b172],
28	2011	CD	DATE	2011	num	29	SENT_392	[p26l636t107r833b172],
29	)	CD	NUMBER	)	dobj	27	SENT_392	[p26l636t107r833b172],
30	Single	JJ	O	single	amod	32	SENT_392	[p26l904t107r1095b176],
31	nucleotide	NN	O	nucleotide	nn	32	SENT_392	[p26l1162t107r1478b160],
32	polymorphisms	NNS	O	polymorphism	nsubj	35	SENT_392	[p26l1545t107r2017b175],
33	of	IN	O	of	_	0	SENT_392	[p26l2086t107r2152b160],
34	CYP19A1	NN	O	cyp19a1	prep_of	32	SENT_392	[p26l138t195r445b248],
35	predict	VBP	O	predict	dep	27	SENT_392	[p26l483t194r695b263],
36	clinical	JJ	O	clinical	amod	37	SENT_392	[p26l728t194r951b247],
37	outcomes	NNS	O	outcome	dobj	35	SENT_392	[p26l984t202r1273b247],
38	and	CC	O	and	_	0	SENT_392	[p26l1308t194r1416b247],
39	adverse	JJ	O	adverse	amod	40	SENT_392	[p26l1450t194r1678b247],
40	events	NNS	O	event	dobj	35	SENT_392	[p26l1712t202r1903b248],
41	associated	VBN	O	associate	partmod	40	SENT_392	[p26l1938t194r2144b247, p26l139t283r263b336],
42	with	IN	O	with	_	0	SENT_392	[p26l307t282r440b336],
43	letrozole	NN	O	letrozole	prep_with	41	SENT_392	[p26l484t283r749b336],
44	in	IN	O	in	_	0	SENT_392	[p26l794t282r852b335],
45	patients	NNS	O	patient	prep_in	41	SENT_392	[p26l894t282r1130b351],
46	with	IN	O	with	_	0	SENT_392	[p26l1175t282r1309b336],
47	metastatic	JJ	O	metastatic	amod	49	SENT_392	[p26l1353t282r1660b336],
48	breast	NN	O	breast	nn	49	SENT_392	[p26l1705t283r1887b336],
49	cancer	NN	O	cancer	prep_with	45	SENT_392	[p26l1930t299r2142b336],
50	.	.	O	.	_	0	SENT_392	[p26l1930t299r2142b336],

1	Cancer	NNP	O	Cancer	nn	3	SENT_393	[p26l138t372r353b425],
2	Chemother	NNP	O	Chemother	nn	3	SENT_393	[p26l403t372r741b425],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_393	[p26l789t372r1113b425],
4	68	CD	NUMBER	68	number	5	SENT_393	[p26l1166t372r1707b437],
5	(	CD	NUMBER	(	dep	3	SENT_393	[p26l1166t372r1707b437],
6	5	CD	NUMBER	5	num	7	SENT_393	[p26l1166t372r1707b437],
7	)	NN	O	)	dep	5	SENT_393	[p26l1166t372r1707b437],
8	:1263	CD	NUMBER	:1263	number	9	SENT_393	[p26l1166t372r1707b437],
9	—	CD	NUMBER	—	dep	3	SENT_393	[p26l1166t372r1707b437],
10	1271	CD	DATE	1271	dep	9	SENT_393	[p26l1166t372r1707b437],
11	.	.	O	.	_	0	SENT_393	[p26l1166t372r1707b437],

1	doi	FW	O	doi	nsubj	23	SENT_394	[p26l1762t372r2148b425],
2	:10.1007	CD	NUMBER	:10.1007	dep	1	SENT_394	[p26l1762t372r2148b425],
3	/	:	O	/	punct	5	SENT_394	[p26l1762t372r2148b425],
4	s00280	CD	NUMBER	s00280	num	5	SENT_394	[p26l140t461r450b514],
5	—	CD	NUMBER	—	dep	2	SENT_394	[p26l140t461r450b514],
6	01	NN	NUMBER	01	dep	5	SENT_394	[p26l140t461r450b514],
7	1	CD	NUMBER	1	num	6	SENT_394	[p26l466t461r735b529],
8	—	CD	NUMBER	—	number	9	SENT_394	[p26l466t461r735b529],
9	1615	CD	DATE	1615	num	13	SENT_394	[p26l466t461r735b529],
10	—	NN	O	—	nn	13	SENT_394	[p26l466t461r735b529],
11	y	NN	O	y	nn	13	SENT_394	[p26l466t461r735b529],
12	Pfeilschifter	NN	O	pfeilschifter	nn	13	SENT_394	[p26l137t548r510b602],
13	J	NN	O	j	dep	6	SENT_394	[p26l538t550r582b612],
14	,	,	O	,	_	0	SENT_394	[p26l538t550r582b612],
15	Koditz	NNP	PERSON	Koditz	nn	16	SENT_394	[p26l616t548r819b602],
16	R	NNP	PERSON	R	appos	1	SENT_394	[p26l850t550r915b611],
17	,	,	O	,	_	0	SENT_394	[p26l850t550r915b611],
18	Pfohl	NNP	PERSON	Pfohl	nn	19	SENT_394	[p26l947t548r1110b602],
19	M	NNP	O	M	appos	16	SENT_394	[p26l1140t550r1222b611],
20	,	,	O	,	_	0	SENT_394	[p26l1140t550r1222b611],
21	Schatz	NNP	PERSON	Schatz	nn	22	SENT_394	[p26l1256t549r1456b602],
22	H	NNP	PERSON	H	appos	16	SENT_394	[p26l1486t550r1539b601],
23	(	VBD	O	(	_	0	SENT_394	[p26l1571t549r1767b614],
24	2002	CD	DATE	2002	num	26	SENT_394	[p26l1571t549r1767b614],
25	)	CD	NUMBER	)	num	26	SENT_394	[p26l1571t549r1767b614],
26	Changes	NNS	O	change	dobj	23	SENT_394	[p26l1800t549r2058b617],
27	in	IN	O	in	_	0	SENT_394	[p26l2089t548r2147b601],
28	proinﬂammatory	JJ	O	proinﬂammatory	amod	30	SENT_394	[p26l136t637r648b705],
29	cytokine	NN	O	cytokine	nn	30	SENT_394	[p26l678t637r937b705],
30	activity	NN	O	activity	prep_in	23	SENT_394	[p26l968t637r1194b705],
31	after	IN	O	after	_	0	SENT_394	[p26l1225t637r1363b690],
32	menopause	NN	O	menopause	prep_after	23	SENT_394	[p26l1389t653r1746b705],
33	.	.	O	.	_	0	SENT_394	[p26l1389t653r1746b705],

1	Endocr	NNP	O	Endocr	nn	2	SENT_395	[p26l1779t637r1999b690],
2	Rev	NN	O	rev	dep	11	SENT_395	[p26l2026t638r2147b690],
3	23	CD	NUMBER	23	num	4	SENT_395	[p26l138t726r548b791],
4	(	NN	O	(	dep	2	SENT_395	[p26l138t726r548b791],
5	1	CD	NUMBER	1	number	6	SENT_395	[p26l138t726r548b791],
6	)	CD	NUMBER	)	dep	4	SENT_395	[p26l138t726r548b791],
7	:90	CD	NUMBER	:90	num	8	SENT_395	[p26l138t726r548b791],
8	—	NN	O	—	dep	11	SENT_395	[p26l138t726r548b791],
9	119	CD	NUMBER	119	num	11	SENT_395	[p26l138t726r548b791],
10	Quaye	NN	O	quaye	nn	11	SENT_395	[p26l139t814r333b882],
11	L	NN	O	l	_	0	SENT_395	[p26l356t815r417b876],
12	,	,	O	,	_	0	SENT_395	[p26l356t815r417b876],
13	Tyrer	NNP	PERSON	Tyrer	nn	14	SENT_395	[p26l441t815r610b882],
14	J	NNP	PERSON	J	appos	11	SENT_395	[p26l630t815r674b876],
15	,	,	O	,	_	0	SENT_395	[p26l630t815r674b876],
16	Ramus	NNP	PERSON	Ramus	nn	17	SENT_395	[p26l698t815r907b867],
17	SJ	NNP	O	SJ	appos	11	SENT_395	[p26l932t814r1016b876],
18	,	,	O	,	_	0	SENT_395	[p26l932t814r1016b876],
19	Song	NN	O	song	nn	20	SENT_395	[p26l1042t814r1194b882],
20	H	NN	O	h	appos	11	SENT_395	[p26l1216t815r1285b876],
21	,	,	O	,	_	0	SENT_395	[p26l1216t815r1285b876],
22	Wozniak	NNP	PERSON	Wozniak	nn	23	SENT_395	[p26l1308t813r1585b867],
23	E	NNP	O	E	appos	11	SENT_395	[p26l1605t815r1666b876],
24	,	,	O	,	_	0	SENT_395	[p26l1605t815r1666b876],
25	DiCioccio	NNP	PERSON	DiCioccio	nn	26	SENT_395	[p26l1690t813r2001b867],
26	RA	NN	O	ra	appos	11	SENT_395	[p26l2024t814r2144b876],
27	,	,	O	,	_	0	SENT_395	[p26l2024t814r2144b876],
28	McGuire	NNP	PERSON	McGuire	nn	29	SENT_395	[p26l137t901r410b955],
29	V	NNP	O	V	appos	11	SENT_395	[p26l457t903r526b965],
30	,	,	O	,	_	0	SENT_395	[p26l457t903r526b965],
31	Hogdall	NNP	O	Hogdall	nn	32	SENT_395	[p26l575t901r818b970],
32	E	NNP	O	E	appos	11	SENT_395	[p26l865t903r926b964],
33	,	,	O	,	_	0	SENT_395	[p26l865t903r926b964],
34	Hogdall	NNP	O	Hogdall	nn	35	SENT_395	[p26l976t901r1219b970],
35	C	NNP	O	C	appos	11	SENT_395	[p26l1267t902r1331b964],
36	,	,	O	,	_	0	SENT_395	[p26l1267t902r1331b964],
37	Blaakaer	NNP	PERSON	Blaakaer	nn	38	SENT_395	[p26l1380t902r1651b955],
38	J	NNP	PERSON	J	appos	11	SENT_395	[p26l1696t903r1740b965],
39	,	,	O	,	_	0	SENT_395	[p26l1696t903r1740b965],
40	Goode	NNP	ORGANIZATION	Goode	nn	41	SENT_395	[p26l1790t901r1989b955],
41	EL	NNP	ORGANIZATION	EL	appos	11	SENT_395	[p26l2036t903r2144b964],
42	,	,	O	,	_	0	SENT_395	[p26l2036t903r2144b964],
43	Schildkraut	NNP	PERSON	Schildkraut	nn	44	SENT_395	[p26l139t990r488b1043],
44	JM	NN	O	jm	appos	11	SENT_395	[p26l527t991r638b1053],
45	,	,	O	,	_	0	SENT_395	[p26l527t991r638b1053],
46	Easton	NNP	ORGANIZATION	Easton	nn	47	SENT_395	[p26l681t991r887b1043],
47	DF	NNP	ORGANIZATION	DF	appos	11	SENT_395	[p26l927t991r1038b1053],
48	,	,	O	,	_	0	SENT_395	[p26l927t991r1038b1053],
49	Kruger	NNP	PERSON	Kruger	appos	11	SENT_395	[p26l1083t990r1491b1059],
50	.	.	O	.	_	0	SENT_395	[p26l1083t990r1491b1059],

1	—	NN	O	—	_	0	SENT_396	[p26l1083t990r1491b1059],
2	.	.	O	.	_	0	SENT_396	[p26l1083t990r1491b1059],

1	Kjaer	NNP	PERSON	Kjaer	nn	2	SENT_397	[p26l1083t990r1491b1059],
2	S	NNP	O	S	_	0	SENT_397	[p26l1532t990r1586b1052],
3	,	,	O	,	_	0	SENT_397	[p26l1532t990r1586b1052],
4	Whittemore	NNP	PERSON	Whittemore	nn	5	SENT_397	[p26l1628t990r1992b1043],
5	AS	NNP	O	AS	appos	2	SENT_397	[p26l2033t990r2144b1053],
6	,	,	O	,	_	0	SENT_397	[p26l2033t990r2144b1053],
7	Gayther	NNP	O	Gayther	nn	8	SENT_397	[p26l138t1078r382b1147],
8	SA	NNP	O	SA	appos	2	SENT_397	[p26l416t1078r525b1141],
9	,	,	O	,	_	0	SENT_397	[p26l416t1078r525b1141],
10	Pharoah	NNP	PERSON	Pharoah	appos	8	SENT_397	[p26l561t1078r809b1131],
11	PD	NN	PERSON	pd	nn	15	SENT_397	[p26l842t1079r936b1130],
12	(	CD	NUMBER	(	num	15	SENT_397	[p26l972t1078r1169b1143],
13	2009	CD	DATE	2009	num	15	SENT_397	[p26l972t1078r1169b1143],
14	)	NNP	O	)	nn	15	SENT_397	[p26l972t1078r1169b1143],
15	Association	NNP	O	Association	dep	2	SENT_397	[p26l1204t1078r1562b1131],
16	between	IN	O	between	_	0	SENT_397	[p26l1594t1078r1848b1131],
17	common	JJ	O	common	amod	18	SENT_397	[p26l1882t1095r2147b1131],
18	germline	NN	O	germline	prep_between	15	SENT_397	[p26l138t1165r407b1234],
19	genetic	JJ	O	genetic	amod	20	SENT_397	[p26l438t1165r654b1234],
20	variation	NN	O	variation	dep	2	SENT_397	[p26l685t1165r955b1219],
21	in	IN	O	in	_	0	SENT_397	[p26l984t1165r1042b1218],
22	94	CD	NUMBER	94	num	24	SENT_397	[p26l1073t1166r1145b1219],
23	candidate	NN	O	candidate	nn	24	SENT_397	[p26l1175t1165r1465b1219],
24	genes	NNS	O	gene	prep_in	20	SENT_397	[p26l1496t1182r1666b1234],
25	or	CC	O	or	_	0	SENT_397	[p26l1697t1182r1759b1219],
26	regions	NNS	O	region	conj_or	20	SENT_397	[p26l1786t1165r2008b1234],
27	and	CC	O	and	_	0	SENT_397	[p26l2041t1166r2148b1219],
28	risks	NNS	O	risk	conj_and	26	SENT_397	[p26l136t1255r277b1308],
29	of	IN	O	of	_	0	SENT_397	[p26l352t1255r418b1308],
30	invasive	JJ	O	invasive	amod	33	SENT_397	[p26l484t1255r736b1308],
31	epithelial	JJ	O	epithelial	amod	33	SENT_397	[p26l810t1255r1092b1323],
32	ovarian	JJ	O	ovarian	amod	33	SENT_397	[p26l1166t1255r1392b1308],
33	cancer	NN	O	cancer	prep_of	26	SENT_397	[p26l1465t1271r1677b1308],
34	.	.	O	.	_	0	SENT_397	[p26l1465t1271r1677b1308],

1	PLoS	NN	O	plo	_	0	SENT_398	[p26l1753t1255r1917b1308],
2	ONE	CD	NUMBER	one	number	3	SENT_398	[p26l1994t1255r2147b1308],
3	4	CD	NUMBER	4	amod	4	SENT_398	[p26l137t1343r485b1409],
4	(	NN	O	(	dep	1	SENT_398	[p26l137t1343r485b1409],
5	6	CD	NUMBER	6	num	6	SENT_398	[p26l137t1343r485b1409],
6	)	NN	O	)	dep	1	SENT_398	[p26l137t1343r485b1409],
7	:	:	O	:	_	0	SENT_398	[p26l137t1343r485b1409],
8	e5983	NN	O	e5983	dep	1	SENT_398	[p26l137t1343r485b1409],
9	.	.	O	.	_	0	SENT_398	[p26l137t1343r485b1409],

1	doi	FW	O	doi	_	0	SENT_399	[p26l518t1343r1570b1412],
2	:10.1371	CD	NUMBER	:10.1371	dep	1	SENT_399	[p26l518t1343r1570b1412],
3	/	:	O	/	punct	4	SENT_399	[p26l518t1343r1570b1412],
4	journal	NN	O	journal	dep	2	SENT_399	[p26l518t1343r1570b1412],
5	.	.	O	.	_	0	SENT_399	[p26l518t1343r1570b1412],

1	pone	NN	O	pone	_	0	SENT_400	[p26l518t1343r1570b1412],
2	.0005983	CD	NUMBER	.0005983	num	4	SENT_400	[p26l518t1343r1570b1412],
3	Rae	NNP	PERSON	Rae	nn	4	SENT_400	[p26l137t1431r253b1483],
4	JM	NN	PERSON	jm	dep	1	SENT_400	[p26l287t1431r399b1493],
5	,	,	O	,	_	0	SENT_400	[p26l287t1431r399b1493],
6	Sestak	NNP	PERSON	Sestak	appos	4	SENT_400	[p26l437t1430r633b1483],
7	1	CD	NUMBER	1	num	6	SENT_400	[p26l665t1431r705b1493],
8	,	,	O	,	_	0	SENT_400	[p26l665t1431r705b1493],
9	Henry	NNP	ORGANIZATION	Henry	nn	10	SENT_400	[p26l741t1431r928b1499],
10	NL	NNP	ORGANIZATION	NL	appos	4	SENT_400	[p26l962t1431r1079b1493],
11	,	,	O	,	_	0	SENT_400	[p26l962t1431r1079b1493],
12	Drury	NNP	PERSON	Drury	nn	13	SENT_400	[p26l1115t1431r1294b1499],
13	S	NNP	O	S	appos	4	SENT_400	[p26l1330t1430r1384b1493],
14	,	,	O	,	_	0	SENT_400	[p26l1330t1430r1384b1493],
15	Hayes	NNP	PERSON	Hayes	nn	16	SENT_400	[p26l1420t1431r1607b1499],
16	DF	NNP	O	DF	appos	4	SENT_400	[p26l1642t1431r1753b1493],
17	,	,	O	,	_	0	SENT_400	[p26l1642t1431r1753b1493],
18	Thibert	NNP	PERSON	Thibert	nn	19	SENT_400	[p26l1789t1430r2013b1483],
19	JN	NN	O	jn	appos	4	SENT_400	[p26l2046t1431r2144b1493],
20	,	,	O	,	_	0	SENT_400	[p26l2046t1431r2144b1493],
21	Lopez	NNP	PERSON	Lopez	appos	4	SENT_400	[p26l136t1519r621b1587],
22	.	.	O	.	_	0	SENT_400	[p26l136t1519r621b1587],

1	—	NN	O	—	_	0	SENT_401	[p26l136t1519r621b1587],
2	.	.	O	.	_	0	SENT_401	[p26l136t1519r621b1587],

1	Knowles	NNP	PERSON	Knowles	nn	2	SENT_402	[p26l136t1519r621b1587],
2	E	NNP	O	E	_	0	SENT_402	[p26l666t1520r727b1581],
3	,	,	O	,	_	0	SENT_402	[p26l666t1520r727b1581],
4	Salter	NNP	PERSON	Salter	nn	5	SENT_402	[p26l776t1519r952b1572],
5	J	NNP	PERSON	J	appos	2	SENT_402	[p26l994t1520r1038b1581],
6	,	,	O	,	_	0	SENT_402	[p26l994t1520r1038b1581],
7	Pineda	NNP	PERSON	Pineda	nn	8	SENT_402	[p26l1085t1518r1291b1572],
8	S	NNP	O	S	appos	2	SENT_402	[p26l1336t1519r1391b1581],
9	,	,	O	,	_	0	SENT_402	[p26l1336t1519r1391b1581],
10	Cuzick	NNP	O	Cuzick	nn	11	SENT_402	[p26l1438t1518r1653b1572],
11	J	NNP	O	J	appos	2	SENT_402	[p26l1695t1520r1739b1581],
12	,	,	O	,	_	0	SENT_402	[p26l1695t1520r1739b1581],
13	Dowsett	NNP	PERSON	Dowsett	nn	14	SENT_402	[p26l1786t1520r2039b1572],
14	M	NN	O	m	appos	2	SENT_402	[p26l2082t1520r2147b1571],

1	Q	NNP	O	Q	nn	2	SENT_403	[p26l1778t1749r1855b1825],
2	Springer	NNP	O	Springer	_	0	SENT_403	[p26l1885t1772r2147b1847],

1	Breast	NN	ORGANIZATION	breast	nn	4	SENT_404	[p26l1450t1922r1540b1947],
2	Cancer	NN	ORGANIZATION	cancer	nn	4	SENT_404	[p26l1552t1922r1652b1947],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_404	[p26l1664t1922r1716b1947],
4	Treat	NNP	ORGANIZATION	Treat	_	0	SENT_404	[p26l1729t1922r1804b1947],
5	(	CD	NUMBER	(	num	6	SENT_404	[p26l1817t1922r1908b1952],
6	2013	CD	DATE	2013	dep	4	SENT_404	[p26l1817t1922r1908b1952],
7	)	CD	NUMBER	)	number	8	SENT_404	[p26l1817t1922r1908b1952],
8	138:807	CD	NUMBER	138:807	num	9	SENT_404	[p26l1925t1922r2107b1947],
9	—	NN	O	—	dep	6	SENT_404	[p26l1925t1922r2107b1947],
10	816	CD	NUMBER	816	dep	4	SENT_404	[p26l1925t1922r2107b1947],

1	(	RB	O	(	advmod	2	SENT_405	[p26l114t2026r205b2057],
2	2011	CD	DATE	2011	_	0	SENT_405	[p26l114t2026r205b2057],
3	)	CD	NUMBER	)	num	4	SENT_405	[p26l114t2026r205b2057],
4	Correlation	NN	O	correlation	dep	2	SENT_405	[p26l218t2026r378b2051],
5	between	IN	O	between	_	0	SENT_405	[p26l389t2026r506b2051],
6	gene	NN	O	gene	nn	7	SENT_405	[p26l518t2034r583b2058],
7	variants	NNS	O	variant	prep_between	4	SENT_405	[p26l594t2026r705b2051],
8	in	IN	O	in	_	0	SENT_405	[p26l717t2026r743b2051],
9	CYP19	NN	O	cyp19	nn	12	SENT_405	[p26l755t2026r856b2051],
10	(	CD	NUMBER	(	num	12	SENT_405	[p26l869t2026r1043b2057],
11	Aromatase	NNP	O	Aromatase	nn	12	SENT_405	[p26l869t2026r1043b2057],
12	)	NN	O	)	prep_in	7	SENT_405	[p26l869t2026r1043b2057],
13	and	CC	O	and	_	0	SENT_405	[p26l114t2067r164b2092],
14	TCL1A	NN	O	tcl1a	conj_and	7	SENT_405	[p26l175t2067r284b2092],
15	with	IN	O	with	_	0	SENT_405	[p26l295t2067r357b2092],
16	disease	NN	O	disease	nn	19	SENT_405	[p26l369t2067r469b2092],
17	and	CC	O	and	_	0	SENT_405	[p26l482t2067r532b2092],
18	tolerability	NN	O	tolerability	nn	19	SENT_405	[p26l543t2067r697b2099],
19	endpoints	NNS	O	endpoint	prep_with	14	SENT_405	[p26l709t2067r845b2099],
20	in	IN	O	in	_	0	SENT_405	[p26l857t2067r884b2091],
21	the	DT	O	the	det	23	SENT_405	[p26l895t2067r937b2092],
22	ATAC	NN	ORGANIZATION	atac	nn	23	SENT_405	[p26l949t2067r1043b2092],
23	trial	NN	O	trial	prep_in	19	SENT_405	[p26l113t2108r177b2133],
24	.	.	O	.	_	0	SENT_405	[p26l113t2108r177b2133],

1	Cancer	NN	O	cancer	_	0	SENT_406	[p26l191t2108r291b2133],
2	Res	NNP	O	Res	dep	1	SENT_406	[p26l303t2109r355b2133],
3	71	CD	NUMBER	71	num	2	SENT_406	[p26l368t2108r708b2140],
4	(	CD	NUMBER	(	number	5	SENT_406	[p26l368t2108r708b2140],
5	24	CD	NUMBER	24	num	7	SENT_406	[p26l368t2108r708b2140],
6	(	NN	O	(	nn	7	SENT_406	[p26l368t2108r708b2140],
7	Suppl	NN	O	suppl	nsubj	42	SENT_406	[p26l368t2108r708b2140],
8	)	NN	O	)	npadvmod	7	SENT_406	[p26l368t2108r708b2140],
9	)	CD	NUMBER	)	num	8	SENT_406	[p26l368t2108r708b2140],
10	:	:	O	:	_	0	SENT_406	[p26l368t2108r708b2140],
11	P1-06-02	NN	O	p1-06-02	nn	12	SENT_406	[p26l368t2108r708b2140],
12	Sestak	NN	O	sestak	dep	8	SENT_406	[p26l114t2149r205b2174],
13	I	PRP	O	I	dep	12	SENT_406	[p26l217t2150r235b2178],
14	,	,	O	,	_	0	SENT_406	[p26l217t2150r235b2178],
15	Cuzick	NNP	O	Cuzick	nn	16	SENT_406	[p26l249t2149r349b2174],
16	J	NNP	O	J	dep	36	SENT_406	[p26l361t2150r381b2178],
17	,	,	O	,	_	0	SENT_406	[p26l361t2150r381b2178],
18	Sapunar	NNP	O	Sapunar	nn	19	SENT_406	[p26l396t2149r511b2181],
19	F	NN	O	f	appos	16	SENT_406	[p26l522t2150r549b2178],
20	,	,	O	,	_	0	SENT_406	[p26l522t2150r549b2178],
21	Eastell	NN	ORGANIZATION	eastell	nn	22	SENT_406	[p26l562t2149r657b2174],
22	R	NN	ORGANIZATION	r	appos	16	SENT_406	[p26l670t2150r701b2178],
23	,	,	O	,	_	0	SENT_406	[p26l670t2150r701b2178],
24	Forbes	NNP	ORGANIZATION	Forbes	nn	25	SENT_406	[p26l714t2149r809b2174],
25	JF	NNP	ORGANIZATION	JF	appos	16	SENT_406	[p26l822t2150r861b2178],
26	,	,	O	,	_	0	SENT_406	[p26l822t2150r861b2178],
27	Bianco	NNP	ORGANIZATION	Bianco	nn	28	SENT_406	[p26l875t2149r974b2174],
28	AR	NNS	ORGANIZATION	ar	appos	16	SENT_406	[p26l987t2149r1043b2178],
29	,	,	O	,	_	0	SENT_406	[p26l987t2149r1043b2178],
30	Buzdar	NNP	ORGANIZATION	Buzdar	appos	16	SENT_406	[p26l113t2190r215b2215],
31	AU	NN	ORGANIZATION	au	dep	36	SENT_406	[p26l230t2190r280b2215],
32	(	CD	NUMBER	(	num	31	SENT_406	[p26l297t2190r388b2220],
33	2008	CD	DATE	2008	num	36	SENT_406	[p26l297t2190r388b2220],
34	)	NN	O	)	nn	36	SENT_406	[p26l297t2190r388b2220],
35	Risk	NN	O	risk	nn	36	SENT_406	[p26l405t2190r469b2215],
36	factors	NNS	O	factor	dep	8	SENT_406	[p26l485t2190r579b2215],
37	for	IN	O	for	_	0	SENT_406	[p26l596t2190r637b2215],
38	joint	JJ	O	joint	amod	39	SENT_406	[p26l649t2190r716b2222],
39	symptoms	NNS	O	symptom	prep_for	36	SENT_406	[p26l733t2194r876b2222],
40	in	IN	O	in	_	0	SENT_406	[p26l892t2190r919b2214],
41	patients	NNS	O	patient	prep_in	7	SENT_406	[p26l934t2190r1043b2222],
42	enrolled	VBN	O	enrol	rcmod	2	SENT_406	[p26l114t2231r229b2256],
43	in	IN	O	in	_	0	SENT_406	[p26l240t2231r267b2256],
44	the	DT	O	the	det	46	SENT_406	[p26l279t2231r321b2256],
45	ATAC	NN	ORGANIZATION	atac	nn	46	SENT_406	[p26l333t2231r427b2256],
46	trial	NN	O	trial	prep_in	42	SENT_406	[p26l440t2231r504b2256],
47	:	:	O	:	_	0	SENT_406	[p26l440t2231r504b2256],
48	a	DT	O	a	det	49	SENT_406	[p26l519t2239r534b2256],
49	retrospective	NN	O	retrospective	dep	1	SENT_406	[p26l545t2231r735b2263],
50	,	,	O	,	_	0	SENT_406	[p26l545t2231r735b2263],
51	exploratory	JJ	O	exploratory	amod	52	SENT_406	[p26l748t2231r910b2263],
52	analysis	NN	O	analysis	appos	49	SENT_406	[p26l923t2231r1042b2263],
53	.	.	O	.	_	0	SENT_406	[p26l923t2231r1042b2263],

1	Lancet	NNP	O	Lancet	nn	2	SENT_407	[p26l113t2273r209b2297],
2	Oncol	NNP	O	Oncol	_	0	SENT_407	[p26l222t2272r307b2297],
3	9	CD	NUMBER	9	number	4	SENT_407	[p26l320t2272r511b2303],
4	(	CD	NUMBER	(	dep	2	SENT_407	[p26l320t2272r511b2303],
5	9	CD	NUMBER	9	num	6	SENT_407	[p26l320t2272r511b2303],
6	)	NN	O	)	dep	4	SENT_407	[p26l320t2272r511b2303],
7	:866	CD	NUMBER	:866	num	8	SENT_407	[p26l320t2272r511b2303],
8	—	NN	O	—	dep	2	SENT_407	[p26l320t2272r511b2303],
9	872	CD	NUMBER	872	num	11	SENT_407	[p26l320t2272r511b2303],
10	Simon	NNP	PERSON	Simon	nn	11	SENT_407	[p26l114t2313r205b2338],
11	RM	NN	PERSON	rm	dep	8	SENT_407	[p26l216t2314r277b2343],
12	,	,	O	,	_	0	SENT_407	[p26l216t2314r277b2343],
13	Paik	NNP	LOCATION	Paik	nn	14	SENT_407	[p26l290t2313r353b2338],
14	S	NNP	LOCATION	S	appos	2	SENT_407	[p26l364t2313r389b2343],
15	,	,	O	,	_	0	SENT_407	[p26l364t2313r389b2343],
16	Hayes	NNP	PERSON	Hayes	nn	17	SENT_407	[p26l402t2314r488b2346],
17	DF	NN	O	df	appos	2	SENT_407	[p26l500t2314r545b2338],
18	(	CD	NUMBER	(	num	19	SENT_407	[p26l557t2313r648b2344],
19	2009	CD	DATE	2009	dep	17	SENT_407	[p26l557t2313r648b2344],
20	)	CD	NUMBER	)	num	21	SENT_407	[p26l557t2313r648b2344],
21	Use	NN	O	use	dep	2	SENT_407	[p26l660t2314r713b2338],
22	of	IN	O	of	_	0	SENT_407	[p26l726t2313r756b2338],
23	archived	JJ	O	archived	amod	24	SENT_407	[p26l766t2313r886b2338],
24	specimens	NNS	O	specimen	prep_of	21	SENT_407	[p26l899t2313r1043b2346],
25	in	IN	O	in	_	0	SENT_407	[p26l113t2354r140b2379],
26	evaluation	NN	O	evaluation	prep_in	24	SENT_407	[p26l159t2354r305b2379],
27	of	IN	O	of	_	0	SENT_407	[p26l324t2354r355b2379],
28	prognostic	JJ	O	prognostic	amod	31	SENT_407	[p26l371t2354r519b2386],
29	and	CC	O	and	_	0	SENT_407	[p26l539t2354r589b2379],
30	predictive	JJ	O	predictive	conj_and	28	SENT_407	[p26l607t2354r747b2386],
31	biomarkers	NNS	O	biomarker	prep_of	26	SENT_407	[p26l766t2354r932b2379],
32	.	.	O	.	_	0	SENT_407	[p26l766t2354r932b2379],

1	J	NNP	O	J	nn	5	SENT_408	[p26l952t2355r965b2379],
2	Natl	NNP	O	Natl	nn	5	SENT_408	[p26l984t2354r1043b2379],
3	Cancer	NNP	O	Cancer	nn	5	SENT_408	[p26l114t2395r213b2420],
4	Inst	NNP	O	Inst	nn	5	SENT_408	[p26l225t2396r278b2420],
5	l01	NN	O	l01	_	0	SENT_408	[p26l294t2395r577b2426],
6	(	CD	NUMBER	(	number	7	SENT_408	[p26l294t2395r577b2426],
7	21	CD	NUMBER	21	num	8	SENT_408	[p26l294t2395r577b2426],
8	)	NN	O	)	dep	5	SENT_408	[p26l294t2395r577b2426],
9	:	:	O	:	_	0	SENT_408	[p26l294t2395r577b2426],
10	l446	CD	NUMBER	l446	dep	5	SENT_408	[p26l294t2395r577b2426],
11	—	CD	NUMBER	—	number	12	SENT_408	[p26l294t2395r577b2426],
12	1452	CD	DATE	1452	dep	10	SENT_408	[p26l294t2395r577b2426],
13	.	.	O	.	_	0	SENT_408	[p26l294t2395r577b2426],

1	doi	FW	O	doi	nn	2	SENT_409	[p26l591t2395r930b2427],
2	:10.1093	FW	O	:10.1093	_	0	SENT_409	[p26l591t2395r930b2427],
3	/	:	O	/	punct	6	SENT_409	[p26l591t2395r930b2427],
4	jnci/djp335	NNP	O	jnci/djp335	nn	6	SENT_409	[p26l591t2395r930b2427],
5	Smith	NNP	ORGANIZATION	Smith	nn	6	SENT_409	[p26l114t2436r197b2461],
6	YR	NNP	ORGANIZATION	YR	dep	2	SENT_409	[p26l215t2437r270b2465],
7	,	,	O	,	_	0	SENT_409	[p26l215t2437r270b2465],
8	Stohler	NNP	ORGANIZATION	Stohler	nn	9	SENT_409	[p26l290t2436r391b2461],
9	CS	NNP	ORGANIZATION	CS	appos	6	SENT_409	[p26l409t2436r458b2465],
10	,	,	O	,	_	0	SENT_409	[p26l409t2436r458b2465],
11	Nichols	NNP	ORGANIZATION	Nichols	nn	12	SENT_409	[p26l477t2436r586b2461],
12	TE	NNP	ORGANIZATION	TE	appos	6	SENT_409	[p26l605t2437r655b2465],
13	,	,	O	,	_	0	SENT_409	[p26l605t2437r655b2465],
14	Bueller	NNP	O	Bueller	nn	15	SENT_409	[p26l674t2436r778b2461],
15	JA	NNP	O	JA	appos	6	SENT_409	[p26l795t2437r841b2465],
16	,	,	O	,	_	0	SENT_409	[p26l795t2437r841b2465],
17	Koeppe	NNP	PERSON	Koeppe	nn	18	SENT_409	[p26l861t2437r969b2468],
18	RA	NN	O	ra	appos	6	SENT_409	[p26l987t2436r1043b2465],
19	,	,	O	,	_	0	SENT_409	[p26l987t2436r1043b2465],
20	Zubieta	NNP	ORGANIZATION	Zubieta	nn	22	SENT_409	[p26l113t2477r221b2502],
21	JK	NNP	ORGANIZATION	JK	nn	22	SENT_409	[p26l234t2477r273b2502],
22	(	NNP	O	(	appos	6	SENT_409	[p26l286t2477r377b2508],
23	2006	CD	DATE	2006	num	22	SENT_409	[p26l286t2477r377b2508],
24	)	CD	NUMBER	)	num	25	SENT_409	[p26l286t2477r377b2508],
25	Pronociceptive	NNP	O	Pronociceptive	dep	2	SENT_409	[p26l392t2477r603b2509],
26	and	CC	O	and	_	0	SENT_409	[p26l617t2477r667b2502],
27	antinociceptive	JJ	O	antinociceptive	amod	28	SENT_409	[p26l680t2477r895b2509],
28	effects	NNS	O	effect	conj_and	25	SENT_409	[p26l909t2477r1001b2502],
29	of	IN	O	of	_	0	SENT_409	[p26l1016t2477r1046b2502],
30	estradiol	NN	O	estradiol	prep_of	25	SENT_409	[p26l1177t2026r1297b2051],
31	through	IN	O	through	_	0	SENT_409	[p26l1329t2026r1438b2058],
32	endogenous	JJ	O	endogenous	amod	34	SENT_409	[p26l1470t2026r1637b2058],
33	opioid	JJ	O	opioid	amod	34	SENT_409	[p26l1670t2026r1759b2058],
34	neurotransmission	NN	O	neurotransmission	prep_through	25	SENT_409	[p26l1791t2026r2049b2051],
35	in	IN	O	in	_	0	SENT_409	[p26l2081t2026r2107b2051],
36	women	NNS	O	woman	prep_in	25	SENT_409	[p26l1177t2075r1287b2092],
37	.	.	O	.	_	0	SENT_409	[p26l1177t2075r1287b2092],

1	J	NNP	O	J	nn	2	SENT_410	[p26l1301t2068r1314b2092],
2	Neurosci	NNP	O	Neurosci	_	0	SENT_410	[p26l1326t2067r1452b2092],
3	26	CD	NUMBER	26	number	4	SENT_410	[p26l1466t2067r1726b2097],
4	(	CD	NUMBER	(	dep	2	SENT_410	[p26l1466t2067r1726b2097],
5	2l	NN	O	2l	nn	11	SENT_410	[p26l1466t2067r1726b2097],
6	)	CD	NUMBER	)	num	11	SENT_410	[p26l1466t2067r1726b2097],
7	:5777	CD	NUMBER	:5777	num	11	SENT_410	[p26l1466t2067r1726b2097],
8	—	CD	NUMBER	—	num	11	SENT_410	[p26l1466t2067r1726b2097],
9	5785	CD	NUMBER	5785	num	11	SENT_410	[p26l1466t2067r1726b2097],
10	Wang	NNP	PERSON	Wang	nn	11	SENT_410	[p26l1176t2109r1260b2140],
11	L	NNP	PERSON	L	dep	2	SENT_410	[p26l1272t2109r1300b2137],
12	,	,	O	,	_	0	SENT_410	[p26l1272t2109r1300b2137],
13	McLeod	NNP	PERSON	McLeod	nn	14	SENT_410	[p26l1314t2108r1433b2133],
14	HL	NNS	O	hl	conj_and	11	SENT_410	[p26l1445t2109r1499b2137],
15	,	,	O	,	_	0	SENT_410	[p26l1445t2109r1499b2137],
16	Weinshilboum	NNP	O	Weinshilboum	nn	17	SENT_410	[p26l1511t2108r1719b2133],
17	RM	NN	O	rm	conj_and	11	SENT_410	[p26l1731t2109r1785b2133],
18	(	CD	NUMBER	(	num	21	SENT_410	[p26l1798t2108r1889b2139],
19	2011	CD	DATE	2011	num	21	SENT_410	[p26l1798t2108r1889b2139],
20	)	CD	NUMBER	)	num	21	SENT_410	[p26l1798t2108r1889b2139],
21	Genomics	NNS	O	genomic	dep	17	SENT_410	[p26l1903t2108r2044b2133],
22	and	CC	O	and	_	0	SENT_410	[p26l2058t2108r2108b2133],
23	drug	NN	O	drug	nn	24	SENT_410	[p26l1177t2149r1240b2181],
24	response	NN	O	response	conj_and	11	SENT_410	[p26l1254t2157r1384b2181],
25	.	.	O	.	_	0	SENT_410	[p26l1254t2157r1384b2181],

1	N	NN	O	n	nn	3	SENT_411	[p26l1400t2150r1425b2174],
2	Engl	NNP	O	Engl	nn	3	SENT_411	[p26l1439t2149r1505b2181],
3	J	NNP	O	J	nsubj	4	SENT_411	[p26l1520t2150r1533b2174],
4	Med	VBD	O	med	_	0	SENT_411	[p26l1547t2149r1611b2174],
5	364	CD	NUMBER	364	number	6	SENT_411	[p26l1626t2149r1912b2180],
6	(	CD	NUMBER	(	dobj	4	SENT_411	[p26l1626t2149r1912b2180],
7	12	CD	NUMBER	12	num	8	SENT_411	[p26l1626t2149r1912b2180],
8	)	NN	O	)	dep	6	SENT_411	[p26l1626t2149r1912b2180],
9	:	:	O	:	_	0	SENT_411	[p26l1626t2149r1912b2180],
10	l144	NN	O	l144	nn	12	SENT_411	[p26l1626t2149r1912b2180],
11	—	CD	NUMBER	—	num	12	SENT_411	[p26l1626t2149r1912b2180],
12	1l53	NN	O	1l53	dep	6	SENT_411	[p26l1626t2149r1912b2180],
13	.	.	O	.	_	0	SENT_411	[p26l1626t2149r1912b2180],

1	doi	FW	O	doi	nn	2	SENT_412	[p26l1929t2149r2108b2174],
2	:10.1056	FW	O	:10.1056	_	0	SENT_412	[p26l1929t2149r2108b2174],
3	/	:	O	/	punct	25	SENT_412	[p26l1929t2149r2108b2174],
4	NEJMra1010600	NN	O	nejmra1010600	nn	6	SENT_412	[p26l1176t2190r1418b2215],
5	Woods	NNP	ORGANIZATION	Woods	nn	6	SENT_412	[p26l1176t2231r1275b2256],
6	NF	NN	ORGANIZATION	nf	dep	25	SENT_412	[p26l1285t2232r1336b2260],
7	,	,	O	,	_	0	SENT_412	[p26l1285t2232r1336b2260],
8	Mitchell	NNP	PERSON	Mitchell	nn	9	SENT_412	[p26l1347t2231r1466b2256],
9	ES	NN	O	e	appos	6	SENT_412	[p26l1476t2231r1524b2260],
10	,	,	O	,	_	0	SENT_412	[p26l1476t2231r1524b2260],
11	Tao	NNP	O	Tao	nn	12	SENT_412	[p26l1534t2232r1588b2256],
12	Y	NN	O	y	appos	6	SENT_412	[p26l1598t2232r1630b2260],
13	,	,	O	,	_	0	SENT_412	[p26l1598t2232r1630b2260],
14	Viernes	NNP	ORGANIZATION	Viernes	nn	15	SENT_412	[p26l1640t2231r1749b2256],
15	HM	NNS	ORGANIZATION	hm	appos	6	SENT_412	[p26l1759t2232r1822b2260],
16	,	,	O	,	_	0	SENT_412	[p26l1759t2232r1822b2260],
17	Stapleton	NNP	ORGANIZATION	Stapleton	nn	18	SENT_412	[p26l1834t2231r1965b2263],
18	PL	NNP	ORGANIZATION	PL	appos	6	SENT_412	[p26l1975t2232r2023b2260],
19	,	,	O	,	_	0	SENT_412	[p26l1975t2232r2023b2260],
20	Farin	NNP	PERSON	Farin	nn	22	SENT_412	[p26l2033t2231r2107b2256],
21	FM	NNP	O	FM	nn	22	SENT_412	[p26l1176t2273r1226b2297],
22	(	NNP	O	(	appos	6	SENT_412	[p26l1240t2272r1331b2303],
23	2006	CD	DATE	2006	dep	25	SENT_412	[p26l1240t2272r1331b2303],
24	)	CD	NUMBER	)	num	25	SENT_412	[p26l1240t2272r1331b2303],
25	Polymorphisms	NNS	O	polymorphism	dep	2	SENT_412	[p26l1345t2272r1565b2304],
26	in	IN	O	in	_	0	SENT_412	[p26l1579t2272r1605b2297],
27	the	DT	O	the	det	29	SENT_412	[p26l1618t2272r1660b2297],
28	estrogen	NN	O	estrogen	nn	29	SENT_412	[p26l1674t2276r1792b2304],
29	synthesis	NN	O	synthesis	prep_in	25	SENT_412	[p26l1806t2272r1933b2304],
30	and	CC	O	and	_	0	SENT_412	[p26l1947t2272r1997b2297],
31	metabolism	NN	O	metabolism	nn	32	SENT_412	[p26l2010t2272r2106b2297, p26l1177t2313r1255b2338],
32	pathways	NNS	O	pathway	prep_in	25	SENT_412	[p26l1265t2313r1398b2346],
33	and	CC	O	and	_	0	SENT_412	[p26l1411t2313r1460b2338],
34	symptoms	NNS	O	symptom	conj_and	32	SENT_412	[p26l1473t2317r1615b2346],
35	during	IN	O	during	dep	25	SENT_412	[p26l1628t2313r1719b2346],
36	the	DT	O	the	det	38	SENT_412	[p26l1731t2313r1773b2338],
37	menopausal	JJ	O	menopausal	amod	38	SENT_412	[p26l1785t2313r1953b2346],
38	transition	NN	O	transition	pobj	35	SENT_412	[p26l1964t2313r2105b2338],
39	:	:	O	:	_	0	SENT_412	[p26l1964t2313r2105b2338],
40	observations	NNS	O	observation	dep	2	SENT_412	[p26l1177t2354r1353b2379],
41	from	IN	O	from	_	0	SENT_412	[p26l1372t2354r1440b2379],
42	the	DT	O	the	det	45	SENT_412	[p26l1457t2354r1499b2379],
43	Seattle	NNP	ORGANIZATION	Seattle	nn	45	SENT_412	[p26l1517t2354r1612b2379],
44	Midlife	NNP	ORGANIZATION	Midlife	nn	45	SENT_412	[p26l1629t2354r1734b2379],
45	Women	NNP	O	Women	poss	48	SENT_412	[p26l1752t2354r1888b2379],
46	’s	POS	O	’s	_	0	SENT_412	[p26l1752t2354r1888b2379],
47	Health	NNP	O	Health	nn	48	SENT_412	[p26l1906t2354r1999b2379],
48	Study	NNP	O	Study	prep_from	40	SENT_412	[p26l2018t2354r2105b2386],
49	.	.	O	.	_	0	SENT_412	[p26l2018t2354r2105b2386],

1	Menopause	NN	O	menopause	nn	3	SENT_413	[p26l1176t2396r1338b2427],
2	13	CD	NUMBER	13	num	3	SENT_413	[p26l1378t2395r1591b2426],
3	(	NN	O	(	_	0	SENT_413	[p26l1378t2395r1591b2426],
4	6	CD	NUMBER	6	num	5	SENT_413	[p26l1378t2395r1591b2426],
5	)	NN	O	)	dep	3	SENT_413	[p26l1378t2395r1591b2426],
6	:902	CD	NUMBER	:902	number	7	SENT_413	[p26l1378t2395r1591b2426],
7	—	CD	NUMBER	—	num	8	SENT_413	[p26l1378t2395r1591b2426],
8	9l0	NN	O	9l0	dep	5	SENT_413	[p26l1378t2395r1591b2426],
9	.	.	O	.	_	0	SENT_413	[p26l1378t2395r1591b2426],

1	doi	FW	O	doi	_	0	SENT_414	[p26l1629t2395r2105b2427],
2	:	:	O	:	_	0	SENT_414	[p26l1629t2395r2105b2427],
3	l0	NN	O	l0	dep	1	SENT_414	[p26l1629t2395r2105b2427],
4	.1097	CD	NUMBER	.1097	num	3	SENT_414	[p26l1629t2395r2105b2427],
5	/	:	O	/	punct	6	SENT_414	[p26l1629t2395r2105b2427],
6	01	CD	NUMBER	01	dep	3	SENT_414	[p26l1629t2395r2105b2427],
7	.	.	O	.	_	0	SENT_414	[p26l1629t2395r2105b2427],

1	gme	NN	O	gme	_	0	SENT_415	[p26l1629t2395r2105b2427],
2	.0000227058	CD	NUMBER	.0000227058	dep	1	SENT_415	[p26l1629t2395r2105b2427],
3	.	.	O	.	_	0	SENT_415	[p26l1629t2395r2105b2427],

1	70903.9	CD	NUMBER	70903.9	_	0	SENT_416	[p26l1177t2436r1304b2461],
2	f	SYM	O	f	dep	1	SENT_416	[p26l1177t2436r1304b2461],

1	@	IN	O	@	_	0	SENT_417	[p26l52t2584r88b2629],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_417	[p26l101t2595r223b2630],

